JP3951136B2 - Novel pyridonecarboxylic acid derivative or salt thereof and antibacterial agent comprising the substance as an active ingredient - Google Patents
Novel pyridonecarboxylic acid derivative or salt thereof and antibacterial agent comprising the substance as an active ingredient Download PDFInfo
- Publication number
- JP3951136B2 JP3951136B2 JP2003379669A JP2003379669A JP3951136B2 JP 3951136 B2 JP3951136 B2 JP 3951136B2 JP 2003379669 A JP2003379669 A JP 2003379669A JP 2003379669 A JP2003379669 A JP 2003379669A JP 3951136 B2 JP3951136 B2 JP 3951136B2
- Authority
- JP
- Japan
- Prior art keywords
- dihydro
- amino
- group
- chloro
- fluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000003839 salts Chemical class 0.000 title claims description 41
- YSLIPUSJNFIFAB-UHFFFAOYSA-N 2-oxopyridine-1-carboxylic acid Chemical class OC(=O)N1C=CC=CC1=O YSLIPUSJNFIFAB-UHFFFAOYSA-N 0.000 title claims description 12
- 239000003242 anti bacterial agent Substances 0.000 title claims description 9
- 239000004480 active ingredient Substances 0.000 title claims description 3
- 239000000126 substance Substances 0.000 title 1
- 125000003277 amino group Chemical group 0.000 claims description 30
- 125000000217 alkyl group Chemical group 0.000 claims description 27
- 125000005843 halogen group Chemical group 0.000 claims description 24
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 24
- 125000004432 carbon atom Chemical group C* 0.000 claims description 11
- 125000003545 alkoxy group Chemical group 0.000 claims description 10
- 125000004122 cyclic group Chemical group 0.000 claims description 9
- 125000002252 acyl group Chemical group 0.000 claims description 8
- 125000003282 alkyl amino group Chemical group 0.000 claims description 8
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 8
- 125000000539 amino acid group Chemical group 0.000 claims description 7
- 108010038807 Oligopeptides Chemical group 0.000 claims description 6
- 102000015636 Oligopeptides Human genes 0.000 claims description 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 125000003342 alkenyl group Chemical group 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 3
- 125000003435 aroyl group Chemical group 0.000 claims description 3
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 3
- 125000000524 functional group Chemical group 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 342
- 150000001875 compounds Chemical class 0.000 description 342
- 239000000843 powder Substances 0.000 description 244
- 238000002844 melting Methods 0.000 description 241
- 230000008018 melting Effects 0.000 description 241
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 216
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 204
- 239000000203 mixture Substances 0.000 description 118
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 111
- -1 heptenyl group Chemical group 0.000 description 111
- 238000001914 filtration Methods 0.000 description 99
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 95
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 94
- 238000000354 decomposition reaction Methods 0.000 description 91
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 87
- 238000006243 chemical reaction Methods 0.000 description 70
- 239000000243 solution Substances 0.000 description 70
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 60
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 60
- 239000007787 solid Substances 0.000 description 59
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 57
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 54
- 239000002244 precipitate Substances 0.000 description 41
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 39
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 36
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 34
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 30
- 239000002904 solvent Substances 0.000 description 29
- 239000012153 distilled water Substances 0.000 description 28
- 238000003756 stirring Methods 0.000 description 28
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 27
- 238000010992 reflux Methods 0.000 description 27
- LRLCUJUKUQSKGI-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-7-chloro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=NC(Cl)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F LRLCUJUKUQSKGI-UHFFFAOYSA-N 0.000 description 21
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 21
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 20
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 20
- OZZOPPAGBMJCGW-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-8-chloro-6,7-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=C(Cl)C(F)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F OZZOPPAGBMJCGW-UHFFFAOYSA-N 0.000 description 18
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 239000013078 crystal Substances 0.000 description 18
- 238000001816 cooling Methods 0.000 description 17
- 239000005457 ice water Substances 0.000 description 17
- 229910000027 potassium carbonate Inorganic materials 0.000 description 17
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 16
- 239000002253 acid Substances 0.000 description 16
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 16
- 238000000034 method Methods 0.000 description 16
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 16
- 239000000706 filtrate Substances 0.000 description 15
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 14
- 239000003054 catalyst Substances 0.000 description 14
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 13
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 12
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 12
- OOSDLMAZIRAMDN-UHFFFAOYSA-N azetidin-3-amine;dihydrochloride Chemical compound Cl.Cl.NC1CNC1 OOSDLMAZIRAMDN-UHFFFAOYSA-N 0.000 description 11
- 229910052731 fluorine Inorganic materials 0.000 description 11
- 125000001153 fluoro group Chemical group F* 0.000 description 11
- 239000012044 organic layer Substances 0.000 description 11
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 10
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 10
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 235000019253 formic acid Nutrition 0.000 description 10
- 229910052739 hydrogen Inorganic materials 0.000 description 10
- 239000001257 hydrogen Substances 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 9
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 239000010410 layer Substances 0.000 description 8
- 239000012528 membrane Substances 0.000 description 8
- 239000004323 potassium nitrate Substances 0.000 description 8
- 235000010333 potassium nitrate Nutrition 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- NGXSWUFDCSEIOO-BYPYZUCNSA-N (3s)-pyrrolidin-3-amine Chemical compound N[C@H]1CCNC1 NGXSWUFDCSEIOO-BYPYZUCNSA-N 0.000 description 7
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 7
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 7
- 229910052801 chlorine Inorganic materials 0.000 description 7
- 125000001309 chloro group Chemical group Cl* 0.000 description 7
- 238000010908 decantation Methods 0.000 description 7
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 7
- 235000019341 magnesium sulphate Nutrition 0.000 description 7
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 7
- 229910000029 sodium carbonate Inorganic materials 0.000 description 7
- 125000001424 substituent group Chemical group 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 7
- YERBIIGGQGJNEE-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-6,7-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=CC(F)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F YERBIIGGQGJNEE-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000012298 atmosphere Substances 0.000 description 6
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 6
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 6
- 125000006239 protecting group Chemical group 0.000 description 6
- 230000035484 reaction time Effects 0.000 description 6
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 6
- PAYJRJYWAOQVRD-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-6,7,8-trifluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=C(F)C(F)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F PAYJRJYWAOQVRD-UHFFFAOYSA-N 0.000 description 5
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 5
- 150000007514 bases Chemical class 0.000 description 5
- XZSVWPVJCOHZJF-UHFFFAOYSA-N benzyl n-(3-amino-2,4-difluorophenyl)carbamate Chemical compound NC1=C(F)C=CC(NC(=O)OCC=2C=CC=CC=2)=C1F XZSVWPVJCOHZJF-UHFFFAOYSA-N 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- MBMJDELICBDLEE-UHFFFAOYSA-N ethanamine;dihydrochloride Chemical compound Cl.Cl.CCN MBMJDELICBDLEE-UHFFFAOYSA-N 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 229940098779 methanesulfonic acid Drugs 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- ZBJPBVABJYBOQP-UHFFFAOYSA-N 1-(5-amino-2-chloro-4-fluorophenyl)-7-chloro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=NC(Cl)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1Cl ZBJPBVABJYBOQP-UHFFFAOYSA-N 0.000 description 4
- 239000005973 Carvone Substances 0.000 description 4
- GQHTUMJGOHRCHB-UHFFFAOYSA-N DBU Substances C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- 206010034972 Photosensitivity reaction Diseases 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- FDPKMJDUXJFKOI-UHFFFAOYSA-N azetidin-3-amine Chemical compound NC1CNC1 FDPKMJDUXJFKOI-UHFFFAOYSA-N 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 150000002170 ethers Chemical class 0.000 description 4
- LZMXLCPYJNRWNQ-UHFFFAOYSA-N ethyl 3-(3-chloro-2,4,5-trifluorophenyl)-3-oxopropanoate Chemical compound CCOC(=O)CC(=O)C1=CC(F)=C(F)C(Cl)=C1F LZMXLCPYJNRWNQ-UHFFFAOYSA-N 0.000 description 4
- VTNSEHKWOJYHFW-UHFFFAOYSA-N ethyl 7-chloro-1-(2,4-difluoro-5-nitrophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC([N+]([O-])=O)=C(F)C=C1F VTNSEHKWOJYHFW-UHFFFAOYSA-N 0.000 description 4
- 150000008282 halocarbons Chemical class 0.000 description 4
- 239000003701 inert diluent Substances 0.000 description 4
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 4
- 238000006396 nitration reaction Methods 0.000 description 4
- 208000007578 phototoxic dermatitis Diseases 0.000 description 4
- 231100000018 phototoxicity Toxicity 0.000 description 4
- 239000002798 polar solvent Substances 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- CGXLVFZJJOXEDF-UHFFFAOYSA-N 1,8-naphthyridine-3-carboxylic acid Chemical compound N1=CC=CC2=CC(C(=O)O)=CN=C21 CGXLVFZJJOXEDF-UHFFFAOYSA-N 0.000 description 3
- ZRRALEYZDRZJQV-UHFFFAOYSA-N 1-(3-amino-2,4-difluorophenyl)-7-chloro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound NC1=C(F)C=CC(N2C3=NC(Cl)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F ZRRALEYZDRZJQV-UHFFFAOYSA-N 0.000 description 3
- BAMGQMHXFMQFES-UHFFFAOYSA-N 1-(3-amino-4-fluorophenyl)-7-chloro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=NC(Cl)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1 BAMGQMHXFMQFES-UHFFFAOYSA-N 0.000 description 3
- SLKDYRKRHBXVAU-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-6,7-difluoro-5-hydroxy-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=CC(F)=C(F)C(O)=C3C(=O)C(C(O)=O)=C2)=C1F SLKDYRKRHBXVAU-UHFFFAOYSA-N 0.000 description 3
- FRWGCLCLEACEGW-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-6,7-difluoro-5-methyl-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)C=2C(C)=C(F)C(F)=CC=2N1C1=CC(N)=C(F)C=C1F FRWGCLCLEACEGW-UHFFFAOYSA-N 0.000 description 3
- CNBAZXBBKBNALQ-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-6-chloro-7,8-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=C(F)C(F)=C(Cl)C=C3C(=O)C(C(O)=O)=C2)=C1F CNBAZXBBKBNALQ-UHFFFAOYSA-N 0.000 description 3
- BZNRBYHJGJFPBC-UHFFFAOYSA-N 1-(5-amino-2-chloro-4-fluorophenyl)-8-chloro-6,7-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=C(Cl)C(F)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1Cl BZNRBYHJGJFPBC-UHFFFAOYSA-N 0.000 description 3
- GERISUUGEQHYJI-UHFFFAOYSA-N 1-(5-amino-4-chloro-2-fluorophenyl)-7-chloro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1=C(Cl)C(N)=CC(N2C3=NC(Cl)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F GERISUUGEQHYJI-UHFFFAOYSA-N 0.000 description 3
- AVFZOVWCLRSYKC-UHFFFAOYSA-N 1-methylpyrrolidine Chemical compound CN1CCCC1 AVFZOVWCLRSYKC-UHFFFAOYSA-N 0.000 description 3
- MDFSGDMPHMKKGB-UHFFFAOYSA-N 2,4-difluoro-5-nitrobenzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=C(F)C=C1F MDFSGDMPHMKKGB-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- XRAKCYJTJGTSMM-UHFFFAOYSA-N 2-chloro-4-fluoroaniline Chemical compound NC1=CC=C(F)C=C1Cl XRAKCYJTJGTSMM-UHFFFAOYSA-N 0.000 description 3
- NISQVIGKJGDWDB-UHFFFAOYSA-N 5-amino-1-(5-amino-2,4-difluorophenyl)-6,7,8-trifluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=C(F)C(F)=C(F)C(N)=C3C(=O)C(C(O)=O)=C2)=C1F NISQVIGKJGDWDB-UHFFFAOYSA-N 0.000 description 3
- HHTUWZXQYXINDU-UHFFFAOYSA-N 7-chloro-1-(2,4-difluoro-5-formamidophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1=CC(NC=O)=C(F)C=C1F HHTUWZXQYXINDU-UHFFFAOYSA-N 0.000 description 3
- UCWZBUISHLVVQI-UHFFFAOYSA-N 7-chloro-1-[2,4-difluoro-5-(methylamino)phenyl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1=C(F)C(NC)=CC(N2C3=NC(Cl)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F UCWZBUISHLVVQI-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- AHVYPIQETPWLSZ-UHFFFAOYSA-N N-methyl-pyrrolidine Natural products CN1CC=CC1 AHVYPIQETPWLSZ-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- UQUPQEUNHVVNKW-UHFFFAOYSA-N azetidin-1-ium-3-ol;chloride Chemical compound Cl.OC1CNC1 UQUPQEUNHVVNKW-UHFFFAOYSA-N 0.000 description 3
- 238000010531 catalytic reduction reaction Methods 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 150000002148 esters Chemical group 0.000 description 3
- OBODZCWZOLFVRW-UHFFFAOYSA-N ethyl 1-(5-amino-2,4-difluorophenyl)-6,7-difluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=CC(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC(N)=C(F)C=C1F OBODZCWZOLFVRW-UHFFFAOYSA-N 0.000 description 3
- GDYGQBFXPOZUGJ-UHFFFAOYSA-N ethyl 1-(5-amino-2,4-difluorophenyl)-7-chloro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC(N)=C(F)C=C1F GDYGQBFXPOZUGJ-UHFFFAOYSA-N 0.000 description 3
- XGBWSGSFWFLFHD-UHFFFAOYSA-N ethyl 7-chloro-1-(2,4-difluoro-5-formamidophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC(NC=O)=C(F)C=C1F XGBWSGSFWFLFHD-UHFFFAOYSA-N 0.000 description 3
- VPACNOOOSRXKPD-UHFFFAOYSA-N ethyl 7-chloro-1-[5-(ethoxycarbonylamino)-2,4-difluorophenyl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C1=C(F)C(NC(=O)OCC)=CC(N2C3=NC(Cl)=C(F)C=C3C(=O)C(C(=O)OCC)=C2)=C1F VPACNOOOSRXKPD-UHFFFAOYSA-N 0.000 description 3
- HDUVCFIIMIMFJO-UHFFFAOYSA-N ethyl n-(3-amino-2,4-difluorophenyl)carbamate;methanesulfonic acid Chemical compound CS(O)(=O)=O.CCOC(=O)NC1=CC=C(F)C(N)=C1F HDUVCFIIMIMFJO-UHFFFAOYSA-N 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 230000003301 hydrolyzing effect Effects 0.000 description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 3
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- XHVYAOXNULEUHH-ALUAXPQUSA-N (3s,4r)-4-methylpyrrolidin-3-amine;dihydrochloride Chemical compound Cl.Cl.C[C@@H]1CNC[C@H]1N XHVYAOXNULEUHH-ALUAXPQUSA-N 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- WORJRXHJTUTINR-UHFFFAOYSA-N 1,4-dioxane;hydron;chloride Chemical compound Cl.C1COCCO1 WORJRXHJTUTINR-UHFFFAOYSA-N 0.000 description 2
- BHSXOGUKZHTXIB-UHFFFAOYSA-N 1-(2,4-difluoro-5-nitrophenyl)-6,7,8-trifluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C12=C(F)C(F)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1=CC([N+]([O-])=O)=C(F)C=C1F BHSXOGUKZHTXIB-UHFFFAOYSA-N 0.000 description 2
- LPLWUYVPBHRBDR-UHFFFAOYSA-N 1-(2,4-difluoro-5-nitrophenyl)-6,7-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C12=CC(F)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1=CC([N+]([O-])=O)=C(F)C=C1F LPLWUYVPBHRBDR-UHFFFAOYSA-N 0.000 description 2
- MCUPPVPPCQVPBV-UHFFFAOYSA-N 1-(3-amino-2,4,6-trifluorophenyl)-7-chloro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound NC1=C(F)C=C(F)C(N2C3=NC(Cl)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F MCUPPVPPCQVPBV-UHFFFAOYSA-N 0.000 description 2
- FSKPAAGJHOFMFU-UHFFFAOYSA-N 1-(3-amino-2,4,6-trifluorophenyl)-8-chloro-6,7-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound NC1=C(F)C=C(F)C(N2C3=C(Cl)C(F)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F FSKPAAGJHOFMFU-UHFFFAOYSA-N 0.000 description 2
- OGPYJAMOFFNOOV-QMMMGPOBSA-N 1-(3-amino-2,4-difluorophenyl)-7-[(3s)-3-aminopyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1[C@@H](N)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC=C(F)C(N)=C1F OGPYJAMOFFNOOV-QMMMGPOBSA-N 0.000 description 2
- YPMJZQLYZMSVDU-UHFFFAOYSA-N 1-(3-amino-4-fluoro-2-methoxyphenyl)-6,7-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound COC1=C(N)C(F)=CC=C1N1C2=CC(F)=C(F)C=C2C(=O)C(C(O)=O)=C1 YPMJZQLYZMSVDU-UHFFFAOYSA-N 0.000 description 2
- DDAAMKXLNVPKBH-UHFFFAOYSA-N 1-(3-amino-4-fluoro-2-methylphenyl)-7-chloro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound CC1=C(N)C(F)=CC=C1N1C2=NC(Cl)=C(F)C=C2C(=O)C(C(O)=O)=C1 DDAAMKXLNVPKBH-UHFFFAOYSA-N 0.000 description 2
- UDYDRFCPSXIYRS-UHFFFAOYSA-N 1-(3-amino-4-fluorophenyl)-8-chloro-6,7-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=C(Cl)C(F)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1 UDYDRFCPSXIYRS-UHFFFAOYSA-N 0.000 description 2
- RRVLZKCOEFIOPR-UHFFFAOYSA-N 1-(5-amino-2,3,4-trifluorophenyl)-6,7-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound FC1=C(F)C(N)=CC(N2C3=CC(F)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F RRVLZKCOEFIOPR-UHFFFAOYSA-N 0.000 description 2
- XFEREPMVIBXHCO-UHFFFAOYSA-N 1-(5-amino-2,3,4-trifluorophenyl)-7-chloro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound FC1=C(F)C(N)=CC(N2C3=NC(Cl)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F XFEREPMVIBXHCO-UHFFFAOYSA-N 0.000 description 2
- UONKFHKRTPQYJR-UHFFFAOYSA-N 1-(5-amino-2,3,4-trifluorophenyl)-8-chloro-6,7-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound FC1=C(F)C(N)=CC(N2C3=C(Cl)C(F)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F UONKFHKRTPQYJR-UHFFFAOYSA-N 0.000 description 2
- FFDOQISLDHBMOC-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-6,7,8-trifluoro-5-hydroxy-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=C(F)C(F)=C(F)C(O)=C3C(=O)C(C(O)=O)=C2)=C1F FFDOQISLDHBMOC-UHFFFAOYSA-N 0.000 description 2
- ZAOTZAXXNIRGFS-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-6,7-difluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid Chemical compound COC1=C(F)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1=CC(N)=C(F)C=C1F ZAOTZAXXNIRGFS-UHFFFAOYSA-N 0.000 description 2
- YVSIKZSKAYRSLM-WLRWDXFRSA-N 1-(5-amino-2,4-difluorophenyl)-7-[(3s)-3-[[(2s)-2-amino-3-methylbutanoyl]amino]pyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1[C@@H](NC(=O)[C@@H](N)C(C)C)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F YVSIKZSKAYRSLM-WLRWDXFRSA-N 0.000 description 2
- KWLSEHQZFGCROZ-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-7-chloro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=NC(Cl)=CC=C3C(=O)C(C(O)=O)=C2)=C1F KWLSEHQZFGCROZ-UHFFFAOYSA-N 0.000 description 2
- WVNPPPWEDSAELS-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-8-bromo-6,7-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=C(Br)C(F)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F WVNPPPWEDSAELS-UHFFFAOYSA-N 0.000 description 2
- DKHBLWGLXLIOSP-UHFFFAOYSA-N 1-(5-amino-2-bromo-4-fluorophenyl)-8-chloro-6,7-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=C(Cl)C(F)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1Br DKHBLWGLXLIOSP-UHFFFAOYSA-N 0.000 description 2
- HLMWHDGFRZYPJJ-UHFFFAOYSA-N 1-(5-amino-2-chloro-4-fluorophenyl)-6,7-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=CC(F)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1Cl HLMWHDGFRZYPJJ-UHFFFAOYSA-N 0.000 description 2
- PVOQZGLTYPXKDQ-UHFFFAOYSA-N 1-(5-amino-2-chloro-4-fluorophenyl)-7-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=CC(Cl)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1Cl PVOQZGLTYPXKDQ-UHFFFAOYSA-N 0.000 description 2
- FCOFPVGWZMCVRK-UHFFFAOYSA-N 1-(5-amino-4-chloro-2-fluorophenyl)-8-chloro-6,7-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(Cl)C(N)=CC(N2C3=C(Cl)C(F)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F FCOFPVGWZMCVRK-UHFFFAOYSA-N 0.000 description 2
- JVUUUYXWHLSUFO-UHFFFAOYSA-N 1-(5-amino-4-fluoro-2-methoxyphenyl)-8-chloro-6,7-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound COC1=CC(F)=C(N)C=C1N1C2=C(Cl)C(F)=C(F)C=C2C(=O)C(C(O)=O)=C1 JVUUUYXWHLSUFO-UHFFFAOYSA-N 0.000 description 2
- YDZNUYXZOLGJMC-UHFFFAOYSA-N 1-(5-amino-4-fluoro-2-methylphenyl)-7-chloro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound CC1=CC(F)=C(N)C=C1N1C2=NC(Cl)=C(F)C=C2C(=O)C(C(O)=O)=C1 YDZNUYXZOLGJMC-UHFFFAOYSA-N 0.000 description 2
- XHAANXSKJRGHGZ-UHFFFAOYSA-N 1-(5-amino-4-fluoro-2-methylphenyl)-8-chloro-6,7-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound CC1=CC(F)=C(N)C=C1N1C2=C(Cl)C(F)=C(F)C=C2C(=O)C(C(O)=O)=C1 XHAANXSKJRGHGZ-UHFFFAOYSA-N 0.000 description 2
- VJGHDZMYIBRSJN-UHFFFAOYSA-N 1-(5-benzamido-2,4-difluorophenyl)-7-chloro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)O)=CN1C(C(=CC=1F)F)=CC=1NC(=O)C1=CC=CC=C1 VJGHDZMYIBRSJN-UHFFFAOYSA-N 0.000 description 2
- RKGIKRYPCBUKQY-UHFFFAOYSA-N 1-[2,4-difluoro-5-(methylamino)phenyl]-6,7-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(NC)=CC(N2C3=CC(F)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F RKGIKRYPCBUKQY-UHFFFAOYSA-N 0.000 description 2
- 125000006017 1-propenyl group Chemical group 0.000 description 2
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- DCTOHCCUXLBQMS-UHFFFAOYSA-N 1-undecene Chemical compound CCCCCCCCCC=C DCTOHCCUXLBQMS-UHFFFAOYSA-N 0.000 description 2
- BJSVKBGQDHUBHZ-UHFFFAOYSA-N 2,4,6-trifluoroaniline Chemical compound NC1=C(F)C=C(F)C=C1F BJSVKBGQDHUBHZ-UHFFFAOYSA-N 0.000 description 2
- IFNWESYYDINUHV-UHFFFAOYSA-N 2,6-dimethylpiperazine Chemical compound CC1CNCC(C)N1 IFNWESYYDINUHV-UHFFFAOYSA-N 0.000 description 2
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 2
- XYWIPYBIIRTJMM-IBGZPJMESA-N 4-[[(2S)-2-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-5-methoxy-2-oxopyridin-1-yl]butanoyl]amino]-2-fluorobenzamide Chemical compound CC[C@H](N1C=C(OC)C(=CC1=O)C1=C(C=CC(Cl)=C1)N1C=C(N=N1)C(F)(F)F)C(=O)NC1=CC(F)=C(C=C1)C(N)=O XYWIPYBIIRTJMM-IBGZPJMESA-N 0.000 description 2
- CSFDTBRRIBJILD-UHFFFAOYSA-N 4-chloro-2-fluoroaniline Chemical compound NC1=CC=C(Cl)C=C1F CSFDTBRRIBJILD-UHFFFAOYSA-N 0.000 description 2
- KMHLGVTVACLEJE-UHFFFAOYSA-N 4-fluoro-2-methylaniline Chemical compound CC1=CC(F)=CC=C1N KMHLGVTVACLEJE-UHFFFAOYSA-N 0.000 description 2
- FWOKKOGCZVECBY-UHFFFAOYSA-N 5-amino-1-(5-amino-2,4-difluorophenyl)-8-chloro-6,7-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=C(Cl)C(F)=C(F)C(N)=C3C(=O)C(C(O)=O)=C2)=C1F FWOKKOGCZVECBY-UHFFFAOYSA-N 0.000 description 2
- WARAWTAAXTXRPN-UHFFFAOYSA-N 6,7-difluoro-4-oxo-1-(2,3,4-trifluoro-5-nitrophenyl)quinoline-3-carboxylic acid Chemical compound C12=CC(F)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1=CC([N+]([O-])=O)=C(F)C(F)=C1F WARAWTAAXTXRPN-UHFFFAOYSA-N 0.000 description 2
- LOMRYIPUYPZPEA-UHFFFAOYSA-N 7-chloro-1-[5-(dimethylamino)-2,4-difluorophenyl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1=C(F)C(N(C)C)=CC(N2C3=NC(Cl)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F LOMRYIPUYPZPEA-UHFFFAOYSA-N 0.000 description 2
- XODAOWQIXYGHNB-UHFFFAOYSA-N 7-chloro-1-[5-(ethoxycarbonylamino)-2,4-difluorophenyl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1=C(F)C(NC(=O)OCC)=CC(N2C3=NC(Cl)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F XODAOWQIXYGHNB-UHFFFAOYSA-N 0.000 description 2
- MOJORAUGKGIOSI-UHFFFAOYSA-N 7-chloro-6-fluoro-4-oxo-1-(2,3,4-trifluoro-5-nitrophenyl)-1,8-naphthyridine-3-carboxylic acid Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1=CC([N+]([O-])=O)=C(F)C(F)=C1F MOJORAUGKGIOSI-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- LEKKHESJKLEYQZ-UHFFFAOYSA-N 8-chloro-1-[2,4-difluoro-5-(methylamino)phenyl]-6,7-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(NC)=CC(N2C3=C(Cl)C(F)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F LEKKHESJKLEYQZ-UHFFFAOYSA-N 0.000 description 2
- DPCJZZHTZHUCAH-UHFFFAOYSA-N 8-chloro-6,7-difluoro-4-oxo-1-(2,4,6-trifluorophenyl)quinoline-3-carboxylic acid Chemical compound C12=C(Cl)C(F)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1=C(F)C=C(F)C=C1F DPCJZZHTZHUCAH-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 150000001241 acetals Chemical class 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 125000005236 alkanoylamino group Chemical group 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- GNMZOTQIHJUMJF-UHFFFAOYSA-N azetidine;dihydrochloride Chemical compound Cl.Cl.C1CNC1 GNMZOTQIHJUMJF-UHFFFAOYSA-N 0.000 description 2
- VYWVTDQZMWVMAY-UHFFFAOYSA-N benzyl 1,5-diamino-2,6-difluorocyclohexa-2,4-diene-1-carboxylate Chemical compound FC1C(N)=CC=C(F)C1(N)C(=O)OCC1=CC=CC=C1 VYWVTDQZMWVMAY-UHFFFAOYSA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- WJJYKRVCBRUCDD-UHFFFAOYSA-N benzyl n-(2,4-difluoro-5-nitrophenyl)carbamate Chemical compound C1=C(F)C([N+](=O)[O-])=CC(NC(=O)OCC=2C=CC=CC=2)=C1F WJJYKRVCBRUCDD-UHFFFAOYSA-N 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 150000001639 boron compounds Chemical class 0.000 description 2
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 239000006196 drop Substances 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 239000012156 elution solvent Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- RVCIVUKSEZJLRB-UHFFFAOYSA-N ethyl 1-(2,4-difluoro-5-formamidophenyl)-5,6,7,8-tetrafluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=C(F)C(F)=C(F)C(F)=C2C(=O)C(C(=O)OCC)=CN1C1=CC(NC=O)=C(F)C=C1F RVCIVUKSEZJLRB-UHFFFAOYSA-N 0.000 description 2
- JSFXPUSDABFDCB-UHFFFAOYSA-N ethyl 1-(2,4-difluoro-5-nitrophenyl)-5,6,7,8-tetrafluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=C(F)C(F)=C(F)C(F)=C2C(=O)C(C(=O)OCC)=CN1C1=CC([N+]([O-])=O)=C(F)C=C1F JSFXPUSDABFDCB-UHFFFAOYSA-N 0.000 description 2
- HQYFVESMFLMEMQ-UHFFFAOYSA-N ethyl 1-(2,4-difluoro-5-nitrophenyl)-6,7-difluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=CC(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC([N+]([O-])=O)=C(F)C=C1F HQYFVESMFLMEMQ-UHFFFAOYSA-N 0.000 description 2
- QMZLCHBVQNZKKS-UHFFFAOYSA-N ethyl 1-(2,4-difluorophenyl)-5,6,7,8-tetrafluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=C(F)C(F)=C(F)C(F)=C2C(=O)C(C(=O)OCC)=CN1C1=CC=C(F)C=C1F QMZLCHBVQNZKKS-UHFFFAOYSA-N 0.000 description 2
- WOERBVIJQMCLGZ-UHFFFAOYSA-N ethyl 1-(2-bromo-4-fluoro-5-nitrophenyl)-8-chloro-6,7-difluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=C(Cl)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC([N+]([O-])=O)=C(F)C=C1Br WOERBVIJQMCLGZ-UHFFFAOYSA-N 0.000 description 2
- YJMKQOBULYTEAU-UHFFFAOYSA-N ethyl 1-(2-bromo-4-fluorophenyl)-8-chloro-6,7-difluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=C(Cl)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC=C(F)C=C1Br YJMKQOBULYTEAU-UHFFFAOYSA-N 0.000 description 2
- JCFGURRCWKPGHY-UHFFFAOYSA-N ethyl 1-(2-chloro-4-fluoro-5-nitrophenyl)-6,7-difluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=CC(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC([N+]([O-])=O)=C(F)C=C1Cl JCFGURRCWKPGHY-UHFFFAOYSA-N 0.000 description 2
- AAKDFOAGQMEDNL-UHFFFAOYSA-N ethyl 1-(2-chloro-4-fluorophenyl)-6,7-difluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=CC(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC=C(F)C=C1Cl AAKDFOAGQMEDNL-UHFFFAOYSA-N 0.000 description 2
- ZLBFPKYJUOGLGV-UHFFFAOYSA-N ethyl 1-(3-amino-2,4,6-trifluorophenyl)-7-chloro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=C(F)C=C(F)C(N)=C1F ZLBFPKYJUOGLGV-UHFFFAOYSA-N 0.000 description 2
- VZYCXHPTJIKCAO-UHFFFAOYSA-N ethyl 1-(3-amino-4-fluoro-2-methylphenyl)-7-chloro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC=C(F)C(N)=C1C VZYCXHPTJIKCAO-UHFFFAOYSA-N 0.000 description 2
- VBUMCZLNDDIABM-UHFFFAOYSA-N ethyl 1-(5-amino-2,3,4-trifluorophenyl)-6,7-difluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=CC(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC(N)=C(F)C(F)=C1F VBUMCZLNDDIABM-UHFFFAOYSA-N 0.000 description 2
- SPWSZNAXRLIERY-UHFFFAOYSA-N ethyl 1-(5-amino-2,3,4-trifluorophenyl)-7-chloro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC(N)=C(F)C(F)=C1F SPWSZNAXRLIERY-UHFFFAOYSA-N 0.000 description 2
- QYISLJJPQBZEGZ-UHFFFAOYSA-N ethyl 1-(5-amino-2,4-difluorophenyl)-6,7,8-trifluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=C(F)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC(N)=C(F)C=C1F QYISLJJPQBZEGZ-UHFFFAOYSA-N 0.000 description 2
- PTFIWIZWXDMYLW-UHFFFAOYSA-N ethyl 1-(5-amino-2,4-difluorophenyl)-6,7-difluoro-8-methoxy-4-oxoquinoline-3-carboxylate Chemical compound C12=C(OC)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC(N)=C(F)C=C1F PTFIWIZWXDMYLW-UHFFFAOYSA-N 0.000 description 2
- WBVZRFHJYYZKOF-UHFFFAOYSA-N ethyl 1-(5-amino-2,4-difluorophenyl)-6,7-difluoro-8-methyl-4-oxoquinoline-3-carboxylate Chemical compound C12=C(C)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC(N)=C(F)C=C1F WBVZRFHJYYZKOF-UHFFFAOYSA-N 0.000 description 2
- JQAULFBMBQAQNK-UHFFFAOYSA-N ethyl 1-(5-amino-2-chloro-4-fluorophenyl)-6,7-difluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=CC(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC(N)=C(F)C=C1Cl JQAULFBMBQAQNK-UHFFFAOYSA-N 0.000 description 2
- HZABLQLBDDGDOO-UHFFFAOYSA-N ethyl 1-(5-amino-2-chloro-4-fluorophenyl)-7-chloro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC(N)=C(F)C=C1Cl HZABLQLBDDGDOO-UHFFFAOYSA-N 0.000 description 2
- NNAXXXBYDWADAI-UHFFFAOYSA-N ethyl 1-(5-amino-4-chloro-2-fluorophenyl)-7-chloro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC(N)=C(Cl)C=C1F NNAXXXBYDWADAI-UHFFFAOYSA-N 0.000 description 2
- IZBHOMCPXFYMQE-UHFFFAOYSA-N ethyl 1-[2,4-difluoro-5-(methylamino)phenyl]-6,7-difluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=CC(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC(NC)=C(F)C=C1F IZBHOMCPXFYMQE-UHFFFAOYSA-N 0.000 description 2
- VDYWHIYIJNDVNE-UHFFFAOYSA-N ethyl 1-[5-(ethoxycarbonylamino)-2,4-difluorophenyl]-6,7-difluoro-4-oxo-5-phenylmethoxyquinoline-3-carboxylate Chemical compound C1=C(F)C(NC(=O)OCC)=CC(N2C3=CC(F)=C(F)C(OCC=4C=CC=CC=4)=C3C(=O)C(C(=O)OCC)=C2)=C1F VDYWHIYIJNDVNE-UHFFFAOYSA-N 0.000 description 2
- QIMFWMRJJFGYOP-UHFFFAOYSA-N ethyl 5-(benzylamino)-1-(2,4-difluoro-5-formamidophenyl)-6,7,8-trifluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=C(F)C(F)=C(F)C(NCC=3C=CC=CC=3)=C2C(=O)C(C(=O)OCC)=CN1C1=CC(NC=O)=C(F)C=C1F QIMFWMRJJFGYOP-UHFFFAOYSA-N 0.000 description 2
- HSCFXGBMGUAUCQ-UHFFFAOYSA-N ethyl 5-amino-1-(2,4-difluoro-5-formamidophenyl)-6,7,8-trifluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=C(F)C(F)=C(F)C(N)=C2C(=O)C(C(=O)OCC)=CN1C1=CC(NC=O)=C(F)C=C1F HSCFXGBMGUAUCQ-UHFFFAOYSA-N 0.000 description 2
- ILGJVAMSZBRVIU-UHFFFAOYSA-N ethyl 6,7,8-trichloro-1-[2,4-difluoro-5-(phenylmethoxycarbonylamino)phenyl]-4-oxoquinoline-3-carboxylate Chemical compound C12=C(Cl)C(Cl)=C(Cl)C=C2C(=O)C(C(=O)OCC)=CN1C(C(=CC=1F)F)=CC=1NC(=O)OCC1=CC=CC=C1 ILGJVAMSZBRVIU-UHFFFAOYSA-N 0.000 description 2
- JEEZAIHLLPEHJG-UHFFFAOYSA-N ethyl 6,7-difluoro-1-[4-fluoro-2-methoxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]-4-oxoquinoline-3-carboxylate Chemical compound C12=CC(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC=C(F)C(NC(=O)OC(C)(C)C)=C1OC JEEZAIHLLPEHJG-UHFFFAOYSA-N 0.000 description 2
- SJRGGFUKTDPRGY-UHFFFAOYSA-N ethyl 6,7-difluoro-4-oxo-1-(2,3,4-trifluoro-5-nitrophenyl)quinoline-3-carboxylate Chemical compound C12=CC(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC([N+]([O-])=O)=C(F)C(F)=C1F SJRGGFUKTDPRGY-UHFFFAOYSA-N 0.000 description 2
- JUMGNFZXOYUPDC-UHFFFAOYSA-N ethyl 6-chloro-1-[2,4-difluoro-5-(phenylmethoxycarbonylamino)phenyl]-7,8-difluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=C(F)C(F)=C(Cl)C=C2C(=O)C(C(=O)OCC)=CN1C(C(=CC=1F)F)=CC=1NC(=O)OCC1=CC=CC=C1 JUMGNFZXOYUPDC-UHFFFAOYSA-N 0.000 description 2
- KBOKSQMVTQJQIR-UHFFFAOYSA-N ethyl 7-chloro-1-(2-chloro-4-fluoro-5-nitrophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC([N+]([O-])=O)=C(F)C=C1Cl KBOKSQMVTQJQIR-UHFFFAOYSA-N 0.000 description 2
- NTKIMYNXHFNKJE-UHFFFAOYSA-N ethyl 7-chloro-1-(2-chloro-4-fluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC=C(F)C=C1Cl NTKIMYNXHFNKJE-UHFFFAOYSA-N 0.000 description 2
- CETFGXMHZHYFPS-UHFFFAOYSA-N ethyl 7-chloro-1-(4-chloro-2-fluoro-5-nitrophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC([N+]([O-])=O)=C(Cl)C=C1F CETFGXMHZHYFPS-UHFFFAOYSA-N 0.000 description 2
- GTXXYHNQKGHSRY-UHFFFAOYSA-N ethyl 7-chloro-1-(4-chloro-2-fluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC=C(Cl)C=C1F GTXXYHNQKGHSRY-UHFFFAOYSA-N 0.000 description 2
- LORKODLWYZNJPV-UHFFFAOYSA-N ethyl 7-chloro-1-[2,4-difluoro-3-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC=C(F)C(NC(=O)OC(C)(C)C)=C1F LORKODLWYZNJPV-UHFFFAOYSA-N 0.000 description 2
- NBLUXHVFWGIWNK-UHFFFAOYSA-N ethyl 7-chloro-1-[2,4-difluoro-5-(methylamino)phenyl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC(NC)=C(F)C=C1F NBLUXHVFWGIWNK-UHFFFAOYSA-N 0.000 description 2
- HKGLARVIRMEJMM-UHFFFAOYSA-N ethyl 7-chloro-1-[2,4-difluoro-5-(phenylmethoxycarbonylamino)phenyl]-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=CC=C2C(=O)C(C(=O)OCC)=CN1C(C(=CC=1F)F)=CC=1NC(=O)OCC1=CC=CC=C1 HKGLARVIRMEJMM-UHFFFAOYSA-N 0.000 description 2
- LCJXKMOGHQXXPW-UHFFFAOYSA-N ethyl 7-chloro-6-fluoro-1-(4-fluoro-2-methylphenyl)-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC=C(F)C=C1C LCJXKMOGHQXXPW-UHFFFAOYSA-N 0.000 description 2
- CTDXWDKKXXUUMV-UHFFFAOYSA-N ethyl 7-chloro-6-fluoro-4-oxo-1-(2,3,4-trifluoro-5-nitrophenyl)-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC([N+]([O-])=O)=C(F)C(F)=C1F CTDXWDKKXXUUMV-UHFFFAOYSA-N 0.000 description 2
- IVSFYRXPBLRACJ-UHFFFAOYSA-N ethyl 7-chloro-6-fluoro-4-oxo-1-(2,4,6-trifluoro-3-nitrophenyl)-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=C(F)C=C(F)C([N+]([O-])=O)=C1F IVSFYRXPBLRACJ-UHFFFAOYSA-N 0.000 description 2
- KHMIIZQVJSYEEW-UHFFFAOYSA-N ethyl 7-chloro-6-fluoro-4-oxo-1-(2,4,6-trifluorophenyl)-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=C(F)C=C(F)C=C1F KHMIIZQVJSYEEW-UHFFFAOYSA-N 0.000 description 2
- YIAZFWDRVDSOLC-UHFFFAOYSA-N ethyl 8-bromo-1-[2,4-difluoro-5-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]-6,7-difluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=C(Br)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC(NC(=O)OC(C)(C)C)=C(F)C=C1F YIAZFWDRVDSOLC-UHFFFAOYSA-N 0.000 description 2
- LVOVXJLGFJNIQN-UHFFFAOYSA-N ethyl 8-chloro-1-(2,4-difluoro-5-formamidophenyl)-6,7-difluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=C(Cl)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC(NC=O)=C(F)C=C1F LVOVXJLGFJNIQN-UHFFFAOYSA-N 0.000 description 2
- PQGAYYKEYKUMLE-UHFFFAOYSA-N ethyl 8-chloro-1-(2,4-difluoro-5-nitrophenyl)-6,7-difluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=C(Cl)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC([N+]([O-])=O)=C(F)C=C1F PQGAYYKEYKUMLE-UHFFFAOYSA-N 0.000 description 2
- VRXGLZOUSPEJNG-UHFFFAOYSA-N ethyl 8-chloro-1-(2,4-difluorophenyl)-6,7-difluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=C(Cl)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC=C(F)C=C1F VRXGLZOUSPEJNG-UHFFFAOYSA-N 0.000 description 2
- QJMAPGPJIJGSKF-UHFFFAOYSA-N ethyl 8-chloro-1-(2-chloro-4-fluoro-5-nitrophenyl)-6,7-difluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=C(Cl)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC([N+]([O-])=O)=C(F)C=C1Cl QJMAPGPJIJGSKF-UHFFFAOYSA-N 0.000 description 2
- MPGGXBXAUFWGLH-UHFFFAOYSA-N ethyl 8-chloro-1-(2-chloro-4-fluorophenyl)-6,7-difluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=C(Cl)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC=C(F)C=C1Cl MPGGXBXAUFWGLH-UHFFFAOYSA-N 0.000 description 2
- LBEKDQNECNUGEV-UHFFFAOYSA-N ethyl 8-chloro-1-(4-chloro-2-fluoro-5-formamidophenyl)-6,7-difluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=C(Cl)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC(NC=O)=C(Cl)C=C1F LBEKDQNECNUGEV-UHFFFAOYSA-N 0.000 description 2
- XFEWCJUTVUOWKW-UHFFFAOYSA-N ethyl 8-chloro-1-(4-chloro-2-fluoro-5-nitrophenyl)-6,7-difluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=C(Cl)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC([N+]([O-])=O)=C(Cl)C=C1F XFEWCJUTVUOWKW-UHFFFAOYSA-N 0.000 description 2
- XKASTRVBBYLQJL-UHFFFAOYSA-N ethyl 8-chloro-1-(4-chloro-2-fluorophenyl)-6,7-difluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=C(Cl)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC=C(Cl)C=C1F XKASTRVBBYLQJL-UHFFFAOYSA-N 0.000 description 2
- GFMUQQTUNTUQBJ-UHFFFAOYSA-N ethyl 8-chloro-1-[2,4-difluoro-5-(phenylmethoxycarbonylamino)phenyl]-6,7-difluoro-5-nitro-4-oxoquinoline-3-carboxylate Chemical compound C12=C(Cl)C(F)=C(F)C([N+]([O-])=O)=C2C(=O)C(C(=O)OCC)=CN1C(C(=CC=1F)F)=CC=1NC(=O)OCC1=CC=CC=C1 GFMUQQTUNTUQBJ-UHFFFAOYSA-N 0.000 description 2
- CHQVESKLZHFLEQ-UHFFFAOYSA-N ethyl 8-chloro-6,7-difluoro-1-(4-fluoro-2-methoxy-5-nitrophenyl)-4-oxoquinoline-3-carboxylate Chemical compound C12=C(Cl)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC([N+]([O-])=O)=C(F)C=C1OC CHQVESKLZHFLEQ-UHFFFAOYSA-N 0.000 description 2
- VBHVEMXMMHVNGM-UHFFFAOYSA-N ethyl 8-chloro-6,7-difluoro-1-(4-fluoro-2-methoxyphenyl)-4-oxoquinoline-3-carboxylate Chemical compound C12=C(Cl)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC=C(F)C=C1OC VBHVEMXMMHVNGM-UHFFFAOYSA-N 0.000 description 2
- BDNFAWHRXIDAPM-UHFFFAOYSA-N ethyl 8-chloro-6,7-difluoro-1-(4-fluoro-2-methyl-5-nitrophenyl)-4-oxoquinoline-3-carboxylate Chemical compound C12=C(Cl)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC([N+]([O-])=O)=C(F)C=C1C BDNFAWHRXIDAPM-UHFFFAOYSA-N 0.000 description 2
- MMSCOMBNAPQGKX-UHFFFAOYSA-N ethyl 8-chloro-6,7-difluoro-1-(4-fluoro-2-methylphenyl)-4-oxoquinoline-3-carboxylate Chemical compound C12=C(Cl)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC=C(F)C=C1C MMSCOMBNAPQGKX-UHFFFAOYSA-N 0.000 description 2
- GFPUZBMDHKUVRL-UHFFFAOYSA-N ethyl 8-chloro-6,7-difluoro-1-(4-fluorophenyl)-4-oxoquinoline-3-carboxylate Chemical compound C12=C(Cl)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC=C(F)C=C1 GFPUZBMDHKUVRL-UHFFFAOYSA-N 0.000 description 2
- PAKGMLNGAYMPRC-UHFFFAOYSA-N ethyl 8-chloro-6,7-difluoro-4-oxo-1-(2,4,6-trifluoro-3-formamidophenyl)quinoline-3-carboxylate Chemical compound C12=C(Cl)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=C(F)C=C(F)C(NC=O)=C1F PAKGMLNGAYMPRC-UHFFFAOYSA-N 0.000 description 2
- SKYKGKJGHQWOLA-UHFFFAOYSA-N ethyl 8-chloro-6,7-difluoro-4-oxo-1-(2,4,6-trifluoro-3-nitrophenyl)quinoline-3-carboxylate Chemical compound C12=C(Cl)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=C(F)C=C(F)C([N+]([O-])=O)=C1F SKYKGKJGHQWOLA-UHFFFAOYSA-N 0.000 description 2
- HCLOLIVQJXYCSY-UHFFFAOYSA-N ethyl 8-chloro-6,7-difluoro-4-oxo-1-(2,4,6-trifluorophenyl)quinoline-3-carboxylate Chemical compound C12=C(Cl)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=C(F)C=C(F)C=C1F HCLOLIVQJXYCSY-UHFFFAOYSA-N 0.000 description 2
- BLQXOVNUYXSGBF-UHFFFAOYSA-N ethyl 8-chloro-6,7-difluoro-4-oxo-1-[2,3,4-trifluoro-5-(phenylmethoxycarbonylamino)phenyl]quinoline-3-carboxylate Chemical compound C12=C(Cl)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C(C(=C(F)C=1F)F)=CC=1NC(=O)OCC1=CC=CC=C1 BLQXOVNUYXSGBF-UHFFFAOYSA-N 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 125000006038 hexenyl group Chemical group 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- VZXNZYZPKBHNEC-UHFFFAOYSA-N methyl 7-chloro-6-fluoro-1-(4-fluoro-3-nitrophenyl)-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OC)=CN1C1=CC=C(F)C([N+]([O-])=O)=C1 VZXNZYZPKBHNEC-UHFFFAOYSA-N 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- NQPTWMKTGPWPMX-UHFFFAOYSA-N n-methylazetidin-3-amine Chemical compound CNC1CNC1 NQPTWMKTGPWPMX-UHFFFAOYSA-N 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 229910017051 nitrogen difluoride Inorganic materials 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- JHHZLHWJQPUNKB-UHFFFAOYSA-N pyrrolidin-3-ol Chemical compound OC1CCNC1 JHHZLHWJQPUNKB-UHFFFAOYSA-N 0.000 description 2
- DTFYAPWMJMCTCC-UHFFFAOYSA-N pyrrolidin-3-ylmethanamine;dihydrochloride Chemical compound Cl.Cl.NCC1CCNC1 DTFYAPWMJMCTCC-UHFFFAOYSA-N 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 239000012453 solvate Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000003206 sterilizing agent Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- YLESTKCQLPTXBC-UHFFFAOYSA-N tert-butyl n-(3-amino-2,4-difluorophenyl)carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC=C(F)C(N)=C1F YLESTKCQLPTXBC-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- PYOKUURKVVELLB-UHFFFAOYSA-N trimethyl orthoformate Chemical compound COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- SZXBQTSZISFIAO-ZETCQYMHSA-N (2s)-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)OC(C)(C)C SZXBQTSZISFIAO-ZETCQYMHSA-N 0.000 description 1
- NGXSWUFDCSEIOO-SCSAIBSYSA-N (3r)-pyrrolidin-3-amine Chemical compound N[C@@H]1CCNC1 NGXSWUFDCSEIOO-SCSAIBSYSA-N 0.000 description 1
- ZCZJKVCIYONNJR-QWWZWVQMSA-N (3r,4r)-4-aminopyrrolidin-3-ol Chemical compound N[C@@H]1CNC[C@H]1O ZCZJKVCIYONNJR-QWWZWVQMSA-N 0.000 description 1
- XHVYAOXNULEUHH-CIFXRNLBSA-N (3r,4r)-4-methylpyrrolidin-3-amine;dihydrochloride Chemical compound Cl.Cl.C[C@@H]1CNC[C@@H]1N XHVYAOXNULEUHH-CIFXRNLBSA-N 0.000 description 1
- XHVYAOXNULEUHH-RSLHMRQOSA-N (3r,4s)-4-methylpyrrolidin-3-amine;dihydrochloride Chemical compound Cl.Cl.C[C@H]1CNC[C@@H]1N XHVYAOXNULEUHH-RSLHMRQOSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- JINYTXTYILIBHR-ILKKLZGPSA-N (3s)-n-ethylpyrrolidin-3-amine;dihydrochloride Chemical compound Cl.Cl.CCN[C@H]1CCNC1 JINYTXTYILIBHR-ILKKLZGPSA-N 0.000 description 1
- NGZYRKGJWYJGRS-YFKPBYRVSA-N (3s)-n-methylpyrrolidin-3-amine Chemical compound CN[C@H]1CCNC1 NGZYRKGJWYJGRS-YFKPBYRVSA-N 0.000 description 1
- ZJOAFRACLXVOAV-XRIGFGBMSA-N (3s)-n-methylpyrrolidin-3-amine;dihydrochloride Chemical compound Cl.Cl.CN[C@H]1CCNC1 ZJOAFRACLXVOAV-XRIGFGBMSA-N 0.000 description 1
- SLTMFXXAJKCIPQ-CRCLSJGQSA-N (3s,4s)-4-methylpyrrolidin-3-amine Chemical compound C[C@H]1CNC[C@H]1N SLTMFXXAJKCIPQ-CRCLSJGQSA-N 0.000 description 1
- XHVYAOXNULEUHH-YAQRUTEZSA-N (3s,4s)-4-methylpyrrolidin-3-amine;dihydrochloride Chemical compound Cl.Cl.C[C@H]1CNC[C@H]1N XHVYAOXNULEUHH-YAQRUTEZSA-N 0.000 description 1
- KSCPLKVBWDOSAI-NKWVEPMBSA-N (4as,7as)-2,3,4,4a,5,6,7,7a-octahydro-1h-pyrrolo[3,4-b]pyridine Chemical compound N1CCC[C@H]2CNC[C@H]21 KSCPLKVBWDOSAI-NKWVEPMBSA-N 0.000 description 1
- UKGJZDSUJSPAJL-YPUOHESYSA-N (e)-n-[(1r)-1-[3,5-difluoro-4-(methanesulfonamido)phenyl]ethyl]-3-[2-propyl-6-(trifluoromethyl)pyridin-3-yl]prop-2-enamide Chemical compound CCCC1=NC(C(F)(F)F)=CC=C1\C=C\C(=O)N[C@H](C)C1=CC(F)=C(NS(C)(=O)=O)C(F)=C1 UKGJZDSUJSPAJL-YPUOHESYSA-N 0.000 description 1
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- SSUJUUNLZQVZMO-UHFFFAOYSA-N 1,2,3,4,8,9,10,10a-octahydropyrimido[1,2-a]azepine Chemical compound C1CCC=CN2CCCNC21 SSUJUUNLZQVZMO-UHFFFAOYSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical group N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 description 1
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 1
- RLKQFGFEEROESJ-UHFFFAOYSA-N 1-(2,4-difluorophenyl)-6,7,8-trifluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C12=C(F)C(F)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1=CC=C(F)C=C1F RLKQFGFEEROESJ-UHFFFAOYSA-N 0.000 description 1
- BNYMEXVJUDGTJS-UHFFFAOYSA-N 1-(2,4-difluorophenyl)-6,7-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C12=CC(F)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1=CC=C(F)C=C1F BNYMEXVJUDGTJS-UHFFFAOYSA-N 0.000 description 1
- ZVQSHYUDKONDSM-VIFPVBQESA-N 1-(3-amino-2,4-difluorophenyl)-6-fluoro-7-[(3s)-3-formamidopyrrolidin-1-yl]-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound NC1=C(F)C=CC(N2C3=NC(=C(F)C=C3C(=O)C(C(O)=O)=C2)N2C[C@H](CC2)NC=O)=C1F ZVQSHYUDKONDSM-VIFPVBQESA-N 0.000 description 1
- NNZNCFRTBSBMQG-QRPNPIFTSA-N 1-(3-amino-2,4-difluorophenyl)-7-[(3s)-3-aminopyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;4-methylbenzenesulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1.C1[C@@H](N)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC=C(F)C(N)=C1F NNZNCFRTBSBMQG-QRPNPIFTSA-N 0.000 description 1
- AABTYMZCZCZHCG-QRPNPIFTSA-N 1-(3-amino-2,4-difluorophenyl)-7-[(3s)-3-aminopyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;formic acid Chemical compound OC=O.C1[C@@H](N)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC=C(F)C(N)=C1F AABTYMZCZCZHCG-QRPNPIFTSA-N 0.000 description 1
- UVOBZFFFFGWSPA-ISVAXAHUSA-N 1-(3-amino-2,4-difluorophenyl)-7-[(3s,4s)-3-amino-4-methylpyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1[C@@H](N)[C@@H](C)CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC=C(F)C(N)=C1F UVOBZFFFFGWSPA-ISVAXAHUSA-N 0.000 description 1
- LAUOXMADEIKNJV-JTQLQIEISA-N 1-(3-amino-4-fluoro-2-methylphenyl)-7-[(3s)-3-aminopyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound CC1=C(N)C(F)=CC=C1N1C2=NC(N3C[C@@H](N)CC3)=C(F)C=C2C(=O)C(C(O)=O)=C1 LAUOXMADEIKNJV-JTQLQIEISA-N 0.000 description 1
- RUXBOYKFTSKPRX-VIFPVBQESA-N 1-(3-amino-4-fluorophenyl)-7-[(3s)-3-aminopyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1[C@@H](N)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC=C(F)C(N)=C1 RUXBOYKFTSKPRX-VIFPVBQESA-N 0.000 description 1
- IHRFMKBZUWJWFO-XXFAHNHDSA-N 1-(3-amino-4-fluorophenyl)-7-[(3s,4s)-3-amino-4-methylpyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1[C@@H](N)[C@@H](C)CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC=C(F)C(N)=C1 IHRFMKBZUWJWFO-XXFAHNHDSA-N 0.000 description 1
- COGVZWXKCSIENP-UHFFFAOYSA-N 1-(4-amino-4,6-difluorocyclohexa-1,5-dien-1-yl)-8-chloro-6,7-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound FC1=CC(N)(F)CC=C1N1C2=C(Cl)C(F)=C(F)C=C2C(=O)C(C(O)=O)=C1 COGVZWXKCSIENP-UHFFFAOYSA-N 0.000 description 1
- SNNHZLQWYMUUAA-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-6,7,8-trichloro-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=C(Cl)C(Cl)=C(Cl)C=C3C(=O)C(C(O)=O)=C2)=C1F SNNHZLQWYMUUAA-UHFFFAOYSA-N 0.000 description 1
- WVAWPIPXKLBDKO-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-6,7-difluoro-8-methyl-4-oxoquinoline-3-carboxylic acid Chemical compound CC1=C(F)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1=CC(N)=C(F)C=C1F WVAWPIPXKLBDKO-UHFFFAOYSA-N 0.000 description 1
- TXDGDSRTVTYDGI-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-6,8-difluoro-7-(3-hydroxyazetidin-1-yl)-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=C(F)C(N4CC(O)C4)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F TXDGDSRTVTYDGI-UHFFFAOYSA-N 0.000 description 1
- SSCKZHOMASUKCS-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-6,8-difluoro-7-(3-hydroxypyrrolidin-1-yl)-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=C(F)C(N4CC(O)CC4)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F SSCKZHOMASUKCS-UHFFFAOYSA-N 0.000 description 1
- GFUKMSKAYJEYAR-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=NC(=C(F)C=C3C(=O)C(C(O)=O)=C2)N2CCNCC2)=C1F GFUKMSKAYJEYAR-UHFFFAOYSA-N 0.000 description 1
- RSTIFVRGALKXJE-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=CC(=C(F)C=C3C(=O)C(C(O)=O)=C2)N2CCNCC2)=C1F RSTIFVRGALKXJE-UHFFFAOYSA-N 0.000 description 1
- RCKOHOGXFFIGTO-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-6-fluoro-4-oxo-7-pyrrolidin-1-ylquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=CC(=C(F)C=C3C(=O)C(C(O)=O)=C2)N2CCCC2)=C1F RCKOHOGXFFIGTO-UHFFFAOYSA-N 0.000 description 1
- AFLSAUBRXAPIBS-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=NC(=C(F)C=C3C(=O)C(C(O)=O)=C2)N2CC(O)C2)=C1F AFLSAUBRXAPIBS-UHFFFAOYSA-N 0.000 description 1
- QWQXPHXGRFBVOF-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-6-fluoro-7-(3-hydroxypyrrolidin-1-yl)-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=NC(=C(F)C=C3C(=O)C(C(O)=O)=C2)N2CC(O)CC2)=C1F QWQXPHXGRFBVOF-UHFFFAOYSA-N 0.000 description 1
- VWGNNODMPQOCFM-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.C1CNC(C)CN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F VWGNNODMPQOCFM-UHFFFAOYSA-N 0.000 description 1
- OWDBJPUGBWAVRF-VIFPVBQESA-N 1-(5-amino-2,4-difluorophenyl)-6-fluoro-7-[(3s)-3-(methylamino)pyrrolidin-1-yl]-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1[C@@H](NC)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F OWDBJPUGBWAVRF-VIFPVBQESA-N 0.000 description 1
- SFCCURDTFXOJQB-JTQLQIEISA-N 1-(5-amino-2,4-difluorophenyl)-6-fluoro-7-[(3s)-3-(methylamino)pyrrolidin-1-yl]-4-oxoquinoline-3-carboxylic acid Chemical compound C1[C@@H](NC)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F SFCCURDTFXOJQB-JTQLQIEISA-N 0.000 description 1
- GFDXGKPYOJKXSL-ZRNGKTOUSA-N 1-(5-amino-2,4-difluorophenyl)-6-fluoro-7-[(3s,4s)-3-hydroxy-4-methylpyrrolidin-1-yl]-4-oxoquinoline-3-carboxylic acid Chemical compound C1[C@@H](O)[C@@H](C)CN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F GFDXGKPYOJKXSL-ZRNGKTOUSA-N 0.000 description 1
- CZXGCEFMGZHCNB-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-6-fluoro-7-[3-(methylamino)azetidin-1-yl]-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1C(NC)CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F CZXGCEFMGZHCNB-UHFFFAOYSA-N 0.000 description 1
- KXVGCSXSMQLGHC-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-6-fluoro-7-[3-(methylamino)piperidin-1-yl]-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(NC)CCCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F KXVGCSXSMQLGHC-UHFFFAOYSA-N 0.000 description 1
- OWDBJPUGBWAVRF-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-6-fluoro-7-[3-(methylamino)pyrrolidin-1-yl]-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1C(NC)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F OWDBJPUGBWAVRF-UHFFFAOYSA-N 0.000 description 1
- QYZAEZLQNLPYAM-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-7-(3,5-dimethylpiperazin-1-yl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1C(C)NC(C)CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F QYZAEZLQNLPYAM-UHFFFAOYSA-N 0.000 description 1
- ONEYBHYJJFBTNY-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-7-(3,5-dimethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(C)NC(C)CN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F ONEYBHYJJFBTNY-UHFFFAOYSA-N 0.000 description 1
- STDYPVMYRFUELR-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-7-(3-amino-3-methylazetidin-1-yl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1C(C)(N)CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F STDYPVMYRFUELR-UHFFFAOYSA-N 0.000 description 1
- WMWLSMPCYPNKAE-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-7-(3-amino-3-methylazetidin-1-yl)-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(C)(N)CN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1Cl WMWLSMPCYPNKAE-UHFFFAOYSA-N 0.000 description 1
- JYYNKIHLDGXVPI-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-7-(3-amino-3-methylpyrrolidin-1-yl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1C(C)(N)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F JYYNKIHLDGXVPI-UHFFFAOYSA-N 0.000 description 1
- ASPFZTMNZTYKSN-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-7-(3-carboxyazetidin-1-yl)-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=C(Cl)C(N4CC(C4)C(O)=O)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F ASPFZTMNZTYKSN-UHFFFAOYSA-N 0.000 description 1
- HEQBJVPEAGSEPE-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-7-(4-aminopiperidin-1-yl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1CC(N)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F HEQBJVPEAGSEPE-UHFFFAOYSA-N 0.000 description 1
- OHLKHXWKSQNVIA-RKDXNWHRSA-N 1-(5-amino-2,4-difluorophenyl)-7-[(1r,4r)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C([C@@]1(NC[C@@]2([H])C1)[H])N2C(C(=CC=1C(=O)C(C(O)=O)=C2)F)=NC=1N2C1=CC(N)=C(F)C=C1F OHLKHXWKSQNVIA-RKDXNWHRSA-N 0.000 description 1
- UFMBTLRFDAGZSZ-JKYUHCHBSA-N 1-(5-amino-2,4-difluorophenyl)-7-[(2s,3r)-3-amino-2-methylazetidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C[C@H]1[C@H](N)CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F UFMBTLRFDAGZSZ-JKYUHCHBSA-N 0.000 description 1
- IFOXMMLZVZQXLL-JKYUHCHBSA-N 1-(5-amino-2,4-difluorophenyl)-7-[(2s,3r)-3-amino-2-methylazetidin-1-yl]-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C[C@H]1[C@H](N)CN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1Cl IFOXMMLZVZQXLL-JKYUHCHBSA-N 0.000 description 1
- VVEIPGVRYWSKEL-MRVPVSSYSA-N 1-(5-amino-2,4-difluorophenyl)-7-[(3r)-3-aminopyrrolidin-1-yl]-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1[C@H](N)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1Cl VVEIPGVRYWSKEL-MRVPVSSYSA-N 0.000 description 1
- MPOLDQWPCKUHDS-UKRRQHHQSA-N 1-(5-amino-2,4-difluorophenyl)-7-[(3r,4r)-3-amino-4-hydroxypyrrolidin-1-yl]-6,8-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1[C@@H](O)[C@H](N)CN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1F MPOLDQWPCKUHDS-UKRRQHHQSA-N 0.000 description 1
- HJJBASGPVTZBOX-GLEZIHRCSA-N 1-(5-amino-2,4-difluorophenyl)-7-[(3r,4r)-3-amino-4-methylpyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1[C@H](N)[C@H](C)CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F HJJBASGPVTZBOX-GLEZIHRCSA-N 0.000 description 1
- AWCXSZMJSFNYIH-ZBFHGGJFSA-N 1-(5-amino-2,4-difluorophenyl)-7-[(3r,4s)-3-amino-4-methoxypyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1[C@@H](N)[C@@H](OC)CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F AWCXSZMJSFNYIH-ZBFHGGJFSA-N 0.000 description 1
- HJJBASGPVTZBOX-AYVTZFPOSA-N 1-(5-amino-2,4-difluorophenyl)-7-[(3r,4s)-3-amino-4-methylpyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1[C@H](N)[C@@H](C)CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F HJJBASGPVTZBOX-AYVTZFPOSA-N 0.000 description 1
- LTAKDZHQVUBIND-JTQLQIEISA-N 1-(5-amino-2,4-difluorophenyl)-7-[(3s)-3-(ethylamino)pyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1[C@@H](NCC)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F LTAKDZHQVUBIND-JTQLQIEISA-N 0.000 description 1
- JUEOVKPWDDSZDQ-ZWLLKMRYSA-N 1-(5-amino-2,4-difluorophenyl)-7-[(3s)-3-[[(2s)-2-amino-3-methylbutanoyl]amino]pyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;methanesulfonic acid Chemical compound CS(O)(=O)=O.C1[C@@H](NC(=O)[C@@H](N)C(C)C)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F JUEOVKPWDDSZDQ-ZWLLKMRYSA-N 0.000 description 1
- WJHNHASSIQCJGQ-BUXKBTBVSA-N 1-(5-amino-2,4-difluorophenyl)-7-[(3s)-3-[[(2s)-2-amino-4-methylpentanoyl]amino]pyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1[C@@H](NC(=O)[C@@H](N)CC(C)C)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F WJHNHASSIQCJGQ-BUXKBTBVSA-N 0.000 description 1
- IBBXZTJSUPQXLP-VIFPVBQESA-N 1-(5-amino-2,4-difluorophenyl)-7-[(3s)-3-aminopyrrolidin-1-yl]-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1[C@@H](N)CCN1C1=CC=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=N1 IBBXZTJSUPQXLP-VIFPVBQESA-N 0.000 description 1
- SNQVUULQMYWEKV-QMMMGPOBSA-N 1-(5-amino-2,4-difluorophenyl)-7-[(3s)-3-aminopyrrolidin-1-yl]-6,8-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1[C@@H](N)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1F SNQVUULQMYWEKV-QMMMGPOBSA-N 0.000 description 1
- WUSPDLJDGWLFGY-QMMMGPOBSA-N 1-(5-amino-2,4-difluorophenyl)-7-[(3s)-3-aminopyrrolidin-1-yl]-6-chloro-8-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1[C@@H](N)CCN1C1=C(Cl)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1F WUSPDLJDGWLFGY-QMMMGPOBSA-N 0.000 description 1
- XVQJVEKLFWCVBG-QMMMGPOBSA-N 1-(5-amino-2,4-difluorophenyl)-7-[(3s)-3-aminopyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1[C@@H](N)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F XVQJVEKLFWCVBG-QMMMGPOBSA-N 0.000 description 1
- JRMDYQBQBZAFFK-JZGIKJSDSA-N 1-(5-amino-2,4-difluorophenyl)-7-[(3s)-3-aminopyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.C1[C@@H](N)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F JRMDYQBQBZAFFK-JZGIKJSDSA-N 0.000 description 1
- OQPFSGSCBYDUHP-QRPNPIFTSA-N 1-(5-amino-2,4-difluorophenyl)-7-[(3s)-3-aminopyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;n,n-diethylethanamine Chemical compound CCN(CC)CC.C1[C@@H](N)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F OQPFSGSCBYDUHP-QRPNPIFTSA-N 0.000 description 1
- LSMXHEVQBUYMAJ-VIFPVBQESA-N 1-(5-amino-2,4-difluorophenyl)-7-[(3s)-3-aminopyrrolidin-1-yl]-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1[C@@H](N)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F LSMXHEVQBUYMAJ-VIFPVBQESA-N 0.000 description 1
- WXOHEYXFFAWKMX-QMMMGPOBSA-N 1-(5-amino-2,4-difluorophenyl)-7-[(3s)-3-aminopyrrolidin-1-yl]-6-fluoro-5-hydroxy-4-oxoquinoline-3-carboxylic acid Chemical compound C1[C@@H](N)CCN1C(C(=C1O)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F WXOHEYXFFAWKMX-QMMMGPOBSA-N 0.000 description 1
- VVEIPGVRYWSKEL-QMMMGPOBSA-N 1-(5-amino-2,4-difluorophenyl)-7-[(3s)-3-aminopyrrolidin-1-yl]-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1[C@@H](N)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1Cl VVEIPGVRYWSKEL-QMMMGPOBSA-N 0.000 description 1
- HJJBASGPVTZBOX-ANRSDYALSA-N 1-(5-amino-2,4-difluorophenyl)-7-[(3s,4r)-3-amino-4-methylpyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1[C@@H](N)[C@H](C)CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F HJJBASGPVTZBOX-ANRSDYALSA-N 0.000 description 1
- UCRZCAQODBRVJS-JDNHERCYSA-N 1-(5-amino-2,4-difluorophenyl)-7-[(3s,4r)-3-amino-4-methylpyrrolidin-1-yl]-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1[C@@H](N)[C@H](C)CN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F UCRZCAQODBRVJS-JDNHERCYSA-N 0.000 description 1
- MZWINKSYQFHEOD-ANRSDYALSA-N 1-(5-amino-2,4-difluorophenyl)-7-[(3s,4r)-3-amino-4-methylpyrrolidin-1-yl]-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1[C@@H](N)[C@H](C)CN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1Cl MZWINKSYQFHEOD-ANRSDYALSA-N 0.000 description 1
- HJJBASGPVTZBOX-VXJOIVPMSA-N 1-(5-amino-2,4-difluorophenyl)-7-[(3s,4s)-3-amino-4-methylpyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1[C@@H](N)[C@@H](C)CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F HJJBASGPVTZBOX-VXJOIVPMSA-N 0.000 description 1
- RBKUEWIWDHOQLO-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-7-[3-(2-aminoethyl)azetidin-1-yl]-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1C(CCN)CN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1Cl RBKUEWIWDHOQLO-UHFFFAOYSA-N 0.000 description 1
- OZYUKPFYYTVBEL-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-7-[3-(aminomethyl)-3-hydroxyazetidin-1-yl]-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(CN)(O)CN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1Cl OZYUKPFYYTVBEL-UHFFFAOYSA-N 0.000 description 1
- KDZVJCCUWHFKNN-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-7-[3-(aminomethyl)azetidin-1-yl]-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(CN)CN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1Cl KDZVJCCUWHFKNN-UHFFFAOYSA-N 0.000 description 1
- IGWMOZLIEIRYGM-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-7-[3-(aminomethyl)pyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1C(CN)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F IGWMOZLIEIRYGM-UHFFFAOYSA-N 0.000 description 1
- JXFDMNRXMVICON-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-7-[3-(aminomethyl)pyrrolidin-1-yl]-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(CN)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1Cl JXFDMNRXMVICON-UHFFFAOYSA-N 0.000 description 1
- XLBOIIHEEBOGAQ-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-7-[3-(dimethylamino)azetidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.C1C(N(C)C)CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F XLBOIIHEEBOGAQ-UHFFFAOYSA-N 0.000 description 1
- CMMICNHESRQWAF-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-7-[3-(ethylamino)azetidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1C(NCC)CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F CMMICNHESRQWAF-UHFFFAOYSA-N 0.000 description 1
- YQQQZICDEORJDC-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-7-[3-(ethylaminomethyl)pyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1C(CNCC)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F YQQQZICDEORJDC-UHFFFAOYSA-N 0.000 description 1
- VXHULUWRKUZHFN-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-8-chloro-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=C(Cl)C(N4CCNCC4)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F VXHULUWRKUZHFN-UHFFFAOYSA-N 0.000 description 1
- UPJALNGUOFFJLF-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=C(Cl)C(N4CC(O)C4)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F UPJALNGUOFFJLF-UHFFFAOYSA-N 0.000 description 1
- YBGMHQFQJPJMLP-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-8-chloro-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid Chemical compound C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1Cl YBGMHQFQJPJMLP-UHFFFAOYSA-N 0.000 description 1
- UBMQUKDOSUSIDP-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-8-chloro-6-fluoro-7-[3-(methylamino)azetidin-1-yl]-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(NC)CN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1Cl UBMQUKDOSUSIDP-UHFFFAOYSA-N 0.000 description 1
- GSRSOYBUWQNHQE-UHFFFAOYSA-N 1-(5-amino-2,4-difluorophenyl)-8-chloro-7-[3-(dimethylamino)azetidin-1-yl]-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(N(C)C)CN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1Cl GSRSOYBUWQNHQE-UHFFFAOYSA-N 0.000 description 1
- KFWVXAFHGWCWPU-UHFFFAOYSA-N 1-(5-amino-2-chloro-4-fluorophenyl)-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=NC(=C(F)C=C3C(=O)C(C(O)=O)=C2)N2CCNCC2)=C1Cl KFWVXAFHGWCWPU-UHFFFAOYSA-N 0.000 description 1
- UBJPAHMHXWEHSX-UHFFFAOYSA-N 1-(5-amino-2-chloro-4-fluorophenyl)-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=CC(=C(F)C=C3C(=O)C(C(O)=O)=C2)N2CCNCC2)=C1Cl UBJPAHMHXWEHSX-UHFFFAOYSA-N 0.000 description 1
- ALGYRMDTDOFFDN-QMMMGPOBSA-N 1-(5-amino-2-chloro-4-fluorophenyl)-7-[(3s)-3-aminopyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1[C@@H](N)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1Cl ALGYRMDTDOFFDN-QMMMGPOBSA-N 0.000 description 1
- DJQIRKDRRSIGHR-VIFPVBQESA-N 1-(5-amino-2-chloro-4-fluorophenyl)-7-[(3s)-3-aminopyrrolidin-1-yl]-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1[C@@H](N)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1Cl DJQIRKDRRSIGHR-VIFPVBQESA-N 0.000 description 1
- WZXVKDYKHATIGI-QMMMGPOBSA-N 1-(5-amino-2-chloro-4-fluorophenyl)-7-[(3s)-3-aminopyrrolidin-1-yl]-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1[C@@H](N)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)Cl)C2=C1Cl WZXVKDYKHATIGI-QMMMGPOBSA-N 0.000 description 1
- OBBBHSDZSYOLPK-UHFFFAOYSA-N 1-(5-amino-4-chloro-2-fluorophenyl)-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid Chemical compound C1=C(Cl)C(N)=CC(N2C3=NC(=C(F)C=C3C(=O)C(C(O)=O)=C2)N2CCNCC2)=C1F OBBBHSDZSYOLPK-UHFFFAOYSA-N 0.000 description 1
- WHEIWODKIHUHJE-QMMMGPOBSA-N 1-(5-amino-4-chloro-2-fluorophenyl)-7-[(3s)-3-aminopyrrolidin-1-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1[C@@H](N)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(Cl)C=C1F WHEIWODKIHUHJE-QMMMGPOBSA-N 0.000 description 1
- IAMXANQLIQZLLI-UHFFFAOYSA-N 1-(5-amino-4-fluoro-2-methylphenyl)-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid Chemical compound CC1=CC(F)=C(N)C=C1N1C2=NC(N3CCNCC3)=C(F)C=C2C(=O)C(C(O)=O)=C1 IAMXANQLIQZLLI-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- NOGFHTGYPKWWRX-UHFFFAOYSA-N 2,2,6,6-tetramethyloxan-4-one Chemical compound CC1(C)CC(=O)CC(C)(C)O1 NOGFHTGYPKWWRX-UHFFFAOYSA-N 0.000 description 1
- LXFQSRIDYRFTJW-UHFFFAOYSA-N 2,4,6-trimethylbenzenesulfonic acid Chemical compound CC1=CC(C)=C(S(O)(=O)=O)C(C)=C1 LXFQSRIDYRFTJW-UHFFFAOYSA-N 0.000 description 1
- CEPCPXLLFXPZGW-UHFFFAOYSA-N 2,4-difluoroaniline Chemical compound NC1=CC=C(F)C=C1F CEPCPXLLFXPZGW-UHFFFAOYSA-N 0.000 description 1
- NJYBIFYEWYWYAN-UHFFFAOYSA-N 2,4-difluorobenzoic acid Chemical compound OC(=O)C1=CC=C(F)C=C1F NJYBIFYEWYWYAN-UHFFFAOYSA-N 0.000 description 1
- PIDOCGDMKRSJMT-UHFFFAOYSA-N 2,5-diazabicyclo[2.2.1]heptane;dihydrochloride Chemical compound Cl.Cl.C1NC2CNC1C2 PIDOCGDMKRSJMT-UHFFFAOYSA-N 0.000 description 1
- QBQZALKPPLUCQY-UHFFFAOYSA-N 2-(4-fluoro-1h-indol-3-yl)acetic acid Chemical compound C1=CC(F)=C2C(CC(=O)O)=CNC2=C1 QBQZALKPPLUCQY-UHFFFAOYSA-N 0.000 description 1
- FHEILDDDTFMKAC-UHFFFAOYSA-N 2-(pyrrolidin-3-ylamino)ethanol;dihydrochloride Chemical compound Cl.Cl.OCCNC1CCNC1 FHEILDDDTFMKAC-UHFFFAOYSA-N 0.000 description 1
- VRPJIFMKZZEXLR-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid Chemical compound CC(C)(C)OC(=O)NCC(O)=O VRPJIFMKZZEXLR-UHFFFAOYSA-N 0.000 description 1
- YLMFXCIATJJKQL-UHFFFAOYSA-N 2-bromo-4-fluoroaniline Chemical compound NC1=CC=C(F)C=C1Br YLMFXCIATJJKQL-UHFFFAOYSA-N 0.000 description 1
- JOMNTHCQHJPVAZ-UHFFFAOYSA-N 2-methylpiperazine Chemical compound CC1CNCCN1 JOMNTHCQHJPVAZ-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- YGYGASJNJTYNOL-CQSZACIVSA-N 3-[(4r)-2,2-dimethyl-1,1-dioxothian-4-yl]-5-(4-fluorophenyl)-1h-indole-7-carboxamide Chemical compound C1CS(=O)(=O)C(C)(C)C[C@@H]1C1=CNC2=C(C(N)=O)C=C(C=3C=CC(F)=CC=3)C=C12 YGYGASJNJTYNOL-CQSZACIVSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- PYBBRDLRXFWWFU-UHFFFAOYSA-N 3-methylazetidin-3-amine Chemical compound CC1(N)CNC1 PYBBRDLRXFWWFU-UHFFFAOYSA-N 0.000 description 1
- APTTXTPGJFSWJS-UHFFFAOYSA-N 3-methylpyrrolidin-1-amine Chemical compound CC1CCN(N)C1 APTTXTPGJFSWJS-UHFFFAOYSA-N 0.000 description 1
- LVWLJFTUJCADPB-UHFFFAOYSA-N 3-methylpyrrolidin-3-amine;dihydrochloride Chemical compound Cl.Cl.CC1(N)CCNC1 LVWLJFTUJCADPB-UHFFFAOYSA-N 0.000 description 1
- KYINPWAJIVTFBW-UHFFFAOYSA-N 3-methylpyrrolidine Chemical compound CC1CCNC1 KYINPWAJIVTFBW-UHFFFAOYSA-N 0.000 description 1
- GNXDGZLOZSVGJF-UHFFFAOYSA-N 4,4-dimethylpyrrolidin-3-amine;dihydrochloride Chemical compound Cl.Cl.CC1(C)CNCC1N GNXDGZLOZSVGJF-UHFFFAOYSA-N 0.000 description 1
- CSDQQAQKBAQLLE-UHFFFAOYSA-N 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1=CC(Cl)=CC=C1C1C(C=CS2)=C2CCN1 CSDQQAQKBAQLLE-UHFFFAOYSA-N 0.000 description 1
- VJPPLCNBDLZIFG-ZDUSSCGKSA-N 4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide Chemical compound C(C#CC)(=O)N[C@@H]1CN(CCC1)C1=C2C(=C(NC2=C(C=C1F)C(=O)N)C)C VJPPLCNBDLZIFG-ZDUSSCGKSA-N 0.000 description 1
- YFCIFWOJYYFDQP-PTWZRHHISA-N 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide Chemical compound CNC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@H](O)[C@@H](F)C1)c1cc(F)cc(Br)c1 YFCIFWOJYYFDQP-PTWZRHHISA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- BNRRMRUVYDETQC-UHFFFAOYSA-N 4-fluoro-2-methoxyaniline Chemical compound COC1=CC(F)=CC=C1N BNRRMRUVYDETQC-UHFFFAOYSA-N 0.000 description 1
- KRZCOLNOCZKSDF-UHFFFAOYSA-N 4-fluoroaniline Chemical compound NC1=CC=C(F)C=C1 KRZCOLNOCZKSDF-UHFFFAOYSA-N 0.000 description 1
- KBPHGYUXEIDPPV-UHFFFAOYSA-N 4-oxo-1h-1,8-naphthyridine-3-carboxylic acid Chemical compound C1=CC=C2C(=O)C(C(=O)O)=CNC2=N1 KBPHGYUXEIDPPV-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- MJMNYHGQVXQGPO-ZETCQYMHSA-N 5-amino-1-(5-amino-2,4-difluorophenyl)-7-[(3s)-3-aminopyrrolidin-1-yl]-6,8-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1[C@@H](N)CCN1C1=C(F)C(N)=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1F MJMNYHGQVXQGPO-ZETCQYMHSA-N 0.000 description 1
- OEIXBNJRTHCNJT-UHFFFAOYSA-N 5-amino-7-(3-aminoazetidin-1-yl)-1-(5-amino-2,4-difluorophenyl)-6,8-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(N)CN1C1=C(F)C(N)=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1F OEIXBNJRTHCNJT-UHFFFAOYSA-N 0.000 description 1
- XAGBGHBEAZFCBJ-UHFFFAOYSA-N 5-amino-7-(3-aminoazetidin-1-yl)-1-(5-amino-2,4-difluorophenyl)-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(N)CN1C1=C(F)C(N)=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1Cl XAGBGHBEAZFCBJ-UHFFFAOYSA-N 0.000 description 1
- MSPJADOPFBUGGL-UHFFFAOYSA-N 6,7-difluoro-4-oxo-1-(2,3,4-trifluorophenyl)quinoline-3-carboxylic acid Chemical compound C12=CC(F)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1=CC=C(F)C(F)=C1F MSPJADOPFBUGGL-UHFFFAOYSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- BTNUYBNOCRZDIT-UHFFFAOYSA-N 7-(2,3,3a,4,6,6a-hexahydro-1h-pyrrolo[3,4-c]pyrrol-5-yl)-1-(5-amino-2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.C1=C(F)C(N)=CC(N2C3=NC(=C(F)C=C3C(=O)C(C(O)=O)=C2)N2CC3CNCC3C2)=C1F BTNUYBNOCRZDIT-UHFFFAOYSA-N 0.000 description 1
- LWCSMHUNJZBGIE-UHFFFAOYSA-N 7-(2,3,3a,4,6,6a-hexahydro-1h-pyrrolo[3,4-c]pyrrol-5-yl)-1-(5-amino-2,4-difluorophenyl)-6-fluoro-4-oxoquinoline-3-carboxylic acid;hydrochloride Chemical compound Cl.C1=C(F)C(N)=CC(N2C3=CC(=C(F)C=C3C(=O)C(C(O)=O)=C2)N2CC3CNCC3C2)=C1F LWCSMHUNJZBGIE-UHFFFAOYSA-N 0.000 description 1
- AGRBQVJVZYJREG-UHFFFAOYSA-N 7-(2,3,3a,4,6,6a-hexahydro-1h-pyrrolo[3,4-c]pyrrol-5-yl)-1-(5-amino-2,4-difluorophenyl)-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid;hydrochloride Chemical compound Cl.C1=C(F)C(N)=CC(N2C3=C(Cl)C(N4CC5CNCC5C4)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F AGRBQVJVZYJREG-UHFFFAOYSA-N 0.000 description 1
- SNWUTSRSBMHBKA-UHFFFAOYSA-N 7-(3-acetamidoazetidin-1-yl)-1-(5-amino-2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1C(NC(=O)C)CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F SNWUTSRSBMHBKA-UHFFFAOYSA-N 0.000 description 1
- XWDAIRBHTQSZIU-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(3-amino-2,4,6-trifluorophenyl)-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(N)CN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=C(N)C(F)=CC=3F)F)C2=C1Cl XWDAIRBHTQSZIU-UHFFFAOYSA-N 0.000 description 1
- LEUZPTQGRPOSSH-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(3-amino-4-fluoro-2-methoxyphenyl)-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound COC1=C(N)C(F)=CC=C1N1C2=CC(N3CC(N)C3)=C(F)C=C2C(=O)C(C(O)=O)=C1 LEUZPTQGRPOSSH-UHFFFAOYSA-N 0.000 description 1
- MLZWDJNIUYDKDP-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-2,3,4-trifluorophenyl)-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(N)CN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=C(F)C(F)=C(N)C=3)F)C2=C1Cl MLZWDJNIUYDKDP-UHFFFAOYSA-N 0.000 description 1
- FDRHGGUJWBQQIS-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-2,4-difluorophenyl)-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1C(N)CN1C1=CC=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=N1 FDRHGGUJWBQQIS-UHFFFAOYSA-N 0.000 description 1
- RLHGTSLWFBHNPD-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-2,4-difluorophenyl)-6,8-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(N)CN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1F RLHGTSLWFBHNPD-UHFFFAOYSA-N 0.000 description 1
- SOAHEOYMFTUMKX-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-2,4-difluorophenyl)-6,8-difluoro-5-hydroxy-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(N)CN1C1=C(F)C(O)=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1F SOAHEOYMFTUMKX-UHFFFAOYSA-N 0.000 description 1
- LXAPVZAIEOYQDF-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-2,4-difluorophenyl)-6-chloro-8-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(N)CN1C1=C(Cl)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1F LXAPVZAIEOYQDF-UHFFFAOYSA-N 0.000 description 1
- CTGCRMXKQNKBPY-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1C(N)CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F CTGCRMXKQNKBPY-UHFFFAOYSA-N 0.000 description 1
- SZOBGODOETWWAX-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;4-methylbenzenesulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1.C1C(N)CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F SZOBGODOETWWAX-UHFFFAOYSA-N 0.000 description 1
- BONZAOZGVNBYLA-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;methanesulfonic acid Chemical compound CS(O)(=O)=O.C1C(N)CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F BONZAOZGVNBYLA-UHFFFAOYSA-N 0.000 description 1
- BIKZZZFYLADFLM-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-2,4-difluorophenyl)-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(N)CN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F BIKZZZFYLADFLM-UHFFFAOYSA-N 0.000 description 1
- OCYMVPJZTIMQJE-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-2,4-difluorophenyl)-6-fluoro-5-hydroxy-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(N)CN1C(C(=C1O)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1F OCYMVPJZTIMQJE-UHFFFAOYSA-N 0.000 description 1
- BZTNZADUMBRFKE-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-2,4-difluorophenyl)-6-fluoro-5-methyl-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)C=2C(C)=C(F)C(N3CC(N)C3)=CC=2N1C1=CC(N)=C(F)C=C1F BZTNZADUMBRFKE-UHFFFAOYSA-N 0.000 description 1
- GGAHLKRTHCXMQF-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-2,4-difluorophenyl)-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=CN2C=3C(=CC(F)=C(N)C=3)F)=O)=C2C(OC)=C1N1CC(N)C1 GGAHLKRTHCXMQF-UHFFFAOYSA-N 0.000 description 1
- BQFXEKAUTNWUHO-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-2,4-difluorophenyl)-8-bromo-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(N)CN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1Br BQFXEKAUTNWUHO-UHFFFAOYSA-N 0.000 description 1
- ATHBCDQPZRXUNJ-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-2,4-difluorophenyl)-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(N)CN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1Cl ATHBCDQPZRXUNJ-UHFFFAOYSA-N 0.000 description 1
- VYISEXBCSLDSBH-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-2,4-difluorophenyl)-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid;4-methylbenzenesulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1.C1C(N)CN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1Cl VYISEXBCSLDSBH-UHFFFAOYSA-N 0.000 description 1
- AIOFEWPHXXRACO-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-2,4-difluorophenyl)-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid;methanesulfonic acid Chemical compound CS(O)(=O)=O.C1C(N)CN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)F)C2=C1Cl AIOFEWPHXXRACO-UHFFFAOYSA-N 0.000 description 1
- YHLXTBZLTCKHCI-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-2-bromo-4-fluorophenyl)-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(N)CN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)Br)C2=C1Cl YHLXTBZLTCKHCI-UHFFFAOYSA-N 0.000 description 1
- NQAVDIHNDVIDBM-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-2-chloro-4-fluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1C(N)CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1Cl NQAVDIHNDVIDBM-UHFFFAOYSA-N 0.000 description 1
- QAZPMLSGWUGPBM-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-2-chloro-4-fluorophenyl)-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(N)CN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C=C1Cl QAZPMLSGWUGPBM-UHFFFAOYSA-N 0.000 description 1
- QFLQEIZFCFVHPT-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-2-chloro-4-fluorophenyl)-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(N)CN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(F)=C(N)C=3)Cl)C2=C1Cl QFLQEIZFCFVHPT-UHFFFAOYSA-N 0.000 description 1
- SJOYUQVNWLLPRX-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-4-chloro-2-fluorophenyl)-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1C(N)CN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C=3C(=CC(Cl)=C(N)C=3)F)C2=C1Cl SJOYUQVNWLLPRX-UHFFFAOYSA-N 0.000 description 1
- GUOGXMKZJFMMTR-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-4-fluoro-2-methoxyphenyl)-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound COC1=CC(F)=C(N)C=C1N1C2=C(Cl)C(N3CC(N)C3)=C(F)C=C2C(=O)C(C(O)=O)=C1 GUOGXMKZJFMMTR-UHFFFAOYSA-N 0.000 description 1
- HPHOPDWKUSMIOH-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-4-fluoro-2-methylphenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound CC1=CC(F)=C(N)C=C1N1C2=NC(N3CC(N)C3)=C(F)C=C2C(=O)C(C(O)=O)=C1 HPHOPDWKUSMIOH-UHFFFAOYSA-N 0.000 description 1
- WIYJKHUZUMIITM-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-(5-amino-4-fluoro-2-methylphenyl)-8-chloro-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound CC1=CC(F)=C(N)C=C1N1C2=C(Cl)C(N3CC(N)C3)=C(F)C=C2C(=O)C(C(O)=O)=C1 WIYJKHUZUMIITM-UHFFFAOYSA-N 0.000 description 1
- KBILDOQNZRPGKS-UHFFFAOYSA-N 7-(3-aminoazetidin-1-yl)-1-[2,4-difluoro-5-(methylamino)phenyl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1=C(F)C(NC)=CC(N2C3=NC(=C(F)C=C3C(=O)C(C(O)=O)=C2)N2CC(N)C2)=C1F KBILDOQNZRPGKS-UHFFFAOYSA-N 0.000 description 1
- ADAABAVNZWPEFU-UHFFFAOYSA-N 7-(7-amino-5-azaspiro[2.4]heptan-5-yl)-1-(5-amino-2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.NC1CN(C=2C(=CC=3C(=O)C(C(O)=O)=CN(C=3N=2)C=2C(=CC(F)=C(N)C=2)F)F)CC11CC1 ADAABAVNZWPEFU-UHFFFAOYSA-N 0.000 description 1
- TWFMCSAGXSIKRV-VIFPVBQESA-N 7-[(3s)-3-aminopyrrolidin-1-yl]-1-(2,4-difluoro-5-formamidophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1[C@@H](N)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(NC=O)=C(F)C=C1F TWFMCSAGXSIKRV-VIFPVBQESA-N 0.000 description 1
- VNTOYJLUZSOVAS-ZETCQYMHSA-N 7-[(3s)-3-aminopyrrolidin-1-yl]-1-(3-amino-2,4,6-trifluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1[C@@H](N)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=C(F)C=C(F)C(N)=C1F VNTOYJLUZSOVAS-ZETCQYMHSA-N 0.000 description 1
- ZDUDPLCEPNYLRG-ZETCQYMHSA-N 7-[(3s)-3-aminopyrrolidin-1-yl]-1-(5-amino-2,3,4-trifluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1[C@@H](N)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C(F)=C1F ZDUDPLCEPNYLRG-ZETCQYMHSA-N 0.000 description 1
- GLLOXDARCYLDPM-QMMMGPOBSA-N 7-[(3s)-3-aminopyrrolidin-1-yl]-1-(5-amino-2,3,4-trifluorophenyl)-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1[C@@H](N)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1=CC(N)=C(F)C(F)=C1F GLLOXDARCYLDPM-QMMMGPOBSA-N 0.000 description 1
- RYZRKSDLBQOGAA-AWEZNQCLSA-N 7-[(3s)-3-aminopyrrolidin-1-yl]-1-(5-benzamido-2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1[C@@H](N)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(NC(=O)C=2C=CC=CC=2)=C(F)C=C1F RYZRKSDLBQOGAA-AWEZNQCLSA-N 0.000 description 1
- DSNYOHDHJXFDQN-VIFPVBQESA-N 7-[(3s)-3-aminopyrrolidin-1-yl]-1-[2,4-difluoro-5-(methylamino)phenyl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1=C(F)C(NC)=CC(N2C3=NC(=C(F)C=C3C(=O)C(C(O)=O)=C2)N2C[C@@H](N)CC2)=C1F DSNYOHDHJXFDQN-VIFPVBQESA-N 0.000 description 1
- CZYGUCMIJYRWAA-JTQLQIEISA-N 7-[(3s)-3-aminopyrrolidin-1-yl]-1-[2,4-difluoro-5-(methylamino)phenyl]-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(NC)=CC(N2C3=CC(=C(F)C=C3C(=O)C(C(O)=O)=C2)N2C[C@@H](N)CC2)=C1F CZYGUCMIJYRWAA-JTQLQIEISA-N 0.000 description 1
- KLQBWSPXCSMPJE-JTQLQIEISA-N 7-[(3s)-3-aminopyrrolidin-1-yl]-1-[5-(dimethylamino)-2,4-difluorophenyl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1=C(F)C(N(C)C)=CC(N2C3=NC(=C(F)C=C3C(=O)C(C(O)=O)=C2)N2C[C@@H](N)CC2)=C1F KLQBWSPXCSMPJE-JTQLQIEISA-N 0.000 description 1
- GQWVUNZRAGRFKY-JTQLQIEISA-N 7-[(3s)-3-aminopyrrolidin-1-yl]-1-[5-(ethoxycarbonylamino)-2,4-difluorophenyl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1=C(F)C(NC(=O)OCC)=CC(N2C3=NC(=C(F)C=C3C(=O)C(C(O)=O)=C2)N2C[C@@H](N)CC2)=C1F GQWVUNZRAGRFKY-JTQLQIEISA-N 0.000 description 1
- JZQMSCNLLZRMSB-BJOHPYRUSA-N 7-[(3s,4s)-3-amino-4-methylpyrrolidin-1-yl]-1-(2,4-difluoro-5-formamidophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C1[C@@H](N)[C@@H](C)CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC(NC=O)=C(F)C=C1F JZQMSCNLLZRMSB-BJOHPYRUSA-N 0.000 description 1
- MAYXUGXLBXBMBQ-BBATYDOGSA-N 7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-(5-amino-2,4-difluorophenyl)-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(F)C(N)=CC(N2C3=CC(=C(F)C=C3C(=O)C(C(O)=O)=C2)N2C[C@H]3NCCC[C@H]3C2)=C1F MAYXUGXLBXBMBQ-BBATYDOGSA-N 0.000 description 1
- JICNLVRBWLQPNP-UHFFFAOYSA-N 7-chloro-1-(2,4-difluoro-5-nitrophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1=CC([N+]([O-])=O)=C(F)C=C1F JICNLVRBWLQPNP-UHFFFAOYSA-N 0.000 description 1
- WTCJJEJMYYASNT-UHFFFAOYSA-N 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1=CC=C(F)C=C1F WTCJJEJMYYASNT-UHFFFAOYSA-N 0.000 description 1
- JVBDNUFWJWKHMS-UHFFFAOYSA-N 7-chloro-6-fluoro-1-(4-fluoro-3-nitrophenyl)-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1=CC=C(F)C([N+]([O-])=O)=C1 JVBDNUFWJWKHMS-UHFFFAOYSA-N 0.000 description 1
- MSHYEQPKGREGMS-UHFFFAOYSA-N 7-chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1=CC=C(F)C=C1 MSHYEQPKGREGMS-UHFFFAOYSA-N 0.000 description 1
- PTEWWRIGYNMURH-UHFFFAOYSA-N 7-chloro-6-fluoro-4-oxo-1-(2,3,4-trifluorophenyl)-1,8-naphthyridine-3-carboxylic acid Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1=CC=C(F)C(F)=C1F PTEWWRIGYNMURH-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- JGMZQQVXPINGHY-UHFFFAOYSA-N 8-chloro-6,7-difluoro-4-oxo-1-(2,4,6-trifluoro-3-nitrophenyl)quinoline-3-carboxylic acid Chemical compound C12=C(Cl)C(F)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1=C(F)C=C(F)C([N+]([O-])=O)=C1F JGMZQQVXPINGHY-UHFFFAOYSA-N 0.000 description 1
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- ZRPZPNYZFSJUPA-UHFFFAOYSA-N ARS-1620 Chemical compound Oc1cccc(F)c1-c1c(Cl)cc2c(ncnc2c1F)N1CCN(CC1)C(=O)C=C ZRPZPNYZFSJUPA-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 1
- ZSZYPJVPIRCYDZ-UHFFFAOYSA-N C1=C2C(=CC(=C1F)F)N(C(=C(C2=O)C(=O)O)Cl)C3=C(C(=C(C=C3F)F)[N+](=O)[O-])F Chemical compound C1=C2C(=CC(=C1F)F)N(C(=C(C2=O)C(=O)O)Cl)C3=C(C(=C(C=C3F)F)[N+](=O)[O-])F ZSZYPJVPIRCYDZ-UHFFFAOYSA-N 0.000 description 1
- ULMAAWYTRWPDRJ-UHFFFAOYSA-N C1=CC(=C(C=C1N2C=CC(=O)C3=CC(=C(N=C32)Cl)F)[N+](=O)[O-])F Chemical compound C1=CC(=C(C=C1N2C=CC(=O)C3=CC(=C(N=C32)Cl)F)[N+](=O)[O-])F ULMAAWYTRWPDRJ-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 208000031404 Chromosome Aberrations Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010067477 Cytogenetic abnormality Diseases 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- GISRWBROCYNDME-PELMWDNLSA-N F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C Chemical compound F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C GISRWBROCYNDME-PELMWDNLSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 238000005684 Liebig rearrangement reaction Methods 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- MDXGYYOJGPFFJL-QMMMGPOBSA-N N(alpha)-t-butoxycarbonyl-L-leucine Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)OC(C)(C)C MDXGYYOJGPFFJL-QMMMGPOBSA-N 0.000 description 1
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- XQAXGZLFSSPBMK-UHFFFAOYSA-M [7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium;chloride;trihydrate Chemical compound O.O.O.[Cl-].C1=CC(=[N+](C)C)C=C2SC3=CC(N(C)C)=CC=C3N=C21 XQAXGZLFSSPBMK-UHFFFAOYSA-M 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- WJGAPUXHSQQWQF-UHFFFAOYSA-N acetic acid;hydrochloride Chemical compound Cl.CC(O)=O WJGAPUXHSQQWQF-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- KXHASNSMMQNKFI-UHFFFAOYSA-N acetyloxyboron Chemical compound [B]OC(C)=O KXHASNSMMQNKFI-UHFFFAOYSA-N 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 125000001980 alanyl group Chemical group 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 description 1
- 150000001347 alkyl bromides Chemical class 0.000 description 1
- 150000001351 alkyl iodides Chemical class 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- VQJJCDGFRSTMEA-UHFFFAOYSA-N azetidin-1-amine dihydrochloride Chemical compound Cl.Cl.NN1CCC1 VQJJCDGFRSTMEA-UHFFFAOYSA-N 0.000 description 1
- 125000004566 azetidin-1-yl group Chemical group N1(CCC1)* 0.000 description 1
- QQAHPBUCLORFBD-UHFFFAOYSA-N azetidin-3-ylmethanamine;dihydrochloride Chemical compound Cl.Cl.NCC1CNC1 QQAHPBUCLORFBD-UHFFFAOYSA-N 0.000 description 1
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 1
- RNIZUCJGSDJAOQ-UHFFFAOYSA-N azetidine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC(=O)C1CNC1 RNIZUCJGSDJAOQ-UHFFFAOYSA-N 0.000 description 1
- UPABQMWFWCMOFV-UHFFFAOYSA-N benethamine Chemical compound C=1C=CC=CC=1CNCCC1=CC=CC=C1 UPABQMWFWCMOFV-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- SNWXTTROEWQLQF-UHFFFAOYSA-N benzyl n-(5-amino-2,3,4-trifluorophenyl)carbamate Chemical compound FC1=C(F)C(N)=CC(NC(=O)OCC=2C=CC=CC=2)=C1F SNWXTTROEWQLQF-UHFFFAOYSA-N 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- ARQRPTNYUOLOGH-UHFFFAOYSA-N chcl3 chloroform Chemical compound ClC(Cl)Cl.ClC(Cl)Cl ARQRPTNYUOLOGH-UHFFFAOYSA-N 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- ONCCWDRMOZMNSM-FBCQKBJTSA-N compound Z Chemical compound N1=C2C(=O)NC(N)=NC2=NC=C1C(=O)[C@H]1OP(O)(=O)OC[C@H]1O ONCCWDRMOZMNSM-FBCQKBJTSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 150000008050 dialkyl sulfates Chemical class 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- IDYZIJYBMGIQMJ-UHFFFAOYSA-N enoxacin Chemical compound N1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 IDYZIJYBMGIQMJ-UHFFFAOYSA-N 0.000 description 1
- 229960002549 enoxacin Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- CZOARLWRCKYXTB-UHFFFAOYSA-N ethyl 1-(2,4-difluoro-5-nitrophenyl)-6,7,8-trifluoro-4-oxoquinoline-3-carboxylate Chemical compound C12=C(F)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC([N+]([O-])=O)=C(F)C=C1F CZOARLWRCKYXTB-UHFFFAOYSA-N 0.000 description 1
- DJWIAGWUYHLTIX-UHFFFAOYSA-N ethyl 1-[2,4-difluoro-5-(phenylmethoxycarbonylamino)phenyl]-6,7,8-trifluoro-4-oxo-5-phenylmethoxyquinoline-3-carboxylate Chemical compound C12=C(F)C(F)=C(F)C(OCC=3C=CC=CC=3)=C2C(=O)C(C(=O)OCC)=CN1C(C(=CC=1F)F)=CC=1NC(=O)OCC1=CC=CC=C1 DJWIAGWUYHLTIX-UHFFFAOYSA-N 0.000 description 1
- MMCFWXSPCSBANH-UHFFFAOYSA-N ethyl 1-[2,4-difluoro-5-(phenylmethoxycarbonylamino)phenyl]-6,7-difluoro-5-methyl-4-oxoquinoline-3-carboxylate Chemical compound C12=CC(F)=C(F)C(C)=C2C(=O)C(C(=O)OCC)=CN1C(C(=CC=1F)F)=CC=1NC(=O)OCC1=CC=CC=C1 MMCFWXSPCSBANH-UHFFFAOYSA-N 0.000 description 1
- UAELSWPMQFFVHB-UHFFFAOYSA-N ethyl 2-(2,6-dichloro-5-fluoropyridine-3-carbonyl)-3-ethoxyprop-2-enoate Chemical compound CCOC=C(C(=O)OCC)C(=O)C1=CC(F)=C(Cl)N=C1Cl UAELSWPMQFFVHB-UHFFFAOYSA-N 0.000 description 1
- IEUHWNLWVMLHHC-UHFFFAOYSA-N ethyl 3-(2,6-dichloro-5-fluoropyridin-3-yl)-3-oxopropanoate Chemical compound CCOC(=O)CC(=O)C1=CC(F)=C(Cl)N=C1Cl IEUHWNLWVMLHHC-UHFFFAOYSA-N 0.000 description 1
- MZSMCLGNJHSWEJ-UHFFFAOYSA-N ethyl 3-(3-chloro-2,4,5-trifluoro-6-nitrophenyl)-3-oxopropanoate Chemical compound CCOC(=O)CC(=O)C1=C(F)C(Cl)=C(F)C(F)=C1[N+]([O-])=O MZSMCLGNJHSWEJ-UHFFFAOYSA-N 0.000 description 1
- KQKDPROKNKSZOD-UHFFFAOYSA-N ethyl 3-ethoxy-2-(2,4,5-trifluorobenzoyl)prop-2-enoate Chemical compound CCOC=C(C(=O)OCC)C(=O)C1=CC(F)=C(F)C=C1F KQKDPROKNKSZOD-UHFFFAOYSA-N 0.000 description 1
- SFYYMUUQGSQVFT-UHFFFAOYSA-N ethyl 3-oxo-3-(2,3,4,5,6-pentafluorophenyl)propanoate Chemical compound CCOC(=O)CC(=O)C1=C(F)C(F)=C(F)C(F)=C1F SFYYMUUQGSQVFT-UHFFFAOYSA-N 0.000 description 1
- WTKWXCRLEWADRT-UHFFFAOYSA-N ethyl 3-oxo-3-(2,4,5-trifluoro-3-methoxyphenyl)propanoate Chemical compound CCOC(=O)CC(=O)C1=CC(F)=C(F)C(OC)=C1F WTKWXCRLEWADRT-UHFFFAOYSA-N 0.000 description 1
- FTINRPRTRKCTHJ-UHFFFAOYSA-N ethyl 3-oxo-3-(2,4,5-trifluoro-3-methylphenyl)propanoate Chemical compound CCOC(=O)CC(=O)C1=CC(F)=C(F)C(C)=C1F FTINRPRTRKCTHJ-UHFFFAOYSA-N 0.000 description 1
- PKVJTIRTPGHBRU-UHFFFAOYSA-N ethyl 3-oxo-3-(3,4,6-trifluoro-2-methylphenyl)propanoate Chemical compound CCOC(=O)CC(=O)C1=C(F)C=C(F)C(F)=C1C PKVJTIRTPGHBRU-UHFFFAOYSA-N 0.000 description 1
- JLSXYCZRMYCIMY-UHFFFAOYSA-N ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC=C(F)C=C1F JLSXYCZRMYCIMY-UHFFFAOYSA-N 0.000 description 1
- QXBLKUCVMPYJCV-UHFFFAOYSA-N ethyl 7-chloro-1-[2,4-difluoro-5-(2-oxoethylamino)phenyl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC(NCC=O)=C(F)C=C1F QXBLKUCVMPYJCV-UHFFFAOYSA-N 0.000 description 1
- CIUWXIHIALMKNV-UHFFFAOYSA-N ethyl 7-chloro-1-[5-(dimethylamino)-2,4-difluorophenyl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC(N(C)C)=C(F)C=C1F CIUWXIHIALMKNV-UHFFFAOYSA-N 0.000 description 1
- IYAQYZWGTAUAEK-UHFFFAOYSA-N ethyl 7-chloro-6-fluoro-1-(4-fluoro-2-methyl-3-nitrophenyl)-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC=C(F)C([N+]([O-])=O)=C1C IYAQYZWGTAUAEK-UHFFFAOYSA-N 0.000 description 1
- UMTUUBLYEUGOOC-UHFFFAOYSA-N ethyl 7-chloro-6-fluoro-1-(4-fluoro-2-methyl-5-nitrophenyl)-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(Cl)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC([N+]([O-])=O)=C(F)C=C1C UMTUUBLYEUGOOC-UHFFFAOYSA-N 0.000 description 1
- GWBFOYYPVAJLAH-UHFFFAOYSA-N ethyl 8-chloro-5,6,7-trifluoro-1-(4-fluoro-3-nitrophenyl)-4-oxoquinoline-3-carboxylate Chemical compound C12=C(Cl)C(F)=C(F)C(F)=C2C(=O)C(C(=O)OCC)=CN1C1=CC=C(F)C([N+]([O-])=O)=C1 GWBFOYYPVAJLAH-UHFFFAOYSA-N 0.000 description 1
- AGIGZSKEWUFSAY-UHFFFAOYSA-N ethyl 8-chloro-6,7-difluoro-1-(4-fluoro-3-nitrophenyl)-4-oxoquinoline-3-carboxylate Chemical compound C12=C(Cl)C(F)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC=C(F)C([N+]([O-])=O)=C1 AGIGZSKEWUFSAY-UHFFFAOYSA-N 0.000 description 1
- ZJHRFYKIKWZLDW-UHFFFAOYSA-N ethyl n-(2,4-difluoro-5-nitrophenyl)carbamate Chemical compound CCOC(=O)NC1=CC([N+]([O-])=O)=C(F)C=C1F ZJHRFYKIKWZLDW-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 208000010824 fish disease Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 150000002366 halogen compounds Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 229950003188 isovaleryl diethylamide Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000008297 liquid dosage form Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910001512 metal fluoride Inorganic materials 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 230000031864 metaphase Effects 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- ACTNHJDHMQSOGL-UHFFFAOYSA-N n',n'-dibenzylethane-1,2-diamine Chemical compound C=1C=CC=CC=1CN(CCN)CC1=CC=CC=C1 ACTNHJDHMQSOGL-UHFFFAOYSA-N 0.000 description 1
- SOXVXKUTVVNZLA-UHFFFAOYSA-N n,n-dimethylaniline;1-methylpiperidine Chemical compound CN1CCCCC1.CN(C)C1=CC=CC=C1 SOXVXKUTVVNZLA-UHFFFAOYSA-N 0.000 description 1
- IRQWCOFOSMREBQ-UHFFFAOYSA-N n,n-dimethylazetidin-3-amine Chemical compound CN(C)C1CNC1 IRQWCOFOSMREBQ-UHFFFAOYSA-N 0.000 description 1
- DHXXDTCOJUYKOQ-UHFFFAOYSA-N n,n-dimethylazetidin-3-amine;dihydrochloride Chemical compound Cl.Cl.CN(C)C1CNC1 DHXXDTCOJUYKOQ-UHFFFAOYSA-N 0.000 description 1
- SXGRRNXWWIQUOO-UHFFFAOYSA-N n-(azetidin-3-yl)acetamide Chemical compound CC(=O)NC1CNC1 SXGRRNXWWIQUOO-UHFFFAOYSA-N 0.000 description 1
- CRYIRCLLUHFZLF-UHFFFAOYSA-N n-(pyrrolidin-3-ylmethyl)ethanamine;dihydrochloride Chemical compound Cl.Cl.CCNCC1CCNC1 CRYIRCLLUHFZLF-UHFFFAOYSA-N 0.000 description 1
- 125000006606 n-butoxy group Chemical group 0.000 description 1
- QLBGCEBVDMZPPN-UHFFFAOYSA-N n-ethylazetidin-3-amine Chemical compound CCNC1CNC1 QLBGCEBVDMZPPN-UHFFFAOYSA-N 0.000 description 1
- VEXIRMPBAHTVNL-UHFFFAOYSA-N n-methylpiperidin-3-amine;dihydrochloride Chemical compound Cl.Cl.CNC1CCCNC1 VEXIRMPBAHTVNL-UHFFFAOYSA-N 0.000 description 1
- ZJOAFRACLXVOAV-UHFFFAOYSA-N n-methylpyrrolidin-3-amine;dihydrochloride Chemical compound Cl.Cl.CNC1CCNC1 ZJOAFRACLXVOAV-UHFFFAOYSA-N 0.000 description 1
- 125000003506 n-propoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- 125000001038 naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 description 1
- 230000000802 nitrating effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- JCZMXVGQBBATMY-UHFFFAOYSA-N nitro acetate Chemical compound CC(=O)O[N+]([O-])=O JCZMXVGQBBATMY-UHFFFAOYSA-N 0.000 description 1
- 229960001180 norfloxacin Drugs 0.000 description 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 229960001699 ofloxacin Drugs 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002895 organic esters Chemical class 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 125000000405 phenylalanyl group Chemical group 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 125000005633 phthalidyl group Chemical group 0.000 description 1
- SGQDWDWJCYEUNC-UHFFFAOYSA-N piperidin-1-ium-4-ylazanium;dichloride Chemical compound Cl.Cl.NC1CCNCC1 SGQDWDWJCYEUNC-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- LZMJNVRJMFMYQS-UHFFFAOYSA-N poseltinib Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(OC=2C=C(NC(=O)C=C)C=CC=2)=C(OC=C2)C2=N1 LZMJNVRJMFMYQS-UHFFFAOYSA-N 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- SBMSLRMNBSMKQC-UHFFFAOYSA-N pyrrolidin-1-amine Chemical compound NN1CCCC1 SBMSLRMNBSMKQC-UHFFFAOYSA-N 0.000 description 1
- MXAQYXXHPDEVDM-UHFFFAOYSA-N pyrrolidin-1-amine;dihydrochloride Chemical compound Cl.Cl.NN1CCCC1 MXAQYXXHPDEVDM-UHFFFAOYSA-N 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- DJXNJVFEFSWHLY-UHFFFAOYSA-N quinoline-3-carboxylic acid Chemical compound C1=CC=CC2=CC(C(=O)O)=CN=C21 DJXNJVFEFSWHLY-UHFFFAOYSA-N 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- HYHCSLBZRBJJCH-UHFFFAOYSA-M sodium hydrosulfide Chemical compound [Na+].[SH-] HYHCSLBZRBJJCH-UHFFFAOYSA-M 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000004763 sulfides Chemical class 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- FYUVLZRRIRGSTE-UHFFFAOYSA-N tert-butyl 2,3,3a,4,6,6a-hexahydro-1h-pyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1NCC2CN(C(=O)OC(C)(C)C)CC21 FYUVLZRRIRGSTE-UHFFFAOYSA-N 0.000 description 1
- LDPQUEYAWYVYES-UHFFFAOYSA-N tert-butyl n-(2,4-difluoro-5-nitrophenyl)carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC([N+]([O-])=O)=C(F)C=C1F LDPQUEYAWYVYES-UHFFFAOYSA-N 0.000 description 1
- AYTDAUGIOKENGZ-UHFFFAOYSA-N tert-butyl n-(2,6-difluoro-3-nitrophenyl)carbamate Chemical compound CC(C)(C)OC(=O)NC1=C(F)C=CC([N+]([O-])=O)=C1F AYTDAUGIOKENGZ-UHFFFAOYSA-N 0.000 description 1
- ZLIAUSGQDVCEAP-UHFFFAOYSA-N tert-butyl n-(3-amino-6-fluoro-2-methoxyphenyl)carbamate Chemical compound COC1=C(N)C=CC(F)=C1NC(=O)OC(C)(C)C ZLIAUSGQDVCEAP-UHFFFAOYSA-N 0.000 description 1
- OWPOOOGXODOWIM-UHFFFAOYSA-N tert-butyl n-(5-amino-2,4-difluorophenyl)carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(N)=C(F)C=C1F OWPOOOGXODOWIM-UHFFFAOYSA-N 0.000 description 1
- CGEBPOMWRHSMLI-UHFFFAOYSA-N tert-butyl n-(5-azaspiro[2.4]heptan-7-yl)carbamate Chemical compound CC(C)(C)OC(=O)NC1CNCC11CC1 CGEBPOMWRHSMLI-UHFFFAOYSA-N 0.000 description 1
- IUHRDCVRNBKBMO-UHFFFAOYSA-N tert-butyl n-pyrrolidin-1-ylcarbamate Chemical compound CC(C)(C)OC(=O)NN1CCCC1 IUHRDCVRNBKBMO-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 125000002114 valyl group Chemical group 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Description
本発明は優れた抗菌作用と経口吸収性を有する新規なピリドンカルボン酸誘導体又はその塩及びこれを含有する抗菌剤に関する。 The present invention relates to a novel pyridonecarboxylic acid derivative having excellent antibacterial action and oral absorption or a salt thereof and an antibacterial agent containing the same.
ピリドンカルボン酸を基本骨格とする化合物の中には、優れた抗菌力と幅広い抗菌スペクトルとを有することから、合成抗菌剤として有用なものが数多く知られている。その中でも、ノルフロキサシン(特開昭53−141286号公報)、エノキサシン(特開昭55−31042号公報)、オフロキサシン(特開昭57−46986号公報)、シプロフロキサシン(特開昭58−76667号公報)、トスフロキサキン(特開昭60−228479号公報)等は感染症治療剤として、臨床において広く使用されている。 Many compounds having pyridonecarboxylic acid as a basic skeleton are known to be useful as synthetic antibacterial agents because they have excellent antibacterial activity and a broad antibacterial spectrum. Among them, norfloxacin (Japanese Patent Laid-Open No. 53-141286), enoxacin (Japanese Patent Laid-Open No. 55-31042), ofloxacin (Japanese Patent Laid-Open No. 57-46986), ciprofloxacin (Japanese Patent Laid-Open No. 58-76667). Nos.), Tosufloxaquin (Japanese Patent Laid-Open No. 60-228479) and the like are widely used in clinical practice as therapeutic agents for infectious diseases.
しかしながら、これらの化合物は抗菌力、腸管吸収性、代謝安定性及び副作用、特に光毒性や細胞毒性等の点で未だ不充分なものであった。 However, these compounds are still insufficient in terms of antibacterial activity, intestinal absorption, metabolic stability and side effects, particularly phototoxicity and cytotoxicity.
本発明は、上記事情に鑑みなされたもので、抗菌力、腸管吸収性、代謝安定性及び副作用、特に光毒性や細胞毒性等の点を満足する新規なピリドンカルボン酸誘導体又はその塩、及びこれを含有する抗菌剤を提供することを目的とする。 The present invention has been made in view of the above circumstances, and includes a novel pyridonecarboxylic acid derivative or salt thereof that satisfies the antibacterial activity, intestinal absorbability, metabolic stability and side effects, particularly phototoxicity and cytotoxicity, and the like. It aims at providing the antibacterial agent containing this.
本発明者らは、かかる実情に鑑み、臨床上優れた合成抗菌剤となり得る化合物を得るべく鋭意検討した結果、下記一般式(1)で表わされる化合物が、グラム陰性菌及びグラム陽性菌に対し優れた抗菌性を有すると共に極めて低毒性であって合成抗菌剤として有用であることを見い出し、本発明をなすに至ったものである。 In view of such circumstances, the present inventors have intensively studied to obtain a compound that can be a clinically superior synthetic antibacterial agent. As a result, the compound represented by the following general formula (1) is a gram-negative bacterium and a gram-positive bacterium. It has been found that it has excellent antibacterial properties, is extremely low in toxicity and is useful as a synthetic antibacterial agent, and has led to the present invention.
即ち、本発明は、次の一般式(1)
〔式中、R1は水素原子又はカルボキシ保護基を示し、R2はニトロ基、アミノ基若しくは、低級アルキル基,低級アルケニル基,炭素数7〜11のアラルキル基,炭素数6〜14のアリール基,ホルミル基,低級アルカノイル基,低級アルコキシカルボニル基,炭素数7〜15のアロイル基,アミノ酸残基あるいはオリゴペプチド残基及びこれらの官能基がアシル基や低級アラルキル等のペプチド化学で慣用の保護基で保護されたアミノ酸残基あるいはオリゴペプチド残基、又は環状アミノ基で置換された置換アミノ基を示し、R3はハロゲン原子を示し、R4及びR5は同一又は異なっていてもよい水素原子、ハロゲン原子、低級アルキル基又は低級アルコキシ基を示し、R6は水素原子、ハロゲン原子、ヒドロキシ基、低級アルキル基又はアミノ基を示し、R7は水素原子又はハロゲン原子を示し、Aは窒素原子又は−CX=(ここで、Xは水素原子、ハロゲン原子、低級アルキル基又は低級アルコキシ基を示す)を示し、Zは後述する次式(a)示される飽和環状アミノ基を示す。〕
で表わされるピリドンカルボン酸誘導体又はその塩を提供する。
また、本発明は当該ピリドンカルボン酸誘導体又はその塩を有効成分とする抗菌剤を提供する。
That is, the present invention provides the following general formula (1)
[Wherein, R 1 represents a hydrogen atom or a carboxy protecting group, and R 2 represents a nitro group, an amino group, a lower alkyl group, a lower alkenyl group, an aralkyl group having 7 to 11 carbon atoms, or an aryl having 6 to 14 carbon atoms. Group, formyl group, lower alkanoyl group, lower alkoxycarbonyl group, aroyl group having 7 to 15 carbon atoms, amino acid residue or oligopeptide residue, and these functional groups are commonly used in peptide chemistry such as acyl group and lower aralkyl. An amino acid residue or oligopeptide residue protected with a group, or a substituted amino group substituted with a cyclic amino group, R 3 represents a halogen atom, and R 4 and R 5 may be the same or different hydrogen atom, a halogen atom, a lower alkyl group or a lower alkoxy group, R 6 is a hydrogen atom, a halogen atom, hydroxy group, lower alkyl group or Shows the amino group, R 7 represents a hydrogen atom or a halogen atom, A is a nitrogen atom or -CX = (wherein, X represents a hydrogen atom, a halogen atom, a lower alkyl group or a lower alkoxy group) a, Z Represents a saturated cyclic amino group represented by the following formula (a) . ]
A pyridonecarboxylic acid derivative represented by the formula:
Moreover, this invention provides the antibacterial agent which uses the said pyridone carboxylic acid derivative or its salt as an active ingredient.
本発明化合物(1)及びその塩は極めて抗菌効果が高く、光毒性、細胞毒性が低いため、人体及び動物用の医薬品として、また魚病薬、農薬、食品保存剤等として広く使用することができる。更に本発明の化合物は抗ウイルス作用、特に抗HIV(ヒト免疫不全ウイルス)作用を有することが期待でき、エイズの予防又は治療に効果を有すると考えられる。 The compound (1) of the present invention and its salt have a very high antibacterial effect, and have low phototoxicity and cytotoxicity. Therefore, the compound (1) and its salt can be widely used as pharmaceuticals for human bodies and animals, fish diseases, agricultural chemicals, food preservatives, etc. it can. Furthermore, the compound of the present invention can be expected to have an antiviral action, particularly an anti-HIV (human immunodeficiency virus) action, and is considered to have an effect on the prevention or treatment of AIDS.
以下、本発明について更に詳しく説明する。なお、本発明の上記一般式(1)で表わされるピリドンカルボン酸誘導体の置換基において「低級」とは、該置換基が鎖状である場合、炭素数1〜7のものを示すが、特に炭素数1〜5のものが好ましく、環状である場合、炭素数3〜7のものを意味する。 Hereinafter, the present invention will be described in more detail. In addition, in the substituent of the pyridonecarboxylic acid derivative represented by the above general formula (1) of the present invention, “lower” means that having 1 to 7 carbon atoms when the substituent is a chain, The thing of C1-C5 is preferable, and when it is cyclic, it means a C3-C7 thing.
上記一般式(1)中、R1で示されるカルボキシ保護基とは、カルボン酸エステルのエステル残基をいい、比較的容易に解裂して、対応する遊離のカルボキシル基を生じる任意のものが挙げられ、この具体例としては、メチル基、エチル基、n−プロピル基、i−プロピル基、n−ブチル基、i−ブチル基、t−ブチル基、ペンチル基、ヘキシル基、ヘプチル基等の低級アルキル基;ビニル基、アリル基、1−プロペニル基、ブテニル基、ペンテニル基、ヘキセニル基、ヘプテニル基等の低級アルケニル基;ベンジル基等の炭素数7〜11のアラルキル基;フェニル基、ナフチル基等の炭素数6〜14のアリール基等の加水分解や接触還元等の穏和な条件で処理することにより脱離するもの、又はアセトキシメチル基、ピバロイルオキシメチル基等の低級アルカノイルオキシ低級アルキル基;メトキシカルボニルオキシメチル基、1−エトキシカルボニルオキシエチル基等の低級アルコキシカルボニルオキシ低級アルキル基;メトキシメチル基等の低級アルコキシ低級アルキル基;フタリジル基等のラクトニル基;1−ジメチルアミノエチル基等のジ低級アルキルアミノ低級アルキル基;(5−メチル−2−オキソ−1,3−ジオキソ−ル−4−イル)メチル基等の生体内で容易に脱離するもの等が挙げられる。なお、R1としては水素原子が特に好ましい。 In the general formula (1), the carboxy-protecting group represented by R 1, refers to an ester residue of a carboxylic acid ester, is relatively easy to cleave, any resulting in the corresponding free carboxyl group as Specific examples thereof include methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, i-butyl group, t-butyl group, pentyl group, hexyl group, heptyl group and the like. Lower alkyl group; lower alkenyl group such as vinyl group, allyl group, 1-propenyl group, butenyl group, pentenyl group, hexenyl group and heptenyl group; aralkyl group having 7 to 11 carbon atoms such as benzyl group; phenyl group and naphthyl group Such as an aryl group having 6 to 14 carbon atoms, etc., which is eliminated by treatment under mild conditions such as hydrolysis or catalytic reduction, or an acetoxymethyl group, pivaloyloxymethyl Lower alkanoyloxy lower alkyl group such as a group; lower alkoxycarbonyloxy lower alkyl group such as methoxycarbonyloxymethyl group and 1-ethoxycarbonyloxyethyl group; lower alkoxy lower alkyl group such as methoxymethyl group; lactonyl group such as phthalidyl group Di-lower alkylamino lower alkyl groups such as 1-dimethylaminoethyl group; (5-methyl-2-oxo-1,3-dioxo-l-4-yl) methyl group and the like easily desorb in vivo And the like. R 1 is particularly preferably a hydrogen atom.
R2で示される置換アミノ基における置換基としては、例えばメチル基、エチル基、n−プロピル基、i−プロピル基、n−ブチル基、i−ブチル基、t−ブチル基、ペンチル基、ヘキシル基、ヘプチル基等の低級アルキル基;ビニル基、アリル基、1−プロペニル基、ブテニル基、ペンテニル基、ヘキセニル基、ヘプテニル基等の低級アルケニル基;ベンジル基、1−フェニルエチル基等の炭素数7〜11のアラルキル基;フェニル基、ナフチル基等の炭素数6〜14のアリール基;ホルミル基、アセチル基、プロピオニル基、ブチリル基、イソブチリル基等の低級アルカノイル基;メトキシカルボニル基、エトキシカルボニル基等の低級アルコキシカルボニル基;ベンゾイル基、ナフトイル等の炭素数7〜15のアロイル基;グリシル、ロイシル、バリル、アラニル、フェニルアラニル、アラニル−アラニル、グリシル−バリル、グリシル−グリシル−バリルなどのアミノ酸残基あるいはオリゴペプチド残基及びこれらの官能基がアシル基や低級アラルキル等のペプチド化学で慣用の保護基で保護されたアミノ酸残基あるいはオリゴペプチド残基、又は環状アミノ基などが挙げられる。これらの置換基は1〜2個の同種もしくは異種のものから任意に選ぶことができる。かかるアミノ酸残基あるいはペプチド残基で保護された化合物は水溶性が向上することが期待される。 Examples of the substituent in the substituted amino group represented by R 2 include methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, pentyl, and hexyl. Group, lower alkyl group such as heptyl group; lower alkenyl group such as vinyl group, allyl group, 1-propenyl group, butenyl group, pentenyl group, hexenyl group and heptenyl group; carbon number such as benzyl group and 1-phenylethyl group Aralkyl group having 7 to 11; aryl group having 6 to 14 carbon atoms such as phenyl group and naphthyl group; lower alkanoyl group such as formyl group, acetyl group, propionyl group, butyryl group and isobutyryl group; methoxycarbonyl group and ethoxycarbonyl group Lower alkoxycarbonyl group such as benzoyl group, aroyl group having 7 to 15 carbon atoms such as naphthoyl; glycyl, Amino acid residues or oligopeptide residues such as isyl, valyl, alanyl, phenylalanyl, alanyl-alanyl, glycyl-valyl, glycyl-glycyl-valyl and their functional groups are commonly used in peptide chemistry such as acyl groups and lower aralkyls. An amino acid residue or an oligopeptide residue protected with a protecting group, or a cyclic amino group. These substituents can be arbitrarily selected from 1 to 2 of the same type or different types. Compounds protected with such amino acid residues or peptide residues are expected to have improved water solubility.
より好ましいR2としては、アミノ基、低級アルキルアミノ基、ジ低級アルキルアミノ基、低級アルカノイルアミノ基、アミノ酸置換アミノ基及びオリゴペプチド置換アミノ基が挙げられる。更に好ましいR2の例としては、アミノ基、メチルアミノ基、エチルアミノ基、ジメチルアミノ基、ホルミルアミノ基、グリシル−アミノ基、ロイシル−アミノ基、バリル−アミノ基、アラニル−アミノ基、アラニル−アラニル−アミノ基等が挙げられ、このうちアミノ基が特に好ましい。 More preferable R 2 includes an amino group, a lower alkylamino group, a di-lower alkylamino group, a lower alkanoylamino group, an amino acid-substituted amino group, and an oligopeptide-substituted amino group. More preferred examples of R 2 include amino group, methylamino group, ethylamino group, dimethylamino group, formylamino group, glycyl-amino group, leucyl-amino group, valyl-amino group, alanyl-amino group, alanyl- An alanyl-amino group etc. are mentioned, Among these, an amino group is especially preferable.
R3、R4、R5、R6及びR7で示されるハロゲン原子としては、フッ素原子、塩素原子、臭素原子、ヨウ素原子が挙げられるが、就中フッ素原子又は塩素原子が好ましく、フッ素原子が特に好ましい。 Examples of the halogen atom represented by R 3 , R 4 , R 5 , R 6 and R 7 include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom. Among them, a fluorine atom or a chlorine atom is preferable, and a fluorine atom Is particularly preferred.
R4、R5、R6及びXで示される低級アルキル基としては、メチル基、エチル基、n−プロピル基、1−プロピル基、n−ブチル基、i−ブチル基、t−ブチル基、ペンチル基、ヘキシル基、ヘプチル基等が挙げられ、就中メチル基が好ましい。R4、R5及びXで示される低級アルコキシ基としては、例えばメトキシ基、エトキシ基、n−プロポキシ基、n−ブトキシ基、t−ブトキシ基等が挙げられる。 Examples of the lower alkyl group represented by R 4 , R 5 , R 6 and X include methyl group, ethyl group, n-propyl group, 1-propyl group, n-butyl group, i-butyl group, t-butyl group, A pentyl group, a hexyl group, a heptyl group, etc. are mentioned, and especially a methyl group is preferable. Examples of the lower alkoxy group represented by R 4 , R 5 and X include a methoxy group, an ethoxy group, an n-propoxy group, an n-butoxy group and a t-butoxy group.
好ましいR4及びR5の組み合わせはハロゲン原子及び水素原子であり、R4がフッ素原子又は塩素原子でありR5が水素原子である場合がより好ましく、R4がフッ素原子でありR5が水素原子である場合が特に好ましい。なお、このR4はR2のパラ位に置換しているのが特に好ましい。 A preferred combination of R 4 and R 5 is a halogen atom and a hydrogen atom, more preferably R 4 is a fluorine atom or a chlorine atom and R 5 is a hydrogen atom, and R 4 is a fluorine atom and R 5 is a hydrogen atom. Particularly preferred is an atom. R 4 is particularly preferably substituted at the para position of R 2 .
Xで示されるハロゲン原子としては、フッ素原子、塩素原子、臭素原子、ヨウ素原子が挙げられるが、特にフッ素原子、塩素原子が好ましい。
Examples of the halogen atom represented by X include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom, and a fluorine atom and a chlorine atom are particularly preferable.
また、式(1)の化合物はAが窒素原子を示す場合にはナフチリジン骨格を有し、Aが−CX=を示す場合にはキノリン骨格を有することとなるが、Aが窒素原子を示す場合及び−CCl=である場合が特に好ましい。 Further, the compound of formula (1) has a naphthyridine skeleton when A represents a nitrogen atom, and has a quinoline skeleton when A represents -CX =, but when A represents a nitrogen atom. And -CCl = is particularly preferred.
本発明では、Zで示される飽和環状アミノ基は、下記式(a)に示されるものである。
式(a)における低級アルキル基、アミノ低級アルキル基、低級アルキルアミノ基、低級アルコキシ基及びハロゲン原子としては、上記R2〜R5で示した基と同様なものが例示される。 Examples of the lower alkyl group, amino lower alkyl group, lower alkylamino group, lower alkoxy group and halogen atom in the formula (a) are the same as the groups shown for R 2 to R 5 above.
式(a)で示される環状アミノ基としては、例えばアゼチジン−1−イル基、ピロリジン−1−イル基が挙げられる。 Examples of the cyclic amino group represented by the formula (a) include an azetidin-1-yl group and a pyrrolidin-1-yl group.
式(a)で示される基の特に好ましい具体例を示せば次のとおりである。 A particularly preferred specific example of the group represented by the formula (a) is as follows.
3−アミノアゼチジン−1−イル基、3−メチルアミノアゼチジン−1−イル基、3−ジメチルアミノアゼチジン−1−イル基、3−アミノメチルアゼチジン−1−イル基、3−アミノ−2−メチルアゼチジン−1−イル基、3−アミノ−3−メチルアゼチジン−1−イル基、3−アラニル−アミノアゼチジン−1−イル基、3−バリル−アミノアゼチジン−1−イル基、ピロリジン−1−イル基、3−ヒドロキシピロリジン−1−イル基、3,4−ジヒドロキシピロリジン−1−イル基、3−メトキシピロリジン−1−イル基、3−メチルピロリジン−1−イル基、3−ヒドロキシ−4−メチルピロリジン−1−イル基、3−アミノピロリジン−1−イル基、3−メチルアミノピロリジン−1−イル基、3−ジメチルアミノピロリジン−1−イル基、3−エチルアミノピロリジン−1−イル基、3−ジエチルアミノピロリジン−1−イル基、3−アミノメチルピロリジン−1−イル基、3−アミノ−3−メチルピロリジン−1−イル基、3−アミノ−4−メチルピロリジン−1−イル基、3−アミノ−5−メチルピロリジン−1−イル基、3−メチルアミノ−4−メチルピロリジン−1−イル基、3−ジメチルアミノ−4−メチルピロリジン−1−イル基、3−エチルアミノ−4−メチルピロリジン−1−イル基、3−ジエチルアミノ−3−メチルピロリジン−1−イル基、3−ジエチルアミノ−4−メチルピロリジン−1−イル基、3−アミノメチル−4−メチルピロリジン−1−イル基、3−メチルアミノメチル−4−メチルピロリジン−1−イル基、3−ジメチルアミノメチル−4−メチルピロリジン−1−イル基、3−エチルアミノメチル−4−メチルピロリジン−1−イル基、3−(1−アミノエチル)−4−メチルピロリジン−1−イル基、3−(2−アミノエチル)−4−メチルピロリジン−1−イル基、3−アミノ−4−エチルピロリジン−1−イル基、3−メチルアミノ−4−エチルピロリジン−1−イル基、3−ジメチルアミノ−4−エチルピロリジン−1−イル基、3−エチルアミノ−4−エチルピロリジン−1−イル基、3−ジエチルアミノ−4−エチルピロリジン−1−イル基、3−アミノメチル−4−エチルピロリジン−1−イル基、3−メチルアミノメチル−4−エチルピロリジン−1−イル基、3−ジメチルアミノメチル−4−エチルピロリジン−1−イル基、3−アミノ−3−メチルピロリジン−1−イル基、3−メチルアミノ−3−メチルピロリジン−1−イル基、3−ジメチルアミノ−3−メチルピロリジン−1−イル基、3−アミノ−3,4−ジメチルピロリジン−1−イル基、3−アミノ−4,4−ジメチルピロリジン−1−イル基、3−アミノ−4,5−ジメチルピロリジン−1−イル基、3−アミノ−2,4−ジメチルピロリジン−1−イル基、3−メチルアミノ−3,4−ジメチルピロリジン−1−イル基、2−メチル−3−アミノピロリジン−1−イル基、2−メチル−3−ジメチルアミノピロリジン−1−イル基、3−アミノ−4−メトキシピロリジン−1−イル基、3−アラニル−アミノピロリジン−1−イル基、3−バリル−アミノピロリジン−1−イル基。
3-aminoazetidin-1-yl group, 3-methylaminoazetidin-1-yl group, 3-dimethylaminoazetidin-1-yl group, 3-aminomethylazetidin-1-yl group, 3-amino 2-methylazetidin-1-yl group, 3-amino-3-methylazetidin-1-yl group, 3-alanyl-aminoazetidin-1-yl group, 3-valyl-aminoazetidin-1- Yl group, pyrrolidin-1-yl group, 3-hydroxypyrrolidin-1-yl group, 3,4-dihydroxypyrrolidin-1-yl group, 3-methoxypyrrolidin-1-yl group, 3-methylpyrrolidin-1-yl Group, 3-hydroxy-4-methylpyrrolidin-1-yl group, 3-aminopyrrolidin-1-yl group, 3-methylaminopyrrolidin-1-yl group, 3-dimethylaminopyrrolidin-1 Yl group, 3-ethylaminopyrrolidin-1-yl group, 3-diethylaminopyrrolidin-1-yl group, 3-aminomethylpyrrolidin-1-yl group, 3-amino-3-methylpyrrolidin-1-yl group, 3 -Amino-4-methylpyrrolidin-1-yl group, 3-amino-5-methylpyrrolidin-1-yl group, 3-methylamino-4-methylpyrrolidin-1-yl group, 3-dimethylamino-4-methyl Pyrrolidin-1-yl group, 3-ethylamino-4-methylpyrrolidin-1-yl group, 3-diethylamino-3-methylpyrrolidin-1-yl group, 3-diethylamino-4-methylpyrrolidin-1-yl group, 3-aminomethyl-4-methylpyrrolidin-1-yl group, 3-methylaminomethyl-4-methylpyrrolidin-1-yl group, 3-dimethylaminomethyl group Ru-4-methylpyrrolidin-1-yl group, 3-ethylaminomethyl-4-methylpyrrolidin-1-yl group, 3- (1-aminoethyl) -4-methylpyrrolidin-1-yl group, 3- ( 2-aminoethyl) -4-methylpyrrolidin-1-yl group, 3-amino-4-ethylpyrrolidin-1-yl group, 3-methylamino-4-ethylpyrrolidin-1-yl group, 3-dimethylamino- 4-ethylpyrrolidin-1-yl group, 3-ethylamino-4-ethylpyrrolidin-1-yl group, 3-diethylamino-4-ethylpyrrolidin-1-yl group, 3-aminomethyl-4-ethylpyrrolidin-1 -Yl group, 3-methylaminomethyl-4-ethylpyrrolidin-1-yl group, 3-dimethylaminomethyl-4-ethylpyrrolidin-1-yl group, 3-amino-3-methyl Pyrrolidin-1-yl group, 3-methylamino-3-methylpyrrolidin-1-yl group, 3-dimethylamino-3-methylpyrrolidin-1-yl group, 3-amino-3,4-dimethylpyrrolidin-1- Yl group, 3-amino-4,4-dimethylpyrrolidin-1-yl group, 3-amino-4,5-dimethylpyrrolidin-1-yl group, 3-amino-2,4-dimethylpyrrolidin-1-yl group 3-methylamino-3,4-dimethylpyrrolidin-1-yl group, 2-methyl-3-aminopyrrolidin-1-yl group, 2-methyl-3-dimethylaminopyrrolidin-1-yl group, 3-amino -4-methoxypyrrolidin-1-yl group, 3-alanyl-aminopyrrolidin-1-yl group, 3-valyl-aminopyrrolidin-1-yl group.
一般式(1)における、より好ましいR1、R2、R3、R4、R5、R6、R7、A及びZの組み合わせは、R1が水素原子;R2がアミノ基、低級アルキルアミノ基、ジ低級アルキルアミノ基、低級アルカノイルアミノ基、アミノ酸置換アミノ基又はオリゴペプチド置換アミノ基;R3がハロゲン原子;R4がハロゲン原子;R5が水素原子;R6が水素原子;R7がフッ素原子;Aが窒素原子、−CH=又は−CCl=;Zが式(a)で示される基の場合である。更に好ましいR1、R2、R3、R4、R5、R6、R7、A及びZの組み合わせは、R1が水素原子;R2がアミノ基;R3がフッ素原子又は塩素原子;R4がフッ素原子又は塩素原子(R2のパラ位に置換);R5が水素原子;R6が水素原子;R7がフッ素原子;Aが窒素原子又は−CCl=;はZが式(a)で示される基(e=3又は4)の場合である。 In the combination of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , A and Z in the general formula (1), R 1 is a hydrogen atom; R 2 is an amino group, lower Alkylamino group, di-lower alkylamino group, lower alkanoylamino group, amino acid-substituted amino group or oligopeptide-substituted amino group; R 3 is a halogen atom; R 4 is a halogen atom; R 5 is a hydrogen atom; R 6 is a hydrogen atom; In this case, R 7 is a fluorine atom; A is a nitrogen atom, —CH═ or —CCl═; Z is a group represented by the formula (a). More preferred combinations of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , A and Z are as follows: R 1 is a hydrogen atom; R 2 is an amino group; R 3 is a fluorine atom or a chlorine atom R 4 is a fluorine atom or a chlorine atom (substituted at the para position of R 2 ); R 5 is a hydrogen atom; R 6 is a hydrogen atom; R 7 is a fluorine atom; A is a nitrogen atom or —CCl =; This is the case of the group represented by (a) (e = 3 or 4).
ピリドンカルボン酸誘導体又はその塩(1)は酸付加塩又は塩基付加塩の両方を形成することができる。なお、この塩にはホウ素化合物とのキレート塩を形成したものも含まれる。酸付加塩としては、例えば(A)塩酸、硫酸などの鉱酸との塩、(B)ギ酸、クエン酸、トリクロロ酢酸、トリフルオロ酢酸、フマール酸、マレイン酸などの有機カルボン酸との塩、(C)メタンスルホン酸、ベンゼンスルホン酸、p−トルエンスルホン酸、メシチレンスルホン酸、ナフタレンスルホン酸などのスルホン酸との塩を、また塩基付加塩としては、例えば、(A′)ナトリウム、カリウムなどのアルカリ金属との塩、(B′)カルシウム、マグネシウムなどのアルカリ土類金属との塩、(C′)アンモニウム塩、(D′)トリメチルアミン、トリエチルアミン、トリブチルアミン、ピリジン、N,N−ジメチルアニリン、N−メチルピペリジン、N−メチルモルホリン、ジエチルアミン、シクロヘキシルアミン、プロカイン、ジベンジルアミン、N−ベンジル−β−フェネチルアミン、1−エフェナミン、N,N′−ジベンジルエチレンジアミンなどの含窒素有機塩基との塩を挙げることができる。また、ホウ素化合物としては、フッ化ホウ素などのハロゲン化ホウ素、アセトキシホウ素などの低級アシルオキシホウ素が挙げられる。 The pyridonecarboxylic acid derivative or its salt (1) can form both an acid addition salt or a base addition salt. This salt includes those formed with a chelate salt with a boron compound. Examples of acid addition salts include (A) salts with mineral acids such as hydrochloric acid and sulfuric acid, (B) salts with organic carboxylic acids such as formic acid, citric acid, trichloroacetic acid, trifluoroacetic acid, fumaric acid and maleic acid, (C) Salts with sulfonic acids such as methanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, mesitylenesulfonic acid and naphthalenesulfonic acid, and as base addition salts, for example, (A ′) sodium, potassium, etc. (B ′) salts with alkaline earth metals such as calcium and magnesium, (C ′) ammonium salts, (D ′) trimethylamine, triethylamine, tributylamine, pyridine, N, N-dimethylaniline N-methylpiperidine, N-methylmorpholine, diethylamine, cyclohexylamine, procaine, di Njiruamin, N- benzyl -β- phenethylamine, 1-Efenamin, N, may be mentioned salts with nitrogen-containing organic bases such as N'- dibenzylethylenediamine. Examples of the boron compound include boron halides such as boron fluoride and lower acyloxyborons such as acetoxyboron.
ピリドンカルボン酸誘導体又はその塩(1)は、未溶媒和型のみならず、水和物又は溶媒和物としても存在することができる。従って、本発明の化合物は、そのすべての結晶型及び水和若しくは溶媒和物を含むものである。 The pyridonecarboxylic acid derivative or salt (1) thereof can exist not only as an unsolvated form but also as a hydrate or a solvate. Accordingly, the compounds of the present invention include all crystal forms and hydrates or solvates thereof.
ピリドンカルボン酸誘導体又はその塩(1)は、光学活性体として存在し得る。これらの光学活性体も本発明の化合物に包含される。更に、化合物(1)は、異なる立体異性体(シス型、トランス型)として存在し得る。これらの立体異性体もまた本発明の化合物に包含される。 The pyridonecarboxylic acid derivative or salt (1) thereof can exist as an optically active substance. These optically active substances are also included in the compound of the present invention. Furthermore, the compound (1) can exist as different stereoisomers (cis type, trans type). These stereoisomers are also included in the compounds of the present invention.
ピリドンカルボン酸誘導体又はその塩(1)は、置換基の種類等によって、それにあった任意の方法によって製造されるが、その一例を挙げれば次のとおりである。 The pyridonecarboxylic acid derivative or its salt (1) is produced by an arbitrary method depending on the type of the substituent and the like, and an example thereof is as follows.
(工程1)一般式(1)で表わされる化合物のうち、R1が水素原子又は低級アルキル基で、Zがハロゲン原子である化合物の製造は、例えば以下の反応式に表される一連の工程1によって製造される。
すなわち、本発明化合物(1a)〜(1d)は化合物(A)にオルトギ酸エチル又はオルトギ酸メチルなどのオルトギ酸エステル類(H)を反応させた後、化合物(J)を反応させ、次いで環化反応させ、得られた化合物(C)をニトロ化して化合物(1a)とし、これを還元すれば化合物(1b)が得られ、これをアルキル化又はアシル化すれば化合物(1c)が得られ、これを加水分解すれば化合物(1d)が得られる。また化合物(1b)を加水分解しても化合物(1d)を得ることができる。 That is, the compounds (1a) to (1d) of the present invention are obtained by reacting a compound (A) with an orthoformate ester (H) such as ethyl orthoformate or methyl orthoformate, followed by reacting the compound (J), The resulting compound (C) is nitrated to give compound (1a), which is reduced to give compound (1b), and this is alkylated or acylated to give compound (1c). If this is hydrolyzed, compound (1d) is obtained. The compound (1d) can also be obtained by hydrolyzing the compound (1b).
化合物(A)とオルトギ酸エステル類(H)との反応は通常0〜160℃、好ましくは50〜150℃で行なわれ、反応時間は、通常10分〜48時間、好ましくは、1〜10時間である。またオルトギ酸エステル類の使用量は、化合物(A)に対して等モル以上、とりわけ約1〜10倍モルが好ましい。 The reaction between compound (A) and orthoformate ester (H) is usually carried out at 0 to 160 ° C., preferably 50 to 150 ° C., and the reaction time is usually 10 minutes to 48 hours, preferably 1 to 10 hours. It is. Further, the amount of orthoformate used is preferably equimolar or more, particularly about 1 to 10-fold mol relative to compound (A).
上記化合物(J)との反応は無溶媒又は適当な溶媒中で行なわれる。また、反応補助剤として、無水酢酸等のカルボン酸無水物を加えることが望ましい。ここで使用される溶媒としては、該反応に影響しないものであればいずれでもよく、例えばベンゼン、トルエン、キシレンなどのような芳香族炭化水素類;ジエチルエーテル、テトラヒドロフラン、ジオキサン、モノグライム、ジグライムなどのようなエーテル類;ペンタン、ヘキサン、ヘプタン、リグロインなどのような脂肪族炭化水素類;塩化メチレン、クロロホルム、四塩化炭素などのようなハロゲン化炭化水素類;ジメチルホルムアミド、ジメチルスルホキシドなどのような非プロトン性極性溶媒;メタノール、エタノール、プロパノールなどのようなアルコール類等が挙げられる。本反応は通常0〜150℃、好ましくは0〜100℃で行なわれ、反応時間は、通常10分〜48時間である。化合物(J)の使用量は化合物(A)に対して、等モル以上、好ましくは等モル〜2倍モルである。 The reaction with the compound (J) is carried out without solvent or in a suitable solvent. Further, it is desirable to add a carboxylic acid anhydride such as acetic anhydride as a reaction aid. Any solvent may be used as long as it does not affect the reaction. For example, aromatic hydrocarbons such as benzene, toluene and xylene; diethyl ether, tetrahydrofuran, dioxane, monoglyme, diglyme and the like. Ethers such as; aliphatic hydrocarbons such as pentane, hexane, heptane, ligroin, etc .; halogenated hydrocarbons such as methylene chloride, chloroform, carbon tetrachloride, etc .; non-such as dimethylformamide, dimethyl sulfoxide, etc. Protic polar solvents; alcohols such as methanol, ethanol, propanol and the like. This reaction is usually carried out at 0 to 150 ° C., preferably 0 to 100 ° C., and the reaction time is usually 10 minutes to 48 hours. The amount of compound (J) to be used is equimolar or more, preferably equimolar to 2-fold molar with respect to compound (A).
また別法として、化合物(A)にN,N−ジメチルホルムアミドジメチルアセタール、N−ジメチルホルムアミドジエチルアセタールなどのアセタール類を反応させた後、化合物(J)を反応させて化合物(B)へ導くこともできる。アセタール類との反応に使用される溶媒としては、本反応に影響しないものならいずれを用いてもよく、例えば、前述したものが挙げられる。本反応は通常0〜150℃、好ましくは室温〜100℃で行われ、反応時間は、通常10分〜48時間、好ましくは1〜10時間である。 As another method, compound (A) is reacted with acetals such as N, N-dimethylformamide dimethyl acetal and N-dimethylformamide diethyl acetal, and then compound (J) is reacted to lead to compound (B). You can also. Any solvent may be used as the solvent used in the reaction with the acetals as long as it does not affect the reaction, and examples thereof include those described above. This reaction is usually carried out at 0 to 150 ° C., preferably room temperature to 100 ° C., and the reaction time is usually 10 minutes to 48 hours, preferably 1 to 10 hours.
化合物(B)を環化反応に付して化合物(C)を得る。本反応は、塩基性化合物の存在下又は非存在下適当な溶媒中で行われる。本反応に使用される溶媒としては、反応に影響を与えないものであればいずれも使用でき、例えば、ベンゼン、トルエン、キシレンなどのような芳香族炭化水素類;ジエチルエーテル、テトラヒドロフラン、ジオキサン、モノグライムなどのようなエーテル類;塩化メチレン、クロロホルム、四塩化炭素などのようなハロゲン化炭化水素類;メタノール、エタノール、プロパノール、ブタノールなどのようなアルコール類;ジメチルホルムアミド、ジメチルスルホキシドなどのような非プロトン性極性溶媒が挙げられる。また使用される塩基性化合物としては、金属ナトリウム、金属カリウムなどのようなアルカリ金属類;水素化ナトリウム、水素化カルシウムなどのような金属水素化物;水酸化ナトリウム、水酸化カリウム、炭酸ナトリウム、炭酸カリウムなどのような無機塩類;ナトリウムメトキシド、ナトリウムエトキシド、カリウム−t−ブトキシドなどのようなアルコキシド類;フッ化ナトリウム、フッ化カリウムなどのような金属フッ化物;トリエチルアミン、1,8−ジアザビシクロ[5.4.0]ウンデセン(DBU)などのような有機塩類が挙げられる。本反応の反応温度は通常0〜200℃、好ましくは室温〜180℃がよく、反応は通常5分〜24時間で終了する。塩基性化合物の使用量は化合物(B)に対して等モル以上、好ましくは等モル〜2倍モルがよい。 Compound (B) is subjected to a cyclization reaction to obtain compound (C). This reaction is carried out in a suitable solvent in the presence or absence of a basic compound. Any solvent can be used as long as it does not affect the reaction. For example, aromatic hydrocarbons such as benzene, toluene, xylene, etc .; diethyl ether, tetrahydrofuran, dioxane, monoglyme Ethers such as; halogenated hydrocarbons such as methylene chloride, chloroform, carbon tetrachloride, etc .; alcohols such as methanol, ethanol, propanol, butanol, etc .; non-protons such as dimethylformamide, dimethyl sulfoxide, etc. A polar solvent. Examples of basic compounds used include alkali metals such as sodium metal and potassium; metal hydrides such as sodium hydride and calcium hydride; sodium hydroxide, potassium hydroxide, sodium carbonate and carbonate. Inorganic salts such as potassium; alkoxides such as sodium methoxide, sodium ethoxide, potassium-t-butoxide; metal fluorides such as sodium fluoride, potassium fluoride; triethylamine, 1,8-diazabicyclo [5.4.0] Organic salts such as undecene (DBU). The reaction temperature of this reaction is usually 0 to 200 ° C., preferably room temperature to 180 ° C., and the reaction is usually completed in 5 minutes to 24 hours. The usage-amount of a basic compound is equimolar or more with respect to a compound (B), Preferably equimolar-2 times mole are good.
化合物(C)をニトロ化反応に付すことによって本発明化合物(1a)を製造することができる。ニトロ化は、芳香族化合物のニトロ化に用いられる一般的方法が適用され、ニトロ化剤としては硝酸若しくは硝酸塩と硫酸とを組み合わせた混酸や、硝酸アセチル等が挙げられる。反応に供される混酸の使用量は化合物(C)1当量に対して硫酸は1当量から大過剰量、硝酸は1当量から大過剰量であり、反応は例えば混酸に化合物(C)を添加することによって行われる。また、反応温度は−10℃〜80℃、反応時間は5分〜5時間が好ましい。 The compound (1a) of the present invention can be produced by subjecting the compound (C) to a nitration reaction. For the nitration, a general method used for nitration of aromatic compounds is applied, and examples of the nitrating agent include nitric acid or a mixed acid in which nitrate and sulfuric acid are combined, acetyl nitrate, and the like. The amount of mixed acid used in the reaction is 1 equivalent to a large excess of sulfuric acid and 1 equivalent to a large excess of sulfuric acid with respect to 1 equivalent of compound (C). For example, compound (C) is added to the mixed acid in the reaction. Is done by doing. The reaction temperature is preferably −10 ° C. to 80 ° C., and the reaction time is preferably 5 minutes to 5 hours.
化合物(1a)を還元することにより化合物(1b)を得ることができる。
還元は、一般に用いられる方法が適用でき、例えば酸性溶液中、亜鉛、鉄、スズ、塩化スズ(II)等を用いる溶解金属還元、硫化ナトリウム、ナトリウムヒドロスルフィド、亜二チオン酸ナトリウム等の硫化物を用いた還元及び白金、ラネーニッケル、白金−黒(Pt−C)、パラジウム−炭素(Pd−C)等を用いた接触還元法が挙げられる。
Compound (1b) can be obtained by reducing compound (1a).
For the reduction, generally used methods can be applied, for example, dissolved metal reduction using zinc, iron, tin, tin (II) chloride, etc. in an acidic solution, sulfides such as sodium sulfide, sodium hydrosulfide, sodium dithionite, etc. And catalytic reduction using platinum, Raney nickel, platinum-black (Pt-C), palladium-carbon (Pd-C), and the like.
R1が素原子である化合物(1d)は、化合物(1b)を加水分解することにより、又は所望により化合物(1b)をアルキル化又はアシル化等した後加水分解することにより得ることができる。 The compound (1d) in which R 1 is an elementary atom can be obtained by hydrolyzing the compound (1b), or by hydrolyzing the compound (1b) after alkylating or acylating, if desired.
加水分解は、通常の加水分解反応に用いられる反応条件のいずれも適用できるが、例えば、水酸化ナトリウム、水酸化カリウム、炭酸ナトリウム、炭酸カリウムなどの塩基性化合物;塩酸、硫酸、臭化水素酸などの鉱酸;あるいはp−トルエンスルホン酸などの有機酸等の存在下、水、メタノール、エタノール、プロパノールなどのようなアルコール類、テトラヒドロフラン、ジオキサンなどのようなエーテル類、アセトン、メチルエチルケトンなどのようなケトン類、酢酸等の溶媒又はこれらの混合溶媒中で行われる。本反応は、通常室温〜180℃、好ましくは室温〜140℃で行われ、反応時間は通常1〜24時間である。 For the hydrolysis, any of the reaction conditions used in ordinary hydrolysis reactions can be applied. For example, basic compounds such as sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate; hydrochloric acid, sulfuric acid, hydrobromic acid Mineral acids such as; or in the presence of organic acids such as p-toluenesulfonic acid, water, alcohols such as methanol, ethanol and propanol, ethers such as tetrahydrofuran and dioxane, acetone and methyl ethyl ketone It is carried out in a solvent such as ketones and acetic acid or a mixed solvent thereof. This reaction is usually performed at room temperature to 180 ° C, preferably room temperature to 140 ° C, and the reaction time is usually 1 to 24 hours.
本発明化合物(1c)を得るためのアルキル化反応は、所望のアルキル基に対応するジアルキル硫酸、アルキルヨージド、アルキルブロミド等のアルキル化剤を、好ましくは炭酸ナトリウム、炭酸カリウム等の塩基の存在下、N,N−ジメチルホルムアミド、N−メチルピロリドン等の溶液中、室温〜150℃程度の温度で化合物(1b)と反応させることに行うことができる。また、このアルキル化反応は所望のアルキル基に対応するカルボニル化合物を共存させた上で、白金、ラネーニッケル、白金−黒、パラジウム炭素を用いた接触還元法によって行うこともできる。アシル化反応は、通常のアミノ基のアシル化に用いられる任意の反応により行うことができ、例えば所望のアシル基に対応するアシルクロリド又は酸無水物と化合物(1b)を塩化メチレン、クロロホルム、四塩化炭素、クロロベンゼン等のハロゲン化炭化水素類;ベンゼン、トルエン等の芳香族炭化水素類;テトラヒドロフラン、ジオキサン等のエーテル類又はアセトニトリル、N,N−ジメチルホルムアミド等の非プロトン性極性溶媒中、0℃〜室温においてピリジン、ピコリン、N,N−ジメチルアニリン、N−メチルモルホリン、ジメチルアミン、トリエチルアミン、炭酸ナトリウム、炭酸カリウム等の塩基の存在下又は非存在下に−70〜100℃で反応させることにより、あるいはギ酸、酢酸等の酸又はそれらの酸無水物を室温〜150℃で反応させることにより行うこともできる。 The alkylation reaction for obtaining the compound (1c) of the present invention is carried out by using an alkylating agent such as dialkyl sulfate, alkyl iodide, or alkyl bromide corresponding to the desired alkyl group, preferably the presence of a base such as sodium carbonate or potassium carbonate. The reaction can be carried out by reacting with compound (1b) in a solution of N, N-dimethylformamide, N-methylpyrrolidone, etc. at a temperature of about room temperature to about 150 ° C. This alkylation reaction can also be carried out by a catalytic reduction method using platinum, Raney nickel, platinum-black, or palladium carbon after coexisting a carbonyl compound corresponding to the desired alkyl group. The acylation reaction can be carried out by any reaction commonly used for acylation of amino groups. For example, an acyl chloride or acid anhydride corresponding to the desired acyl group and compound (1b) are mixed with methylene chloride, chloroform, Halogenated hydrocarbons such as carbon chloride and chlorobenzene; aromatic hydrocarbons such as benzene and toluene; ethers such as tetrahydrofuran and dioxane; or aprotic polar solvents such as acetonitrile and N, N-dimethylformamide at 0 ° C. By reacting at −70 to 100 ° C. in the presence or absence of a base such as pyridine, picoline, N, N-dimethylaniline, N-methylmorpholine, dimethylamine, triethylamine, sodium carbonate, potassium carbonate at room temperature Or an acid such as formic acid or acetic acid or an acid anhydride thereof at room temperature It can also be carried out by reacting at 0.99 ° C..
なお、一般式(1)中R6がアミノ基である化合物は、R6がハロゲン原子である化合物(A)を出発原料として用いて前記反応を行うことにより化合物(1a)、(1b)、(1c)又は(1d)とした後、当該ハロゲン原子をアミノ化することによって得るのが好ましい。 In the general formula (1), the compound in which R 6 is an amino group is obtained by performing the above reaction using the compound (A) in which R 6 is a halogen atom as a starting material. After (1c) or (1d), the halogen atom is preferably obtained by amination.
また、化合物(1b)は以下の方法によっても合成することができる。
即ち、前記の化合物(A)にオルトギ酸エステル類(H)を反応させることによって得られるアクリル酸エステル類(D)とフェニレンジアミン類(K)とを縮合、環化させることによって化合物(L)とし、次いでアミノ保護基を脱離することにより化合物(1b)を得ることができる。 That is, compound (L) is obtained by condensing and cyclizing acrylic ester (D) and phenylenediamine (K) obtained by reacting orthoformate (H) with compound (A). And then removing the amino protecting group can give compound (1b).
化合物(A)から化合物(L)を得る反応は、前述の化合物(A)から化合物(C)を得る反応と同様の条件によって行うことができる。 The reaction for obtaining the compound (L) from the compound (A) can be performed under the same conditions as the reaction for obtaining the compound (C) from the compound (A).
アミノ保護基(主にアシル基、カルバモイル基)の脱離は酸又はアルカリで加水分解することによって行われる。この条件は前述の化合物(1b)、(1c)への加水分解で記述したのと同様である。 Amino protecting groups (mainly acyl groups, carbamoyl groups) are removed by hydrolysis with acid or alkali. This condition is the same as described in the hydrolysis to the compounds (1b) and (1c).
(工程2)一般式(1)で示される化合物のうち、Zが置換基を有していてもよい飽和環状アミノ基である化合物は、例えば以下の反応式に表される工程2によって製造される。
すなわち、化合物(N)を、式Z2−Hで表される化合物を用いてアミノ化することにより化合物(O)が得られる。 That is, compound (O) is obtained by aminating compound (N) with a compound represented by formula Z 2 —H.
本反応は、ベンゼン、トルエン、キシレンなどのような芳香族炭化水素類;メタノール、エタノールなどのようなアルコール類;テトラヒドロフラン、ジオキサン、モノグライムなどのようなエーテル類;塩化メチレン、クロロホルム、四塩化炭素などのようなハロゲン化炭化水素類;ジメチルホルムアミド、ジメチルスルホキシド、N−メチルピロリドンなどのような非プロトン性極性溶媒;アセトニトリル、ピリジン等の、反応に影響を与えない溶媒中、必要に応じて脱酸剤、例えば炭酸ナトリウム、炭酸カルシウム、炭酸水素ナトリウム、トリエチルアミン、1,8−ジアザビシクロ[5.4.0]ウンデセン(DBU)などの存在下室温〜160℃において行われる。反応時間は数分〜48時間、好ましくは10分〜24時間である。化合物Z2−Hの使用量は化合物(N)に対して等モル以上、好ましくは等モル〜5倍モルとするのがよい。なお、R1がカルボキシ保設基である場合、所望により加水分解することにより水素原子に変換することができる。 In this reaction, aromatic hydrocarbons such as benzene, toluene and xylene; alcohols such as methanol and ethanol; ethers such as tetrahydrofuran, dioxane and monoglyme; methylene chloride, chloroform and carbon tetrachloride Halogenated hydrocarbons such as: aprotic polar solvents such as dimethylformamide, dimethyl sulfoxide, N-methylpyrrolidone, etc .; deacidification as necessary in a solvent that does not affect the reaction, such as acetonitrile, pyridine, etc. It is carried out at room temperature to 160 ° C. in the presence of an agent such as sodium carbonate, calcium carbonate, sodium hydrogen carbonate, triethylamine, 1,8-diazabicyclo [5.4.0] undecene (DBU). The reaction time is several minutes to 48 hours, preferably 10 minutes to 24 hours. The amount of compound Z 2 —H to be used is equimolar or more, preferably equimolar to 5-fold molar to compound (N). When R 1 is a carboxy-retaining group, it can be converted to a hydrogen atom by hydrolysis if desired.
(工程3)一般式(1)で表わされる化合物のうち、R1がカルボキシ保護基である化合物は、例えば以下の反応式に示される工程3によって製造される。
すなわち、化合物(Q)は化合物(P)にハロゲン化合物R1b−L2を反応させることによって得られる。ここで使用される溶媒としては、ベンゼン、トルエンなどのような芳香族炭化水素類;塩化メチレン、クロロホルムなどのようなハロゲン化炭化水素類;ジメチルホルムアミド、ジメチルスルホキシドなどのような非プロトン性極性溶媒類;アセトニトリルなどの不活性溶媒を挙げることができる。反応温度は通常室温〜100℃付近である。本反応はトリエチルアミン、ジイソプロピルエチルアミン、ジシクロヘキシルアミン、DBU、炭酸ナトリウム、炭酸カリウム、水酸化ナトリウムなどのような塩基性化合物の存在下に行うことが好ましい。 That is, the compound (Q) can be obtained by reacting the compound (P) with the halogen compound R 1b -L 2 . Solvents used here include aromatic hydrocarbons such as benzene and toluene; halogenated hydrocarbons such as methylene chloride and chloroform; aprotic polar solvents such as dimethylformamide and dimethyl sulfoxide. And an inert solvent such as acetonitrile. The reaction temperature is usually from room temperature to around 100 ° C. This reaction is preferably carried out in the presence of a basic compound such as triethylamine, diisopropylethylamine, dicyclohexylamine, DBU, sodium carbonate, potassium carbonate, sodium hydroxide and the like.
上記の工程1〜3で使用される原料化合物中本反応に関与しないアミノ基、イミノ基、ヒドロキシ基、メルカプト基又はカルボキシル基等が存在する場合、これらの基を保護した形で用い、反応完了後、常法によってその保護基を除去してもよい。保護基としては、反応によって形成される本発明の化合物の構造を破壊することなく除去しうるものであればいかなるものでもよく、ペプチト、アミノ糖、核酸の化学の分野で通常用いられている基が使用される。 When amino group, imino group, hydroxy group, mercapto group, carboxyl group, etc. not involved in this reaction are present in the raw material compounds used in steps 1 to 3, these groups are used in a protected form, and the reaction is completed. Thereafter, the protecting group may be removed by a conventional method. The protecting group may be any as long as it can be removed without destroying the structure of the compound of the present invention formed by the reaction, and is a group usually used in the field of peptide, amino sugar, or nucleic acid chemistry. Is used.
原料化合物(A)は以下の文献に記載の方法或いは、これに準じた方法で製造しうる。
1)J.Heterocyclic Chem.22,1033(1985)
2)Liebigs Ann.Chem.29(1987)
3)J.Med.Chem.31,991(1988)
4)J.Org.Chem.35,930(1970)
5)特開昭62−246541号公報
6)特開昭62−26272号公報
7)特開昭63−145268号公報
8)J.Med.Chem.29,2363(1986)
9)J.Fluorin Chem.28,361(1985)
10)特開昭63−198664号公報
11)特開昭63−264461号公報
12)特開昭63−104974号公報
13)欧州特許出願第230948号公報
14)特開平2−282384号公報
15)特表平3−502452号公報
16)J.Het.Chem.27,1609(1990)
The starting compound (A) can be produced by the method described in the following literature or a method analogous thereto.
1) J. et al. Heterocyclic Chem. 22, 1033 (1985)
2) Liebigs Ann. Chem. 29 (1987)
3) J. et al. Med. Chem. 31, 991 (1988)
4) J.A. Org. Chem. 35, 930 (1970)
5) Japanese Patent Application Laid-Open No. Sho 62-246541 6) Japanese Patent Application Laid-Open No. Sho 62-26272 7) Japanese Patent Application Laid-Open No. Sho 63-145268 8) Med. Chem. 29, 2363 (1986)
9) J. et al. Fluorin Chem. 28, 361 (1985)
10) JP 63-198664 11) JP 63-264461 12) JP 63-104974 13) European Patent Application 230948 14) JP 2-282384 15) Japanese National Publication No. Hei 3-502452 16). Het. Chem. 27, 1609 (1990)
このようにして得られた本発明の化合物は常法に従い単離、精製される。単離、精製条件によって、塩の形、遊離カルボン酸や遊離アミンの形で得られるが、これらは所望により相互に変換され、目的とする形の本発明の化合物が製造される。 The compound of the present invention thus obtained is isolated and purified according to a conventional method. Depending on the isolation and purification conditions, it can be obtained in the form of a salt, a free carboxylic acid or a free amine, which are converted to each other as desired to produce the desired form of the compound of the present invention.
本発明化合物(1)又はその塩は、抗菌剤として、注射、経直腸、点眼等の非経口投与、固形若しくは液体形態での経口投与等のための製薬上許容し得る担体とともに組成物を処方することができる。 The compound (1) of the present invention or a salt thereof is formulated as an antibacterial agent together with a pharmaceutically acceptable carrier for parenteral administration such as injection, rectal administration, ophthalmic administration, oral administration in a solid or liquid form, etc. can do.
注射剤のための本発明抗菌剤組成物の形態としては製薬上許容し得る無菌水若しくは非水溶液、懸濁液若しくは乳濁液が挙げられる。適当な非水担体、希釈剤、溶媒又はビヒクルの例としては、プロピレングリコール、ポリエチレングリコール、植物油、例えばオリーブ油及び注射可能な有機エステル、例えばオレイン酸エチルが挙げられる。このような組成物は補助剤、例えば防腐剤、湿潤剤、乳化剤及び分散剤をも含有することができる。これら組成物は例えば細菌保持フィルターによる濾過により、又は使用直前に減菌剤あるいは若干の他の減菌注射可能な媒質に溶解し得る無菌固形組成物の形態で減菌剤を混入することにより減菌することができる。 Examples of the form of the antibacterial composition of the present invention for injection include pharmaceutically acceptable sterile water or non-aqueous solution, suspension or emulsion. Examples of suitable non-aqueous carriers, diluents, solvents or vehicles include propylene glycol, polyethylene glycol, vegetable oils such as olive oil and injectable organic esters such as ethyl oleate. Such compositions can also contain adjuvants such as preservatives, wetting agents, emulsifying agents and dispersing agents. These compositions can be reduced, for example, by filtration through a bacteria retaining filter or by incorporating the sterilizing agent in the form of a sterile solid composition that can be dissolved in a sterilizing agent or some other sterilized injectable medium immediately before use. Can be fungus.
点眼投与のための製剤は、好ましくは本発明化合物に加えて、溶解補助剤、保存剤、等張化剤及び増粘剤等を加えることができる。 In preparations for eye drop administration, a solubilizing agent, preservative, isotonic agent, thickener and the like can be preferably added in addition to the compound of the present invention.
経口投与のための固形製剤にはカプセル剤、錠剤、丸剤、散剤及び顆粒剤等が挙げられる。この固形製剤の調製にあたっては一般に本発明化合物を少なくとも1種の不活性希釈剤、例えばスクロース、乳糖又はでんぷんと混和する。この製剤はまた通常の製剤化において不活性希釈剤以外の追加の物質例えば滑沢剤(例えばステアリン酸マグネシウム等)を用いてもよい。カプセル剤、錠剤及び丸剤の場合には、更に、緩衝剤を用いてもよい。錠剤及び丸剤には腸溶性被膜を施してもよい。 Solid preparations for oral administration include capsules, tablets, pills, powders and granules. In preparing this solid preparation, the compound of the present invention is generally mixed with at least one inert diluent such as sucrose, lactose or starch. This formulation may also use additional materials other than inert diluents, such as lubricants (eg, magnesium stearate) in normal formulations. In the case of capsules, tablets and pills, a buffering agent may be further used. Tablets and pills may be enteric coated.
経口投与のための液体製剤には、当業者間で普通に使用される不活性希釈剤、例えば水を含む製薬上許容し得る乳剤、溶液、懸濁剤、シロップ剤及びエリキシール剤が挙げられる。かかる不活性希釈剤に加えて、組成物には補助剤例えば湿潤剤、乳化、懸濁剤、ならびに甘味、調味及び香味剤も配合することができる。経直腸投与のための製剤は、好ましくは本発明化合物に加えて賦形剤例えばカカオ脂若しくは坐剤ワックスを含有していてもよい。 Liquid dosage forms for oral administration include pharmaceutically acceptable emulsions, solutions, suspensions, syrups and elixirs containing inert diluents commonly used by those skilled in the art, such as water. In addition to such inert diluents, the composition may also contain adjuvants such as wetting agents, emulsifying agents, suspending agents, and sweetening, flavoring and flavoring agents. Formulations for rectal administration may preferably contain excipients such as cocoa butter or suppository waxes in addition to the compound of the present invention.
本発明化合物(1)の投与量は投与される化合物の性状、投与経路、所望の処置期間及びその他の要因によって左右されるが、一般に成人で一日当り約0.1〜1000mg/kg、特に約0.5〜100mg/kgが好ましい。また、所望によりこの一日量を2〜4回に分割して投与することもできる。 The dosage of the compound (1) of the present invention depends on the properties of the compound to be administered, the administration route, the desired treatment period and other factors, but is generally about 0.1 to 1000 mg / kg per day in adults, especially about 0.5-100 mg / kg is preferred. If desired, this daily dose can be divided into 2 to 4 doses.
以下、実施例及び参考例により本発明を更に詳細に説明するが、本発明はこれらに限定されるものではない。 Hereinafter, although an example and a reference example explain the present invention still in detail, the present invention is not limited to these.
〔参考例1〕
エチル 7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1−(2,4,6−トリフルオロフェニル)−1,8−ナフチリジン−3−カルボキシレート:
エチル 2−(2,6−ジクロロ−5−フルオロニコチノイル)−3−エトキシアクリレート6.40gのトルエン溶液10mlへ氷冷下、2,4,6−トリフルオロアニリン1.39mlのトルエン溶液5mlを滴下し、室温で一晩撹拌した。溶媒を留去し、エタノールを加え結晶を濾取し、ジエチルエーテルで洗い、エチル 2,6−ジクロロ−5−フルオロニコチノイル−3−トリフルオロフェニルアミノアクリレートを得た。このエチル2,6−ジクロロ−5−フルオロニコチノイル−3−(2,4,6−トリフルオロフェニルアミノ)アクリレート2.0gのN,N−ジメチルホルムアミド(9ml)溶液へ炭酸カリウム0.63gを加え室温で90分間撹拌した。反応液を氷水に注入し析出した固体を濾取し、エタノール、ジエチルエーテルで洗い1.38gの標記化合物を得た。
性状:無色粉末
融点:158−160℃
1HNMR(CDCl3)δ;
1.41(t,J=7Hz.3H),4.42(q,J=7Hz,2H),6.92−7.06(m,2H),8.48(d,J=11Hz,1H),8.49(s,1H)
[Reference Example 1]
Ethyl 7-chloro-6-fluoro-1,4-dihydro-4-oxo-1- (2,4,6-trifluorophenyl) -1,8-naphthyridine-3-carboxylate:
Ethyl 2- (2,6-dichloro-5-fluoronicotinoyl) -3-ethoxyacrylate 6.40 g of toluene solution 10 ml of toluene solution under ice cooling, 5 ml of 2,4,6-trifluoroaniline 1.39 ml of toluene solution Add dropwise and stir overnight at room temperature. The solvent was distilled off, ethanol was added and the crystals were collected by filtration and washed with diethyl ether to give ethyl 2,6-dichloro-5-fluoronicotinoyl-3-trifluorophenylaminoacrylate. 0.63 g of potassium carbonate was added to a solution of 2.0 g of ethyl 2,6-dichloro-5-fluoronicotinoyl-3- (2,4,6-trifluorophenylamino) acrylate in N, N-dimethylformamide (9 ml). The mixture was stirred at room temperature for 90 minutes. The reaction solution was poured into ice water and the precipitated solid was collected by filtration and washed with ethanol and diethyl ether to obtain 1.38 g of the title compound.
Property: Colorless powder Melting point: 158-160 ° C
1 H NMR (CDCl 3 ) δ;
1.41 (t, J = 7 Hz, 3H), 4.42 (q, J = 7 Hz, 2H), 6.92-7.06 (m, 2H), 8.48 (d, J = 11 Hz, 1H) ), 8.49 (s, 1H)
〔参考例2〕
エチル 7−クロロ−1−(2−クロロ−4−フルオロフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート:
2−クロロ−4−フルオロアニリンを用いたほかは参考例1と同様にして標記化合物を得た。
性状:無色粉末
融点:177−178℃
1HNMR(CDCl3)δ;
1.41(t,J=7Hz,3H),4.41(q,J=7Hz,2H),7.23(dd,J=3Hz,8Hz,1H),7.36−7.51(m,2H),8.49(d,J=7Hz,1H),8.49(s,1H)
[Reference Example 2]
Ethyl 7-chloro-1- (2-chloro-4-fluorophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate:
The title compound was obtained in the same manner as in Reference Example 1 except that 2-chloro-4-fluoroaniline was used.
Properties: Colorless powder Melting point: 177-178 ° C
1 H NMR (CDCl 3 ) δ;
1.41 (t, J = 7 Hz, 3H), 4.41 (q, J = 7 Hz, 2H), 7.23 (dd, J = 3 Hz, 8 Hz, 1H), 7.36-7.51 (m , 2H), 8.49 (d, J = 7 Hz, 1H), 8.49 (s, 1H)
〔参考例3〕
エチル 1−(2−クロロ−4−フルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボキシレート:
エチル 2−(2,4,5−トリフルオロベンゾイル)−3−エトキシアクリレート 2.46gのクロロホルム溶液13mlへ氷冷下、2−クロロ−4−フルオロアニリン1.2mlのクロロホルム溶液5mlを滴下し、室温で一晩撹拌した。溶媒を留去し、エタノールを加え結晶を濾取し,ジエチルエーテルで洗い、エチル 2−(2,4,5−トリフルオロベンゾイル)−3−(2−クロロ−4−フルオロフェニルアミノ)アクリレートを得た。このエチル 2−(2,4,5−トリフルオロベンゾイル)−3−(2−クロロ−4−フルオロフェニルアミノ)アクリレート3.00gのN,N−ジメチルホルムアミド溶液15mlへ炭酸カリウム1.03gを加え室温で90分間撹拌した。反応液を氷水に注入し析出した固体を濾取し、エタノール、ジエチルエーテルで洗い2.74gの標記化合物を得た。
性状:無色鱗片状結晶
融点:220℃(分解)
1HNMR(CDCl3)δ;
1.40(t,J=7Hz,3H),4.39(q,J=7Hz,2H),6.54(dd,J=6Hz,11Hz,1H),7.46(dd,J=3Hz,7Hz,1H),7.56(dd,J=5Hz,9Hz,1H),7.50−7.64(m,2H),8.25−8.38(m,1H),8.34(s,1H)
[Reference Example 3]
Ethyl 1- (2-chloro-4-fluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylate:
Ethyl 2- (2,4,5-trifluorobenzoyl) -3-ethoxyacrylate 2 ml of chloroform solution 1.2 ml of 2-chloro-4-fluoroaniline was added dropwise to 13 ml of chloroform solution 2.46 g, Stir overnight at room temperature. The solvent was distilled off, ethanol was added, the crystals were collected by filtration, washed with diethyl ether, and ethyl 2- (2,4,5-trifluorobenzoyl) -3- (2-chloro-4-fluorophenylamino) acrylate was added. Obtained. To 15 ml of an N, N-dimethylformamide solution of 3.00 g of this ethyl 2- (2,4,5-trifluorobenzoyl) -3- (2-chloro-4-fluorophenylamino) acrylate, 1.03 g of potassium carbonate was added. Stir at room temperature for 90 minutes. The reaction solution was poured into ice water and the precipitated solid was collected by filtration and washed with ethanol and diethyl ether to obtain 2.74 g of the title compound.
Property: Colorless scaly crystal Melting point: 220 ° C. (decomposition)
1 H NMR (CDCl 3 ) δ;
1.40 (t, J = 7 Hz, 3H), 4.39 (q, J = 7 Hz, 2H), 6.54 (dd, J = 6 Hz, 11 Hz, 1H), 7.46 (dd, J = 3 Hz) , 7 Hz, 1H), 7.56 (dd, J = 5 Hz, 9 Hz, 1H), 7.50-7.64 (m, 2H), 8.25-8.38 (m, 1H), 8.34 (S, 1H)
〔参考例4〕
エチル 7−クロロ−1−(4−クロロ−2−フルオロフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート:
4−クロロ−2−フルオロアニリンを用いたほかは参考例1と同様にして標記化合物を得た。
性状:無色粉末
融点:216−218℃
1HNMR(CDCl3)δ;
1.41(t,J=7Hz,3H),4.40(q,J=7Hz,2H),7.34−7.45(m,3H)8.47(d,J=9Hz,1H),8.55(s,1H)
[Reference Example 4]
Ethyl 7-chloro-1- (4-chloro-2-fluorophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate:
The title compound was obtained in the same manner as in Reference Example 1 except that 4-chloro-2-fluoroaniline was used.
Property: Colorless powder Melting point: 216-218 ° C
1 H NMR (CDCl 3 ) δ;
1.41 (t, J = 7 Hz, 3H), 4.40 (q, J = 7 Hz, 2H), 7.34-7.45 (m, 3H) 8.47 (d, J = 9 Hz, 1H) , 8.55 (s, 1H)
〔参考例5〕
エチル 7−クロロ−6−フルオロ−1−(4−フルオロ−2−メチルフェニル)−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート:
4−フルオロ−2−メチルアニリンを用いたほかは参考例1と同様にして標記化合物を得た。
性状:無色粉末
融点:199−200℃
1HNMR(CDCl3)δ;
1.40(t,J=7Hz,3H),2.06(s,3H),4.41(q,J=7Hz,2H),7.05−7.17(m,2H),7.23(d,J=5Hz,1H),8.48(d,J=7Hz,1H),8.51(s,1H)
[Reference Example 5]
Ethyl 7-chloro-6-fluoro-1- (4-fluoro-2-methylphenyl) -1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate:
The title compound was obtained in the same manner as in Reference Example 1 except that 4-fluoro-2-methylaniline was used.
Properties: Colorless powder Melting point: 199-200 ° C
1 H NMR (CDCl 3 ) δ;
1.40 (t, J = 7 Hz, 3H), 2.06 (s, 3H), 4.41 (q, J = 7 Hz, 2H), 7.05-7.17 (m, 2H), 7. 23 (d, J = 5 Hz, 1H), 8.48 (d, J = 7 Hz, 1H), 8.51 (s, 1H)
〔実施例1〕
エチル 7−クロロ−1−(2,4−ジフルオロ−5−ニトロフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート:
エチル 7−クロロ−1−(2,4−ジフルオロフェニル)−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボキシレート2.00gを8mlの濃硫酸に加え、氷冷下撹拌しながら600mgの硝酸カリウムを少量ずつ加えた。室温で30分間撹拌してニトロ化を完了させ、ついで150mlのクロロホルムと100mlの氷水を撹拌している中に反応液をそそぎ込み、室温で15分間撹拌後分液し、クロロホルム層を無水硫酸マグネシウムで乾燥後減圧下に濃縮した。析出晶をエタノールに分散して濾取、エタノール、ジイソプロピルエーテルの順に洗って、2.08gの標記化合物を得た。
性状:無色針状結晶
融点:256−257℃
1HNMR(CDCl3)δ;
1.41(t,J=7Hz,3H),4.42(d,J=7Hz,1H),7.37(t,J=9Hz,1H),8.35(t,J=7Hz,1H),8.49(d,J=7Hz,1H),8.54(s,1H)
[Example 1]
Ethyl 7-chloro-1- (2,4-difluoro-5-nitrophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate:
2.00 g of ethyl 7-chloro-1- (2,4-difluorophenyl) -6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate is added to 8 ml of concentrated sulfuric acid. While stirring under ice cooling, 600 mg of potassium nitrate was added little by little. The mixture was stirred at room temperature for 30 minutes to complete the nitration, and then the reaction solution was poured into 150 ml of chloroform and 100 ml of ice water while stirring. And dried under reduced pressure. The precipitated crystals were dispersed in ethanol, collected by filtration, and washed successively with ethanol and diisopropyl ether to obtain 2.08 g of the title compound.
Properties: colorless needle crystal Melting point: 256-257 ° C
1 H NMR (CDCl 3 ) δ;
1.41 (t, J = 7 Hz, 3H), 4.42 (d, J = 7 Hz, 1H), 7.37 (t, J = 9 Hz, 1H), 8.35 (t, J = 7 Hz, 1H) ), 8.49 (d, J = 7 Hz, 1H), 8.54 (s, 1H)
〔実施例2〕
7−クロロ−6−フルオロ−1−(2,4−ジフルオロ−5−ニトロフェニル)−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
7−クロロ−1−(2,4−ジフルオロフェニル)−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸6.0gを25mlの濃硫酸に加え、氷冷下撹拌しながら5.0gの硝酸カリウムを少量ずつ加えた。徐々に温度を上げ80℃で2時間撹拌した。放冷し、200gの氷水に加え一晩放置した。析出物を濾取、蒸留水、エタノール、ジイソプロピルエーテルで洗ったのち風乾し、6.4gの標記化合物を得た。
性状:無色粉末
融点:262−265℃(分解)
1HNMR(CDCl3)δ;
8.15(t,J=11Hz,1H,),8.79(d,J=7Hz,1H),8.86(t,J=8Hz,1H),9.17(s,1H)
[Example 2]
7-Chloro-6-fluoro-1- (2,4-difluoro-5-nitrophenyl) -1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid:
6.0 g of 7-chloro-1- (2,4-difluorophenyl) -6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid is added to 25 ml concentrated sulfuric acid, While stirring with ice cooling, 5.0 g of potassium nitrate was added little by little. The temperature was gradually raised and the mixture was stirred at 80 ° C. for 2 hours. The mixture was allowed to cool, then added to 200 g of ice water and left overnight. The precipitate was collected by filtration, washed with distilled water, ethanol and diisopropyl ether and then air-dried to obtain 6.4 g of the title compound.
Properties: colorless powder Melting point: 262-265 ° C. (decomposition)
1 H NMR (CDCl 3 ) δ;
8.15 (t, J = 11 Hz, 1H,), 8.79 (d, J = 7 Hz, 1H), 8.86 (t, J = 8 Hz, 1H), 9.17 (s, 1H)
〔実施例3〕
1−(2,4−ジフルオロ−5−ニトロフェニノレ)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
1−(2,4−ジフルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸4gを濃硫酸40mlに加え、硝酸カリウム3.6mgを少じずつ加え、室温で1時間撹拌した。反応液を氷水に注ぎ一晩撹拌した。析出した固体を濾取し、水、エタノール、ジエチルエーテルで洗浄した。4.2gの標記化合物を得た。
性状:淡黄色粉末
融点:>270℃
1HNMR(CDCl3)δ;
7.70(dd,J=6Hz,12Hz,1H),8.21(t,J=11Hz,1H),8.36(t,J=9Hz,1H),8.93(t,J=8Hz,1H),9.10(s,1H)
Example 3
1- (2,4-Difluoro-5-nitrophenyl) -6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid:
4 g of 1- (2,4-difluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid is added to 40 ml of concentrated sulfuric acid, and 3.6 mg of potassium nitrate is added little by little. And stirred at room temperature for 1 hour. The reaction solution was poured into ice water and stirred overnight. The precipitated solid was collected by filtration and washed with water, ethanol, and diethyl ether. 4.2 g of the title compound was obtained.
Properties: Pale yellow powder Melting point:> 270 ° C
1 H NMR (CDCl 3 ) δ;
7.70 (dd, J = 6 Hz, 12 Hz, 1H), 8.21 (t, J = 11 Hz, 1H), 8.36 (t, J = 9 Hz, 1H), 8.93 (t, J = 8 Hz) , 1H), 9.10 (s, 1H)
〔実施例4〕
エチル 1−(2,4−ジフルオロ−5−ニトロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボキシレート:
1−(2,4−ジフルオロ−5−ニトロフェニル)−6,7−ジフルオロ−1.4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸 4.2gをジクロロエタン40mlに加え、氷冷下、塩化オキサリル7gを滴下した。滴下終了後、室温で2時間撹拌した。この反応液にエタノール15mlを滴下し、室温で一晩撹拌した。反応液を減圧濃縮し、残渣にエタノールを加え、固体を濾取し、ジエチルエーテルで固体を洗浄した。3.7gの標記化合物を得た。
性状:淡黄色粉末
融点:165−173℃
1HNMR(d6−DMSO)δ;
2.74(t,J=7Hz,3H),4.37(q,J=7Hz,2H),7.47(dd,J=10Hz,11Hz,1H),8.11−8.24(m,2H),8.72(s,1H),8.93(t,J=9Hz,1H)
Example 4
Ethyl 1- (2,4-difluoro-5-nitrophenyl) -6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylate:
4.2 g of 1- (2,4-difluoro-5-nitrophenyl) -6,7-difluoro-1.4-dihydro-4-oxo-quinoline-3-carboxylic acid was added to 40 ml of dichloroethane. 7 g of oxalyl chloride was added dropwise. After completion of dropping, the mixture was stirred at room temperature for 2 hours. To this reaction solution, 15 ml of ethanol was added dropwise and stirred overnight at room temperature. The reaction mixture was concentrated under reduced pressure, ethanol was added to the residue, the solid was collected by filtration, and the solid was washed with diethyl ether. 3.7 g of the title compound was obtained.
Properties: Pale yellow powder Melting point: 165-173 ° C
1 H NMR (d 6 -DMSO) δ;
2.74 (t, J = 7 Hz, 3H), 4.37 (q, J = 7 Hz, 2H), 7.47 (dd, J = 10 Hz, 11 Hz, 1H), 8.11-8.24 (m , 2H), 8.72 (s, 1H), 8.93 (t, J = 9 Hz, 1H)
〔実施例5〕
1−(2,4−ジフルオロ−5−ニトロフェニル)−6,7,8−トリフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
1−(2,4−ジフルオロフェニル)−6,7,8−トリフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸1.7gを濃硫酸10mlに加え、硝酸カリウム1.5gを少しづつ加え、60℃で一晩加熱撹拌した。放冷後、氷水に注ぎ一晩撹拌した。析出した固体を濾取し、水、エタノール、ジエチルエーテルで洗浄した。1.7gの標記化合物を得た。
性状:淡黄色粉末
融点:245−255℃
1HNMR(d6−DMSO)δ;
8.17(t,J=10Hz,1H),8.26(t,J=9Hz,1H),8.97(s,1H),9.00(t,J=8Hz,1H)
Example 5
1- (2,4-Difluoro-5-nitrophenyl) -6,7,8-trifluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid:
1.7 g of 1- (2,4-difluorophenyl) -6,7,8-trifluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid is added to 10 ml of concentrated sulfuric acid and 1.5 g of potassium nitrate is added. Was added little by little, and the mixture was stirred at 60 ° C. overnight. After cooling, the mixture was poured into ice water and stirred overnight. The precipitated solid was collected by filtration and washed with water, ethanol, and diethyl ether. 1.7 g of the title compound was obtained.
Properties: Pale yellow powder Melting point: 245-255 ° C
1 H NMR (d 6 -DMSO) δ;
8.17 (t, J = 10 Hz, 1H), 8.26 (t, J = 9 Hz, 1H), 8.97 (s, 1H), 9.00 (t, J = 8 Hz, 1H)
〔実施例6〕
エチル 1−(2,4−ジフルオロ−5−ニトロフェニル)−6,7,8−トリフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボキンレート:
1−(2,4−ジフルオロ−5−ニトロフェニル)−6,7,8−トリフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸を用いたほかは実施例4と同様にして標記化合物を得た。
性状:無色粉末
融点:210−217℃
1HNMR(d6−DMSO)δ;
1.27(t,J=7Hz,3H),4.26(q,J=7Hz,2H),8.07(t,J=11Hz,1H),8.16(t,J=10Hz,1H),8.64(s,1H),9.00(t,J=8Hz,1H)
Example 6
Ethyl 1- (2,4-difluoro-5-nitrophenyl) -6,7,8-trifluoro-1,4-dihydro-4-oxo-quinoline-3-carboquinate:
Similar to Example 4 except that 1- (2,4-difluoro-5-nitrophenyl) -6,7,8-trifluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid was used. To give the title compound.
Properties: Colorless powder Melting point: 210-217 ° C
1 H NMR (d 6 -DMSO) δ;
1.27 (t, J = 7 Hz, 3H), 4.26 (q, J = 7 Hz, 2H), 8.07 (t, J = 11 Hz, 1H), 8.16 (t, J = 10 Hz, 1H) ), 8.64 (s, 1H), 9.00 (t, J = 8 Hz, 1H)
〔実施例7〕
7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1−(2,3,4−トリフルオロ−5−ニトロフェニル)−1,8−ナフチリジン−3−カルボン酸:
7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1−(2,3,4−トリフルオロフェニル)−1,8−ナフチリジン−3−カルボン酸890mgを濃硫酸10mlに加え、硝酸カリウム730mgを少しづつ加え、室温で2日間撹拌した。放冷後、氷水に注ぎ一晩撹拌した。析出した固体を濾取し、水、エタノール、ジエチルエーテルで洗浄した。860mgの標記化合物を得た。
性状:黄色粉末
融点:216−221℃
1HNMR(d6−DMSO)δ;
8.72−8.84(m,2H),9.11(s,1H)
Example 7
7-Chloro-6-fluoro-1,4-dihydro-4-oxo-1- (2,3,4-trifluoro-5-nitrophenyl) -1,8-naphthyridine-3-carboxylic acid:
Add 890 mg of 7-chloro-6-fluoro-1,4-dihydro-4-oxo-1- (2,3,4-trifluorophenyl) -1,8-naphthyridine-3-carboxylic acid to 10 ml of concentrated sulfuric acid, 730 mg of potassium nitrate was added little by little, and the mixture was stirred at room temperature for 2 days. After cooling, the mixture was poured into ice water and stirred overnight. The precipitated solid was collected by filtration and washed with water, ethanol, and diethyl ether. 860 mg of the title compound was obtained.
Property: Yellow powder Melting point: 216-221 ° C
1 H NMR (d 6 -DMSO) δ;
8.72-8.84 (m, 2H), 9.11 (s, 1H)
〔実施例8〕
エチル 7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1−(2,3,4−トリフルオロ−5−ニトロフェニル)−1,8−ナフチリジン−3−カルボキシレート:
7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1−(2,3,4−トリフルオロ−5−ニトロフェニル)−1,8−ナフチリジン−3−カルボン酸を用いたほかは実施例4と同様にして標記化合物を得た。
1HNMR(CDCl3)δ;
1.41(t,J=7Hz,3H),4.42(q,J=7Hz,2H),8.18−8.26(m,1H),8.59(d,J=8Hz,1H),8.54(s,1H)
Example 8
Ethyl 7-chloro-6-fluoro-1,4-dihydro-4-oxo-1- (2,3,4-trifluoro-5-nitrophenyl) -1,8-naphthyridine-3-carboxylate:
Besides using 7-chloro-6-fluoro-1,4-dihydro-4-oxo-1- (2,3,4-trifluoro-5-nitrophenyl) -1,8-naphthyridine-3-carboxylic acid Gave the title compound as in Example 4.
1 H NMR (CDCl 3 ) δ;
1.41 (t, J = 7 Hz, 3H), 4.42 (q, J = 7 Hz, 2H), 8.18-8.26 (m, 1H), 8.59 (d, J = 8 Hz, 1H) ), 8.54 (s, 1H)
〔実施例9〕
6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−1−(2,3,4−トリフルオロ−5−ニトロフェニル)−キノリン−3−カルボン酸:
6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−1−(2,3,4−トリフルオロフェニル)−キノリン−3−カルボン酸830mgを濃硫酸10mlに加え、硝酸カリワム710mgを少しづつ加え、100℃で3日間撹拌した。放冷後、氷水に注ぎ一晩撹拌した。析出した固体を濾取し、水、エタノール、ジエチルエーテルで洗浄した。700mgの標記化合物を得た。
性状:淡黄色粉末
融点:>215℃(分解)
1HNMR(d6−DMSO)δ;
7.76(dd,J=6Hz,11Hz,1H),8.37(t,J=9Hz,1H),8.85(t,J=6Hz,1H),9.07(s,1H)
Example 9
6,7-Difluoro-1,4-dihydro-4-oxo-1- (2,3,4-trifluoro-5-nitrophenyl) -quinoline-3-carboxylic acid:
Add 830 mg of 6,7-difluoro-1,4-dihydro-4-oxo-1- (2,3,4-trifluorophenyl) -quinoline-3-carboxylic acid to 10 ml of concentrated sulfuric acid, and gradually add 710 mg of kaliwam nitrate. In addition, the mixture was stirred at 100 ° C. for 3 days. After cooling, the mixture was poured into ice water and stirred overnight. The precipitated solid was collected by filtration and washed with water, ethanol, and diethyl ether. 700 mg of the title compound were obtained.
Properties: Pale yellow powder Melting point:> 215 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
7.76 (dd, J = 6 Hz, 11 Hz, 1H), 8.37 (t, J = 9 Hz, 1H), 8.85 (t, J = 6 Hz, 1H), 9.07 (s, 1H)
〔実施例10〕
エチル 6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−1−(2,3,4−トリフルオロ−5−ニトロフェニル)−キノリン−3−カルボキシレート:
6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−1−(2,3,4−トリフルオロ−5−ニトロフェニル)−キノリン−3−カルボン酸を用いたほかは実施例4と同様にして標記化合物を得た。
性状:無色粉末
融点:106−115℃
1HNMR(CDCl3)δ;
1.27(t,J=7Hz,3H),4.24(q,J=7Hz,2H),7.53(dd,J=6Hz,11Hz,1H),8.16(t,J=10Hz,1H),8.69(s,1H),8.83(t,J=8Hz,1H)
Example 10
Ethyl 6,7-difluoro-1,4-dihydro-4-oxo-1- (2,3,4-trifluoro-5-nitrophenyl) -quinoline-3-carboxylate:
Similar to Example 4 except that 6,7-difluoro-1,4-dihydro-4-oxo-1- (2,3,4-trifluoro-5-nitrophenyl) -quinoline-3-carboxylic acid was used. To give the title compound.
Property: Colorless powder Melting point: 106-115 ° C
1 H NMR (CDCl 3 ) δ;
1.27 (t, J = 7 Hz, 3H), 4.24 (q, J = 7 Hz, 2H), 7.53 (dd, J = 6 Hz, 11 Hz, 1H), 8.16 (t, J = 10 Hz) , 1H), 8.69 (s, 1H), 8.83 (t, J = 8 Hz, 1H)
〔実施例11〕
エチル 7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1−(2,4,6−トリフルオロ−3−ニトロフェニル)−1,8−ナフチリジン−3−カルボキシレート:
エチル 7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1−(2,4,6−トリフルオロフェニル)−1,8−ナフチリジン−3−カルボキシレートを用いたほかは実施例1と同様にして標記化合物を得た。
性状:黄色粉末
融点:177−184℃
1HNMR(CDCl3)δ;
1.42(t,J=7Hz,3H),4.43(q,J=7Hz,2H),7.24(t,J=11Hz,2H),8.49(s,1H),8.50(d,J=10Hz,1H)
Example 11
Ethyl 7-chloro-6-fluoro-1,4-dihydro-4-oxo-1- (2,4,6-trifluoro-3-nitrophenyl) -1,8-naphthyridine-3-carboxylate:
Example except that ethyl 7-chloro-6-fluoro-1,4-dihydro-4-oxo-1- (2,4,6-trifluorophenyl) -1,8-naphthyridine-3-carboxylate was used 1 gave the title compound.
Properties: Yellow powder Melting point: 177-184 ° C
1 H NMR (CDCl 3 ) δ;
1.42 (t, J = 7 Hz, 3H), 4.43 (q, J = 7 Hz, 2H), 7.24 (t, J = 11 Hz, 2H), 8.49 (s, 1H), 8. 50 (d, J = 10Hz, 1H)
〔実施例12〕
エチル 7−クロロ−1−(2−クロロ−4−フルオロ−5−ニトロフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート:
エチル 7−クロロ−1−(2−クロロ−4−フルオロフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレートを用いたほかは実施例1と同様にして標記化合物を得た。
性状:無色針状結晶
融点:237−242℃(分解)
1HNMR(CDCl3)δ;
1.41(t,J=7Hz,3H),4.40(q,J=7Hz,2H),7.62(d,J=10Hz,1H),8.19(d,J=8Hz,1H),8.50(d,J=8Hz,1H),8.55(s,1H)
Example 12
Ethyl 7-chloro-1- (2-chloro-4-fluoro-5-nitrophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate:
Example 1 except that ethyl 7-chloro-1- (2-chloro-4-fluorophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate was used To give the title compound.
Properties: colorless needle crystal Melting point: 237-242 ° C. (decomposition)
1 H NMR (CDCl 3 ) δ;
1.41 (t, J = 7 Hz, 3H), 4.40 (q, J = 7 Hz, 2H), 7.62 (d, J = 10 Hz, 1H), 8.19 (d, J = 8 Hz, 1H) ), 8.50 (d, J = 8 Hz, 1H), 8.55 (s, 1H)
〔実施例13〕
エチル 1−(2−クロロ−4−フルオロ−5−ニトロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 1−(2−クロロ−4−フルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例1と同様にして標記化合物を得た。
性状:淡黄色針状結晶
融点:216−219℃
1HNMR(CDCl3)δ;
1.41(t,J=7Hz,3H),4.40(q,J=7Hz,2H),6.53(dd,J=6Hz,12Hz,1H),7.77(d,J=11Hz,1H),8.32(s,1H),8.26−8.35(m,1H),8.40(d,J=7Hz,1H)
Example 13
Ethyl 1- (2-chloro-4-fluoro-5-nitrophenyl) -6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate:
The title compound was prepared in the same manner as in Example 1 except that ethyl 1- (2-chloro-4-fluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate was used. Obtained.
Property: Light yellow needle crystal Melting point: 216-219 ° C
1 H NMR (CDCl 3 ) δ;
1.41 (t, J = 7 Hz, 3H), 4.40 (q, J = 7 Hz, 2H), 6.53 (dd, J = 6 Hz, 12 Hz, 1H), 7.77 (d, J = 11 Hz) , 1H), 8.32 (s, 1H), 8.26-8.35 (m, 1H), 8.40 (d, J = 7 Hz, 1H)
〔実施例14〕
エチル 7−クロロ−1−(4−クロロ−2−フルオロ−5−ニトロフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート:
エチル 7−クロロ−1−(4−クロロ−2−フルオロフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレートを用いたほかは実施例1と同様にして標記化合物を得た。
性状:無色針状結晶
融点:219−221℃
1HNMR(CDCl3)δ;
1.41(t,J=7Hz,3H),4.40(q,J=7Hz,2H),7.62(d,J=10Hz,1H),8.19(d,J=8Hz,1H),8.50(d,J=8Hz,1H),8.55(s,1H)
Example 14
Ethyl 7-chloro-1- (4-chloro-2-fluoro-5-nitrophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate:
Example 1 except that ethyl 7-chloro-1- (4-chloro-2-fluorophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate was used To give the title compound.
Property: colorless needle crystal Melting point: 219-221 ° C
1 H NMR (CDCl 3 ) δ;
1.41 (t, J = 7 Hz, 3H), 4.40 (q, J = 7 Hz, 2H), 7.62 (d, J = 10 Hz, 1H), 8.19 (d, J = 8 Hz, 1H) ), 8.50 (d, J = 8 Hz, 1H), 8.55 (s, 1H)
〔実施例15〕
エチル 7−クロロ−6−フルオロ−1−(4−フルオロ−2−メチル−5−ニトロフェニル)−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート:
エチル 7−クロロ−6−フルオロ−1−(4−フルオロ−2−メチルフェニル)−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレートを用いたほかは実施例1と同様にして標記化合物を得た。
性状:無色粉末
融点:215−216℃
1HNMR(CDCl3)δ;
1.41(t,J=7Hz,3H),2.19(s,1H),4.43(q,J=7Hz,2H),7.41(d,J=8Hz,1H),8.11(d,J=7Hz,1H),8.50(s,1H),8.52(d,J=8Hz,1H)
Example 15
Ethyl 7-chloro-6-fluoro-1- (4-fluoro-2-methyl-5-nitrophenyl) -1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate:
Example 1 except that ethyl 7-chloro-6-fluoro-1- (4-fluoro-2-methylphenyl) -1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate was used To give the title compound.
Property: Colorless powder Melting point: 215-216 ° C
1 H NMR (CDCl 3 ) δ;
1.41 (t, J = 7 Hz, 3H), 2.19 (s, 1H), 4.43 (q, J = 7 Hz, 2H), 7.41 (d, J = 8 Hz, 1H), 8. 11 (d, J = 7 Hz, 1H), 8.50 (s, 1H), 8.52 (d, J = 8 Hz, 1H)
〔実施例16〕
エチル 1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート:
エチル 7−クロロ−6−フルオロ−1−(2,4−ジフルオロ−5−ニトロフェニル)−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート3.0gを280mgの10%パラジウム炭素とともに、50mlのジクロロメタン、30mlのエタノール、2mlの濃塩酸の混液に加え室温で一晩水素添加した。ピリジン2mlを加えて減圧下に濃縮した。残渣に80mlのクロロホルム、10mlの蒸留水を加えて分液し、クロロホルム層を無水硫酸マグネシウムで乾燥後減圧下に濃縮し残渣に8mlのエタノールを加えて室温に放置し、析出物を濾取、エタノール、ジイソプロピルエーテルの順に洗って、1.95gの標記化合物を得た。
性状:無色粉末
融点:208−210℃
1HNMR(d6−DMSO)δ;
1.27(t,J=7Hz,3H),4.24(q,J=7Hz,2H),7.11(t,J=8Hz,1H),7.47(t,J=10Hz,1H),8.53(d,J=8Hz,1H),8.71(s,1H)
Example 16
Ethyl 1- (3-amino-4,6-difluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate:
280 mg of 3.0 g of ethyl 7-chloro-6-fluoro-1- (2,4-difluoro-5-nitrophenyl) -1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate Along with 10% palladium on carbon, 50 ml of dichloromethane, 30 ml of ethanol and 2 ml of concentrated hydrochloric acid were added and hydrogenated at room temperature overnight. 2 ml of pyridine was added and concentrated under reduced pressure. To the residue, 80 ml of chloroform and 10 ml of distilled water were added for liquid separation, and the chloroform layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. To the residue was added 8 ml of ethanol and allowed to stand at room temperature. Washing in this order with ethanol and diisopropyl ether gave 1.95 g of the title compound.
Properties: Colorless powder Melting point: 208-210 ° C
1 H NMR (d 6 -DMSO) δ;
1.27 (t, J = 7 Hz, 3H), 4.24 (q, J = 7 Hz, 2H), 7.11 (t, J = 8 Hz, 1H), 7.47 (t, J = 10 Hz, 1H) ), 8.53 (d, J = 8 Hz, 1H), 8.71 (s, 1H)
〔実施例17〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
エチル 1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート0.6gに3規定塩酸−酢酸混液4mlを加え、2時間加熱環流した。3mlの蒸留水を加えて5分間環流した後、析出物を濾取し、エタノールで洗って、0.54gの標記化合物を得た。
性状:黄色粉末
融点:>270℃
1HNMR(d6−DMSO)δ;
5.46(s,2H),7.00(t,J=8Hz,1H),7.43(t,J=10Hz,1H),8.76(d,J=8Hz,1H),8.97(s,1H)
Example 17
1- (3-Amino-4,6-difluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid:
Ethyl 1- (3-amino-4,6-difluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate 4 ml of a hydrochloric acid-acetic acid mixture was added and heated to reflux for 2 hours. After adding 3 ml of distilled water and refluxing for 5 minutes, the precipitate was collected by filtration and washed with ethanol to obtain 0.54 g of the title compound.
Property: Yellow powder Melting point:> 270 ° C
1 H NMR (d 6 -DMSO) δ;
5.46 (s, 2H), 7.00 (t, J = 8 Hz, 1H), 7.43 (t, J = 10 Hz, 1H), 8.76 (d, J = 8 Hz, 1H), 8. 97 (s, 1H)
〔実施例18〕
エチル 1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボキシレート:
エチル 1−(2,4−ジフルオロ−5−ニトロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボキシレート3.7gを酢酸60mlに溶解し、10%パラジウム炭素400mg加えた。水素雰囲気下、室温で2日間撹拌した。メンブランフィルターで触媒を濾去し、濾液を減圧濃縮した。残渣にエタノールを加え、固体を濾取し、ジエチルエーテルで洗浄した。2.9gの標記化合物を得た。
性状:黄色粉末
融点:198−205℃
1HNMR(d6−DMSO)δ;
1.28(t,J=7Hz,3H),4.23(q,J=7Hz,2H),5.52(s,2H),7.01(t,J=9Hz,1H),7.19(dd,J=6Hz,10Hz,1H),8.14(t,J=9Hz,1H),8.54(s,1H)
Example 18
Ethyl 1- (3-amino-4,6-difluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylate:
Ethyl 1- (2,4-difluoro-5-nitrophenyl) -6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylate (3.7 g) was dissolved in acetic acid (60 ml) and 10% 400 mg of palladium on carbon was added. The mixture was stirred at room temperature for 2 days under a hydrogen atmosphere. The catalyst was removed by filtration with a membrane filter, and the filtrate was concentrated under reduced pressure. Ethanol was added to the residue, and the solid was collected by filtration and washed with diethyl ether. 2.9 g of the title compound was obtained.
Property: Yellow powder Melting point: 198-205 ° C
1 H NMR (d 6 -DMSO) δ;
1.28 (t, J = 7 Hz, 3H), 4.23 (q, J = 7 Hz, 2H), 5.52 (s, 2H), 7.01 (t, J = 9 Hz, 1H), 7. 19 (dd, J = 6 Hz, 10 Hz, 1H), 8.14 (t, J = 9 Hz, 1H), 8.54 (s, 1H)
〔実施例19〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
エチル 1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボキシレート1gを酢酸8ml、塩酸2mlに加え、一晩加熱還流した。放冷後、反応液を減圧濃縮し、残渣にエタノールを加え、固体を濾取し、ジエチルエーテルで洗浄した。830mgの標記化合物を得た。
性状:無色粉末
融点:>270℃
1HNMR(d6−DMSO)δ;
7.14(t,J=9Hz,1H),7.47(dd,J=6Hz,10Hz,1H),7.54(t,J=10Hz,1H),8.34(t,J=10Hz,1H),8.89(s,1H)
Example 19
1- (3-Amino-4,6-difluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid:
1 g of ethyl 1- (3-amino-4,6-difluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylate is added to 8 ml acetic acid and 2 ml hydrochloric acid overnight. Heated to reflux. After allowing to cool, the reaction mixture was concentrated under reduced pressure, ethanol was added to the residue, the solid was collected by filtration, and washed with diethyl ether. 830 mg of the title compound were obtained.
Properties: Colorless powder Melting point:> 270 ° C
1 H NMR (d 6 -DMSO) δ;
7.14 (t, J = 9 Hz, 1H), 7.47 (dd, J = 6 Hz, 10 Hz, 1H), 7.54 (t, J = 10 Hz, 1H), 8.34 (t, J = 10 Hz) , 1H), 8.89 (s, 1H)
〔実施例20〕
エチル 1−(3−アミノ−4,6−ジフルオロフェニル)−6,7,8−トリフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボキシレート:
エチル 1−(2,4−ジフルオロ−5−ニトロフェニル)−6,7,8−トリフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボキシレート2.2gをメタノール20ml、酢酸50ml、ジクロロエタン10mlに溶解し、10%パラジウム炭素200mg加えた。水素雰囲気下、室温で一晩撹拌した。メンブランフィルターで触媒を濾去し、濾液を減圧濃縮した。残渣にエタノールを加え、固体を濾取し、ジエチルエーテルで洗浄した。1.12gの標記化合物を得た。
性状:黄色粉末
融点:187−196℃
1HNMR(d6−DMSO)δ;
1.28(t,J=7Hz,3H),4.22(q,J=7Hz,2H),5.49(s,2H),7.11(t,J=8Hz,1H),7.42(t,J=10Hz,1H),8.05(t,J=10Hz,1H),8.46(s,1H)
Example 20
Ethyl 1- (3-amino-4,6-difluorophenyl) -6,7,8-trifluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylate:
Ethyl 1- (2,4-difluoro-5-nitrophenyl) -6,7,8-trifluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylate (2.2 g) in 20 ml of methanol and 50 ml of acetic acid In 10 ml of dichloroethane, 200 mg of 10% palladium on carbon was added. The mixture was stirred overnight at room temperature under a hydrogen atmosphere. The catalyst was removed by filtration with a membrane filter, and the filtrate was concentrated under reduced pressure. Ethanol was added to the residue, and the solid was collected by filtration and washed with diethyl ether. 1.12 g of the title compound was obtained.
Properties: Yellow powder Melting point: 187-196 ° C
1 H NMR (d 6 -DMSO) δ;
1.28 (t, J = 7 Hz, 3H), 4.22 (q, J = 7 Hz, 2H), 5.49 (s, 2H), 7.11 (t, J = 8 Hz, 1H), 7. 42 (t, J = 10 Hz, 1H), 8.05 (t, J = 10 Hz, 1H), 8.46 (s, 1H)
〔実施例21〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6,7,8−トリフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
エチル 1−(3−アミノ−4,6−ジフルオロフェニル)−6,7,8−トリフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボキシレートを用いたほかは実施例19と同様にして標記化合物を得た。
性状:無色粉末
融点:256−261℃
1HNMR(d6−DMSO)δ;
7.15−7.30(m,1H),7.49(t,J=10Hz,1H),8.25(t,J=8Hz,1H),8.77(s,1H)
Example 21
1- (3-Amino-4,6-difluorophenyl) -6,7,8-trifluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid:
Example 19 except that ethyl 1- (3-amino-4,6-difluorophenyl) -6,7,8-trifluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylate was used The title compound was obtained in the same manner.
Properties: Colorless powder Melting point: 256-261 ° C
1 H NMR (d 6 -DMSO) δ;
7.15-7.30 (m, 1H), 7.49 (t, J = 10 Hz, 1H), 8.25 (t, J = 8 Hz, 1H), 8.77 (s, 1H)
〔実施例22〕
エチル 1−(3−アミノ−4,5,6−トリフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート:
エチル 7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1−(2,3,4−トリフルオロ−5−ニトロフェニル)−1,8−ナフチリジン−3−カルボキシレート780mgをメタノール5ml、酢酸10mlに溶解し、10%パラジウム炭素80mg加えた。水素雰囲気下、室温で一晩撹拌した。メンフランフィルターで触媒を濾去し、濾液を減圧濃縮した。残渣にエタノールを加え、固体を濾取し、ジエチルエーテルで洗浄した。200mgの標記化合物を得た。
性状:褐色粉末
融点:165−174℃(分解)
1HNMR(d6−DMSO)δ;
1.29(t,J=7Hz,3H),4.26(q,J=7Hz,2H),5.82(s,2H),8.55(d,J=8Hz,1H),8.75(s,1H)
[Example 22]
Ethyl 1- (3-amino-4,5,6-trifluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate:
Ethyl 7-chloro-6-fluoro-1,4-dihydro-4-oxo-1- (2,3,4-trifluoro-5-nitrophenyl) -1,8-naphthyridine-3-carboxylate 780 mg in methanol It was dissolved in 5 ml and 10 ml of acetic acid, and 80 mg of 10% palladium carbon was added. The mixture was stirred overnight at room temperature under a hydrogen atmosphere. The catalyst was removed by filtration with a Menfuran filter, and the filtrate was concentrated under reduced pressure. Ethanol was added to the residue, and the solid was collected by filtration and washed with diethyl ether. 200 mg of the title compound were obtained.
Property: Brown powder Melting point: 165-174 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.29 (t, J = 7 Hz, 3H), 4.26 (q, J = 7 Hz, 2H), 5.82 (s, 2H), 8.55 (d, J = 8 Hz, 1H), 8. 75 (s, 1H)
〔実施例23〕
1−(3−アミノ−4,5,6−トリフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
エチル1−(3−アミノ−4,5,6−トリフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート600mgをメタノール30ml、酢酸10ml、ジクロロエタン30mlに溶解し、10%パラジウム炭素100mg加えた。水素雰囲気下、室温で一晩撹拌した。メンブランフィルターで触媒を濾去し、濾液を減圧濃縮した。残渣に酢酸4ml、塩酸1mlを加え、100℃で一晩加熱撹拌した。反応液を減圧濃縮し、残渣にジエチルエーテルを加え、固体を濾取し、ジエチルエーテルて洗浄した。160mgの標記化合物を得た。
性状:淡黄色粉末
融点:>242℃(分解)
1HNMR(d6−DMSO)δ;
6.87(t,J=5Hz,1H),7.76(d,J=8Hz,1H),9.02(s,1H)
Example 23
1- (3-Amino-4,5,6-trifluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid:
Ethyl 1- (3-amino-4,5,6-trifluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate 600 mg in methanol It was dissolved in 30 ml, acetic acid 10 ml and dichloroethane 30 ml, and 10% palladium carbon 100 mg was added. The mixture was stirred overnight at room temperature under a hydrogen atmosphere. The catalyst was removed by filtration with a membrane filter, and the filtrate was concentrated under reduced pressure. To the residue were added 4 ml of acetic acid and 1 ml of hydrochloric acid, and the mixture was stirred with heating at 100 ° C. overnight. The reaction solution was concentrated under reduced pressure, diethyl ether was added to the residue, and the solid was collected by filtration and washed with diethyl ether. 160 mg of the title compound were obtained.
Properties: Pale yellow powder Melting point:> 242 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
6.87 (t, J = 5 Hz, 1H), 7.76 (d, J = 8 Hz, 1H), 9.02 (s, 1H)
〔実施例24〕
エチル 1−(3−アミノ−4,5,6−トリフルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボキシレート:
エチル 6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−1−(2,3,4−トリフルオロ−5−ニトロフェニル)−キノリン−3−カルボキシレート280mgをエタノール10ml、酢酸5ml、ジクロロエタン5mlに溶解し、10%パラジウム炭素30mg加えた。水素雰囲気下、室温で一晩撹拌した。メンブランフィルターで触媒を濾去し、濾液を減圧濃縮した。残渣にエタノールを加え、固体を濾取し、ジエチルエーテルで洗浄した。200mgの標記化合物を得た。
性状:黄色粉末
融点:116−124℃
1HNMR(d6−DMSO)δ;
1.27(t,J=7Hz,3H),4.22(q,J=7Hz,2H),5.85(s,2H),6.83(t,J=8Hz,1H),7.42(dd,J=6Hz,12Hz,1H),8.13(t,J=10Hz,1H),8.60(s,1H)
Example 24
Ethyl 1- (3-amino-4,5,6-trifluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylate:
Ethyl 6,7-difluoro-1,4-dihydro-4-oxo-1- (2,3,4-trifluoro-5-nitrophenyl) -quinoline-3-carboxylate (280 mg) in ethanol (10 ml), acetic acid (5 ml), dichloroethane It melt | dissolved in 5 ml and 30 mg of 10% palladium carbon was added. The mixture was stirred overnight at room temperature under a hydrogen atmosphere. The catalyst was removed by filtration with a membrane filter, and the filtrate was concentrated under reduced pressure. Ethanol was added to the residue, and the solid was collected by filtration and washed with diethyl ether. 200 mg of the title compound were obtained.
Property: Yellow powder Melting point: 116-124 ° C
1 H NMR (d 6 -DMSO) δ;
1.27 (t, J = 7 Hz, 3H), 4.22 (q, J = 7 Hz, 2H), 5.85 (s, 2H), 6.83 (t, J = 8 Hz, 1H), 7. 42 (dd, J = 6 Hz, 12 Hz, 1H), 8.13 (t, J = 10 Hz, 1H), 8.60 (s, 1H)
〔実施例25〕
1−(3−アミノ−4,5,6−トリフルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
エチル 1−(3−アミノ−4,5,6−トリフルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボキシレートを用いたほかは実施例23と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>211℃(分解)
1HNMR(d6−DMSO)δ;
5.91(brs,2H),6.86(t,J=7Hz,1H),7.68(dd,J=7Hz,11Hz,1H),8.34(t,J=9Hz,1H),8.94(s,1H)
Example 25
1- (3-Amino-4,5,6-trifluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid:
Example 1 except that ethyl 1- (3-amino-4,5,6-trifluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylate was used In the same manner, the title compound was obtained.
Properties: Pale yellow powder Melting point:> 211 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
5.91 (brs, 2H), 6.86 (t, J = 7 Hz, 1H), 7.68 (dd, J = 7 Hz, 11 Hz, 1H), 8.34 (t, J = 9 Hz, 1H), 8.94 (s, 1H)
〔実施例26〕
エチル 1−(3−アミノ−2,4,6−トリフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート:
エチル 1−(2,4,6−トリフルオロ−3−ニトロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレートを用いたほかは実施例16と同様にして標記化合物を得た。
1HNMR(CDCl3)δ;
1.40(t,J=7Hz,3H),4.40(q,J=7Hz,2H),6.83−7.04(br,2H),7.22−7.35(m,1H),8.48(d,J=8Hz,1H),8.50(s,1H)
Example 26
Ethyl 1- (3-amino-2,4,6-trifluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate:
Ethyl 1- (2,4,6-trifluoro-3-nitrophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate was used. Otherwise in the same manner as in Example 16, the title compound was obtained.
1 H NMR (CDCl 3 ) δ;
1.40 (t, J = 7 Hz, 3H), 4.40 (q, J = 7 Hz, 2H), 6.83-7.04 (br, 2H), 7.22-7.35 (m, 1H) ), 8.48 (d, J = 8 Hz, 1H), 8.50 (s, 1H)
〔実施例27〕
1−(3−アミノ−2,4,6−トリフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
エチル 1−(3−アミノ−2,4,6−トリフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレートを用いたほかは実施例17と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:222−228℃
1HNMR(d6−DMSO)δ;
7.44(t,J=11Hz,1H),8.77(d,J=8Hz,1H),9.21(s,1H)
Example 27
1- (3-Amino-2,4,6-trifluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid:
Ethyl 1- (3-amino-2,4,6-trifluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate was used. Otherwise in the same manner as in Example 17, the title compound was obtained.
Property: Pale yellow powder Melting point: 222-228 ° C
1 H NMR (d 6 -DMSO) δ;
7.44 (t, J = 11 Hz, 1H), 8.77 (d, J = 8 Hz, 1H), 9.21 (s, 1H)
〔実施例28〕
エチル 1−(3−アミノ−6−クロロ−4−フルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート:
エチル 1−(6−クロロ−4−フルオロ−3−ニトロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレートを用いたほかは実施例16と同様にして標記化合物を得た。
性状:黄色粉末
融点:206−208℃
1HNMR(CDCl3)δ;
1.41(t,J=7Hz,3H),4.40(q,J=7Hz,2H),6.86(d,J=8Hz,1H),7.26(d,J=11Hz,1H),8.48(d,J=8Hz,1H),8.49(s,1H)
Example 28
Ethyl 1- (3-amino-6-chloro-4-fluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate:
Besides using ethyl 1- (6-chloro-4-fluoro-3-nitrophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate Gave the title compound as in Example 16.
Property: Yellow powder Melting point: 206-208 ° C
1 H NMR (CDCl 3 ) δ;
1.41 (t, J = 7 Hz, 3H), 4.40 (q, J = 7 Hz, 2H), 6.86 (d, J = 8 Hz, 1H), 7.26 (d, J = 11 Hz, 1H) ), 8.48 (d, J = 8 Hz, 1H), 8.49 (s, 1H)
〔実施例29〕
1−(3−アミノ−6−クロロ−4−フルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
エチル 1−(3−アミノ−6−クロロ−4−フルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレートを用いたほかは実施例17と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:265−267℃
1HNMR(d6−DMSO)δ;
5.81(s,2H),7.07(d,J=8Hz,1H),7.52(d,J=11Hz,1H),8.76(d,J=7Hz,1H),8.93(s,1H)
Example 29
1- (3-Amino-6-chloro-4-fluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid:
Besides using ethyl 1- (3-amino-6-chloro-4-fluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate Gave the title compound as in Example 17.
Properties: Pale yellow powder Melting point: 265-267 ° C
1 H NMR (d 6 -DMSO) δ;
5.81 (s, 2H), 7.07 (d, J = 8 Hz, 1H), 7.52 (d, J = 11 Hz, 1H), 8.76 (d, J = 7 Hz, 1H), 8. 93 (s, 1H)
〔実施例30〕
エチル 1−(3−アミノ−6−クロロ−4−フルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボキシレート:
エチル 1−(6−クロロ−4−フルオロ−3−ニトロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボキシレートを用いたほかは実施例16と同様にして標記化合物を得た。
1HNMR(CDCl3)δ;
1.39(t,J=7Hz,3H),4.38(q,J=7Hz,2H),6.65(dd,J=5Hz,12Hz,1H),6.91(d,J=9Hz,1H),7.31(d,J=11Hz,1H),8.28(q,J=9Hz,16Hz,1H),8.35(s,1H)
Example 30
Ethyl 1- (3-amino-6-chloro-4-fluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylate:
Same as Example 16 except that ethyl 1- (6-chloro-4-fluoro-3-nitrophenyl) -6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylate was used. To give the title compound.
1 H NMR (CDCl 3 ) δ;
1.39 (t, J = 7 Hz, 3H), 4.38 (q, J = 7 Hz, 2H), 6.65 (dd, J = 5 Hz, 12 Hz, 1H), 6.91 (d, J = 9 Hz) , 1H), 7.31 (d, J = 11 Hz, 1H), 8.28 (q, J = 9 Hz, 16 Hz, 1H), 8.35 (s, 1H)
〔実施例31〕
1−(3−アミノ−6−クロロ−4−フルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
エチル 1−(3−アミノ−6−クロロ−4−フルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボキシレートを用いたほかは実施例19と同様にして標記化合物を得た。
性状:無色粉末
融点:>270℃
1HNMR(d6−DMSO)δ;
5.91(brs,1H),7.08(d,J=8Hz,1H),7.34(dd,J=7Hz,11Hz,1H),7.59(d,J=12Hz,1H),8.35(t,J=11Hz,1H),8.83(s,1H)
Example 31
1- (3-Amino-6-chloro-4-fluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid:
Same as Example 19 except that ethyl 1- (3-amino-6-chloro-4-fluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylate was used. To give the title compound.
Properties: Colorless powder Melting point:> 270 ° C
1 H NMR (d 6 -DMSO) δ;
5.91 (brs, 1H), 7.08 (d, J = 8 Hz, 1H), 7.34 (dd, J = 7 Hz, 11 Hz, 1H), 7.59 (d, J = 12 Hz, 1H), 8.35 (t, J = 11 Hz, 1H), 8.83 (s, 1H)
〔実施例32〕
エチル 1−(3−アミノ−4−クロロ−6−フルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート:
エチル1−(4−クロロ−6−フルオロ−3−ニトロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレートを用いたほかは実施例16と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:200−202℃
1HNMR(CDCl3)δ;
1.40(t,J=7Hz,3H),4.40(q,J=7Hz,2H),6.82(d,J=7Hz,1H),7.29(d,J=11Hz,1H),8.47(d,J=8Hz,1H),8.55(s,1H)
[Example 32]
Ethyl 1- (3-amino-4-chloro-6-fluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate:
Besides using ethyl 1- (4-chloro-6-fluoro-3-nitrophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate Gave the title compound as in Example 16.
Property: Pale yellow powder Melting point: 200-202 ° C
1 H NMR (CDCl 3 ) δ;
1.40 (t, J = 7 Hz, 3H), 4.40 (q, J = 7 Hz, 2H), 6.82 (d, J = 7 Hz, 1H), 7.29 (d, J = 11 Hz, 1H) ), 8.47 (d, J = 8 Hz, 1H), 8.55 (s, 1H)
〔実施例33〕
1−(3−アミノ−4−クロロ−6−フルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
エチル 1−(3−アミノ−4−クロロ−6−フルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート1.00gを酢酸10ml、メタノール10ml、ジクロロエタン20mlに溶解し、酢酸20mlに懸濁させた10%パラシウム炭素132mgを加え、水素気流下、一晩撹拌した。パラシウム炭素をメンブランフィルターで濾過しろ液に10%水酸化ナトリウムを加え、クロロホルムで抽出した。有機層を乾燥後、溶媒を留去し、固体を濾取し0.380gの標記化合物を得た。
性状:淡黄色粉末
融点:>270℃
1HNMR(d6−DMSO)δ;
5.76(br,2H),7.03(d,J=9Hz,1H),7.57(d,J=10Hz,1H),8.78(d,J=8Hz,1H),9.00(s,1H)
Example 33
1- (3-Amino-4-chloro-6-fluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid:
1.00 g of ethyl 1- (3-amino-4-chloro-6-fluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate 132 mg of 10% palladium carbon dissolved in 10 ml of acetic acid, 10 ml of methanol and 20 ml of dichloroethane and suspended in 20 ml of acetic acid was added and stirred overnight under a hydrogen stream. Palladium carbon was filtered through a membrane filter, 10% sodium hydroxide was added to the filtrate, and the mixture was extracted with chloroform. After drying the organic layer, the solvent was distilled off, and the solid was collected by filtration to obtain 0.380 g of the title compound.
Properties: Pale yellow powder Melting point:> 270 ° C
1 H NMR (d 6 -DMSO) δ;
5.76 (br, 2H), 7.03 (d, J = 9 Hz, 1H), 7.57 (d, J = 10 Hz, 1H), 8.78 (d, J = 8 Hz, 1H), 9. 00 (s, 1H)
〔実施例34〕
エチル 1−(3−アミノ−4−フルオロ−2−メチルフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−オキソ−1,8−ナフチリジン−3−カルボキシレート:
エチル 1−(4−フルオロ−2−メチル−3−ニトロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレートを用いたほかは実施例16と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:212−213℃
1HNMR(CDCl3)δ;
1.41(t,J=7Hz,3H),1.91(s,3H),3.79−3.96(br,2H),4.40(q,J=7Hz,2H),6.70(d,J=8Hz,1H),7.02(d,J=11Hz,1H),8.50(d,J=11Hz,1H),8.50(s,1H)
Example 34
Ethyl 1- (3-amino-4-fluoro-2-methylphenyl) -7-chloro-6-fluoro-1,4-dihydro-oxo-1,8-naphthyridine-3-carboxylate:
Besides using ethyl 1- (4-fluoro-2-methyl-3-nitrophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate Gave the title compound as in Example 16.
Property: Pale yellow powder Melting point: 212-213 ° C
1 H NMR (CDCl 3 ) δ;
1.41 (t, J = 7 Hz, 3H), 1.91 (s, 3H), 3.79-3.96 (br, 2H), 4.40 (q, J = 7 Hz, 2H), 6. 70 (d, J = 8 Hz, 1H), 7.02 (d, J = 11 Hz, 1H), 8.50 (d, J = 11 Hz, 1H), 8.50 (s, 1H)
〔実施例35〕
1−(3−アミノ−4−フルオロ−2−メチルフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
エチル 1−(3−アミノ−4−フルオロ−2−メチルフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレートを用いたほかは実施例17と同様にして標記化合物を得た。
性状:無色粉末
融点:274−279℃
1HNMR(d6−DMSO)δ;
1.84(s,3H),6.95(d.J=8Hz,1H),7.19(d,J=12Hz,1H),8.75(d,J=8Hz,1H),8.79(s,1H)
Example 35
1- (3-Amino-4-fluoro-2-methylphenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid:
Besides using ethyl 1- (3-amino-4-fluoro-2-methylphenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate Gave the title compound as in Example 17.
Property: Colorless powder Melting point: 274-279 ° C
1 H NMR (d 6 -DMSO) δ;
1.84 (s, 3H), 6.95 (d.J = 8 Hz, 1H), 7.19 (d, J = 12 Hz, 1H), 8.75 (d, J = 8 Hz, 1H), 8. 79 (s, 1H)
〔実施例36〕
エチル 7−クロロ−1−(2,4−ジフルオロ−5−ホルミルアミノフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート:
エチル 7−クロロ−6−フルオロ−1−(2,4−ジフルオロ−5−ニトロフェニル)−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボキシレート3.5gを280mgの10%パラジウム炭素とともに、20mlのジクロロメタン、10mlの蟻酸、0.3mlの濃塩酸の混液に加え室温で5時間水素添加した。1.2mlの無水酢酸を加えて室温に1時間放置し、触媒を濾別したのち、減圧下に濃縮し、析出物をエタノールに分散して濾取、エタノール、ジイソプロピルエーテルの順に洗って、2.65gの標記化合物を得た。
性状:無色粉末
融点:>270℃
1HNMR(d6−DMSO)δ;
1.28(t,J=7Hz,3H),4.25(q,J=7Hz,2H),7.77(dd,J=10Hz,11Hz,1H),8.35(s,1H),8.45(t,J=8Hz,1H),8.54(d.J=8Hz,1H),8.77(s,1H)
Example 36
Ethyl 7-chloro-1- (2,4-difluoro-5-formylaminophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate:
280 mg of ethyl 7-chloro-6-fluoro-1- (2,4-difluoro-5-nitrophenyl) -4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate Along with 10% palladium on carbon, 20 ml of dichloromethane, 10 ml of formic acid and 0.3 ml of concentrated hydrochloric acid were added and hydrogenated at room temperature for 5 hours. After adding 1.2 ml of acetic anhydride and allowing to stand at room temperature for 1 hour, the catalyst is filtered off and concentrated under reduced pressure. The precipitate is dispersed in ethanol and collected by filtration, washed with ethanol and diisopropyl ether in order. Obtained 65 g of the title compound.
Properties: Colorless powder Melting point:> 270 ° C
1 H NMR (d 6 -DMSO) δ;
1.28 (t, J = 7 Hz, 3H), 4.25 (q, J = 7 Hz, 2H), 7.77 (dd, J = 10 Hz, 11 Hz, 1H), 8.35 (s, 1H), 8.45 (t, J = 8 Hz, 1H), 8.54 (d.J = 8 Hz, 1H), 8.77 (s, 1H)
〔実施例37〕
7−クロロ−1−(2,4−ジフルオロ−5−ホルミルアミノフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸465mgを1mlの蟻酸に溶かし、0.2gの無水酢酸を加えて60℃で1時間撹拌した。減圧下に濃縮し残渣に2mlのエタノールを加えて60℃で2時間撹拌した。析出物を濾取、エタノール、ジイソプロピルエーテルの順に洗って、450mgの標記化合物を得た。
性状:無色粉末
融点:>270℃
1HNMR(d6−DMSO)δ;
3.46(brs,1H),7.78(dd,J=10Hz,11Hz,1H),8.35(s,1H),8.50(t,J=8Hz,1H),8.76(d,J=8Hz,1H),9.08(s,1H)
Example 37
7-Chloro-1- (2,4-difluoro-5-formylaminophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid:
465 mg of 1- (3-amino-4,6-difluorophenyl) -7-chloro-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid was dissolved in 1 ml of formic acid. 0.2 g of acetic anhydride was added and stirred at 60 ° C. for 1 hour. The mixture was concentrated under reduced pressure, 2 ml of ethanol was added to the residue, and the mixture was stirred at 60 ° C. for 2 hours. The precipitate was collected by filtration and washed with ethanol and diisopropyl ether in this order to obtain 450 mg of the title compound.
Properties: Colorless powder Melting point:> 270 ° C
1 H NMR (d 6 -DMSO) δ;
3.46 (brs, 1H), 7.78 (dd, J = 10 Hz, 11 Hz, 1H), 8.35 (s, 1H), 8.50 (t, J = 8 Hz, 1H), 8.76 ( d, J = 8 Hz, 1H), 9.08 (s, 1H)
〔実施例38〕
エチル 7−クロロ−1−(2,4−ジフルオロ−5−ホルミルメチルアミノフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート:
エチル 7−クロロ−1−(2,4−ジフルオロ−5−ホルミルアミノフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート500mgを500mgの炭酸カリウム、1.5gのヨウ化メチルとともに2.5mlのN,N−ジメチルホルムアミドに加え50℃で1時間撹拌した。40mlのクロロホルム、150mlの蒸留水を加えて分液し有機層を無水硫酸マグネシウムで乾燥後減圧下に濃縮し、析出物をエタノールに分散して濾取し、エタノール、ジイソプロピルエーテルの順に洗って、455mgの標記化合物を得た。
性状:無色結晶
融点:264−267℃
1HNMR(CDCl3)δ;
1.41(t,J=7Hz,3H),3.34(s,3H),4.42(q,J=7Hz,2H),7.27(t,J=10Hz,1H),7.39(t,J=7Hz,1H),8.35(s,1H),8.49(d,J=7Hz,1H),8.56(s,1H)
Example 38
Ethyl 7-chloro-1- (2,4-difluoro-5-formylmethylaminophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate:
Ethyl 7-chloro-1- (2,4-difluoro-5-formylaminophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate 500 mg Potassium and 1.5 g of methyl iodide were added to 2.5 ml of N, N-dimethylformamide, followed by stirring at 50 ° C. for 1 hour. 40 ml of chloroform and 150 ml of distilled water were added for liquid separation, and the organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The precipitate was dispersed in ethanol and collected by filtration. 455 mg of the title compound were obtained.
Properties: colorless crystals Melting point: 264-267 ° C
1 H NMR (CDCl 3 ) δ;
1.41 (t, J = 7 Hz, 3H), 3.34 (s, 3H), 4.42 (q, J = 7 Hz, 2H), 7.27 (t, J = 10 Hz, 1H), 7. 39 (t, J = 7 Hz, 1H), 8.35 (s, 1H), 8.49 (d, J = 7 Hz, 1H), 8.56 (s, 1H)
〔実施例39〕
エチル 1−(3−t−ブトキシカルボニルアミノ−2,4−ジフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート:
N−(t−ブトキシカルボニル)−2,6−ジフルオロ−3−ニトロアニリン2.0gを20mlのメタノール中、0.2gの10%パラジウム炭素を用いて室温で3日間水素添加した。触媒を濾別したのち、濾液をそのまま0.5mmol/mlのエチル2−(2’6’−ジクロロ−5−フルオロニコチノイル)−3−エトキシ−アクリレートを溶かしたジクロロメタンの溶液20mlに加えた。この溶液を減圧下に濃縮し残渣に、2.5gの無水炭酸カリウムと10mlのN,N−ジメチルホルムアミドを加えて90℃で30分撹拌した。これを放冷し、100mlのクロロホルムと400mlの蒸留水を加えて分液、ついでクロロホルム層を、400mlの蒸留水で2回洗浄した後、無水硫酸マグネシウムで乾燥後減圧下に濃縮し、1mlのエタノールを加えて放置した。残渣を150gのシリカゲルを用いてクロマトに付し(溶出液、クロロホルム−クロロホルム:メタノール=7.5:1)主生成物に対応するフラクションよりの析出物をエタノールに分散して濾取し、575mgの標記化合物を得た。
性状:無色結晶
融点:128−131℃
1HNMR(CDCl3)δ;
1.40(t,J=7Hz,3H),1.51(s,9H),4.40(q,J=7Hz,2H),6.11(s,1H),7.16(t,J=11Hz,1H),7.30(t,J=7Hz,1H),8.48(d,J=7Hz,1H),8.54(s,1H)
Example 39
Ethyl 1- (3-t-butoxycarbonylamino-2,4-difluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate:
2.0 g of N- (t-butoxycarbonyl) -2,6-difluoro-3-nitroaniline was hydrogenated in 0.2 ml of 10% palladium on carbon in 20 ml of methanol at room temperature for 3 days. After the catalyst was filtered off, the filtrate was added as it was to 20 ml of a dichloromethane solution in which 0.5 mmol / ml of ethyl 2- (2′6′-dichloro-5-fluoronicotinoyl) -3-ethoxy-acrylate was dissolved. The solution was concentrated under reduced pressure, 2.5 g of anhydrous potassium carbonate and 10 ml of N, N-dimethylformamide were added to the residue, and the mixture was stirred at 90 ° C. for 30 minutes. The mixture was allowed to cool, and 100 ml of chloroform and 400 ml of distilled water were added for liquid separation, and then the chloroform layer was washed twice with 400 ml of distilled water, dried over anhydrous magnesium sulfate, concentrated under reduced pressure, Ethanol was added and left standing. The residue was chromatographed using 150 g of silica gel (eluent, chloroform-chloroform: methanol = 7.5: 1). The precipitate from the fraction corresponding to the main product was dispersed in ethanol and collected by filtration. Of the title compound.
Properties: colorless crystals Melting point: 128-131 ° C
1 H NMR (CDCl 3 ) δ;
1.40 (t, J = 7 Hz, 3H), 1.51 (s, 9H), 4.40 (q, J = 7 Hz, 2H), 6.11 (s, 1H), 7.16 (t, J = 11 Hz, 1H), 7.30 (t, J = 7 Hz, 1H), 8.48 (d, J = 7 Hz, 1H), 8.54 (s, 1H)
〔実施例40〕
1−(3−アミノ−2,4−ジフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
エチル 1−(3−t−ブトキシカルボニルアミノ−2,4−ジフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート500mgを8mlの3規定塩酸と酢酸の混液に加えて、3.5時間撹拌加熱環流した。16mlの蒸留水を加えて10分間加熱環流したのち放冷した。80mlのクロロホルム、10mlの蒸留水を加えて分液し、クロロホルム層を減圧下に濃縮した。析出物をエタノールに分散して濾取し、エタノール、ジイソプロピルエーテルの順に洗って295mgの標記化合物を得た。
性状:黄色粉末
融点:244−248℃(分解)
1HNMR(CDCl3)δ;
4.04(s,1H),6.64(dt,J=5Hz,8Hz,1H),7.02(ddd,J=2Hz,8Hz,10Hz,1H),8.52(d,J=7Hz,1H),8.87(s,1H)
Example 40
1- (3-Amino-2,4-difluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid:
500 mg of ethyl 1- (3-t-butoxycarbonylamino-2,4-difluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate In addition to 8 ml of a mixture of 3N hydrochloric acid and acetic acid, the mixture was stirred and heated to reflux for 3.5 hours. 16 ml of distilled water was added and heated to reflux for 10 minutes, and then allowed to cool. 80 ml of chloroform and 10 ml of distilled water were added for liquid separation, and the chloroform layer was concentrated under reduced pressure. The precipitate was dispersed in ethanol and collected by filtration, and washed with ethanol and diisopropyl ether in this order to obtain 295 mg of the title compound.
Property: Yellow powder Melting point: 244-248 ° C (decomposition)
1 H NMR (CDCl 3 ) δ;
4.04 (s, 1H), 6.64 (dt, J = 5 Hz, 8 Hz, 1H), 7.02 (ddd, J = 2 Hz, 8 Hz, 10 Hz, 1H), 8.52 (d, J = 7 Hz) , 1H), 8.87 (s, 1H)
〔実施例41〕
1−(3−ベンゾイルアミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸310mgを220mgの無水安息香酸とともに920mgのN,N−ジメチルホルムアミドに加え、70℃で2時間、100℃で2時間半撹拌した。50mlのクロロホルム、150mlの蒸留水を加えて分液し、クロロホルム層を無水硫酸マグネシウムで乾燥後減圧下に濃縮し、残渣に6mlのエタノールを加えて放置し析出物を濾取、エタノール、ジイソプロピルエーテルの順に洗って、184mgの標記化合物を得た。
性状:淡褐色粉末
融点:260−263℃
1HNMR(d6−DMSO)δ;
7.53−7.68(m,3H),7.80(t,J=10Hz,1H),7.98(d,J=8Hz,2H),8.11(t,J=7Hz,1H),9.09(s,1H),10.40(s,1H)
Example 41
1- (3-Benzoylamino-4,6-difluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -7-chloro-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid (310 mg) was added to 220 mg of benzoic anhydride. Together with 920 mg of N, N-dimethylformamide and stirred at 70 ° C. for 2 hours and at 100 ° C. for 2.5 hours. 50 ml of chloroform and 150 ml of distilled water were added for liquid separation, and the chloroform layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. To the residue was added 6 ml of ethanol, and the precipitate was collected by filtration, ethanol, diisopropyl ether. To give 184 mg of the title compound.
Property: Light brown powder Melting point: 260-263 ° C
1 H NMR (d 6 -DMSO) δ;
7.53-7.68 (m, 3H), 7.80 (t, J = 10 Hz, 1H), 7.98 (d, J = 8 Hz, 2H), 8.11 (t, J = 7 Hz, 1H) ), 9.09 (s, 1H), 10.40 (s, 1H)
〔実施例42〕
エチル 7−クロロ−1−(2,4−ジフルオロ−5−メチルアミノフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート:
エチル 1−(5−アミノ−2,4−ジフルオロフェニル)−7−クロロ−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボキシレート500mgを100mgの37%ホルマリンとともに、10mlの1,2−ジクロロエタン、5mlのメタノール、0.5mlの酢酸の混液に加え、0.08gの10%パラジウム炭素を用いて水素添加した(16時間)。触媒を濾別したのち、濾液を減圧下に濃縮し、残渣を50mlのクロロホルムに溶かして50%炭酸ナトリウム水溶液で洗った後、無水硫酸マグネシウムで乾燥後減圧下に濃縮した。残渣を20gのシリカゲルを用いてクロマトに付し(溶出液、クロロホルム)、標記化合物を150mgを得た。
性状:淡黄色針状晶
融点:226−231℃
1HNMR(CDCl3)δ;
1.41(t,J=7Hz,3H),2.89(s,3H),4.41(q,J=7Hz,2H),6.64(t,J=7Hz,1H),7.02(dd,J=9Hz,11Hz,1H),8.47(d,J=7Hz,1H),8.59(s,1H)
Example 42
Ethyl 7-chloro-1- (2,4-difluoro-5-methylaminophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate:
Ethyl 1- (5-amino-2,4-difluorophenyl) -7-chloro-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate 500 mg 100 mg of 37% Along with formalin, it was added to a mixture of 10 ml 1,2-dichloroethane, 5 ml methanol, 0.5 ml acetic acid and hydrogenated with 0.08 g 10% palladium on carbon (16 hours). After the catalyst was filtered off, the filtrate was concentrated under reduced pressure. The residue was dissolved in 50 ml of chloroform, washed with 50% aqueous sodium carbonate solution, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was chromatographed using 20 g of silica gel (eluent, chloroform) to give 150 mg of the title compound.
Properties: Light yellow needles Melting point: 226-231 ° C
1 H NMR (CDCl 3 ) δ;
1.41 (t, J = 7 Hz, 3H), 2.89 (s, 3H), 4.41 (q, J = 7 Hz, 2H), 6.64 (t, J = 7 Hz, 1H), 7. 02 (dd, J = 9 Hz, 11 Hz, 1H), 8.47 (d, J = 7 Hz, 1H), 8.59 (s, 1H)
〔実施例43〕
7−クロロ−1−(2,4−ジフルオロ−5−メチルアミノフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
エチル 7−クロロ−1−(2,4−ジフルオロ−5−メチルアミノ−フェニル)−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボキシレート150mgを1mlの3規定塩酸と酢酸の混液(1:1,v/v)に加えて、2時間撹拌加熱環流した。5mlの蒸留水を加えてさらに10分間加熱環流し、ついで放冷して析出物をエタノールに分散して濾取し、エタノール、ジイソプロピルエーテルの順に洗って70mgの標記化合物を得た。
性状:黄色結晶
融点:250−252℃
1HNMR(d6−DMSO)δ;
2.69(d,J=5Hz,3H),5.90(brs,1H),7.01(t,J=8Hz,1H),7.46(t,J=11Hz,1H),8.76(d,J=8Hz,1H),8.99(s,1H)
Example 43
7-Chloro-1- (2,4-difluoro-5-methylaminophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid:
1 ml of ethyl 7-chloro-1- (2,4-difluoro-5-methylamino-phenyl) -6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate In addition to a mixture of 3N hydrochloric acid and acetic acid (1: 1, v / v), the mixture was refluxed with stirring for 2 hours. 5 ml of distilled water was added and heated to reflux for an additional 10 minutes, then allowed to cool, the precipitate was dispersed in ethanol and collected by filtration, and washed with ethanol and diisopropyl ether in this order to obtain 70 mg of the title compound.
Properties: Yellow crystal Melting point: 250-252 ° C
1 H NMR (d 6 -DMSO) δ;
2.69 (d, J = 5 Hz, 3H), 5.90 (brs, 1H), 7.01 (t, J = 8 Hz, 1H), 7.46 (t, J = 11 Hz, 1H), 8. 76 (d, J = 8 Hz, 1H), 8.99 (s, 1H)
〔実施例44〕
エチル 1−(2,4−ジフルオロ−5−メチルアミノフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボキシレート:
エチル 1−(3−アミノ−4,6−ジフルオロフェニル)−6.7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルキシレートを用いたほかは実施例42と同様にして標記化合物を得た。
性状:黄色粉末
融点:208−216℃
1HNMR(d6−DMSO)δ;
1.28(t,J=7Hz.3H),2.72(d,J=4Hz,3H),4.23(q,J=7Hz,2H),5.94−6.04(m,1H),7.04(t,J=8Hz,1H),7.19(dd,J=4Hz,10Hz,1H),7.52(t,J=10Hz,1H),8.14(t,J=10Hz,1H),8.55(s,1H)
Example 44
Ethyl 1- (2,4-difluoro-5-methylaminophenyl) -6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylate:
The title was obtained in the same manner as in Example 42 except that ethyl 1- (3-amino-4,6-difluorophenyl) -6.7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylate was used. A compound was obtained.
Property: Yellow powder Melting point: 208-216 ° C
1 H NMR (d 6 -DMSO) δ;
1.28 (t, J = 7 Hz, 3H), 2.72 (d, J = 4 Hz, 3H), 4.23 (q, J = 7 Hz, 2H), 5.94-6.04 (m, 1H) ), 7.04 (t, J = 8 Hz, 1H), 7.19 (dd, J = 4 Hz, 10 Hz, 1H), 7.52 (t, J = 10 Hz, 1H), 8.14 (t, J = 10Hz, 1H), 8.55 (s, 1H)
〔実施例45〕
1−(2,4−ジフルオロ−5−メチルアミノフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
エチル 1−(2,4−ジフルオロ−5−メチルアミノフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボキシレートを用いたほかは実施例43と同様にして標記化合物を得た。
性状:褐色粉末
融点:>164℃(分解)
1HNMR(d6−DMSO)δ;
2.71(s,3H),6.01(brs,1H),7.05(t,J=8Hz,1H),7.39−7.51(m,1H),7.53(t,J=10Hz,1H),8.34(t,J=9Hz,1H),8.90(s,1H)
Example 45
1- (2,4-Difluoro-5-methylaminophenyl) -6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid:
The same procedure as in Example 43 except that ethyl 1- (2,4-difluoro-5-methylaminophenyl) -6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylate was used. To give the title compound.
Properties: Brown powder Melting point:> 164 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
2.71 (s, 3H), 6.01 (brs, 1H), 7.05 (t, J = 8 Hz, 1H), 7.39-7.51 (m, 1H), 7.53 (t, J = 10 Hz, 1H), 8.34 (t, J = 9 Hz, 1H), 8.90 (s, 1H)
〔実施例46〕
エチル 7−クロロ−1−(3−ジメチルアミノ−4,6−ジフルオロフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート:
エチル 1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボキシレート500mgを500mgの37%ホルマリンとともに、10mlの1,2−ジクロロエタン、5mlのメタノール、0.5mlの酢酸の混液に加え、0.08gの10%パラシウム炭素を用いて水素添加した(64時間)。触媒を濾別したのち、濾液を減圧下に濃縮し、標記化合物を得た。
性状:黄色粉末
融点:158−163℃
1HNMR(CDCl3)δ;
1.41(t,J=7Hz,3H),2.88(s,6H),4.41(q,J=7Hz,2H),6.85(t,J=7Hz,1H),7.04(dd,J=9Hz,12Hz,1H),8.47(d,J=7Hz,1H),8.57(s,1H)
Example 46
Ethyl 7-chloro-1- (3-dimethylamino-4,6-difluorophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate:
500 mg of 1- (3-amino-4,6-difluorophenyl) -7-chloro-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate 500 mg of 37% Together with formalin, it was added to a mixture of 10 ml 1,2-dichloroethane, 5 ml methanol, 0.5 ml acetic acid and hydrogenated with 0.08 g 10% palladium carbon (64 hours). After the catalyst was filtered off, the filtrate was concentrated under reduced pressure to obtain the title compound.
Properties: Yellow powder Melting point: 158-163 ° C
1 H NMR (CDCl 3 ) δ;
1.41 (t, J = 7 Hz, 3H), 2.88 (s, 6H), 4.41 (q, J = 7 Hz, 2H), 6.85 (t, J = 7 Hz, 1H), 7. 04 (dd, J = 9 Hz, 12 Hz, 1H), 8.47 (d, J = 7 Hz, 1H), 8.57 (s, 1H)
〔実施例47〕
7−クロロ−1−(3−ジメチルアミノ−4,6−ジフルオロ−フェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
実施例46で得たエチル 7−クロロ−1−(3−ジメチルアミノ−4,6−ジフルオロフェニル)−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボキシレートの全量を、4mlの3規定塩酸と酢酸の混液(1:1,v/v)に加えて、2時間撹拌加熱環流した。放冷して減圧下に濃縮し、析出物をエタノールに分散しで濾取し、エタノール、ジイソプロピルエーテルの順に洗って295mgの標記化合物を得た。
性状:淡黄色粉末
融点:244−2470℃
1HNMR(d6−DMSO)δ;
2.79(s,6H),7.41(t,J=8Hz,1H),7.57(dd,J=10Hz,13Hz,1H),8.77(d,J=8Hz,1H),9.04(s,1H)
Example 47
7-Chloro-1- (3-dimethylamino-4,6-difluoro-phenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid:
Ethyl 7-chloro-1- (3-dimethylamino-4,6-difluorophenyl) -6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxy obtained in Example 46 The total amount of the rate was added to 4 ml of a mixture of 3N hydrochloric acid and acetic acid (1: 1, v / v), and refluxed with stirring for 2 hours. The mixture was allowed to cool and concentrated under reduced pressure. The precipitate was dispersed in ethanol and collected by filtration, and washed with ethanol and diisopropyl ether in this order to obtain 295 mg of the title compound.
Properties: Pale yellow powder Melting point: 244-2470 ° C
1 H NMR (d 6 -DMSO) δ;
2.79 (s, 6H), 7.41 (t, J = 8 Hz, 1H), 7.57 (dd, J = 10 Hz, 13 Hz, 1H), 8.77 (d, J = 8 Hz, 1H), 9.04 (s, 1H)
〔実施例48〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸1300mg、(3S)−3−アミノピロリジン600mg、トリエチルアミン1000mgを6500mgのN,N−ジメチルホルムアミドに加え、90℃で1時間撹拌した。放冷後、25mlのエタノールを加えて5分間加熱環流した。放冷し析出物を濾取、エタノール、ジイソプロピルエーテルの順に洗って、1410mgの標記化合物を得た。
性状:淡褐色粉末
融点:260−266℃(分解)
1HNMR(d6−DMSO)δ;
1.81(m,1H),2.06(m,1H),536(brs,2H),6.97(t,J=8Hz,1H),7.35(t,J=10Hz,1H),8.06(d,J=13Hz,1H),8.69(s,1H)
Example 48
1- (3-amino-4,6-difluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6-fluoro-1,4-dihydro-4-oxo-1,8- Naphthyridine-3-carboxylic acid:
1300 mg of 1- (3-amino-4,6-difluorophenyl) -7-chloro-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid, (3S) -3 -Aminopyrrolidine (600 mg) and triethylamine (1000 mg) were added to 6500 mg of N, N-dimethylformamide, followed by stirring at 90 ° C for 1 hour. After cooling, 25 ml of ethanol was added and heated to reflux for 5 minutes. The mixture was allowed to cool and the precipitate was collected by filtration and washed with ethanol and diisopropyl ether in this order to obtain 1410 mg of the title compound.
Property: Light brown powder Melting point: 260-266 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.81 (m, 1H), 2.06 (m, 1H), 536 (brs, 2H), 6.97 (t, J = 8 Hz, 1H), 7.35 (t, J = 10 Hz, 1H) , 8.06 (d, J = 13 Hz, 1H), 8.69 (s, 1H)
〔実施例49〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸 トリエチルアミン塩:
1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸220mg、(3S)−3−アミノピロリジン・二塩酸塩210mg、及びトリエチルアミン400mgを1000mgのN,N−ジメチルホルムアミドに加え、90℃で1時間30分撹拌した。放冷後、10mlのエタノールを加えて5分間加熱環流した。放冷し析出物を濾取、エタノール、ジイソプロピルエーテルの順に洗って、220mgの標記化合物を得た。
性状:淡褐色粉末
融点:245−249℃(分解)
1HNMR(d6−DMSO)δ;
1.06(t,J=7Hz,9H),1.66(m,1H),1.92(m,1H),3.44(q,J=7Hz,6H),5.35(s,2H),6.96(t,J=8Hz,1H),7.35(t,J=10Hz,1H),8.02(d,J=13Hz,1H),8.66(s,1H)
Example 49
1- (3-amino-4,6-difluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6-fluoro-1,4-dihydro-4-oxo-1,8- Naphthyridine-3-carboxylic acid triethylamine salt:
220 mg of 1- (3-amino-4,6-difluorophenyl) -7-chloro-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid, (3S) -3 -210 mg of aminopyrrolidine dihydrochloride and 400 mg of triethylamine were added to 1000 mg of N, N-dimethylformamide, and the mixture was stirred at 90 ° C for 1 hour and 30 minutes. After allowing to cool, 10 ml of ethanol was added and heated to reflux for 5 minutes. The mixture was allowed to cool and the precipitate was collected by filtration and washed with ethanol and diisopropyl ether in this order to obtain 220 mg of the title compound.
Property: Light brown powder Melting point: 245-249 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.06 (t, J = 7 Hz, 9H), 1.66 (m, 1H), 1.92 (m, 1H), 3.44 (q, J = 7 Hz, 6H), 5.35 (s, 2H), 6.96 (t, J = 8 Hz, 1H), 7.35 (t, J = 10 Hz, 1H), 8.02 (d, J = 13 Hz, 1H), 8.66 (s, 1H)
〔実施例50〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸 二塩酸塩:
1−(3−アミノ−4,6−ジフルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸100mgを2.5mlの6規定塩酸にとかし、ついで減圧下に濃縮した。残渣にエタノールを加えて析出物を砕き濾取し、エタノール、ジイソプロピルエーテルの順に洗って標記化合物97mgを得た。
性状:淡褐色粉末
融点:246−250℃(分解)
1HNMR(d6−DMSO)δ;
2.09(m,1H),2.22(m,1H),7.03(brt,1H),7.39(t,J=10Hz,1H),8.12(d,J=12Hz,1H),8.30(brs,2H),8.72(s,1H)
Example 50
1- (3-Amino-4,6-difluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6-fluoro-1,4-dihydro-4-oxo-1,8- Naphthyridine-3-carboxylic acid dihydrochloride:
1- (3-Amino-4,6-difluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6-fluoro-1,4-dihydro-4-oxo-1,8- 100 mg of naphthyridine-3-carboxylic acid was dissolved in 2.5 ml of 6N hydrochloric acid and then concentrated under reduced pressure. Ethanol was added to the residue, the precipitate was crushed and collected by filtration, and washed with ethanol and diisopropyl ether in this order to obtain 97 mg of the title compound.
Property: Light brown powder Melting point: 246-250 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
2.09 (m, 1H), 2.22 (m, 1H), 7.03 (brt, 1H), 7.39 (t, J = 10 Hz, 1H), 8.12 (d, J = 12 Hz, 1H), 8.30 (brs, 2H), 8.72 (s, 1H)
〔実施例51〕
1−(3−アミノ−2,4−ジフルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸蟻酸塩:
1−(3−アミノ−2,4−ジフルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸200mg、蟻酸200mgを1分程度撹拌した後、エタノール200mgを加えて、90℃で一分間撹拌した。2mlのエタノールを加えて同温でさらに2分撹拌後静置し、析出物を濾取、エタノール、ジイソプロピルエーテルの順に洗って、154mgの標記化合物を得た。
性状:淡褐色粉末
融点:223−226℃
1HNMR(d6−DMSO)δ;
1.75(m,1H),2.00(m,1H),5.36(s,2H),6.96(t,J=8Hz,1H),7.35(t,J=11Hz,1H),8.04(d,J=12Hz,1H),8.26(s,1H),9.68(s,1H)
Example 51
1- (3-amino-2,4-difluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6-fluoro-4-oxo-1,4-dihydro-1,8- Naphthyridine-3-carboxylic acid formate:
1- (3-amino-2,4-difluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6-fluoro-4-oxo-1,4-dihydro-1,8- After 200 mg of naphthyridine-3-carboxylic acid and 200 mg of formic acid were stirred for about 1 minute, 200 mg of ethanol was added and stirred at 90 ° C. for 1 minute. 2 ml of ethanol was added, and the mixture was further stirred at the same temperature for 2 minutes and allowed to stand. The precipitate was collected by filtration and washed with ethanol and diisopropyl ether in this order to obtain 154 mg of the title compound.
Property: Light brown powder Melting point: 223-226 ° C
1 H NMR (d 6 -DMSO) δ;
1.75 (m, 1H), 2.00 (m, 1H), 5.36 (s, 2H), 6.96 (t, J = 8 Hz, 1H), 7.35 (t, J = 11 Hz, 1H), 8.04 (d, J = 12 Hz, 1H), 8.26 (s, 1H), 9.68 (s, 1H)
〔実施例52〕
1−(3−アミノ−2,4−ジフルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸 p−トルエンスルホン酸塩:
1−(3−アミノ−2,4−ジフルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸100mg、p−トルエンスルホン酸水和物55mgを300mgのN、N−ジメチルホルムアミドに加え、5分程度撹拌した。均一化した溶液に8mlのジイソアロピルエーテルを加えて撹拌後静置し、上澄をデカンテーションで除いた。ついで1mlのエタノールを加えて2分間加熱環流した後放冷し、析出物を濾取、エタノール、ジイソプロピルエーテルの順に洗って、120mgの標記化合物を得た。
性状:淡褐色粉末
融点:270℃
1HNMR(d6−DMSO)δ;
2.02(m,1H),2.24(m,1H),2.28(s,3H),3.89(m,1H),5.37(brs,2H),6.96(t,J=7Hz,1H),7.11(d,J=8Hz,2H),7.35(dt,J=2Hz,12Hz,1H),7.47(d,J=8Hz,2H),7.95(brs,2H),8.13(d,J=12Hz,1H),8.72(s,1H)
Example 52
1- (3-amino-2,4-difluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6-fluoro-4-oxo-1,4-dihydro-1,8- Naphthyridine-3-carboxylic acid p-toluenesulfonate:
1- (3-amino-2,4-difluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6-fluoro-4-oxo-1,4-dihydro-1,8- 100 mg of naphthyridine-3-carboxylic acid and 55 mg of p-toluenesulfonic acid hydrate were added to 300 mg of N, N-dimethylformamide and stirred for about 5 minutes. 8 ml of diisoallopyl ether was added to the homogenized solution, stirred and allowed to stand, and the supernatant was removed by decantation. Next, 1 ml of ethanol was added and the mixture was refluxed with heating for 2 minutes and then allowed to cool. The precipitate was collected by filtration and washed with ethanol and diisopropyl ether in this order to obtain 120 mg of the title compound.
Properties: Light brown powder Melting point: 270 ° C
1 H NMR (d 6 -DMSO) δ;
2.02 (m, 1H), 2.24 (m, 1H), 2.28 (s, 3H), 3.89 (m, 1H), 5.37 (brs, 2H), 6.96 (t , J = 7 Hz, 1H), 7.11 (d, J = 8 Hz, 2H), 7.35 (dt, J = 2 Hz, 12 Hz, 1H), 7.47 (d, J = 8 Hz, 2H), 7 .95 (brs, 2H), 8.13 (d, J = 12 Hz, 1H), 8.72 (s, 1H)
〔実施例53〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−1,4−ジヒドロ−7−(3−ヒドロキシピロリジン−1−イル)−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸150mg、3−ヒドロキシピロリジン100mg、トリエチルアミン100mgを550mgのN,N−ジメチルホルムアミドに加え、70℃で30分間撹拌した。8mlのジイソプロピルエーテルを加えて撹拌後静置し、上澄をデカンテーションで除いた。ついで2mlのエタノールを加えて析出物を濾取、エタノール、ジイソプロピルエーテルの順に洗って、156mgの標記化合物を得た。
性状:無色粉末
融点:251−253℃
1HNMR(d6−DMSO)δ;
1.56(m,1H),1.70−1.95(m,3H),2.58−2.96(m,4H),4.16(m,1H),4.30(brs,1H),5.35(s,2H),6.95(t,J=8Hz,1H),7.36(t,J=10Hz,1H),8.01(d,J=13Hz,1H),8.59(s,1H)
Example 53
1- (3-Amino-4,6-difluorophenyl) -6-fluoro-1,4-dihydro-7- (3-hydroxypyrrolidin-1-yl) -4-oxo-1,8-naphthyridine-3- carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -7-chloro-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid 150 mg, 3-hydroxypyrrolidine 100 mg 100 mg of triethylamine was added to 550 mg of N, N-dimethylformamide and stirred at 70 ° C. for 30 minutes. 8 ml of diisopropyl ether was added and the mixture was stirred and allowed to stand, and the supernatant was removed by decantation. Subsequently, 2 ml of ethanol was added and the precipitate was collected by filtration and washed with ethanol and diisopropyl ether in this order to obtain 156 mg of the title compound.
Properties: Colorless powder Melting point: 251-253 ° C
1 H NMR (d 6 -DMSO) δ;
1.56 (m, 1H), 1.70-1.95 (m, 3H), 2.58-2.96 (m, 4H), 4.16 (m, 1H), 4.30 (brs, 1H), 5.35 (s, 2H), 6.95 (t, J = 8 Hz, 1H), 7.36 (t, J = 10 Hz, 1H), 8.01 (d, J = 13 Hz, 1H) , 8.59 (s, 1H)
〔実施例54〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−[(3S,4S)−3−アミノ−4−メチルピロリジン−1−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
(3S,4S)−3−アミノ−4−メチルピロリジン・二塩酸塩を用いたほかは実施例48と同様にして標記化合物を得た。
性状:淡褐色粉末
1HNMR(d6−DMSO)δ;
0.93(d,J=7Hz,3H),2.17(m,1H),5.35(s,2H),6.97(t,J=8Hz,1H),7.36(t,J=10Hz,1H),7.99(d,J=12Hz,1H),8.65(s,1H)
Example 54
1- (3-Amino-4,6-difluorophenyl) -7-[(3S, 4S) -3-amino-4-methylpyrrolidin-1-yl] -6-fluoro-1,4-dihydro-4- Oxo-1,8-naphthyridine-3-carboxylic acid:
The title compound was obtained in the same manner as in Example 48 except that (3S, 4S) -3-amino-4-methylpyrrolidine dihydrochloride was used.
Properties: light brown powder
1 H NMR (d 6 -DMSO) δ;
0.93 (d, J = 7 Hz, 3H), 2.17 (m, 1H), 5.35 (s, 2H), 6.97 (t, J = 8 Hz, 1H), 7.36 (t, J = 10 Hz, 1H), 7.99 (d, J = 12 Hz, 1H), 8.65 (s, 1H)
〔実施例55〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−[(3R,4R)−3−アミノ−4−メチルピロリジン−1−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
(3R,4R)−3−アミノ−4−メチルピロリジン・二塩酸塩を用いたほかは実施例48と同様にして標記化合物を得た。
性状:淡褐色粉末
融点:214−217℃
1HNMR(d6−DMSO)δ;
0.93(d,J=7Hz,3H),2.17(m,1H),5.36(s,2H),6.96(t,J=8Hz,1H),7.36(t,J=10Hz,1H),7.99(d,J=12Hz,1H),8.65(s,1H)
Example 55
1- (3-Amino-4,6-difluorophenyl) -7-[(3R, 4R) -3-amino-4-methylpyrrolidin-1-yl] -6-fluoro-1,4-dihydro-4- Oxo-1,8-naphthyridine-3-carboxylic acid:
The title compound was obtained in the same manner as in Example 48 except that (3R, 4R) -3-amino-4-methylpyrrolidine dihydrochloride was used.
Property: Light brown powder Melting point: 214-217 ° C
1 H NMR (d 6 -DMSO) δ;
0.93 (d, J = 7 Hz, 3H), 2.17 (m, 1H), 5.36 (s, 2H), 6.96 (t, J = 8 Hz, 1H), 7.36 (t, J = 10 Hz, 1H), 7.99 (d, J = 12 Hz, 1H), 8.65 (s, 1H)
〔実施例56〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−[(3S,4R)−3−アミノ−4−メチルピロリジン−1−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
(3S,4R)−3−アミノ−4−メチルピロリジン・二塩酸塩を用いたほかは実施例48と同様にして標記化合物を得た。
性状:淡褐色粉末
融点:234−240℃
1HNMR(d6−DMSO)δ;
0.98(d,J=7Hz,3H),1.93(m,1H),3.03(m,1H),5.36(s,2H),6.97(t,J=8Hz,1H),7.37(t,J=10Hz,1H),8.04(d,J=12Hz,1H),8.68(s,1H)
Example 56
1- (3-amino-4,6-difluorophenyl) -7-[(3S, 4R) -3-amino-4-methylpyrrolidin-1-yl] -6-fluoro-1,4-dihydro-4- Oxo-1,8-naphthyridine-3-carboxylic acid:
The title compound was obtained in the same manner as in Example 48 except that (3S, 4R) -3-amino-4-methylpyrrolidine dihydrochloride was used.
Property: Light brown powder Melting point: 234-240 ° C
1 H NMR (d 6 -DMSO) δ;
0.98 (d, J = 7 Hz, 3H), 1.93 (m, 1H), 3.03 (m, 1H), 5.36 (s, 2H), 6.97 (t, J = 8 Hz, 1H), 7.37 (t, J = 10 Hz, 1H), 8.04 (d, J = 12 Hz, 1H), 8.68 (s, 1H)
〔実施例57〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−[(3R,4S)−3−アミノ−4−メチルピロリジン−1−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
(3R,4S)−3−アミノ−4−メチルビロリジン・二塩酸塩を用いたほかは実施例48と同様にして標記化合物を得た。
性状:淡褐色粉末
融点:237−241℃
1HNMR(d6−DMSO)δ;
0.98(d,J=6Hz,3H),1.93(m,1H),3.02(m,1H),5.37(s,2H),6.97(t.J=8Hz,1H),7.37(t,J=10Hz,1H),8.03(d,J=13Hz,1H),8.67(s,1H)
Example 57
1- (3-Amino-4,6-difluorophenyl) -7-[(3R, 4S) -3-amino-4-methylpyrrolidin-1-yl] -6-fluoro-1,4-dihydro-4- Oxo-1,8-naphthyridine-3-carboxylic acid:
The title compound was obtained in the same manner as in Example 48 except that (3R, 4S) -3-amino-4-methylpyrrolidine dihydrochloride was used.
Property: Light brown powder Melting point: 237-241 ° C
1 H NMR (d 6 -DMSO) δ;
0.98 (d, J = 6 Hz, 3H), 1.93 (m, 1H), 3.02 (m, 1H), 5.37 (s, 2H), 6.97 (t.J = 8 Hz, 1H), 7.37 (t, J = 10 Hz, 1H), 8.03 (d, J = 13 Hz, 1H), 8.67 (s, 1H)
〔実施例58〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3−アミノ−、4,4−ジメチルピロリジン−1−イル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
3−アミノ−4,4−ジメチルピロリジン・二塩酸塩を用いたほかは実施例48と同様にして標記化合物を得た。
性状:淡褐色粉末
融点:267−269℃(分解)
1HNMR(d6−DMSO)δ;
0.86(s,3H),0.95(s.3H),2.88−3.05(m,1H),5.36(s,2H),6.97(t,J=8Hz,1H),7.38(t.J=10Hz,1H),8.02(d,J=13Hz,1H),8.66(s,1H)
Example 58
1- (3-Amino-4,6-difluorophenyl) -7- (3-amino-, 4,4-dimethylpyrrolidin-1-yl) -6-fluoro-1,4-dihydro-4-oxo-1 , 8-Naphthyridine-3-carboxylic acid:
The title compound was obtained in the same manner as in Example 48 except that 3-amino-4,4-dimethylpyrrolidine dihydrochloride was used.
Property: Light brown powder Melting point: 267-269 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
0.86 (s, 3H), 0.95 (s. 3H), 2.88-3.05 (m, 1H), 5.36 (s, 2H), 6.97 (t, J = 8 Hz, 1H), 7.38 (t.J = 10 Hz, 1H), 8.02 (d, J = 13 Hz, 1H), 8.66 (s, 1H)
〔実施例59〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−[3−(N−エチルアミノメチル)ピロリジン−1−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
3−(N−エチルアミノメチル)ピロリジン・二塩酸塩を用いたほかは実施例48と同様にして標記化合物を得た。
性状:淡褐色粉末
融点:235−244℃(分解)
1HNMR(d6−DMSO)δ;
1.01(t,J=7Hz,3H),1.61(m,1H),1.98(m,1H),2.32(m,1H),2.54(q,J=7Hz,2H),5.34(s,2H),6.96(t,J=8Hz,1H),7.35(t,J=10Hz,1H),8.02(d,J=12Hz.1H),8.67(s,1H)
Example 59
1- (3-amino-4,6-difluorophenyl) -7- [3- (N-ethylaminomethyl) pyrrolidin-1-yl] -6-fluoro-1,4-dihydro-4-oxo-1, 8-Naphthyridine-3-carboxylic acid:
The title compound was obtained in the same manner as in Example 48 except that 3- (N-ethylaminomethyl) pyrrolidine dihydrochloride was used.
Property: Light brown powder Melting point: 235-244 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.01 (t, J = 7 Hz, 3H), 1.61 (m, 1H), 1.98 (m, 1H), 2.32 (m, 1H), 2.54 (q, J = 7 Hz, 2H), 5.34 (s, 2H), 6.96 (t, J = 8 Hz, 1H), 7.35 (t, J = 10 Hz, 1H), 8.02 (d, J = 12 Hz.1H) , 8.67 (s, 1H)
〔実施例60〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
3S−(−)−アミノピロリジン29mg、トリエチルアミン68mgをジメチルスルホキシド1mlに加え、10分撹拌し、1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸80mgを加え、100℃で2時間加熱撹拌した。放冷後、反応液にジエチルエーテルを加え、上澄みを除いた。残渣にエタノールを加え、固体を濾取し、ジエチルエーテルで洗浄した。76mgの標記化合物を得た。
性状:無色粉末
融点:213−221℃(分解)
1HNMR(d6−DMSO)δ;
1.62−1.76(m,1H),1.88−2.06(m,1H),3.08(brs,1H),5.53(s,2H),5.92(d,J=8Hz,1H),7.03(t,J=8Hz,1H),7.50(t,J=11Hz,1H),7.85(d,J=14Hz,1H),8.61(s,1H)
Example 60
1- (3-amino-4,6-difluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6-fluoro-1,4-dihydro-4-oxo-quinoline-3- carboxylic acid:
29 mg of 3S-(−)-aminopyrrolidine and 68 mg of triethylamine were added to 1 ml of dimethyl sulfoxide, stirred for 10 minutes, and 1- (3-amino-4,6-difluorophenyl) -6,7-difluoro-1,4-dihydro. 80 mg of -4-oxo-quinoline-3-carboxylic acid was added, and the mixture was heated with stirring at 100 ° C. for 2 hours. After allowing to cool, diethyl ether was added to the reaction solution, and the supernatant was removed. Ethanol was added to the residue, and the solid was collected by filtration and washed with diethyl ether. 76 mg of the title compound were obtained.
Properties: colorless powder Melting point: 213-221 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.62-1.76 (m, 1H), 1.88-2.06 (m, 1H), 3.08 (brs, 1H), 5.53 (s, 2H), 5.92 (d, J = 8 Hz, 1H), 7.03 (t, J = 8 Hz, 1H), 7.50 (t, J = 11 Hz, 1H), 7.85 (d, J = 14 Hz, 1H), 8.61 ( s, 1H)
〔実施例61〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−[(3S.4S)−3−アミノ−4−メチルピロリジン−1−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
(3S,4S)−3−アミノ−4−メチルピロリジンを用いたほかは実施例60と同様にして標記化合物を得た。
性状:褐色粉末
融点:196−202℃
1HNMR(d6−DMSO)δ;
0.95(d,J=7Hz,3H),2.20(brs,1H),5.53(s,2H),5.88(d,J=5Hz,1H),7.02(m,1H),7.50(t,J=9Hz,1H),7.85(d,J=14Hz,1H),8.60(s,1H)
Example 61
1- (3-amino-4,6-difluorophenyl) -7-[(3S.4S) -3-amino-4-methylpyrrolidin-1-yl] -6-fluoro-1,4-dihydro-4- Oxo-quinoline-3-carboxylic acid:
The title compound was obtained in the same manner as in Example 60 except that (3S, 4S) -3-amino-4-methylpyrrolidine was used.
Properties: Brown powder Melting point: 196-202 ° C
1 H NMR (d 6 -DMSO) δ;
0.95 (d, J = 7 Hz, 3H), 2.20 (brs, 1H), 5.53 (s, 2H), 5.88 (d, J = 5 Hz, 1H), 7.02 (m, 1H), 7.50 (t, J = 9 Hz, 1H), 7.85 (d, J = 14 Hz, 1H), 8.60 (s, 1H)
〔実施例62〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−7−(ピロリジン−1−イル)−キノリン−3−カルボン酸:
ピロリジンを用いたほかは実施例60と同様にして標記化合物を得た。
性状:無色粉末
融点:264−268℃(分解)
1HNMR(d6−DMSO)δ;
1.89(brs,4H),5.52(s,2H),5.97(d,J=8Hz,1H),7.03(t,J=8Hz,1H),7.49(t,J=10Hz,1H),7.85(d,J=14Hz,1H),8.62(s,1H)
Example 62
1- (3-Amino-4,6-difluorophenyl) -6-fluoro-1,4-dihydro-4-oxo-7- (pyrrolidin-1-yl) -quinoline-3-carboxylic acid:
The title compound was obtained in the same manner as in Example 60 except that pyrrolidine was used.
Properties: colorless powder Melting point: 264-268 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.89 (brs, 4H), 5.52 (s, 2H), 5.97 (d, J = 8 Hz, 1H), 7.03 (t, J = 8 Hz, 1H), 7.49 (t, J = 10 Hz, 1H), 7.85 (d, J = 14 Hz, 1H), 8.62 (s, 1H)
〔実施例63〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−[(1S,6S)−2,8−ジアザビシクロ[4.3.0]ノナ−8−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
(1S,6S)−2,8−ジアザビシクロ[4.3.0]ノナンを用いたほかは実施例60と同様にして標記化合物を得た。
性状:無色粉末
融点:226−233℃(分解)
1HNMR(d6−DMSO)δ;
1.53−1.81(m,4H),2.63(brs,1H),2.88(brs,1H),3.51(m,2H),3.83(brs,2H),5.57(s,2H),5.97(d,J=8Hz,1H),7.05(t,J=9Hz,1H),7.51(t,J=10Hz,1H),7.92(d,J=14Hz,1H),8.65(s,1H)
Example 63
1- (3-Amino-4,6-difluorophenyl) -7-[(1S, 6S) -2,8-diazabicyclo [4.3.0] non-8-yl] -6-fluoro-1,4 -Dihydro-4-oxo-quinoline-3-carboxylic acid:
The title compound was obtained in the same manner as in Example 60 except that (1S, 6S) -2,8-diazabicyclo [4.3.0] nonane was used.
Properties: colorless powder Melting point: 226-233 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.53-1.81 (m, 4H), 2.63 (brs, 1H), 2.88 (brs, 1H), 3.51 (m, 2H), 3.83 (brs, 2H), 5 .57 (s, 2H), 5.97 (d, J = 8 Hz, 1H), 7.05 (t, J = 9 Hz, 1H), 7.51 (t, J = 10 Hz, 1H), 7.92 (D, J = 14 Hz, 1H), 8.65 (s, 1H)
〔実施例64〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6,8−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−6,7,8−トリフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸を用いたほかは実施例60と同様にして標記化合物を得た。
性状:褐色粉末
融点:204−210℃(分解)
1HNMR(d6−DMSO)δ;
1.67(m,1H),1.95(m,1H),5.42(s,2H),7.08(m,1H),7.37(t,J=10Hz,1H),7.78(d,J=14Hz,1H),8.45(s,1H)
[Example 64]
1- (3-amino-4,6-difluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6,8-difluoro-1,4-dihydro-4-oxo-quinoline- 3-carboxylic acid:
Similar to Example 60 except that 1- (3-amino-4,6-difluorophenyl) -6,7,8-trifluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid was used. To give the title compound.
Properties: Brown powder Melting point: 204-210 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.67 (m, 1H), 1.95 (m, 1H), 5.42 (s, 2H), 7.08 (m, 1H), 7.37 (t, J = 10 Hz, 1H), 7 .78 (d, J = 14 Hz, 1H), 8.45 (s, 1H)
〔実施例65〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3−ヒドロキシピロリジン−1−イル)−6,8−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
3−ヒドロキシピロリジンを用いたほかは実施例60と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:144−152℃(分解)
1HNMR(d6−DMSO)δ;
1.81(m,2H),3.79(m,1H),4.29(brs,1H),5.00(s,1H),5.44(s,2H),7.09(t,J=8Hz,1H),7.39(t,J=10Hz,1H),7.80(d,J=14Hz,1H),8.47(s,1H)
Example 65
1- (3-Amino-4,6-difluorophenyl) -7- (3-hydroxypyrrolidin-1-yl) -6,8-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid :
The title compound was obtained in the same manner as in Example 60 except that 3-hydroxypyrrolidine was used.
Properties: Pale yellow powder Melting point: 144-152 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.81 (m, 2H), 3.79 (m, 1H), 4.29 (brs, 1H), 5.00 (s, 1H), 5.44 (s, 2H), 7.09 (t , J = 8 Hz, 1H), 7.39 (t, J = 10 Hz, 1H), 7.80 (d, J = 14 Hz, 1H), 8.47 (s, 1H)
〔実施例66〕
1−[3−アミノ−2,4−ジフルオロフェニル]−7−[(3S)−3−アミノピロリジン−1−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−[3−アミノ−2,4−ジフルオロフェニル]−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸を用いたほかは実施例48と同様にして標記化合物を得た。
性状:淡褐色粉末
融点:268−272℃(分解)
1HNMR(d6−DMSO)δ;
1.79(m,1H),2.05(m,1H),5.58(s,2H),6.84(m,1H),7.11(t,J=10Hz,1H),8.07(d,J=13Hz,1H),8.69(s,1H)
Example 66
1- [3-Amino-2,4-difluorophenyl] -7-[(3S) -3-aminopyrrolidin-1-yl] -6-fluoro-1,4-dihydro-4-oxo-1,8- Naphthyridine-3-carboxylic acid:
Examples except that 1- [3-amino-2,4-difluorophenyl] -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid was used 48 gave the title compound.
Property: Light brown powder Melting point: 268-272 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.79 (m, 1H), 2.05 (m, 1H), 5.58 (s, 2H), 6.84 (m, 1H), 7.11 (t, J = 10 Hz, 1H), 8 .07 (d, J = 13 Hz, 1H), 8.69 (s, 1H)
〔実施例67〕
1−[3−アミノ−2,4−ジフルオロフェニル]−7−[(3S,4S)−3−アミノ−4−メチルピロリジン−1−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−[3−アミノ−2,4−ジフルオロフェニル]−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸を用いたほかは実施例48と同様にして標記化合物を得た。
性状:淡褐色粉末
1HNMR(d6−DMSO)δ;
0.91(brd,1H),2.14(m,1H),5.58(s,2H),6.83(m,1H),7.10(t,J=10Hz,1H),8.02(d,J=12Hz,1H),8.65(s,1H)
Example 67
1- [3-Amino-2,4-difluorophenyl] -7-[(3S, 4S) -3-amino-4-methylpyrrolidin-1-yl] -6-fluoro-1,4-dihydro-4- Oxo-1,8-naphthyridine-3-carboxylic acid:
Examples except that 1- [3-amino-2,4-difluorophenyl] -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid was used 48 gave the title compound.
Properties: light brown powder
1 H NMR (d 6 -DMSO) δ;
0.91 (brd, 1H), 2.14 (m, 1H), 5.58 (s, 2H), 6.83 (m, 1H), 7.10 (t, J = 10 Hz, 1H), 8 .02 (d, J = 12 Hz, 1H), 8.65 (s, 1H)
〔実施例68〕
1−(3−アミノ−4,5,6−トリフルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−4,5,6−トリフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸を用いたほかは実施例60と同様にして標記化合物を得た。
性状:褐色粉末
融点:>256℃(分解)
1HNMR(d6−DMSO)δ;
1.58−1.84(m,1H),1.84−2.23(m,1H),5.74(s,2H),6.81(t,J=5Hz,1H),8.03(d,J=12Hz,1H),8.73(s,1H)
Example 68
1- (3-Amino-4,5,6-trifluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6-fluoro-1,4-dihydro-4-oxo-1 , 8-Naphthyridine-3-carboxylic acid:
Besides using 1- (3-amino-4,5,6-trifluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid Gave the title compound as in Example 60.
Properties: Brown powder Melting point:> 256 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.58-1.84 (m, 1H), 1.84-2.23 (m, 1H), 5.74 (s, 2H), 6.81 (t, J = 5 Hz, 1H), 8. 03 (d, J = 12 Hz, 1H), 8.73 (s, 1H)
〔実施例69〕
1−(3−アミノ−4,5,6−トリフルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
1−(3−アミノ−4,5,6−トリフルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸を用いたほかは実施例60と同様にして標記化合物を得た。
性状:褐色粉末
融点:>270℃(分解)
1HNMR(d6−DMSO)δ;
1.61−1.81(m,1H),1.89−2.15(m,1H),5.88(s,2H),6.88(brs,1H),7.85(d,J=15Hz,1H),8.69(s,1H)
Example 69
1- (3-amino-4,5,6-trifluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6-fluoro-1,4-dihydro-4-oxo-quinoline -3-carboxylic acid:
Similar to Example 60 except that 1- (3-amino-4,5,6-trifluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid was used. To give the title compound.
Properties: Brown powder Melting point:> 270 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.61-1.81 (m, 1H), 1.89-2.15 (m, 1H), 5.88 (s, 2H), 6.88 (brs, 1H), 7.85 (d, J = 15 Hz, 1H), 8.69 (s, 1H)
〔実施例70〕
1−(3−アミノ−2,4,6−トリフルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−2,4,6−トリフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸70mgをジメチルスルホキシド1mlに溶解し、3(S)−3−アミノピロリジン0.018mlトリエチルアミン0.04mlを加え、1時間80℃で撹拌した。反応液にジエチルエーテルを加え、デカンテーションを2回繰り返した。残渣に少量のエタノールを加えて、10分間還流後、析出した固体を濾取しジエチルエーテルで洗い51mgの標記化合物を得た。
性状:淡茶色粉末
融点:273−277℃
1HNMR(d6−DMSO)δ;
1.75−1.78(m,1H),2.00−2.18(m,1H),5.46(brs,1H),7.39(t,J=10Hz,1H),8.08(d,J=13Hz,1H),8.97(s,1H)
Example 70
1- (3-Amino-2,4,6-trifluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6-fluoro-1,4-dihydro-4-oxo-1 , 8-Naphthyridine-3-carboxylic acid:
70 mg of 1- (3-amino-2,4,6-trifluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid was converted to dimethyl sulfoxide It melt | dissolved in 1 ml, 3 (S) -3-aminopyrrolidine 0.018 ml triethylamine 0.04 ml was added, and it stirred at 80 degreeC for 1 hour. Diethyl ether was added to the reaction solution, and decantation was repeated twice. A small amount of ethanol was added to the residue, and after refluxing for 10 minutes, the precipitated solid was collected by filtration and washed with diethyl ether to obtain 51 mg of the title compound.
Properties: Light brown powder Melting point: 273-277 ° C
1 H NMR (d 6 -DMSO) δ;
1.75-1.78 (m, 1H), 2.00-2.18 (m, 1H), 5.46 (brs, 1H), 7.39 (t, J = 10 Hz, 1H), 8. 08 (d, J = 13 Hz, 1H), 8.97 (s, 1H)
〔実施例71〕
1−(3−アミノ−6−クロロ−4−フルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−6−クロロ−4−フルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸を用いたほかは実施例70と同様にして標記化合物を得た。
性状:淡黄褐色粉末
融点:249−252℃
1HNMR(d6−DMSO)δ;
1.74−1.95(m,1H),2.00−2.16(m,1H),5.69(brs,2H),7.00(d,J=9Hz,1H),7.47(d,J=11Hz,1H),8.02(d,J=12Hz,1H),8.61(s,1H)
Example 71
1- (3-amino-6-chloro-4-fluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6-fluoro-1,4-dihydro-4-oxo-1, 8-Naphthyridine-3-carboxylic acid:
Except that 1- (3-amino-6-chloro-4-fluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid was used The title compound was obtained in the same manner as in Example 70.
Properties: Pale yellow powder Melting point: 249-252 ° C
1 H NMR (d 6 -DMSO) δ;
1.74-1.95 (m, 1H), 2.00-2.16 (m, 1H), 5.69 (brs, 2H), 7.00 (d, J = 9 Hz, 1H), 7. 47 (d, J = 11 Hz, 1H), 8.02 (d, J = 12 Hz, 1H), 8.61 (s, 1H)
〔実施例72〕
1−(3−アミノ−6−クロロ−4−フルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
1−(3−アミノ−6−クロロ−4−フルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸を用いたほかは実施例70と同様にして標記化合物を得た。
性状:淡赤色粉末
融点:177−182℃(分解)
1HNMR(d6−DMSO)δ;
1.59−1.75(m,1H),1.86−2.07(m,1H),5.78(d,J=7Hz,1H),5.89(brs,2H),7.06(d,J=9Hz,1H),7.60(d,J=11Hz,1H),7.86(d,J=14Hz,1H),8.56(s,1H)
Example 72
1- (3-Amino-6-chloro-4-fluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6-fluoro-1,4-dihydro-4-oxo-quinoline- 3-carboxylic acid:
Example 70 with the exception that 1- (3-amino-6-chloro-4-fluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid was used In the same manner, the title compound was obtained.
Property: Pale red powder Melting point: 177-182 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.59-1.75 (m, 1H), 1.86-2.07 (m, 1H), 5.78 (d, J = 7 Hz, 1H), 5.89 (brs, 2H), 7. 06 (d, J = 9 Hz, 1H), 7.60 (d, J = 11 Hz, 1H), 7.86 (d, J = 14 Hz, 1H), 8.56 (s, 1H)
〔実施例73〕
1−(3−アミノ−4−クロロ−6−フルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−4−クロロ−6−フルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸を用いたほかは実施例70と同様にして標記化合物を得た。
性状:茶色粉末
融点:>258℃(分解)
1HNMR(d6−DMSO)δ;
1.53−1.80(m,1H),1.83−2.06(m,1H),5.56(brs,2H),6.99(d,J=7Hz,1H),7.48(d,J=10Hz,1H),8.02(d,J=13Hz,1H),8.68(s,1H)
Example 73
1- (3-amino-4-chloro-6-fluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6-fluoro-1,4-dihydro-4-oxo-1, 8-Naphthyridine-3-carboxylic acid:
Except that 1- (3-amino-4-chloro-6-fluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid was used The title compound was obtained in the same manner as in Example 70.
Properties: Brown powder Melting point:> 258 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.53-1.80 (m, 1H), 1.83-2.06 (m, 1H), 5.56 (brs, 2H), 6.99 (d, J = 7 Hz, 1H), 7. 48 (d, J = 10 Hz, 1H), 8.02 (d, J = 13 Hz, 1H), 8.68 (s, 1H)
〔実施例74〕
1−(3−アミノ−4−フルオロ−2−メチルフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−4−フルオロ−2−メチルフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸を用いたほかは実施例70と同様にして標記化合物を得た。
性状:淡茶色粉末
融点:>165℃(分解)
1HNMR(d6−DMSO)δ;
1.53−1.73(m,1H),1.74−1.98(m,1H),1.83(s,3H),5.25(br,2H),6.75(d,J=9Hz,1H),7.09(d,J=13Hz,1H),8.02(d,J=13Hz,1H),8.48(s,1H)
Example 74
1- (3-amino-4-fluoro-2-methylphenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6-fluoro-1,4-dihydro-4-oxo-1, 8-Naphthyridine-3-carboxylic acid:
Other than using 1- (3-amino-4-fluoro-2-methylphenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid The title compound was obtained in the same manner as in Example 70.
Properties: Pale brown powder Melting point:> 165 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.53-1.73 (m, 1H), 1.74-1.98 (m, 1H), 1.83 (s, 3H), 5.25 (br, 2H), 6.75 (d, J = 9 Hz, 1H), 7.09 (d, J = 13 Hz, 1H), 8.02 (d, J = 13 Hz, 1H), 8.48 (s, 1H)
〔実施例75〕
7−[(3S)−3−アミノピロリジン−1−イル]−1−(2,4−ジフルオロ−5−ホルミルアミノフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
7−クロロ−1−(2,4−ジフルオロ−5−ホルミルアミノフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸を用いたほかは実施例48と同様にして標記化合物を得た。
性状:淡褐色粉末
融点:218−225℃
1HNMR(d6−DMSO)δ;
1.62(m,1H),1.90(m,1H),7.72(t,J=10Hz,1H),8.01(d,J=13Hz,1H),8.34(s,1H),8.38(t,J=8Hz,1H),8.71(s,1H)
Example 75
7-[(3S) -3-Aminopyrrolidin-1-yl] -1- (2,4-difluoro-5-formylaminophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8 -Naphthyridine-3-carboxylic acid:
Implemented except using 7-chloro-1- (2,4-difluoro-5-formylaminophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid The title compound was obtained in the same manner as in Example 48.
Property: Light brown powder Melting point: 218-225 ° C
1 H NMR (d 6 -DMSO) δ;
1.62 (m, 1H), 1.90 (m, 1H), 7.72 (t, J = 10 Hz, 1H), 8.01 (d, J = 13 Hz, 1H), 8.34 (s, 1H), 8.38 (t, J = 8 Hz, 1H), 8.71 (s, 1H)
〔実施例76〕
7−[(3S,4S)−3−アミノ−4−メチルピロリジン−1−イル]−1−(2,4−ジフルオロ−5−ホルミルアミノフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
7−クロロ−1−(2,4−ジフルオロ−5−ホルミルアミノフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸を用いたほかは実施例54と同様にして標記化合物を得た。
性状:無色粉末
融点:215−216℃
1HNMR(d6−DN4SO)δ;
0.92(brd,3H),2.15(m,1H),7.71(t,J=10Hz,1H),8.01(d,J=12Hz,1H),8.34(s,1H),8.38(t,J=8Hz,1H),8.78(s,1H)
Example 76
7-[(3S, 4S) -3-Amino-4-methylpyrrolidin-1-yl] -1- (2,4-difluoro-5-formylaminophenyl) -6-fluoro-1,4-dihydro-4 -Oxo-1,8-naphthyridine-3-carboxylic acid:
Implemented except using 7-chloro-1- (2,4-difluoro-5-formylaminophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid The title compound was obtained in the same manner as in Example 54.
Property: Colorless powder Melting point: 215-216 ° C
1 H NMR (d 6 -DN 4 SO) δ;
0.92 (brd, 3H), 2.15 (m, 1H), 7.71 (t, J = 10 Hz, 1H), 8.01 (d, J = 12 Hz, 1H), 8.34 (s, 1H), 8.38 (t, J = 8 Hz, 1H), 8.78 (s, 1H)
〔実施例77〕
7−[(3S)−3−アミノピロリジン−1−イル]−1−(3−ベンゾイルアミノ−4,6−ジフルオロフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−ベンゾイルアミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸を用いたほかは実施例48と同様にして標記化合物を得た。
性状:淡褐色粉末
融点:197−200℃
1HNMR(d6−DMSO)δ;
1.65(m,3H),1.92(m,1H),7.51−7.63(m,3H) ,7.72(t,J=10Hz,1H),7.94−8.07(m,4H),8.78(s,1H)
Example 77
7-[(3S) -3-Aminopyrrolidin-1-yl] -1- (3-benzoylamino-4,6-difluorophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8 -Naphthyridine-3-carboxylic acid:
Implemented except using 1- (3-benzoylamino-4,6-difluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid The title compound was obtained in the same manner as in Example 48.
Properties: Light brown powder Melting point: 197-200 ° C
1 H NMR (d 6 -DMSO) δ;
1.65 (m, 3H), 1.92 (m, 1H), 7.51-7.63 (m, 3H), 7.72 (t, J = 10 Hz, 1H), 7.94-8. 07 (m, 4H), 8.78 (s, 1H)
〔実施例78〕
7−[(3S)−3−アミノピロリジン−1−イル]−1−(2,4−ジフルオロ−5−メチルアミノフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
7−クロロ−1−(2,4−ジフルオロ−5−メチルアミノフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸を用いたほかは実施例48と同様にして標記化合物を得た。
性状:淡褐色粉末
融点:256−258℃(分解)
1HNMR(d6−DMSO)δ;
1.63(m,1H),1.91(m,1H),2.70(d,J=5Hz,3H),5.79(brs,1H),6.96(t,J=8Hz,1H),7.39(t,J=10Hz,1H),8.02(d,J=12Hz,1H),8.68(s,1H)
Example 78
7-[(3S) -3-Aminopyrrolidin-1-yl] -1- (2,4-difluoro-5-methylaminophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8 -Naphthyridine-3-carboxylic acid:
Implemented except using 7-chloro-1- (2,4-difluoro-5-methylaminophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid The title compound was obtained in the same manner as in Example 48.
Property: Light brown powder Melting point: 256-258 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.63 (m, 1H), 1.91 (m, 1H), 2.70 (d, J = 5 Hz, 3H), 5.79 (brs, 1H), 6.96 (t, J = 8 Hz, 1H), 7.39 (t, J = 10 Hz, 1H), 8.02 (d, J = 12 Hz, 1H), 8.68 (s, 1H)
〔実施例79〕
7−[(3S)−3−アミノピロリジン−1−イル]−1−(2,4−ジフルオロ−5−メチルアミノフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
1−(2,4−ジフルオロ−5−メチルアミノフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸を用いたほかは実施例60と同様にして標記化合物を得た。
性状:褐色粉末
融点:219−226℃(分解)
1HNMR(d6−DMSO)δ;
1.59−1.78(m,1H),1.91−2.07(m,1H),2.70(d,J=5Hz,3H),5.91−6.04(m,1H),7.04(t,J=8Hz.1H),7.54(t,J=11Hz,1H),7.86(d,J=14Hz,1H),8.63(s,1H)
Example 79
7-[(3S) -3-Aminopyrrolidin-1-yl] -1- (2,4-difluoro-5-methylaminophenyl) -6-fluoro-1,4-dihydro-4-oxo-quinoline-3 -Carboxylic acid:
Except that 1- (2,4-difluoro-5-methylaminophenyl) -6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid was used, the same procedure as in Example 60 was performed. The title compound was obtained.
Property: Brown powder Melting point: 219-226 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.59-1.78 (m, 1H), 1.91-2.07 (m, 1H), 2.70 (d, J = 5 Hz, 3H), 5.91-6.04 (m, 1H) ), 7.04 (t, J = 8 Hz, 1H), 7.54 (t, J = 11 Hz, 1H), 7.86 (d, J = 14 Hz, 1H), 8.63 (s, 1H)
〔実施例80〕
7−[(3S)−3−アミノピロリジン−1−イル]−1−(3−ジメチルアミノ−4,6−ジフルオロフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
7−クロロ−1−(3−ジメチルアミノ−4,6−ジフルオロ−フェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸を用いたほかは実施例48と同様にして標記化合物を得た。
性状:淡褐色粉末
融点:248−251℃(分解)
1HNMR(d6−DNSO)δ;
1.63(m,1H),1.91(m,1H),2.77(s,6H),7.36(t,J=8Hz,1H),7.49(t,J=10Hz,1H),8.02(d,J=13Hz,1H),8.74(s,1H)
Example 80
7-[(3S) -3-Aminopyrrolidin-1-yl] -1- (3-dimethylamino-4,6-difluorophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8 -Naphthyridine-3-carboxylic acid:
Other than using 7-chloro-1- (3-dimethylamino-4,6-difluoro-phenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid The title compound was obtained in the same manner as in Example 48.
Property: Light brown powder Melting point: 248-251 ° C (decomposition)
1 HNMR (d 6 -DNSO) δ;
1.63 (m, 1H), 1.91 (m, 1H), 2.77 (s, 6H), 7.36 (t, J = 8 Hz, 1H), 7.49 (t, J = 10 Hz, 1H), 8.02 (d, J = 13 Hz, 1H), 8.74 (s, 1H)
〔実施例81〕
7−[(3S)−3−アミノピロリジン−1−イル]−1−[2,4−ジフルオロ−5−(L−グリシルアミノ)−フェニル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸700mg、(3S)−3−(t−ブトキシカルボニルアミノ)ピロリジン450mg、トリエチルアミン400mgを2mlのN,N−ジメチルホルムアミドに加え、70℃で30分間撹拌した。30mlのジイソプロピルエーテルを加えて撹拌後静置し、上澄をデカンテーションで除いた。これをそのまま次の反応に用いた。
N−Boc−グリシン350mg、N−メチルモルホリン210mgを10mlのジクロロメタンに加え、−20℃にして撹拌しながらクロロ蟻酸イソブチル270μlを加えて20分撹拌した。この液を−60℃に冷却し、上記の1−(3−アミノ−4,6−ジフルオロフェニル)−7−[(3S)−3−(t−ブトキシカルボニルアミノ)ピロリジニル]−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸の全量を10mlのジクロロメタンに溶解して加えた。ゆっくりと室温に戻し、ついて2時間加熱環流した。室温に一晩放置し、50mlのクロロホルムと10mlの蒸留水を加えて分液、無水硫酸マグネシウムで乾燥後減圧下に濃縮した。泡状に固まった残渣の3分の1量を6mlのアセトニトリルに溶かし、1.5mlの4N塩化水素ジオキサン溶液を加えて室温で撹拌した。約1分で析出物を生じた。そのまま一晩撹拌し、析出物を濾取した後、約4mlの蒸留水にとかし、10%水酸化ナトリウム水溶液を少量ずつ加えてpH8程度に中和し、析出物を生成させた。1時間加熱環流し、放冷、析出物を濾取し、蒸留水、エタノール、ジイソプロピルエーテルの順に洗って193mgの無色粉末として標記化合物を得た。
性状:無色粉末
融点:>270℃
1HNMR(d6−DMSO)δ;
1.65(m,1H),1.92(m,1H),7.73(t,J=11Hz,1H),8.04(d,J=13Hz,1H),8 38(m,1H),8.78(s,1H)
Example 81
7-[(3S) -3-Aminopyrrolidin-1-yl] -1- [2,4-difluoro-5- (L-glycylamino) -phenyl] -6-fluoro-1,4-dihydro-4-oxo -1,8-naphthyridine-3-carboxylic acid:
700 mg of 1- (3-amino-4,6-difluorophenyl) -7-chloro-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid, (3S) -3 -450 mg of (t-butoxycarbonylamino) pyrrolidine and 400 mg of triethylamine were added to 2 ml of N, N-dimethylformamide and stirred at 70 ° C for 30 minutes. 30 ml of diisopropyl ether was added and the mixture was allowed to stand after stirring, and the supernatant was removed by decantation. This was directly used in the next reaction.
350 mg of N-Boc-glycine and 210 mg of N-methylmorpholine were added to 10 ml of dichloromethane, and 270 μl of isobutyl chloroformate was added to the mixture while stirring at −20 ° C., followed by stirring for 20 minutes. The solution was cooled to −60 ° C. and 1- (3-amino-4,6-difluorophenyl) -7-[(3S) -3- (t-butoxycarbonylamino) pyrrolidinyl] -6-fluoro- The total amount of 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid was added dissolved in 10 ml of dichloromethane. The temperature was slowly returned to room temperature and then heated to reflux for 2 hours. The mixture was allowed to stand overnight at room temperature, 50 ml of chloroform and 10 ml of distilled water were added, and the mixture was separated, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. One third of the foamed residue was dissolved in 6 ml of acetonitrile, 1.5 ml of 4N hydrogen chloride dioxane solution was added, and the mixture was stirred at room temperature. A precipitate was formed in about 1 minute. After stirring overnight, the precipitate was collected by filtration, dissolved in about 4 ml of distilled water and neutralized to about pH 8 by adding 10% aqueous sodium hydroxide solution little by little to produce a precipitate. The mixture was refluxed with heating for 1 hour, allowed to cool, and the precipitate was collected by filtration and washed with distilled water, ethanol and diisopropyl ether in this order to obtain 193 mg of the title compound as a colorless powder.
Properties: Colorless powder Melting point:> 270 ° C
1 H NMR (d 6 -DMSO) δ;
1.65 (m, 1H), 1.92 (m, 1H), 7.73 (t, J = 11 Hz, 1H), 8.04 (d, J = 13 Hz, 1H), 838 (m, 1H) ), 8.78 (s, 1H)
〔実施例82〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−7−[(3S)−3−(L−バリルアミノ)ピロリジン−1−イル]−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
N−Boc−L−バリン220mg、N−メチルモルホリン106mgを5mlのジクロロメタンに加え、−20℃にして撹拌しながらクロロ蟻酸イソブチル140μlを加えて20分撹拌した。この液を−60℃に冷却し、エチル−7−[(3S)−3−アミノピロリジン−1−イル]−1−(2,4−ジフルオロ−5−ホルミルアミノフェニル)−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボキシレート475mgを10mlのジクロロメタンに分散して加えた。ゆっくりと室温に戻し、ついで40℃で30分間撹拌した。20mlのクロロホルムと10mlの蒸留水を加えて分液、無水硫酸マグネシウムで乾燥後減圧下に濃縮した。泡状に固まった残渣のの半量を3mlの1規定塩酸3mlのエタノールの混液に加え、100℃で1時間半撹拌した。減圧下に濃縮し、残渣に3mlの1規定塩酸を加え100℃で40分撹拌した。減圧下に濃縮し、残渣を2mlの蒸留水に溶解した。10%水酸化ナトリウム水溶液を少量ずつ加えてpH8程度に中和し、析出物を生成させた。エタノール2mlを加えて30分加熱環流し、放冷、析出物を濾取し、エタノール、ジイソプロピルエーテルの順に洗って141mgの標記化合物を得た。
性状:無色粉末
融点:162−167℃
1HNMR(d6−DMSO)δ;
0.78(d,J=7Hz,3H),0.80(d,J=7Hz,3H),1.71−1.92(m,2H),1.95−2.10(m,1H),2.88(d,J=6Hz,1H),4.32(brs,1H),5.35(s,2H),6.95(t,J=8Hz,1H),7.35(t,J=10Hz,1H),8.06(d,J=)2Hz,1H),8.69(s,1H)
Example 82
1- (3-amino-4,6-difluorophenyl) -6-fluoro-7-[(3S) -3- (L-valylamino) pyrrolidin-1-yl] -1,4-dihydro-4-oxo- 1,8-naphthyridine-3-carboxylic acid:
N-Boc-L-valine (220 mg) and N-methylmorpholine (106 mg) were added to 5 ml of dichloromethane, and the mixture was stirred at −20 ° C. and 140 μl of isobutyl chloroformate was added and stirred for 20 minutes. The solution was cooled to −60 ° C. and ethyl-7-[(3S) -3-aminopyrrolidin-1-yl] -1- (2,4-difluoro-5-formylaminophenyl) -6-fluoro-4 475 mg of -oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate was added dispersed in 10 ml of dichloromethane. The mixture was slowly returned to room temperature and then stirred at 40 ° C. for 30 minutes. 20 ml of chloroform and 10 ml of distilled water were added, and the mixture was separated, dried over anhydrous magnesium sulfate and concentrated under reduced pressure. Half of the foamed residue was added to a mixture of 3 ml of 1N hydrochloric acid and 3 ml of ethanol, and the mixture was stirred at 100 ° C. for 1.5 hours. The mixture was concentrated under reduced pressure, 3 ml of 1N hydrochloric acid was added to the residue, and the mixture was stirred at 100 ° C. for 40 minutes. Concentrated under reduced pressure and the residue was dissolved in 2 ml of distilled water. A 10% aqueous sodium hydroxide solution was added little by little to neutralize to about pH 8 to produce a precipitate. 2 ml of ethanol was added and heated to reflux for 30 minutes, allowed to cool, and the precipitate was collected by filtration and washed with ethanol and diisopropyl ether in this order to obtain 141 mg of the title compound.
Properties: Colorless powder Melting point: 162-167 ° C
1 H NMR (d 6 -DMSO) δ;
0.78 (d, J = 7 Hz, 3H), 0.80 (d, J = 7 Hz, 3H), 1.71-1.92 (m, 2H), 1.95-2.10 (m, 1H) ), 2.88 (d, J = 6 Hz, 1H), 4.32 (brs, 1H), 5.35 (s, 2H), 6.95 (t, J = 8 Hz, 1H), 7.35 ( t, J = 10 Hz, 1H), 8.06 (d, J =) 2 Hz, 1H), 8.69 (s, 1H)
〔実施例83〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−7−[(3S)−3−(L−バリルアミノ)ピロリジン−1−イル]−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸モノメタンスルホン酸塩:
1−(3−アミノ−4,6ジフルオロフェニル)−6−フルオロ−7−[(3S)−3−(L−バリルアミノ)ピロリジン−1−イル]−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸215mgを、24mgのメタンスルホン酸とともに4mlのエタノールに加え、30分加熱環流撹拌した。放冷し、析出物を濾取、エタノール、ジイソプロピルエーテルの順に洗って風乾し、211mgの標記化合物を得た。
性状:無色粉末
融点:>270℃
1HNMR(d6−DMSO)δ;
0.87(d,J=7Hz,6H),1.84−2.18(m,3H),2.31(s,3H),3.45(brs,1H),4.36(brs,1H),5.36(s,2H),6.96(t,J=8Hz,1H),7.32(m,1H),8.06(brs.2H),8.09(d,J=12Hz,1H).8.64(d,J=7Hz,1H),8.71(s,1H)
Example 83
1- (3-amino-4,6-difluorophenyl) -6-fluoro-7-[(3S) -3- (L-valylamino) pyrrolidin-1-yl] -1,4-dihydro-4-oxo- 1,8-naphthyridine-3-carboxylic acid monomethanesulfonate:
1- (3-Amino-4,6 difluorophenyl) -6-fluoro-7-[(3S) -3- (L-valylamino) pyrrolidin-1-yl] -1,4-dihydro-4-oxo-1 , 8-naphthyridine-3-carboxylic acid (215 mg) was added to 4 ml of ethanol together with 24 mg of methanesulfonic acid, and the mixture was heated and refluxed for 30 minutes. The mixture was allowed to cool, and the precipitate was collected by filtration, washed with ethanol and diisopropyl ether in this order and air-dried to obtain 211 mg of the title compound.
Properties: Colorless powder Melting point:> 270 ° C
1 H NMR (d 6 -DMSO) δ;
0.87 (d, J = 7 Hz, 6H), 1.84-2.18 (m, 3H), 2.31 (s, 3H), 3.45 (brs, 1H), 4.36 (brs, 1H), 5.36 (s, 2H), 6.96 (t, J = 8 Hz, 1H), 7.32 (m, 1H), 8.06 (brs.2H), 8.09 (d, J = 12 Hz, 1 H). 8.64 (d, J = 7 Hz, 1H), 8.71 (s, 1H)
〔実施例84〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−7−[(3S)−3−(L−ロイシルアミノ)ピロリジン−1−イル]−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
N−Boc−L−ロイシンを用いたほかは実施例82と同様にして標記化合物を得た。
性状:淡褐色粉末
融点:149−154℃
1HNMR(d6−DMSO)δ;
0.7(d,J=7Hz,3H),0.82(d,J=7Hz,3H),1.14−1.37(m,2H),1.54−1.65(m,1H),1.79−1.94(m,1H),1.95−2.10(m,2H),3.10(t.J=7Hz,1H),4.28(brd,1H),5.35(s,2H),6.96(t,J=8Hz,1H),7.34(t,J=10Hz,1H),8.05(d,J=12Hz,1H),8.69(s,1H)
Example 84
1- (3-amino-4,6-difluorophenyl) -6-fluoro-7-[(3S) -3- (L-leucylamino) pyrrolidin-1-yl] -1,4-dihydro-4-oxo- 1,8-naphthyridine-3-carboxylic acid:
The title compound was obtained in the same manner as in Example 82 except that N-Boc-L-leucine was used.
Property: Light brown powder Melting point: 149-154 ° C
1 H NMR (d 6 -DMSO) δ;
0.7 (d, J = 7 Hz, 3H), 0.82 (d, J = 7 Hz, 3H), 1.14-1.37 (m, 2H), 1.54-1.65 (m, 1H) ), 1.79-1.94 (m, 1H), 1.95-2.10 (m, 2H), 3.10 (t.J = 7 Hz, 1H), 4.28 (brd, 1H), 5.35 (s, 2H), 6.96 (t, J = 8 Hz, 1H), 7.34 (t, J = 10 Hz, 1H), 8.05 (d, J = 12 Hz, 1H), 8. 69 (s, 1H)
〔実施例85〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3−メチルアミノピペリジノ)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
3−メチルアミノピベリジン・二塩酸塩を用いたほかは実施例48と同様にして標記化合物を得た。
性状:淡褐色粉末
融点:240−242℃(分解)
1HNMR(d6−DMSO)δ;
1.23−1.46(m,2H),1.62−1.87(m,2H),2.11(d,J=9Hz,3H),3.82−4.18(m,2H),5.36(s,2H),6.98(t,J=7Hz,1H),7.39(m,1H),8.09(d,J=14Hz,1H),8.71(s,1H)
Example 85
1- (3-Amino-4,6-difluorophenyl) -7- (3-methylaminopiperidino) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carvone acid:
The title compound was obtained in the same manner as in Example 48 except that 3-methylaminopiberidine dihydrochloride was used.
Property: Light brown powder Melting point: 240-242 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.23-1.46 (m, 2H), 1.62-1.87 (m, 2H), 2.11 (d, J = 9 Hz, 3H), 3.82-4.18 (m, 2H) ), 5.36 (s, 2H), 6.98 (t, J = 7 Hz, 1H), 7.39 (m, 1H), 8.09 (d, J = 14 Hz, 1H), 8.71 ( s, 1H)
〔実施例86〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3−メチルアミノピペリジン−1−イル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
3−メチルアミノピペリジン・二塩酸塩を用いたほかは実施例60と同様にして標記化合物を得た。
性状:無色粉末
融点:254−258℃(分解)
1HNMR(d6−DMSO)δ;
1.62(m.2H),1.85(m,1H),1.99(m,1H),2.55(s,3H),2.91(m,1H),5.58(s,2H),6.52(d,J=7Hz,1H),7.08(t,J=8Hz,1H),7.52(t,J=10Hz,1H),8.02(d,J=13Hz,1H),8.76(s,1H)
Example 86
1- (3-Amino-4,6-difluorophenyl) -7- (3-methylaminopiperidin-1-yl) -6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid:
The title compound was obtained in the same manner as in Example 60 except that 3-methylaminopiperidine dihydrochloride was used.
Properties: colorless powder Melting point: 254-258 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.62 (m.2H), 1.85 (m, 1H), 1.99 (m, 1H), 2.55 (s, 3H), 2.91 (m, 1H), 5.58 (s , 2H), 6.52 (d, J = 7 Hz, 1H), 7.08 (t, J = 8 Hz, 1H), 7.52 (t, J = 10 Hz, 1H), 8.02 (d, J = 13Hz, 1H), 8.76 (s, 1H)
〔実施例87〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−ピペラジノ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
ピペラジンを用いたほかは実施例48と同様にして標記化合物を得た。
性状:淡褐色粉末
融点:174−184℃(分解)
1HNMR(d6−DMSO)δ;
2.69(m,4H),3.56(m,4H),5.37(s,2H),6 98(t,J=7Hz,1H),7.37(t.J=10Hz,1H),8.11(d,J=13Hz,1H),8.73(s,1H)
Example 87
1- (3-Amino-4,6-difluorophenyl) -7-piperazino-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid:
The title compound was obtained in the same manner as in Example 48 except that piperazine was used.
Properties: Light brown powder Melting point: 174-184 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
2.69 (m, 4H), 3.56 (m, 4H), 5.37 (s, 2H), 698 (t, J = 7Hz, 1H), 7.37 (t.J = 10Hz, 1H) ), 8.11 (d, J = 13 Hz, 1H), 8.73 (s, 1H)
〔実施例88〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3,5−ジメチルピペラジノ)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
ピペラジンを用いたほかは実施例48と同様にして標記化合物を得た。
性状:淡褐色粉末
融点:251−256℃(分解)
1HNMR(d6−DMSO)δ;
0.96(brs,6H),2.57−2.90(m,4H),4.08(m,2H),5.39(brs,2H),6.98(t,J=8Hz,1H),7.41(t,J=11Hz,1H),8.16(d,J=13Hz,1H),8.78(s,1H)
Example 88
1- (3-Amino-4,6-difluorophenyl) -7- (3,5-dimethylpiperazino) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3- carboxylic acid:
The title compound was obtained in the same manner as in Example 48 except that piperazine was used.
Property: Light brown powder Melting point: 251-256 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
0.96 (brs, 6H), 2.57-2.90 (m, 4H), 4.08 (m, 2H), 5.39 (brs, 2H), 6.98 (t, J = 8 Hz, 1H), 7.41 (t, J = 11 Hz, 1H), 8.16 (d, J = 13 Hz, 1H), 8.78 (s, 1H)
〔実施例89〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−ピペラジノ−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
ピペラジンを用いたほかは実施例60と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:192−200℃
1HNMR(d6−DMSO)δ;
3.14(m.4H),3.25(m,4H),5.58(brs,2H),6.48(d,J=7Hz,1H),7.08(t,J=8Hz,1H),7.51(t,J=10Hz,1H),8.02(d,J=13Hz,1H),8.75(s,1H)
Example 89
1- (3-Amino-4,6-difluorophenyl) -7-piperazino-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid:
The title compound was obtained in the same manner as in Example 60 except that piperazine was used.
Property: Pale yellow powder Melting point: 192-200 ° C
1 H NMR (d 6 -DMSO) δ;
3.14 (m.4H), 3.25 (m, 4H), 5.58 (brs, 2H), 6.48 (d, J = 7 Hz, 1H), 7.08 (t, J = 8 Hz, 1H), 7.51 (t, J = 10 Hz, 1H), 8.02 (d, J = 13 Hz, 1H), 8.75 (s, 1H)
〔実施例90〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3−メチルピペラジノ)−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸 2塩酸塩:
3−メチルピペラジン35mg、トリエチルアミン120mgをジメチルスルホキシド1mlに加え、10分撹拌し、1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸80mgを加え、100℃で2時間加熱撹拌した。放冷後、反応液にジエチルエーテルを加え、上澄みを除いた。残渣にエタノール、塩酸を加え、室温で30分撹拌した。溶液を減圧濃縮し、残渣にジエチルエーテルを加え、固体を濾取し、ジエチルエーテルで洗浄した。30mgの標記化合物を得た。
性状:淡黄色粉末
融点:206−213℃(分解)
1HNMR(d6−DMSO)δ;
1.26(d,J=7Hz,3H),2.85−3.02(m,1H),6.51(d,J=7Hz,1H),7.08(t,J=8Hz,1H),7.52(t,J=10Hz,1H),8.04(d,J=13Hz,1H),8.76(s,1H)
Example 90
1- (3-Amino-4,6-difluorophenyl) -7- (3-methylpiperazino) -6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid dihydrochloride:
35 mg of 3-methylpiperazine and 120 mg of triethylamine were added to 1 ml of dimethyl sulfoxide, stirred for 10 minutes, and 1- (3-amino-4,6-difluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxo. -80 mg of quinoline-3-carboxylic acid was added, and it heated and stirred at 100 degreeC for 2 hours. After allowing to cool, diethyl ether was added to the reaction solution, and the supernatant was removed. Ethanol and hydrochloric acid were added to the residue, and the mixture was stirred at room temperature for 30 minutes. The solution was concentrated under reduced pressure, diethyl ether was added to the residue, and the solid was collected by filtration and washed with diethyl ether. 30 mg of the title compound were obtained.
Properties: Pale yellow powder Melting point: 206-213 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.26 (d, J = 7 Hz, 3H), 2.85-3.02 (m, 1H), 6.51 (d, J = 7 Hz, 1H), 7.08 (t, J = 8 Hz, 1H) ), 7.52 (t, J = 10 Hz, 1H), 8.04 (d, J = 13 Hz, 1H), 8.76 (s, 1H)
〔実施例91〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3,5−ジメチルピペラジノ)−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
3,5−ジメチルピペラジンを用いたほかは実施例60と同様にして標記化合物を得た。
性状:無色粉末
融点:202−210℃(分解)
1HNMR(d6−DMSO)δ;
1.17(brs,6H),2.74(m,1H),3.54(m,2H),5.57(s,2H),6.50(d,J=7Hz,1H),7.08(t,J=8Hz,1H),7.52(t,J=10Hz,1H),8.02(d,J=13Hz,1H),8.75(s,1H)
Example 91
1- (3-Amino-4,6-difluorophenyl) -7- (3,5-dimethylpiperazino) -6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid:
The title compound was obtained in the same manner as in Example 60 except that 3,5-dimethylpiperazine was used.
Properties: colorless powder Melting point: 202-210 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.17 (brs, 6H), 2.74 (m, 1H), 3.54 (m, 2H), 5.57 (s, 2H), 6.50 (d, J = 7 Hz, 1H), 7 .08 (t, J = 8 Hz, 1H), 7.52 (t, J = 10 Hz, 1H), 8.02 (d, J = 13 Hz, 1H), 8.75 (s, 1H)
〔実施例92〕
1−(3−アミノ−6−クロロ−4−フルオロフェニル)−6−フルオロ−7−ピペラジノ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−6−クロロ−4−フルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸100mgをジメチルスルホキシド8mlに溶解し、ピペラジン120mgを加え、1時間30分80℃で撹拌した。反応液にジエチルエーテルを加え、デカンテーションを2回繰り返した。残渣に少量のエタノールを加えて、10分間還流後、析出した固体を濾取しジエチルエーテルで洗い19mgの標記化合物を得た。
性状:茶褐色粉末
融点:190℃(分解)
1HNMR(d6−DMSO)δ;
2.88(s,4H),3.65(s,4H),5.72(s,2H),7.01(d,J=5Hz,1H),7.46(d,J=11Hz,1H),8.17(d,J=13Hz,1H),8.71(s,1H)
Example 92
1- (3-Amino-6-chloro-4-fluorophenyl) -6-fluoro-7-piperazino-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid:
100 mg of 1- (3-amino-6-chloro-4-fluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid was added to 8 ml of dimethyl sulfoxide. Into the solution, 120 mg of piperazine was added and stirred at 80 ° C. for 1 hour 30 minutes. Diethyl ether was added to the reaction solution, and decantation was repeated twice. A small amount of ethanol was added to the residue, and after refluxing for 10 minutes, the precipitated solid was collected by filtration and washed with diethyl ether to obtain 19 mg of the title compound.
Properties: Brown powder Melting point: 190 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
2.88 (s, 4H), 3.65 (s, 4H), 5.72 (s, 2H), 7.01 (d, J = 5 Hz, 1H), 7.46 (d, J = 11 Hz, 1H), 8.17 (d, J = 13 Hz, 1H), 8.71 (s, 1H)
〔実施例93〕
1−(3−アミノ−6−クロロ−4−フルオロフェニル)−6−フルオロ−7−ピペラジノ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
1−(3−アミノ−6−クロロ−4−フルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸を用いたほかは実施例92と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:228−237℃
1HNMR(d6−DMSO)δ;
2.81(s,4H),5.91(brs,2H),6.30(d,J=7Hz,1H),7.10(d,J=10Hz,1H),7.61(d,J=11Hz,1H),7.97(d,J=12Hz,1H),8.69(s,1H)
Example 93
1- (3-Amino-6-chloro-4-fluorophenyl) -6-fluoro-7-piperazino-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid:
Example 92 with the exception that 1- (3-amino-6-chloro-4-fluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid was used In the same manner, the title compound was obtained.
Properties: Pale yellow powder Melting point: 228-237 ° C
1 H NMR (d 6 -DMSO) δ;
2.81 (s, 4H), 5.91 (brs, 2H), 6.30 (d, J = 7 Hz, 1H), 7.10 (d, J = 10 Hz, 1H), 7.61 (d, J = 11 Hz, 1H), 7.97 (d, J = 12 Hz, 1H), 8.69 (s, 1H)
〔実施例94〕
1−(3−アミノ−4−クロロ−6−フルオロフェニル)−6−フルオロ−7−ピペラジノ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−4−クロロ−6−フルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸を用いたほかは実施例92と同様にして標記化合物を得た。
性状:黄褐色粉末
融点:270℃
1HNMR(d6−DMSO)δ;
2.87(brs,4H),5.59(brs,2H),7.00(d,J=7Hz,1H),7.55(d,J=10Hz,1H),8.12(d,J=13Hz,1H),8.75(s,1H)
Example 94
1- (3-Amino-4-chloro-6-fluorophenyl) -6-fluoro-7-piperazino-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid:
Except that 1- (3-amino-4-chloro-6-fluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid was used The title compound was obtained in the same manner as in Example 92.
Properties: Yellowish brown powder Melting point: 270 ° C
1 H NMR (d 6 -DMSO) δ;
2.87 (brs, 4H), 5.59 (brs, 2H), 7.00 (d, J = 7 Hz, 1H), 7.55 (d, J = 10 Hz, 1H), 8.12 (d, J = 13 Hz, 1H), 8.75 (s, 1H)
〔実施例95〕
1−(3−アミノ−4−フルオロ−6−メチルフェニル)−6−フルオロ−7−ピペラジノ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−4−フルオロ−6−メチルフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸を用いたほかは実施例92と同様にして標記化合物を得た。
性状:黄褐色粉末
融点:239℃(分解)
1HNMR(d6−DMSO)δ;
1.08(s,3H),2.68(brs,4H),3.48(brs,4H),5.28(brs,2H),6.77(d,J=8Hz,1H),7.09(d,J=12Hz,1H),8.11(d,J=14Hz,1H),8 55(s,1H)
Example 95
1- (3-Amino-4-fluoro-6-methylphenyl) -6-fluoro-7-piperazino-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid:
Except that 1- (3-amino-4-fluoro-6-methylphenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid was used The title compound was obtained in the same manner as in Example 92.
Properties: Yellowish brown powder Melting point: 239 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.08 (s, 3H), 2.68 (brs, 4H), 3.48 (brs, 4H), 5.28 (brs, 2H), 6.77 (d, J = 8 Hz, 1H), 7 .09 (d, J = 12 Hz, 1H), 8.11 (d, J = 14 Hz, 1H), 855 (s, 1H)
〔実施例96〕
1−(3−アミノ−2,4−ジフルオロフェニル)−7−[(3S)−3−(ホルミルアミノ)ピロリジン−1−イル]−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−2,4−ジフルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸210mg、蟻酸40mgを600mgのN,N−ジメチルホルムアミドに加え、120℃で一時間撹拌した。8mlのジイソプロピルエーテルを加えて撹拌後静置し、上澄をデカンテーションで除いた。ついて2mlのエタノールを加えて20分間加熱環流した後放冷し、析出物を濾取、エタノール、ジイソプロピルエーテルの順に洗って、180mgの標記化合物を得た。
性状:淡褐色粉末
融点:214−216℃
1HNMR(d6−DMSO)δ;
1.83(m,1H),2.09(m,1H),4.36(m,1H),5.36(s,1H),6.96(t,J=8Hz,1H),7.36(t,J=10Hz,1H),7.96(d,J=4Hz,1H),8.07(d,J=13Hz,1H),8.38(m,1H),8.70(s,1H)
Example 96
1- (3-amino-2,4-difluorophenyl) -7-[(3S) -3- (formylamino) pyrrolidin-1-yl] -6-fluoro-4-oxo-1,4-dihydro-1 , 8-Naphthyridine-3-carboxylic acid:
1- (3-amino-2,4-difluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6-fluoro-4-oxo-1,4-dihydro-1,8- Naphthyridine-3-carboxylic acid (210 mg) and formic acid (40 mg) were added to 600 mg of N, N-dimethylformamide, and the mixture was stirred at 120 ° C. for 1 hour. 8 ml of diisopropyl ether was added and the mixture was stirred and allowed to stand, and the supernatant was removed by decantation. Subsequently, 2 ml of ethanol was added and heated to reflux for 20 minutes, and then allowed to cool. The precipitate was collected by filtration and washed with ethanol and diisopropyl ether in this order to obtain 180 mg of the title compound.
Properties: Light brown powder Melting point: 214-216 ° C
1 H NMR (d 6 -DMSO) δ;
1.83 (m, 1H), 2.09 (m, 1H), 4.36 (m, 1H), 5.36 (s, 1H), 6.96 (t, J = 8 Hz, 1H), 7 .36 (t, J = 10 Hz, 1H), 7.96 (d, J = 4 Hz, 1H), 8.07 (d, J = 13 Hz, 1H), 8.38 (m, 1H), 8.70 (S, 1H)
〔参考例6〕
エチル 8−クロロ−6,7−ジフルオロ−1−(2,4−ジフルオロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 3−クロロ−2,4,5−トリフルオロベンゾイルアセテート5gをオルトぎ酸エチル3.9g、無水酢酸5.5gに加え、3時間加熱還流した。放冷後、減圧濃縮し、残渣にクロロホルム20ml加え、氷冷下、2,4−ジフルオロアニリン2.3ml滴下し、滴下終了後、室温で2時間撹拌した。反応液を減圧濃縮し、残渣にヘキサンを加え、固体を濾取し、エチル 2−(3−クロロ−2,4,5,6−テトラフルオロベンゾイル)−3−(2,4−ジフルオロアミノ)アクリレートを得た。このエチル2−(3−クロロ−2,4,5,6−テトラフルオロベンゾイル)−3−(2,4−ジフルオロアミノ)アクリレート6.3gに炭酸カリウム2.5g、N,N−ジメチルホルムアミド20mlを加え、90℃で1時間加熱撹拌した。放冷後、氷水に反応液を注ぎ析出物を濾取し、水で洗浄した。析出物をクロロホルムに溶解させ、水で洗浄した。硫酸マグネシウムで乾燥後、減圧濃縮し、残渣にジエチルエーテルを加え固体を濾取し、エタノール、ジエチルエーテルで洗い、5.1gの標記化合物を得た。
性状:無色粉末
融点:211−212℃
1HNMR(CDCl3)δ;
1.40(t,J=7Hz,3H),4.40(q,J=7Hz,2H),7.02−7.12(m,2H),7.44(m,1H),8.31−8.37(m,1H),8.33(s,1H)
[Reference Example 6]
Ethyl 8-chloro-6,7-difluoro-1- (2,4-difluorophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate:
5 g of ethyl 3-chloro-2,4,5-trifluorobenzoyl acetate was added to 3.9 g of ethyl orthoformate and 5.5 g of acetic anhydride, and the mixture was heated to reflux for 3 hours. After allowing to cool, the mixture was concentrated under reduced pressure, 20 ml of chloroform was added to the residue, 2.3 ml of 2,4-difluoroaniline was added dropwise under ice cooling, and the mixture was stirred at room temperature for 2 hours. The reaction mixture was concentrated under reduced pressure, hexane was added to the residue, the solid was collected by filtration, and ethyl 2- (3-chloro-2,4,5,6-tetrafluorobenzoyl) -3- (2,4-difluoroamino) was collected. Acrylates were obtained. To 6.3 g of this ethyl 2- (3-chloro-2,4,5,6-tetrafluorobenzoyl) -3- (2,4-difluoroamino) acrylate, 2.5 g of potassium carbonate and 20 ml of N, N-dimethylformamide And heated and stirred at 90 ° C. for 1 hour. After allowing to cool, the reaction solution was poured into ice water, and the precipitate was collected by filtration and washed with water. The precipitate was dissolved in chloroform and washed with water. After drying over magnesium sulfate and concentration under reduced pressure, diethyl ether was added to the residue and the solid was collected by filtration and washed with ethanol and diethyl ether to obtain 5.1 g of the title compound.
Property: Colorless powder Melting point: 211-212 ° C
1 H NMR (CDCl 3 ) δ;
1.40 (t, J = 7 Hz, 3H), 4.40 (q, J = 7 Hz, 2H), 7.02-7.12 (m, 2H), 7.44 (m, 1H), 8. 31-8.37 (m, 1H), 8.33 (s, 1H)
〔参考例7〕
エチル 5,6,7,8−テトラフルオロ−1−(2,4−ジフルオロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 2,3,4,5,6−ペンタフルオロベンゾイルアセテートを用いたほかは参考例6と同様にして標記化合物を得た。
性状:無色粉末
融点:172−173℃
1HNMR(CDCl3)δ;
1.38(t.J=7Hz,3H),4.37(q,J=7Hz,2H),7.08(m,2H),7.50(m,1H),8.18(s,1H)
[Reference Example 7]
Ethyl 5,6,7,8-tetrafluoro-1- (2,4-difluorophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate:
The title compound was obtained in the same manner as in Reference Example 6 except that ethyl 2,3,4,5,6-pentafluorobenzoyl acetate was used.
Property: Colorless powder Melting point: 172-173 ° C
1 H NMR (CDCl 3 ) δ;
1.38 (t.J = 7 Hz, 3H), 4.37 (q, J = 7 Hz, 2H), 7.08 (m, 2H), 7.50 (m, 1H), 8.18 (s, 1H)
〔参考例8〕
N−エトキシカルボニル−2,4−ジフルオロ−m−フェニレンジアミン メタンスルホン酸塩:
濃硫酸500mlに2,4−ジフルオロ安息香酸151gを加え氷冷撹拌しながら硝酸カリウムの粉末114gを30分かけて少量ずつ加えた。そのまま1時間撹拌を続けるとシャーベット状に析出物を生じた。1.5lの氷水に加えて30分間撹拌した後析出物を濾取、1lの蒸留水で洗った後、風乾ついで五酸化りん上で減圧下に乾燥し164.5gの2,4−ジフルオロ−5−ニトロ安息香酸を無色結晶として得た。
2,4−ジフルオロ−5−ニトロ安息香酸6.1gを20mlのジクロロメタンに加え、オギザリルクロリド3ml、N,N−ジメチルホルムアミド4滴を加えて、2時間撹拌したのち溶媒および過剰の試薬を減圧下留去した。残渣を6mlのジクロロメタンに溶かし、ソジウムアジド2.1gを5mlのN,N−ジメチルホルムアミドに加えて氷冷下撹拌している中に滴下した。そのまま10分間、ついで室温に戻して5分間撹拌したのち、45mlのエチルエーテル15mlのn−ヘキサン、100mlの蒸留水を加えて振とう後分液した。有機層を100mlの蒸留水で洗ったのち、無水硫酸マグネシウムで乾燥後減圧下に濃縮した。残渣の3分の2を分け取ってエタノール6mlを加え80℃の湯浴中で2時間加熱して、粗製のN−エトキシカルボニル−2,4−ジフルオロ−5−ニトロアニリンのエタノール溶液を得た。
上記溶液に14mlのエタノールを追加し、2.0gのメタンスルホン酸、0.2gの10%パラジウム炭素を加えて一晩(15時間)室温で水素添加した。析出物があったので20mlのメタノールを加えてとかし触媒を濾別した。濾液を減圧下に濃縮し析出した鱗片状晶を濾取、エタノールとジイソプロピルエーテルの混液で洗って4.0gの微赤色結晶として標記化合物を得た。
[Reference Example 8]
N-ethoxycarbonyl-2,4-difluoro-m-phenylenediamine methanesulfonate:
To 500 ml of concentrated sulfuric acid, 151 g of 2,4-difluorobenzoic acid was added, and 114 g of potassium nitrate powder was added little by little over 30 minutes while stirring with ice cooling. When stirring was continued for 1 hour, a precipitate was formed in a sherbet shape. The mixture was added to 1.5 l of ice water and stirred for 30 minutes. The precipitate was collected by filtration, washed with 1 l of distilled water, air-dried and dried under reduced pressure over phosphorus pentoxide, and 164.5 g of 2,4-difluoro- 5-Nitrobenzoic acid was obtained as colorless crystals.
6.1 g of 2,4-difluoro-5-nitrobenzoic acid was added to 20 ml of dichloromethane, 3 ml of oxalyl chloride and 4 drops of N, N-dimethylformamide were added, and the mixture was stirred for 2 hours. The bottom distilled off. The residue was dissolved in 6 ml of dichloromethane, and 2.1 g of sodium azide was added to 5 ml of N, N-dimethylformamide and added dropwise while stirring under ice-cooling. After stirring for 10 minutes and then returning to room temperature and stirring for 5 minutes, 45 ml of ethyl ether, 15 ml of n-hexane and 100 ml of distilled water were added, and the mixture was separated after shaking. The organic layer was washed with 100 ml of distilled water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. Two-thirds of the residue was separated, 6 ml of ethanol was added, and the mixture was heated in a hot water bath at 80 ° C. for 2 hours to obtain a crude ethanol solution of N-ethoxycarbonyl-2,4-difluoro-5-nitroaniline. .
14 ml of ethanol was added to the above solution, 2.0 g of methanesulfonic acid and 0.2 g of 10% palladium carbon were added, and hydrogenated overnight (15 hours) at room temperature. Since there was a precipitate, 20 ml of methanol was added and the catalyst was removed by filtration. The filtrate was concentrated under reduced pressure, and the precipitated scaly crystals were collected by filtration and washed with a mixture of ethanol and diisopropyl ether to obtain 4.0 g of the title compound as slightly red crystals.
〔参考例9〕
N−ベンジルオキシカルボニル−2,4−ジフルオロ−m−フェニレンジアミン:
2,4−ジフルオロ−5−ニトロ安息香酸20.3gを60mlのジクロロメタンに加え、オギザリルクロリド10ml、N,N−ジメチルホルムアミド15滴を加えて、一晩撹拌したのち溶媒および過剰の試薬を減圧下留去した。残渣を30mlのジクロロメタンに溶かし15mlのN,N−ジメチルホルムアミドに加えて氷冷下撹拌している中に、ソジウムアシド7.5gを少量ずつ加えた。そのまま10分間、ついで室温に戻して10分間撹拌したのち、100mlのエチルエーテル50mlのn−ヘキサン、400mlの蒸留水を加えて振とう後分液した。有機層を400mlの蒸留水で2回洗ったのち、無水硫酸マグネシウムで乾燥後減圧下に濃縮した。ベンジルアルコール12.0gを加え、減圧下に濃縮し150mlのトルエンを加えて40℃の湯浴中で2時間加熱、60℃の湯浴中で25時間加熱、100℃の湯浴中で1時間加熱したのち減圧下に濃縮し、ゆっくりと固形化する残渣として粗製のN−ベンジルオキシカルボニル−2,4−ジフルオロ−5−ニトロアニリン得た。
鉄粉84gを300mlの蒸留水、200mlのエタノールの混液に加え、80℃で撹拌している中に7mlの濃塩酸を少量ずつ加えたのち5分間撹拌した。ついで上記のN−ベンジルオキシカルボニル−2,4−ジフルオロ−5−ニトロアニリンの全量を100mlのエタノールに溶かしておだやかに環流する程度に少量ずつ加えたのち、80℃15分間撹拌した。500mlのベンゼンを加え5分間撹拌した。鉄粉を濾別し、エタノールで洗ったのち200mlの蒸留水を加え、振とう分液した。有機層を無水硫酸マグネシウムで乾燥後、短いシリカゲル粉末の層を通して減圧下に濃縮した。析出した無色の鱗片状晶をジイソプロピルエーテルに分散して濾取し、標記化合物を18.2g得た。
[Reference Example 9]
N-benzyloxycarbonyl-2,4-difluoro-m-phenylenediamine:
20.3 g of 2,4-difluoro-5-nitrobenzoic acid was added to 60 ml of dichloromethane, 10 ml of oxalyl chloride and 15 drops of N, N-dimethylformamide were added, and the mixture was stirred overnight. The bottom was distilled off. The residue was dissolved in 30 ml of dichloromethane, added to 15 ml of N, N-dimethylformamide and stirred under ice-cooling, and 7.5 g of sodium acid was added little by little. After stirring for 10 minutes and then returning to room temperature and stirring for 10 minutes, 100 ml of ethyl ether, 50 ml of n-hexane and 400 ml of distilled water were added, and the mixture was separated after shaking. The organic layer was washed twice with 400 ml of distilled water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. Add 12.0 g of benzyl alcohol, concentrate under reduced pressure, add 150 ml of toluene, heat in a 40 ° C hot water bath for 2 hours, heat in a 60 ° C hot water bath for 25 hours, and in a 100 ° C hot water bath for 1 hour. After heating, the mixture was concentrated under reduced pressure to obtain crude N-benzyloxycarbonyl-2,4-difluoro-5-nitroaniline as a residue that slowly solidified.
84 g of iron powder was added to a mixed solution of 300 ml of distilled water and 200 ml of ethanol, 7 ml of concentrated hydrochloric acid was added little by little while stirring at 80 ° C., and the mixture was stirred for 5 minutes. Next, the whole amount of the above N-benzyloxycarbonyl-2,4-difluoro-5-nitroaniline was dissolved in 100 ml of ethanol and added little by little to gently reflux, followed by stirring at 80 ° C. for 15 minutes. 500 ml of benzene was added and stirred for 5 minutes. The iron powder was filtered off, washed with ethanol, 200 ml of distilled water was added, and the solution was separated by shaking. The organic layer was dried over anhydrous magnesium sulfate and then concentrated under reduced pressure through a layer of short silica gel powder. The precipitated colorless scaly crystals were dispersed in diisopropyl ether and collected by filtration to obtain 18.2 g of the title compound.
〔実施例97〕
エチル 8−クロロ−6,7−ジフルオロ−1−(2,4−ジフルオロ−5−ニトロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 8−クロロ−6,7−ジフルオロ−1−(2,4−ジフルオロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート2.5gを硫酸15mlに加え、氷冷下、硝酸カリウム950mgを少しずつ加え、室温で一晩撹拌した。氷水に反応液を注ぎ、室温で一晩撹拌した。析出物を濾取し、水、エタノール、ジエチルエーテルで洗浄した。2.4gの標記化合物を得た。
性状:無色粉末
融点:209−210℃
1HNMR(CDCl3)δ;
1.40(t,J=7Hz,3H),4.40(q,J=7Hz,2H),7.43(t,J=9Hz,1H),8.30(s,1H),8.36(m,2H)
Example 97
Ethyl 8-chloro-6,7-difluoro-1- (2,4-difluoro-5-nitrophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate:
Ethyl 8-chloro-6,7-difluoro-1- (2,4-difluorophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate (2.5 g) was added to 15 ml of sulfuric acid. 950 mg of potassium nitrate was added little by little, and the mixture was stirred overnight at room temperature. The reaction solution was poured into ice water and stirred overnight at room temperature. The precipitate was collected by filtration and washed with water, ethanol and diethyl ether. 2.4 g of the title compound was obtained.
Properties: Colorless powder Melting point: 209-210 ° C
1 H NMR (CDCl 3 ) δ;
1.40 (t, J = 7 Hz, 3H), 4.40 (q, J = 7 Hz, 2H), 7.43 (t, J = 9 Hz, 1H), 8.30 (s, 1H), 8. 36 (m, 2H)
〔実施例98〕
エチル 8−クロロ−6,7−ジフルオロ−1−(2,4−ジフルオロ−5−ホルミルアミノフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 8−クロロ−6,7−ジフルオロ−1−(2,4−ジフルオロ−5−ニトロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート2g、10%パラジウム炭素200mgをジクロロエタン20ml、ぎ酸10mlに加え、水素気流下、室温で3時間撹拌し、無水酢酸を加えさらに一晩撹拌した。メンブランフィルターで触媒を濾去し、濾液を減圧濃縮した。残渣にジエチルエーテルを加え、固体を濾取し、エタノール、ジエチルエーテルで洗浄し、1.9gの標記化合物を得た。
性状:黄色粉末
融点:223−229℃
1HNMR(d6−DMSO)δ;
1.27(t,J=7Hz,3H),4.23(q,J=7Hz,2H),7.76(t,J=10Hz,1H),8.23(t,J=10Hz,1H),8.33(s,1H),8.47−8.60(m,1H),8.51(S,1H)
Example 98
Ethyl 8-chloro-6,7-difluoro-1- (2,4-difluoro-5-formylaminophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate:
Ethyl 8-chloro-6,7-difluoro-1- (2,4-difluoro-5-nitrophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate 2 g, 200 mg palladium carbon 200 mg in dichloroethane The mixture was added to 20 ml and 10 ml of formic acid, and stirred at room temperature for 3 hours under a hydrogen stream. Acetic anhydride was added and the mixture was further stirred overnight. The catalyst was removed by filtration with a membrane filter, and the filtrate was concentrated under reduced pressure. Diethyl ether was added to the residue, and the solid was collected by filtration and washed with ethanol and diethyl ether to obtain 1.9 g of the title compound.
Property: Yellow powder Melting point: 223-229 ° C
1 H NMR (d 6 -DMSO) δ;
1.27 (t, J = 7 Hz, 3H), 4.23 (q, J = 7 Hz, 2H), 7.76 (t, J = 10 Hz, 1H), 8.23 (t, J = 10 Hz, 1H) ), 8.33 (s, 1H), 8.47-8.60 (m, 1H), 8.51 (S, 1H)
〔実施例99〕
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
エチル 8−クロロ−6,7−ジフルオロ−1−(2,4−ジフルオロ−5−ホルミルアミノフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート1.8gを塩酸5ml、酢酸20mlに加え、3時間加熱還流した。放冷後、減圧濃縮し、残渣にエタノールを加え固体を濾取し、ジエチルエーテルで洗浄した。1.4gの標記化合物を得た。
性状:淡黄色粉末
融点:225−226.5℃
1HNMR(d6−DMSO)δ;
7.09(t,J=8Hz,1H),7.43(t,J=11Hz,1H),8.40(t,J=9Hz,1H),8.69(s.1H)
Example 99
1- (3-Amino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
1.8 g of ethyl 8-chloro-6,7-difluoro-1- (2,4-difluoro-5-formylaminophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate was added to 5 ml of hydrochloric acid and acetic acid. The mixture was added to 20 ml and heated to reflux for 3 hours. After allowing to cool, the mixture was concentrated under reduced pressure, ethanol was added to the residue, and the solid was collected by filtration and washed with diethyl ether. 1.4 g of the title compound was obtained.
Properties: Pale yellow powder Melting point: 225-226.5 ° C
1 H NMR (d 6 -DMSO) δ;
7.09 (t, J = 8 Hz, 1H), 7.43 (t, J = 11 Hz, 1H), 8.40 (t, J = 9 Hz, 1H), 8.69 (s.1H)
〔実施例100〕
エチル 5−ベンジルオキシ−1−(3−エトキシカルボニルアミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 2−ベンシルオキシ−3,4,6−トリフルオロベンソイルアセテート1.35gをオルトぎ酸エチル860mg、無水酢酸1.2gに加え4時間加熱撹拌した。放冷後、反応液を減圧濃縮した。残渣にクロロホルム20ml加え、氷冷下、参考例8のN−エトキシカルボニル−2,4−ジフルオロ−m−フェニレンジアミン メタンスルホン酸塩1.2g、トリエチルアミン0.51mlのメタノール20ml溶液を滴下した。滴下終了後、室温で2時間撹拌した。反応液を減圧濃縮し、残渣に炭酸カリウム630mg、N,N−ジメチルホルムアミド5ml加え、90℃で1時間加熱撹拌した。放冷後、反応液を氷水に加え、析出した固体を濾取し、この固体をクロロホルムに溶かし、有機層を分取した。硫酸マグネシウムで乾燥後、溶媒を留去した。残渣にエタノール、ジエチルエーテルを加え固体を濾取し、ジエチルエーテルで洗浄した。1.2gの標記化合物を得た。
性状:黄色粉末
融点:130−134℃
1HNMR(CDCl3)δ;
1.33(t,J=7Hz,3H),1.38(t, J=7Hz,3H),4.26(q,J=7Hz,2H),4.38(q,J=7Hz,2H),5.32(s,2H),6.41(m,1H),6.97(d,J=3Hz,1H),7.19(dd,J=9Hz,10Hz,1H),7,26−7.42(m,3H),7.64(m,2H),8.25(s,1H),8.38(t,J=8Hz,1H)
Example 100
Ethyl 5-benzyloxy-1- (3-ethoxycarbonylamino-4,6-difluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate:
Ethyl 2-benzyloxy-3,4,6-trifluorobenzoyl acetate (1.35 g) was added to ethyl orthoformate (860 mg) and acetic anhydride (1.2 g), and the mixture was heated and stirred for 4 hours. After allowing to cool, the reaction solution was concentrated under reduced pressure. 20 ml of chloroform was added to the residue, and a solution of 1.2 g of N-ethoxycarbonyl-2,4-difluoro-m-phenylenediamine methanesulfonate of Reference Example 8 and 0.51 ml of triethylamine in 20 ml of methanol was added dropwise under ice cooling. After completion of dropping, the mixture was stirred at room temperature for 2 hours. The reaction solution was concentrated under reduced pressure, and 630 mg of potassium carbonate and 5 ml of N, N-dimethylformamide were added to the residue, followed by heating and stirring at 90 ° C. for 1 hour. After allowing to cool, the reaction solution was added to ice water, the precipitated solid was collected by filtration, this solid was dissolved in chloroform, and the organic layer was separated. After drying with magnesium sulfate, the solvent was distilled off. Ethanol and diethyl ether were added to the residue, and the solid was collected by filtration and washed with diethyl ether. 1.2 g of the title compound was obtained.
Property: Yellow powder Melting point: 130-134 ° C
1 H NMR (CDCl 3 ) δ;
1.33 (t, J = 7 Hz, 3H), 1.38 (t, J = 7 Hz, 3H), 4.26 (q, J = 7 Hz, 2H), 4.38 (q, J = 7 Hz, 2H) ), 5.32 (s, 2H), 6.41 (m, 1H), 6.97 (d, J = 3 Hz, 1H), 7.19 (dd, J = 9 Hz, 10 Hz, 1H), 7, 26-7.42 (m, 3H), 7.64 (m, 2H), 8.25 (s, 1H), 8.38 (t, J = 8Hz, 1H)
〔実施例101〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−5−ヒドロキシ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
エチル 5−ベンジルオキシ−1−(3−エトキシカルボニルアミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート500mgを48%臭化水素酸5ml、酢酸5mlに加え、一晩加熱還流した。放冷後、減圧濃縮し、残渣にエタノールを加え、固体を濾取し、ジエチルエーテルで洗浄した。130mgの標記化合物を得た。
性状:淡黄色粉末
融点:>270℃
1HNMR(d6−DMSO)δ;
6.64(dd,J=6Hz,12Hz,1H),6.99(dd,J=8Hz,9Hz,1H),7.49(dd,J=10Hz,11Hz,1H),8.77(s,1H)
Example 101
1- (3-Amino-4,6-difluorophenyl) -6,7-difluoro-5-hydroxy-1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
Ethyl 5-benzyloxy-1- (3-ethoxycarbonylamino-4,6-difluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate 500 mg is 48% brominated The mixture was added to 5 ml of hydrogen acid and 5 ml of acetic acid and heated to reflux overnight. After allowing to cool, the mixture was concentrated under reduced pressure, ethanol was added to the residue, and the solid was collected by filtration and washed with diethyl ether. 130 mg of the title compound were obtained.
Properties: Pale yellow powder Melting point:> 270 ° C
1 H NMR (d 6 -DMSO) δ;
6.64 (dd, J = 6 Hz, 12 Hz, 1H), 6.99 (dd, J = 8 Hz, 9 Hz, 1H), 7.49 (dd, J = 10 Hz, 11 Hz, 1H), 8.77 (s) , 1H)
〔実施例102〕
エチル 1−(3−ベンジルオキシカルボニルアミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−5−メチル−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 2−メチル−3,4,6−トリフルオロベンゾイルアセテート2.6gをオルトぎ酸エチル2.2mg、無水酢酸3.1gに加え2時間加熱撹拌した。放冷後、反応液を減圧濃縮した。残渣にクロロホルム20ml加え、氷冷下、参考例9のN−ベンジルオキシカルボニル−2,4−ジフルオロ−m−フェニレンジアミン2.78gのクロロホルム10ml溶液を滴下した。滴下終了後、室温で1時間撹拌した。反応液を減圧濃縮し、残渣に炭酸カリウム1.65g、N,N−ジメチルホルムアミド10mlを加え、90℃で1時間加熱撹拌した。放冷後、反応液を氷水に加え、析出した固体を濾取した。この固体をクロロホルムに溶かし、有機層を分取し、硫酸マグネシウムで乾燥後、溶媒を留去した。残渣にエタノール、ジエチルエーテルを加え固体を濾取し、ジエチルエーテルで洗浄し、2.4gの標記化合物を得た。
性状:黄色粉末
融点:202−204℃
1HNMR(CDCl3)δ;
1.38(t,J=7Hz,3H),2.92(d,J=3Hz,3H),4.38(q,J=7Hz,2H),5.21(s,2H),6.50(t,J=9Hz,1H),7.08(brs,1H),7.19(t,J=10Hz,1H),7.39(brs,5H),8.27(s,1H),8.38(t,J=8Hz,1H)
Example 102
Ethyl 1- (3-benzyloxycarbonylamino-4,6-difluorophenyl) -6,7-difluoro-5-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylate:
Ethyl 2-methyl-3,4,6-trifluorobenzoyl acetate (2.6 g) was added to ethyl orthoformate (2.2 mg) and acetic anhydride (3.1 g), and the mixture was heated and stirred for 2 hours. After allowing to cool, the reaction solution was concentrated under reduced pressure. 20 ml of chloroform was added to the residue, and a solution of 2.78 g of N-benzyloxycarbonyl-2,4-difluoro-m-phenylenediamine of Reference Example 9 in 10 ml of chloroform was added dropwise under ice cooling. After completion of dropping, the mixture was stirred at room temperature for 1 hour. The reaction solution was concentrated under reduced pressure, 1.65 g of potassium carbonate and 10 ml of N, N-dimethylformamide were added to the residue, and the mixture was heated and stirred at 90 ° C. for 1 hour. After allowing to cool, the reaction solution was added to ice water, and the precipitated solid was collected by filtration. This solid was dissolved in chloroform, the organic layer was separated, dried over magnesium sulfate, and the solvent was distilled off. Ethanol and diethyl ether were added to the residue, and the solid was collected by filtration and washed with diethyl ether to obtain 2.4 g of the title compound.
Property: Yellow powder Melting point: 202-204 ° C
1 H NMR (CDCl 3 ) δ;
1.38 (t, J = 7 Hz, 3H), 2.92 (d, J = 3 Hz, 3H), 4.38 (q, J = 7 Hz, 2H), 5.21 (s, 2H), 6. 50 (t, J = 9 Hz, 1H), 7.08 (brs, 1H), 7.19 (t, J = 10 Hz, 1H), 7.39 (brs, 5H), 8.27 (s, 1H) , 8.38 (t, J = 8Hz, 1H)
〔実施例103〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−5−メチル−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
エチル 1−[3−(ベンジルオキシカルボニルアミノ−4,6−ジフルオロフェニル)]−6,7−ジフルオロ−5−メチル−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート2gを塩酸10ml、酢酸20mlに加え、3時間加熱還流した。放冷後、減圧濃縮し、残渣にエタノールを加え、固体を濾取し、ジエチルエーテルで洗浄した。940mgの標記化合物を得た。
性状:無色粉末
融点:>270℃
1HNMR(d6−DMSO)δ;
2.86(brs,3H),7.07(t,J=8Hz,1H),7.20(m,1H),7.52(t,J=11Hz,1H),8.81(s,1H)
Example 103
1- (3-Amino-4,6-difluorophenyl) -6,7-difluoro-5-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
2 ml of ethyl 1- [3- (benzyloxycarbonylamino-4,6-difluorophenyl)]-6,7-difluoro-5-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylate was added to 10 ml of hydrochloric acid. The mixture was added to 20 ml of acetic acid and heated to reflux for 3 hours. After allowing to cool, the mixture was concentrated under reduced pressure, ethanol was added to the residue, and the solid was collected by filtration and washed with diethyl ether. 940 mg of the title compound were obtained.
Properties: Colorless powder Melting point:> 270 ° C
1 H NMR (d 6 -DMSO) δ;
2.86 (brs, 3H), 7.07 (t, J = 8 Hz, 1H), 7.20 (m, 1H), 7.52 (t, J = 11 Hz, 1H), 8.81 (s, 1H)
〔実施例104〕
エチル 5,6,7,8−テトラフルオロ−1−(2,4−ジフルオロ−5−ニトロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 5,6,7,8−テトラフルオロ−1−(2,4−ジフルオロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例97と同様にして標記化合物を得た。
性状:無色粉末
融点:235−238℃
1HNMR(d6−DMSO)δ;
1.26(t,J=7Hz,3H),4.23(q,J=7Hz,2H),8.15(t,J=10Hz,1H),8.54(s,1H),8.95(t,J=8Hz,1H)
Example 104
Ethyl 5,6,7,8-tetrafluoro-1- (2,4-difluoro-5-nitrophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate:
Similar to Example 97 except that ethyl 5,6,7,8-tetrafluoro-1- (2,4-difluorophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate was used The title compound was obtained.
Properties: Colorless powder Melting point: 235-238 ° C
1 H NMR (d 6 -DMSO) δ;
1.26 (t, J = 7 Hz, 3H), 4.23 (q, J = 7 Hz, 2H), 8.15 (t, J = 10 Hz, 1H), 8.54 (s, 1H), 8. 95 (t, J = 8Hz, 1H)
〔実施例105〕
エチル 5,6,7,8−テトラフルオロ−1−(2,4−ジフルオロ−5−ホルミルアミノフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 5,6,7,8−テトラフルオロ−1−(2,4−ジフルオロ−5−ニトロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例98と同様にして標記化合物を得た。
性状:淡褐色粉末
融点:179−182℃
1HNMR(d6−DMSO)δ;
1.25(t,J=7Hz,3H),4.22(q,J=7Hz,2H),7.78(t,J=10Hz,1H),8.34(s,1H),8.44(s,1H),8.55(t,J=8Hz,1H)
Example 105
Ethyl 5,6,7,8-tetrafluoro-1- (2,4-difluoro-5-formylaminophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate:
Example 98 except that ethyl 5,6,7,8-tetrafluoro-1- (2,4-difluoro-5-nitrophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate was used To give the title compound.
Properties: Light brown powder Melting point: 179-182 ° C
1 H NMR (d 6 -DMSO) δ;
1.25 (t, J = 7 Hz, 3H), 4.22 (q, J = 7 Hz, 2H), 7.78 (t, J = 10 Hz, 1H), 8.34 (s, 1H), 8. 44 (s, 1H), 8.55 (t, J = 8 Hz, 1H)
〔実施例106〕
エチル 5−ベンジルアミノ−6,7,8−トリフルオロ−1−(2,4−ジフルオロ−5−ホルミルアミノフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 5,6,7,8−テトラフルオロ−1−(2,4−ジフルオロ−5−ホルミルアミノフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート800mg、ベンジルアミン0.21ml、無水炭酸カリウム240mgをトルエン30mlに加え、一晩加熱還流した。放冷後、減圧濃縮し、残渣にクロロホルムを加え、水で洗浄した。硫酸マグネシウムで乾燥後、溶媒を留去し、残渣にジエチルエーテルを加え、固体を濾取し、ジエチルエーテルで洗浄した。600mgの標記化合物を得た。
性状:黄色粉末
融点:151−156℃
1HNMR(d6−DMSO)δ;
1.24(t,J=7Hz,3H),4.19(q,J=7Hz,2H),4.66(m,2H),7.29(m,2H),7.36(s,3H),7.73(t,J=11Hz,1H),8.33(s,2H),8.50(t,J=8Hz,1H)
Example 106
Ethyl 5-benzylamino-6,7,8-trifluoro-1- (2,4-difluoro-5-formylaminophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate:
Ethyl 5,6,7,8-tetrafluoro-1- (2,4-difluoro-5-formylaminophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate 800 mg, benzylamine 0.21 ml Then, 240 mg of anhydrous potassium carbonate was added to 30 ml of toluene, and the mixture was heated to reflux overnight. After allowing to cool, the mixture was concentrated under reduced pressure, and chloroform was added to the residue, followed by washing with water. After drying over magnesium sulfate, the solvent was distilled off, diethyl ether was added to the residue, the solid was collected by filtration, and washed with diethyl ether. 600 mg of the title compound were obtained.
Property: Yellow powder Melting point: 151-156 ° C
1 H NMR (d 6 -DMSO) δ;
1.24 (t, J = 7 Hz, 3H), 4.19 (q, J = 7 Hz, 2H), 4.66 (m, 2H), 7.29 (m, 2H), 7.36 (s, 3H), 7.73 (t, J = 11 Hz, 1H), 8.33 (s, 2H), 8.50 (t, J = 8 Hz, 1H)
〔実施例107〕
エチル 5−アミノ−6,7,8−トリフルオロ−1−(2,4−ジフルオロ−5−ホルミルアミノフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 5−ベンジルアミノ−6,7,8−トリフルオロ−1−(2,4−ジフルオロ−5−ホルミルアミノフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート600mg、10%パラジウム炭素100mgをエタノール20ml、酢酸10mlに加え、水素気流下、室温で2日間撹拌した。メンブランフィルターで触媒を濾去し、濾液を減圧濃縮した。残渣にジエチルエーテルを加え、固体を濾取し、ジエチルエーテルで洗浄した。420mgの標記化合物を得た。
性状:黄色粉末
融点:>230℃(分解)
1HNMR(d6−DMSO)δ;
1.25(t,J=7Hz,3H),4.20(q,J=7Hz,2H),7.73(t,J=11Hz,1H),7.88(brs,2H),8.30(s,1H),8.34(s,1H),8.49(t,J=8Hz,1H)
Example 107
Ethyl 5-amino-6,7,8-trifluoro-1- (2,4-difluoro-5-formylaminophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate:
Ethyl 5-benzylamino-6,7,8-trifluoro-1- (2,4-difluoro-5-formylaminophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate 600 mg, 10% 100 mg of palladium carbon was added to 20 ml of ethanol and 10 ml of acetic acid, and the mixture was stirred at room temperature for 2 days under a hydrogen stream. The catalyst was removed by filtration with a membrane filter, and the filtrate was concentrated under reduced pressure. Diethyl ether was added to the residue, and the solid was collected by filtration and washed with diethyl ether. 420 mg of the title compound were obtained.
Property: Yellow powder Melting point:> 230 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.25 (t, J = 7 Hz, 3H), 4.20 (q, J = 7 Hz, 2H), 7.73 (t, J = 11 Hz, 1H), 7.88 (brs, 2H), 8. 30 (s, 1H), 8.34 (s, 1H), 8.49 (t, J = 8 Hz, 1H)
〔実施例108〕
5−アミノ−1−(3−アミノ−4,6−ジフルオロフェニル)−6,7,8−トリフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
エチル 5−アミノ−6,7,8−トリフルオロ−1−(2,4−ジフルオロ−5−ホルミルアミノフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例99と同様にして標記化合物を得た。
性状:黄色粉末
融点:>270℃
1HNMR(d6−DMSO)δ;
7.14(t,J=8Hz,1H),7.42(t,J=10Hz,1H),8.50(s,1H)
Example 108
5-Amino-1- (3-amino-4,6-difluorophenyl) -6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
Other than using ethyl 5-amino-6,7,8-trifluoro-1- (2,4-difluoro-5-formylaminophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate The title compound was obtained in the same manner as in Example 99.
Property: Yellow powder Melting point:> 270 ° C
1 H NMR (d 6 -DMSO) δ;
7.14 (t, J = 8 Hz, 1H), 7.42 (t, J = 10 Hz, 1H), 8.50 (s, 1H)
〔実施例109〕
エチル 1−(3−ベンジルオキシカルボニルアミノ−4,6−ジフルオロフェニル)−7−クロロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート:
エチル 2,6−ジクロロニコチノイルアセテート11.8gをオルトぎ酸エチル8.8ml、無水酢酸13mlに加え、2時間加熱還流した。反応液を減圧濃縮した。この化合物3.2gにトルエン20mlを加え、参考例9のN−ベンジルオキシカルボニル−2,4−ジフルオロ−m−フェニレンジアミン3.1gのトルエン10ml、エタノール10ml溶液を滴下し、滴下終了後、室温で一晩撹拌した。反応液を減圧濃縮し、エチル 2−(2,6−ジクロロニコチノイル)−3−(3−ベンジルオキシカルボニルアミノ−4,6−ジフルオロフェニルアミノ)アクリレートを得た。その全量をN,N−ジメチルホルムアミド10mlに溶解させ、炭酸カリウム1.39gを加え、室温で一晩撹拌した。反応液を氷水中に注入し固体を濾取し、エタノール、ジエチルエーテルの順に洗い、3.4gの標記化合物を得た。
性状:無色粉末
融点:242−243℃
1HNMR(CDCl3)δ;
1.41(t,J=7Hz,3H),4.41(q,J=7Hz,2H),5.22(s,2H),7.01(brs,1H),7.13(t,J=9Hz,1H),7.37(s,2H),7.40(s,3H),7.50(m,1H),8.35(m,1H),8.54(s,1H),8.72(d,J=8Hz,1H)
Example 109
Ethyl 1- (3-benzyloxycarbonylamino-4,6-difluorophenyl) -7-chloro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate:
11.8 g of ethyl 2,6-dichloronicotinoyl acetate was added to 8.8 ml of ethyl orthoformate and 13 ml of acetic anhydride, and the mixture was heated to reflux for 2 hours. The reaction solution was concentrated under reduced pressure. 20 ml of toluene was added to 3.2 g of this compound, and a solution of 3.1 g of N-benzyloxycarbonyl-2,4-difluoro-m-phenylenediamine of Reference Example 9 in 10 ml of toluene and 10 ml of ethanol was added dropwise. And stirred overnight. The reaction solution was concentrated under reduced pressure to obtain ethyl 2- (2,6-dichloronicotinoyl) -3- (3-benzyloxycarbonylamino-4,6-difluorophenylamino) acrylate. The total amount was dissolved in 10 ml of N, N-dimethylformamide, 1.39 g of potassium carbonate was added, and the mixture was stirred overnight at room temperature. The reaction solution was poured into ice water and the solid was collected by filtration and washed with ethanol and diethyl ether in this order to obtain 3.4 g of the title compound.
Properties: Colorless powder Melting point: 242-243 ° C
1 H NMR (CDCl 3 ) δ;
1.41 (t, J = 7 Hz, 3H), 4.41 (q, J = 7 Hz, 2H), 5.22 (s, 2H), 7.01 (brs, 1H), 7.13 (t, J = 9 Hz, 1H), 7.37 (s, 2H), 7.40 (s, 3H), 7.50 (m, 1H), 8.35 (m, 1H), 8.54 (s, 1H) ), 8.72 (d, J = 8 Hz, 1H)
〔実施例110〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
エチル 1−(3−ベンジルオキシカルボニルアミノ−4,6−ジフルオロフェニル)−7−クロロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート1.0gに12規定塩酸4ml、酢酸8mlを加え、3時間加熱還流し、室温で一晩撹拌した。反応液中に析出した固体を濾取して、エタノール、クロロホルム、ジエチルエーテルの順に洗い、550mgの標記化合物を得た。
性状:無色粉末
融点:>270℃
1HNMR(d6−DMSO)δ;
7.07(t,J=8Hz,1H),7.44(t,J=10Hz,1H),7.80(d,J=8Hz,1H),8.78(d,J=8Hz,1H),8.96(s,1H)
Example 110
1- (3-Amino-4,6-difluorophenyl) -7-chloro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid:
Ethyl 1- (3-benzyloxycarbonylamino-4,6-difluorophenyl) -7-chloro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate in 1.0 g and 12 N hydrochloric acid 4 ml and 8 ml of acetic acid were added and the mixture was heated to reflux for 3 hours and stirred overnight at room temperature. The solid precipitated in the reaction solution was collected by filtration and washed with ethanol, chloroform and diethyl ether in this order to obtain 550 mg of the title compound.
Properties: Colorless powder Melting point:> 270 ° C
1 H NMR (d 6 -DMSO) δ;
7.07 (t, J = 8 Hz, 1H), 7.44 (t, J = 10 Hz, 1H), 7.80 (d, J = 8 Hz, 1H), 8.78 (d, J = 8 Hz, 1H) ), 8.96 (s, 1H)
〔実施例111〕
7−クロロ−6−フルオロ−1−(4−フルオロ−3−ニトロフェニル)−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
7−クロロ−6−フルオロ−1−(4−フルオロフェニル)−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸1.5gを濃硫酸10mlに加え、硝酸カリウム1.4gを少しつつ加え、80℃で2時間加熱撹拌した。放冷後、氷水に注ぎ一晩撹拌した。析出した固体を濾取し、水、エタノール、ジエチルエーテルで洗浄した。1.1gの標記化合物を得た。
性状:淡黄色粉末
融点:>270℃
1HNMR(d6−DMSO)δ;
7.89(t,J=10Hz,1H),8.09−8.17(m,1H),8.59−8.66(m,1H),8.80(d,J=7Hz,1H),9.08(s,1H)
Example 111
7-Chloro-6-fluoro-1- (4-fluoro-3-nitrophenyl) -1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid:
1.5 g of 7-chloro-6-fluoro-1- (4-fluorophenyl) -1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid was added to 10 ml of concentrated sulfuric acid, and potassium nitrate 1. 4g was added a little, and it heated and stirred at 80 degreeC for 2 hours. After cooling, the mixture was poured into ice water and stirred overnight. The precipitated solid was collected by filtration and washed with water, ethanol, and diethyl ether. 1.1 g of the title compound was obtained.
Properties: Pale yellow powder Melting point:> 270 ° C
1 H NMR (d 6 -DMSO) δ;
7.89 (t, J = 10 Hz, 1H), 8.09-8.17 (m, 1H), 8.59-8.66 (m, 1H), 8.80 (d, J = 7 Hz, 1H) ), 9.08 (s, 1H)
〔実施例112〕
メチル 7−クロロ−6−フルオロ−1−(4−フルオロ−3−ニトロフェニル)−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート:
メタノール25mlに塩化チオニル1gを滴下し、この溶液に7−クロロ−6−フルオロ−1−(4−フルオロ−3−ニトロフェニル)−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸1.1gを加え、一晩加熱還流した。放冷後、減圧濃縮し、残渣にジエチルエーテルを加え、固体を濾取した。1.4gの標記化合物を得た。
性状:黄色粉末
融点:207−212℃
1HNMR(d6−DMSO)δ;
3.78(s,3H),7.87(d,J=9Hz,1H),8.10−8.17(m,1H),8.54−8.62(m,2H),8.78(s,1H)
Example 112
Methyl 7-chloro-6-fluoro-1- (4-fluoro-3-nitrophenyl) -1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate:
1 g of thionyl chloride was added dropwise to 25 ml of methanol, and 7-chloro-6-fluoro-1- (4-fluoro-3-nitrophenyl) -1,4-dihydro-4-oxo-1,8-naphthyridine was added to this solution. 1.1 g of 3-carboxylic acid was added and heated to reflux overnight. After allowing to cool, the mixture was concentrated under reduced pressure, diethyl ether was added to the residue, and the solid was collected by filtration. 1.4 g of the title compound was obtained.
Property: Yellow powder Melting point: 207-212 ° C
1 H NMR (d 6 -DMSO) δ;
3.78 (s, 3H), 7.87 (d, J = 9 Hz, 1H), 8.10-8.17 (m, 1H), 8.54-8.62 (m, 2H), 8. 78 (s, 1H)
〔実施例113〕
1−(3−アミノ−4−フルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
メチル 7−クロロ−6−フルオロ−1−(4−フルオロ−3−ニトロフェニル)−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレート600mgをメタノール30ml、酢酸10ml、ジクロロエタン30mlに溶解し、10%パラジウム炭素100mg加えた。水素雰囲気下、室温で一晩撹拌した。メンブランフィルターで触媒を濾去し、濾液を減圧濃縮した。残渣に酢酸4ml、塩酸1mlを加え、100℃で一晩加熱撹拌した。反応液を減圧濃縮し、残渣にジエチルエーテルを加え、固体を濾取し、ジエチルエーテルで洗浄した。160mgの標記化合物を得た。
性状:淡黄色粉末
融点:>270℃
1HNMR(d6−DMSO)δ;
6.74−6.83(m,1H),6.96(dd,J=3Hz,8Hz,1H),7.23(dd,J=9Hz,11Hz,1H),8.76(d,J=8Hz,1H)8.79(s,1H)
Example 113
1- (3-Amino-4-fluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid:
Methyl 7-chloro-6-fluoro-1- (4-fluoro-3-nitrophenyl) -1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate (600 mg) was added to 30 ml of methanol, 10 ml of acetic acid, Dissolved in 30 ml of dichloroethane, 100 mg of 10% palladium on carbon was added. The mixture was stirred overnight at room temperature under a hydrogen atmosphere. The catalyst was removed by filtration with a membrane filter, and the filtrate was concentrated under reduced pressure. To the residue were added 4 ml of acetic acid and 1 ml of hydrochloric acid, and the mixture was stirred with heating at 100 ° C. overnight. The reaction mixture was concentrated under reduced pressure, diethyl ether was added to the residue, and the solid was collected by filtration and washed with diethyl ether. 160 mg of the title compound were obtained.
Properties: Pale yellow powder Melting point:> 270 ° C
1 H NMR (d 6 -DMSO) δ;
6.74-6.83 (m, 1H), 6.96 (dd, J = 3 Hz, 8 Hz, 1H), 7.23 (dd, J = 9 Hz, 11 Hz, 1H), 8.76 (d, J = 8 Hz, 1H) 8.79 (s, 1H)
〔実施例114〕
エチル 7−クロロ−1−(3−エトキシカルボニルアミノ−4,6−ジフルオロフェニル)−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボキシレート:
1.25gの2,6−ジクロロ−5−フルオロニコチノイル酢酸 エチルエステルから常法によって作成した3−エトキシ−2−(2’6’−ジクロロ−5’−フルオロニコチノイル)アクリル酸エチルエステルを溶かしたメタノール溶液10mlに、参考例8のN−エトキシカルボニル−2,4−ジフルオロ−m−フェニレンジアミン・メタンスルホン酸塩1.30gを、500mgのトリエチルアミンとともに加えた。この溶液を減圧下に濃縮した。これに、50mlのクロロホルム50mlの蒸留水を加えて振とう後分液した。有機層を無水硫酸マグネシウムで乾燥後減圧下に濃縮した。残渣に2.1gの無水炭酸カリウムと4mlのN−N−ジメチルホルムアミドを加えて90℃で15分撹拌した。放冷し、50mlのクロロホルムと300mlの蒸留水を加えて分液、ついでクロロホルム層を、300mlの蒸留水で2回洗浄した後、無水硫酸マグネシウムで乾燥後減圧下に濃縮した。析出物をエタノールに分散して濾取、エタノール、ジイソプロピルエーテルの順に洗って、647mgの標記化合物を得た。
性状:淡褐色粉末
融点:209−212℃
1HNMR(d6−DMSO)δ;
1.24(t,J=7Hz,3H),1.28(t,J=7Hz,3H),4.13(q,J=7Hz,2H),4.24(q,J=7Hz,2H),7.70(t,J=10Hz,1H),8.03(t,J=8Hz,1H),8.54(d,J=8Hz,1H),8.76(s,1H)
Example 114
Ethyl 7-chloro-1- (3-ethoxycarbonylamino-4,6-difluorophenyl) -6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate:
3-Ethoxy-2- (2′6′-dichloro-5′-fluoronicotinoyl) acrylic acid ethyl ester prepared by a conventional method from 1.25 g of 2,6-dichloro-5-fluoronicotinoyl acetic acid ethyl ester To 10 ml of the dissolved methanol solution, 1.30 g of N-ethoxycarbonyl-2,4-difluoro-m-phenylenediamine methanesulfonate of Reference Example 8 was added together with 500 mg of triethylamine. The solution was concentrated under reduced pressure. To this, 50 ml of chloroform and 50 ml of distilled water were added, followed by liquid separation. The organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. To the residue, 2.1 g of anhydrous potassium carbonate and 4 ml of NN-dimethylformamide were added and stirred at 90 ° C. for 15 minutes. The mixture was allowed to cool, and 50 ml of chloroform and 300 ml of distilled water were added for liquid separation, and the chloroform layer was washed twice with 300 ml of distilled water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The precipitate was dispersed in ethanol, collected by filtration, and washed successively with ethanol and diisopropyl ether to obtain 647 mg of the title compound.
Properties: Light brown powder Melting point: 209-212 ° C
1 H NMR (d 6 -DMSO) δ;
1.24 (t, J = 7 Hz, 3H), 1.28 (t, J = 7 Hz, 3H), 4.13 (q, J = 7 Hz, 2H), 4.24 (q, J = 7 Hz, 2H) ), 7.70 (t, J = 10 Hz, 1H), 8.03 (t, J = 8 Hz, 1H), 8.54 (d, J = 8 Hz, 1H), 8.76 (s, 1H)
〔実施例115〕
7−クロロ−1−(3−エトキシカルボニルアミノ−4,6−ジフルオロフェニル)−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸:
エチル 7−クロロ−1−(3−エトキシカルボニルアミノ−4,6−ジフルオロフェニル)−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボキシレート200mgを1.5mlの3規定塩酸と1mlの酢酸の混液に加えて、3時間40分撹拌加熱環流した。放冷し、析出物を濾取し、エタノール、ジイソプロピルエーテルの順に洗って149mgの標記化合物を得た。
性状:淡黄色粉末
融点:233−235℃
1HNMR(d6−DMSO)δ;
1.24(t,J=7Hz,3H),4.13(q,J=7Hz,2H),7.71(t,J=10Hz,1H),8.08(t,J=8Hz,1H),8.77(d,J=7Hz,1H),9.06(s,1H),9.65(s,1H)
Example 115
7-Chloro-1- (3-ethoxycarbonylamino-4,6-difluorophenyl) -6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid:
1. 200 mg of ethyl 7-chloro-1- (3-ethoxycarbonylamino-4,6-difluorophenyl) -6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate The mixture was added to 5 ml of 3N hydrochloric acid and 1 ml of acetic acid and stirred and refluxed for 3 hours and 40 minutes. The mixture was allowed to cool, and the precipitate was collected by filtration and washed with ethanol and diisopropyl ether in this order to obtain 149 mg of the title compound.
Property: Pale yellow powder Melting point: 233-235 ° C
1 H NMR (d 6 -DMSO) δ;
1.24 (t, J = 7 Hz, 3H), 4.13 (q, J = 7 Hz, 2H), 7.71 (t, J = 10 Hz, 1H), 8.08 (t, J = 8 Hz, 1H) ), 8.77 (d, J = 7 Hz, 1H), 9.06 (s, 1H), 9.65 (s, 1H)
〔実施例116〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸の別途合成:
エチル 7−クロロ−1−(3−エトキシカルボニルアミノ−4,6−ジフルオロフェニル)−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボキシレート200mgを2mlの6規定塩酸と2mlの酢酸の混液に加えて、4日間撹拌加熱環流した。放冷し、析出物を濾取し、濾液を減圧下に濃縮し、残渣に6mlの6規定塩酸を加えて、18時間撹拌加熱環流した。減圧下に濃縮し1mlのエタノールを加えて放置して生じた析出物を濾取し、エタノール、ジイソプロピルエーテルの順に洗って29mgの淡黄色粉末として標記化合物を得た。
Example 116
Separate synthesis of 1- (3-amino-4,6-difluorophenyl) -7-chloro-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid:
200 ml of ethyl 7-chloro-1- (3-ethoxycarbonylamino-4,6-difluorophenyl) -6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate In addition to 6N hydrochloric acid and 2 ml of acetic acid, the mixture was stirred and heated to reflux for 4 days. The mixture was allowed to cool, the precipitate was collected by filtration, the filtrate was concentrated under reduced pressure, 6 ml of 6N hydrochloric acid was added to the residue, and the mixture was stirred and heated to reflux for 18 hours. After concentration under reduced pressure and addition of 1 ml of ethanol, the precipitate formed upon standing was collected by filtration and washed with ethanol and diisopropyl ether in this order to give 29 mg of the title compound as a pale yellow powder.
〔実施例117〕
7−(3−アミノアゼチジン−1−イル)−1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸3.7gと3−アミノアゼチジン二塩酸塩2.18gとトリエチルアミン6.06gをアセトニトリル200mlに加えた。80℃で15時間撹拌した。冷後生じた固体をろ取した。エタノール、イソプロピルエーテルで洗浄して、3.7gの標記化合物を得た。
性状:淡黄色粉末
融点:168.5−170.5℃
1HNMR(d6−DMSO)δ;
3.60−4.60(m,5H),5.35(brs,2H),6.95(t,J=8Hz,1H),7.35(t,J=10Hz,1H),8.03(d,J=11.5Hz,1H),8.68(s,1H)
Example 117
7- (3-Aminoazetidin-1-yl) -1- (3-amino-4,6-difluorophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3 -Carboxylic acid:
3.7 g of 1- (3-amino-4,6-difluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid and 3-amino 2.18 g of azetidine dihydrochloride and 6.06 g of triethylamine were added to 200 ml of acetonitrile. Stir at 80 ° C. for 15 hours. The solid produced after cooling was collected by filtration. Washing with ethanol and isopropyl ether gave 3.7 g of the title compound.
Properties: Pale yellow powder Melting point: 168.5-170.5 ° C
1 H NMR (d 6 -DMSO) δ;
3.60-4.60 (m, 5H), 5.35 (brs, 2H), 6.95 (t, J = 8 Hz, 1H), 7.35 (t, J = 10 Hz, 1H), 8. 03 (d, J = 11.5 Hz, 1H), 8.68 (s, 1H)
〔実施例118〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−7−(3−ヒドロキシアゼチジン−1−イル)−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸と3−ヒドロキシアゼチジン塩酸塩とトリエチルアミンを用いた他は、実施例117と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>253℃(分解)
1HNMR(d6−DMSO)δ;
3.60−4.65(m,5H),5.35(brs,2H),5.82(brs,1H),6.95(t,J=8Hz,1H),7.35(t,J=10Hz,1H),8.03(d,J=11.5Hz,1H),8.68(s,1H)
Example 118
1- (3-Amino-4,6-difluorophenyl) -6-fluoro-7- (3-hydroxyazetidin-1-yl) -1,4-dihydro-4-oxo-1,8-naphthyridine-3 -Carboxylic acid:
1- (3-Amino-4,6-difluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid and 3-hydroxyazetidine hydrochloride The title compound was obtained in the same manner as in Example 117 except that the salt and triethylamine were used.
Properties: Pale yellow powder Melting point:> 253 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
3.60-4.65 (m, 5H), 5.35 (brs, 2H), 5.82 (brs, 1H), 6.95 (t, J = 8 Hz, 1H), 7.35 (t, J = 10 Hz, 1H), 8.03 (d, J = 11.5 Hz, 1H), 8.68 (s, 1H)
〔実施例119〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−7−(3−メチルアミノアゼチジン−1−イル)−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸と3−メチルアミノアゼチジン二塩酸塩とトリエチルアミンを用いた他は、実施例117と同様にして標記化合物を得た。
性状:無色粉末
融点:135.5−140.5℃
1HNMR(d6−DMSO)δ;
2.53(s,3H),3.80−4.90(m,5H),5.38(brs,2H),6.97(t,J=8Hz,1H),7.36(t,J=10Hz,1H),8.11(d,J=10.7Hz,1H),8.70(s,1H)
Example 119
1- (3-Amino-4,6-difluorophenyl) -6-fluoro-7- (3-methylaminoazetidin-1-yl) -1,4-dihydro-4-oxo-1,8-naphthyridine 3-carboxylic acid:
1- (3-Amino-4,6-difluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid and 3-methylaminoazetidine The title compound was obtained in the same manner as in Example 117 except that dihydrochloride and triethylamine were used.
Properties: colorless powder Melting point: 135.5-140.5 ° C
1 H NMR (d 6 -DMSO) δ;
2.53 (s, 3H), 3.80-4.90 (m, 5H), 5.38 (brs, 2H), 6.97 (t, J = 8 Hz, 1H), 7.36 (t, J = 10 Hz, 1H), 8.11 (d, J = 10.7 Hz, 1H), 8.70 (s, 1H)
〔実施例120〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3−エチルアミノアゼチジン−1−イル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸と3−エチルアミノアゼチジン二塩酸塩とトリエチルアミンを用いた他は、実施例117と同様にして標記化合物を得た。
性状:無色粉末
融点:122.5−124℃
1HNMR(d6−DMSO)δ;
0.98(t,J=7Hz,3H)2.45(q,J=7Hz,2H),3.20−4.80(m,5H),5.34(brs,2H),6.94(t,J=8Hz,1H),7.35(t,J=10Hz,1H),8.01(d,J=10.7Hz,1H),8.67(s,1H)
Example 120
1- (3-Amino-4,6-difluorophenyl) -7- (3-ethylaminoazetidin-1-yl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine 3-carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid and 3-ethylaminoazetidine The title compound was obtained in the same manner as in Example 117 except that dihydrochloride and triethylamine were used.
Properties: Colorless powder Melting point: 122.5-124 ° C
1 H NMR (d 6 -DMSO) δ;
0.98 (t, J = 7 Hz, 3H) 2.45 (q, J = 7 Hz, 2H), 3.20-4.80 (m, 5H), 5.34 (brs, 2H), 6.94 (T, J = 8 Hz, 1H), 7.35 (t, J = 10 Hz, 1H), 8.01 (d, J = 10.7 Hz, 1H), 8.67 (s, 1H)
〔実施例121〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3−ジメチルアミノアゼチジン−1−イル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸 塩酸塩:
1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸と3−ジメチルアミノアゼチジン二塩酸塩とトリエチルアミンを用いた他は、実施例117と同様にして標記化合物のフリー体を得た。この固体110mgをクロロホルム5mlに溶解し、4規定塩酸/1,4−ジオキサン2mlを加えた。溶媒を留去して、残渣にエタノール2mlを加えた。生じた固体をろ取して標記化合物を60mg得た。
性状:淡黄色粉末
融点:>242℃(分解)
1HNMR(d6−DMSO)δ;
2.72(s,6H),3.90−4.80(m,5H),5.20−6.70(br,2H),7.18(t,J=8Hz,1H),7.45(t,J=10Hz,1H),8.13(d,J=11.1Hz,1H),8.73(s,1H)
Example 121
1- (3-Amino-4,6-difluorophenyl) -7- (3-dimethylaminoazetidin-1-yl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine 3-carboxylic acid hydrochloride:
1- (3-Amino-4,6-difluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid and 3-dimethylaminoazetidine A free form of the title compound was obtained in the same manner as in Example 117 except that dihydrochloride and triethylamine were used. 110 mg of this solid was dissolved in 5 ml of chloroform, and 2 ml of 4N hydrochloric acid / 1,4-dioxane was added. The solvent was distilled off, and 2 ml of ethanol was added to the residue. The resulting solid was collected by filtration to obtain 60 mg of the title compound.
Properties: Pale yellow powder Melting point:> 242 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
2.72 (s, 6H), 3.90-4.80 (m, 5H), 5.20-6.70 (br, 2H), 7.18 (t, J = 8 Hz, 1H), 7. 45 (t, J = 10 Hz, 1H), 8.13 (d, J = 11.1 Hz, 1H), 8.73 (s, 1H)
〔実施例122〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−7−(トランス−2−メチル−3−アミノアゼチジン−1−イル)−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸とトランス−2−メチル−3−アミノアゼチジン二塩酸塩とトリエチルアミンを用いた他は、実施例117と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>237℃(分解)
1HNMR(d6−DMSO)δ;
0.90−1.35(m,3H),3.20−3.55(m,2H),3.80−4.60(m,2H),5.37(brs,2H),6.85−7.05(m,1H),7.25−7.50(m,1H),8.09(d,J=9Hz,1H),8.72(s,1H)
Example 122
1- (3-Amino-4,6-difluorophenyl) -6-fluoro-7- (trans-2-methyl-3-aminoazetidin-1-yl) -1,4-dihydro-4-oxo-1 , 8-Naphthyridine-3-carboxylic acid:
1- (3-Amino-4,6-difluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid and trans-2-methyl- The title compound was obtained in the same manner as in Example 117 except that 3-aminoazetidine dihydrochloride and triethylamine were used.
Properties: Pale yellow powder Melting point:> 237 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
0.90-1.35 (m, 3H), 3.20-3.55 (m, 2H), 3.80-4.60 (m, 2H), 5.37 (brs, 2H), 6. 85-7.05 (m, 1H), 7.25-7.50 (m, 1H), 8.09 (d, J = 9 Hz, 1H), 8.72 (s, 1H)
〔実施例123〕
7−(3−アミノアゼチジン−1−イル)−1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸 p−トルエンスルホン酸塩:
化合物117を用いたほかは実施例52と同様にして、標記化合物を得た。
性状:淡赤色粉末
融点:179−184℃
1HNMR(d6−DMSO)δ;
2.28(s,3H),3.50−4.80(m,5H),6.96(t,J=8Hz,1H),7.11(d,J=8Hz,1H),7.37(t,J=10Hz,1H),7.48(d,J=8Hz,1H),8.12(d,J=11.1Hz,1H),8.30(brs,3H),8.74(s,1H)
Example 123
7- (3-Aminoazetidin-1-yl) -1- (3-amino-4,6-difluorophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3 -Carboxylic acid p-toluenesulfonate:
The title compound was obtained in the same manner as in Example 52 except that the compound 117 was used.
Property: Pale red powder Melting point: 179-184 ° C
1 H NMR (d 6 -DMSO) δ;
2.28 (s, 3H), 3.50-4.80 (m, 5H), 6.96 (t, J = 8 Hz, 1H), 7.11 (d, J = 8 Hz, 1H), 7. 37 (t, J = 10 Hz, 1H), 7.48 (d, J = 8 Hz, 1H), 8.12 (d, J = 11.1 Hz, 1H), 8.30 (brs, 3H), 8. 74 (s, 1H)
〔実施例124〕
7−(3−アミノアゼチジン−1−イル)−1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸 メタンスルホン酸塩:
化合物117とメタンスルホン酸を用いたほかは実施例52と同様にして、標記化合物を得た。性状:淡赤色粉末
融点:>214℃(分解)
1HNMR(d6−DMSO)δ;
2.34(s,3H),3.80−4.80(m,5H),6.96(t,J=8Hz,1H),7.37(t,J=10Hz,1H),8.14(d,J=11.2Hz,4H),8.31(brs,3H),8.74(s,1H)
Example 124
7- (3-Aminoazetidin-1-yl) -1- (3-amino-4,6-difluorophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3 -Carboxylic acid methanesulfonate:
The title compound was obtained in the same manner as in Example 52 except that the compound 117 and methanesulfonic acid were used. Properties: Pale red powder Melting point:> 214 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
2.34 (s, 3H), 3.80-4.80 (m, 5H), 6.96 (t, J = 8 Hz, 1H), 7.37 (t, J = 10 Hz, 1H), 8. 14 (d, J = 11.2 Hz, 4H), 8.31 (brs, 3H), 8.74 (s, 1H)
〔実施例125〕
7−(3−アミノ−3−メチルアゼチジン−1−イル)−1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸と3−アミノ−3−メチルアゼチジン二塩酸塩とトリエチルアミンを用いたほかは、実施例117と同様にして標記化合物を得た。
性状:無色粉末
融点:244−246.5℃
1HNMR(d6−DMSO)δ;
1.42(s,3H),3.20−4.55(m,4H),5.37(brs,2H),6.95(t,J=8Hz,1H),7.36(t,J=10Hz,1H),8.07(d,J=11.1Hz,1H),8.71(s,1H)
Example 125
7- (3-Amino-3-methylazetidin-1-yl) -1- (3-amino-4,6-difluorophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8 -Naphthyridine-3-carboxylic acid:
1- (3-Amino-4,6-difluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid and 3-amino-3- The title compound was obtained in the same manner as in Example 117 except that methylazetidine dihydrochloride and triethylamine were used.
Properties: colorless powder Melting point: 244-246.5 ° C
1 H NMR (d 6 -DMSO) δ;
1.42 (s, 3H), 3.20-4.55 (m, 4H), 5.37 (brs, 2H), 6.95 (t, J = 8 Hz, 1H), 7.36 (t, J = 10 Hz, 1H), 8.07 (d, J = 11.1 Hz, 1H), 8.71 (s, 1H)
〔実施例126〕
7−(3−L−アラニルアミノアゼチジン−1−イル)−1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸と3−L−アラニルアミノアゼチジン二塩酸塩とトリエチルアミンを用いたほかは、実施例117と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:208.5−214℃
1HNMR(d6−DMSO)δ;
1.28(d,J=6.8Hz,3H),3.55−3.75(m,1H),3.70−4.80(m,5H),5.38(brs,2H),6.97(t,J=8Hz,1H),7.36(t,J=10Hz,1H),8.07(d,J=11.1Hz,1H),8.70(s,1H),9.07(brs,1H)
Example 126
7- (3-L-alanylaminoazetidin-1-yl) -1- (3-amino-4,6-difluorophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8 -Naphthyridine-3-carboxylic acid:
1- (3-Amino-4,6-difluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid and 3-L-alanyl The title compound was obtained in the same manner as in Example 117 except that aminoazetidine dihydrochloride and triethylamine were used.
Properties: Pale yellow powder Melting point: 208.5-214 ° C
1 H NMR (d 6 -DMSO) δ;
1.28 (d, J = 6.8 Hz, 3H), 3.55-3.75 (m, 1H), 3.70-4.80 (m, 5H), 5.38 (brs, 2H), 6.97 (t, J = 8 Hz, 1H), 7.36 (t, J = 10 Hz, 1H), 8.07 (d, J = 11.1 Hz, 1H), 8.70 (s, 1H), 9.07 (brs, 1H)
〔実施例127〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−7−(3−L−バリルアミノアゼチジン−1−イル)−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸と3−L−バリルアミノアゼチジン二塩酸塩とトリエチルアミンを用いた他は、実施例117と同様にして標記化合物を得た。
性状:無色粉末
融点:262.5−264.5℃
1HNMR(d6−DMSO)δ;
0.78(d,J=7Hz,3H),0.85(d,J=7Hz,3H),1.70−1.95(m,1H),2.91(d,J=5.5Hz,1H),3.70−4.80(m,5H),5.35(brs,2H),6.95(t,J=8Hz,1H),7.35(t,J=10Hz,1H),8.06(d,J=11.1Hz,1H),8.52(brs,1H),8.69(s,1H)
Example 127
1- (3-Amino-4,6-difluorophenyl) -6-fluoro-7- (3-L-valylaminoazetidin-1-yl) -1,4-dihydro-4-oxo-1,8- Naphthyridine-3-carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid and 3-L-valylamino The title compound was obtained in the same manner as in Example 117 except that azetidine dihydrochloride and triethylamine were used.
Property: Colorless powder Melting point: 262.5-264.5 ° C
1 H NMR (d 6 -DMSO) δ;
0.78 (d, J = 7 Hz, 3H), 0.85 (d, J = 7 Hz, 3H), 1.70-1.95 (m, 1H), 2.91 (d, J = 5.5 Hz) , 1H), 3.70-4.80 (m, 5H), 5.35 (brs, 2H), 6.95 (t, J = 8 Hz, 1H), 7.35 (t, J = 10 Hz, 1H) ), 8.06 (d, J = 11.1 Hz, 1H), 8.52 (brs, 1H), 8.69 (s, 1H)
〔実施例128〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−7−(3−メチルアミノピロリジン−1−イル)−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸:
3−メチルアミノピロリジン二塩酸塩を用いたほかは実施例48と同様にして標記化合物を得た。
性状:無色粉末
融点:273−276℃(分解)
1HNMR(d6−DMSO)δ;
1.79(m,1H),1.93(m,1H),2.24(s,3H),5.35(brs,2H),6.96(t,J=8Hz,1H),7.36(t,J=10Hz,1H),8.03(d,J=12Hz,1H),8.68(s,1H)
Example 128
1- (3-Amino-4,6-difluorophenyl) -6-fluoro-7- (3-methylaminopyrrolidin-1-yl) -4-oxo-1,4-dihydro-1,8-naphthyridine-3 -Carboxylic acid:
The title compound was obtained in the same manner as in Example 48 except that 3-methylaminopyrrolidine dihydrochloride was used.
Properties: colorless powder Melting point: 273-276 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.79 (m, 1H), 1.93 (m, 1H), 2.24 (s, 3H), 5.35 (brs, 2H), 6.96 (t, J = 8 Hz, 1H), 7 .36 (t, J = 10 Hz, 1H), 8.03 (d, J = 12 Hz, 1H), 8.68 (s, 1H)
〔実施例129〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−7−[(3S)−3−(メチルアミノ)ピロリジン−1−イル]−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸:
(3S)−3−(メチルアミノ)ピロリジン二塩酸塩を用いたほかは実施例48と同様にして標記化合物を得た。
性状:淡褐色粉末
融点:246−248℃(分解)
1HNMR(d6−DMSO)δ;
1.79(m,1H),1.92(m,1H),2.23(s,3H),3.18(m,2H),5.35(brs,2H),6.97(t,J=8Hz,1H),7.36(t,J=10Hz,1H),8.02(d,J=13Hz,1H),8.68(s,1H)
Example 129
1- (3-Amino-4,6-difluorophenyl) -6-fluoro-7-[(3S) -3- (methylamino) pyrrolidin-1-yl] -4-oxo-1,4-dihydro-1 , 8-Naphthyridine-3-carboxylic acid:
The title compound was obtained in the same manner as in Example 48 except that (3S) -3- (methylamino) pyrrolidine dihydrochloride was used.
Property: Light brown powder Melting point: 246-248 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.79 (m, 1H), 1.92 (m, 1H), 2.23 (s, 3H), 3.18 (m, 2H), 5.35 (brs, 2H), 6.97 (t , J = 8 Hz, 1H), 7.36 (t, J = 10 Hz, 1H), 8.02 (d, J = 13 Hz, 1H), 8.68 (s, 1H)
〔実施例130〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−7−[(3S)−3−(エチルアミノ)ピロリジン−1−イル]−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸:
(3S)−3−(エチルアミノ)ピロリジン二塩酸塩を用いたほかは実施例48と同様にして標記化合物を得た。
性状:淡褐色粉末
融点:248−251℃(分解)
1HNMR(d6−DMSO)δ;
0.98(t,J=7Hz,3H),1.75(m,1H),1.95(m,1H),5.35(brs,2H),6.96(t,J=8Hz,1H),7.36(t,J=11Hz,1H),8.01(d,J=12Hz,1H),8.67(s,1H)
Example 130
1- (3-Amino-4,6-difluorophenyl) -6-fluoro-7-[(3S) -3- (ethylamino) pyrrolidin-1-yl] -4-oxo-1,4-dihydro-1 , 8-Naphthyridine-3-carboxylic acid:
The title compound was obtained in the same manner as in Example 48 except that (3S) -3- (ethylamino) pyrrolidine dihydrochloride was used.
Property: Light brown powder Melting point: 248-251 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
0.98 (t, J = 7 Hz, 3H), 1.75 (m, 1H), 1.95 (m, 1H), 5.35 (brs, 2H), 6.96 (t, J = 8 Hz, 1H), 7.36 (t, J = 11 Hz, 1H), 8.01 (d, J = 12 Hz, 1H), 8.67 (s, 1H)
〔実施例131〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3−アミノ−3−メチルピロリジン−1−イル)−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸:
3−アミノ−3−メチルピロリジン二塩酸塩を用いたほかは実施例48と同様にして標記化合物を得た。
性状:無色粉末
融点:223−225℃
1HNMR(d6−DMSO)δ;
1.20(d,J=3Hz,3H),1.60(m,1H),1.71(m,1H),5.35(brs,2H),6.96(t,J=8Hz,1H),7.36(t,J=10Hz,1H),7.99(d,J=13Hz,1H),8.63(s,1H)
Example 131
1- (3-Amino-4,6-difluorophenyl) -7- (3-amino-3-methylpyrrolidin-1-yl) -6-fluoro-4-oxo-1,4-dihydro-1,8- Naphthyridine-3-carboxylic acid:
The title compound was obtained in the same manner as in Example 48 except that 3-amino-3-methylpyrrolidine dihydrochloride was used.
Properties: Colorless powder Melting point: 223-225 ° C
1 H NMR (d 6 -DMSO) δ;
1.20 (d, J = 3 Hz, 3H), 1.60 (m, 1H), 1.71 (m, 1H), 5.35 (brs, 2H), 6.96 (t, J = 8 Hz, 1H), 7.36 (t, J = 10 Hz, 1H), 7.99 (d, J = 13 Hz, 1H), 8.63 (s, 1H)
〔実施例132〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3−アミノメチルピロリジン−1−イル)−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸:
3−アミノメチルピロリジン二塩酸塩を用いたほかは実施例48と同様にして標記化合物を得た。
性状:無色粉末
融点:205−210℃
1HNMR(d6−DMSO)δ;
1.42−1.98(m,2H),2.60(d,J=7Hz,2H),5.34(s,2H),6.96(t,J=8Hz,1H),7.35(t,J=10Hz,1H),8.01(d,J=12Hz,1H),8.66(s,1H)
Example 132
1- (3-amino-4,6-difluorophenyl) -7- (3-aminomethylpyrrolidin-1-yl) -6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3 -Carboxylic acid:
The title compound was obtained in the same manner as in Example 48 except that 3-aminomethylpyrrolidine dihydrochloride was used.
Property: Colorless powder Melting point: 205-210 ° C
1 H NMR (d 6 -DMSO) δ;
1.42-1.98 (m, 2H), 2.60 (d, J = 7 Hz, 2H), 5.34 (s, 2H), 6.96 (t, J = 8 Hz, 1H), 7. 35 (t, J = 10 Hz, 1H), 8.01 (d, J = 12 Hz, 1H), 8.66 (s, 1H)
〔実施例133〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(4−アミノピペリジン−1−イル)−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸:
4−アミノピペリジン二塩酸塩を用いたほかは実施例48と同様にして標記化合物を得た。
性状:無色粉末
融点:212−215℃
1HNMR(d6−DMSO)δ;
1.28(m,2H),1.74(m,2H),2.95(m,1H),3.10(m,2H),4.06(m,2H),5.39(s,2H),6.97(t,J=8Hz,1H),7.36(t,J=10Hz,1H).8.06(d,J=12Hz,1H),8.67(s,1H)
Example 133
1- (3-Amino-4,6-difluorophenyl) -7- (4-aminopiperidin-1-yl) -6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3- carboxylic acid:
The title compound was obtained in the same manner as in Example 48 except that 4-aminopiperidine dihydrochloride was used.
Property: Colorless powder Melting point: 212-215 ° C
1 H NMR (d 6 -DMSO) δ;
1.28 (m, 2H), 1.74 (m, 2H), 2.95 (m, 1H), 3.10 (m, 2H), 4.06 (m, 2H), 5.39 (s , 2H), 6.97 (t, J = 8 Hz, 1H), 7.36 (t, J = 10 Hz, 1H). 8.06 (d, J = 12 Hz, 1H), 8.67 (s, 1H)
〔実施例134〕
1−(3−アミノ−4.6−ジフルオロフェニル)−7−(シス−3−アミノ−4−メトキシピロリジン−1−イル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
シス−3−アミノ−4−メトキシピロリジンを用いたほかは実施例48と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>164℃(分解)
1HNMR(d6−DMSO)δ;
3.13(s,3H),3.73(m,2H),3.93(m,1H),5.38(brs,2H),6.97(m,1H),7.37(m,1H),8.10(d,J=12Hz,1H),8.71(s,1H)
Example 134
1- (3-amino-4.6-difluorophenyl) -7- (cis-3-amino-4-methoxypyrrolidin-1-yl) -6-fluoro-1,4-dihydro-4-oxo-1, 8-Naphthyridine-3-carboxylic acid:
The title compound was obtained in the same manner as in Example 48 except that cis-3-amino-4-methoxypyrrolidine was used.
Properties: Pale yellow powder Melting point:> 164 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
3.13 (s, 3H), 3.73 (m, 2H), 3.93 (m, 1H), 5.38 (brs, 2H), 6.97 (m, 1H), 7.37 (m , 1H), 8.10 (d, J = 12 Hz, 1H), 8.71 (s, 1H)
〔実施例135〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−7−(3−(2−ヒドロキシエチルアミノ)ピロリジン)−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
3−(2−ヒドロキシエチルアミノ)ピロリジン二塩酸塩を用いたほかは実施例48と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>235℃(分解)
1HNMR(d6−DMSO)δ;
1.65−2.13(m,2H),2.52−2.70(m,2H),3.42−3.58(m,2H),4.55−4.73(m,1H),5.36(brs,2H),6.97(t,J=8Hz,1H),7.36(t,J=11Hz,1H),8.04(d,J=13Hz,1H),8.69(s,1H)
Example 135
1- (3-amino-4,6-difluorophenyl) -6-fluoro-7- (3- (2-hydroxyethylamino) pyrrolidine) -1,4-dihydro-4-oxo-1,8-naphthyridine 3-carboxylic acid:
The title compound was obtained in the same manner as in Example 48 except that 3- (2-hydroxyethylamino) pyrrolidine dihydrochloride was used.
Properties: Pale yellow powder Melting point:> 235 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.65-2.13 (m, 2H), 2.52-2.70 (m, 2H), 3.42-3.58 (m, 2H), 4.55-4.73 (m, 1H) ), 5.36 (brs, 2H), 6.97 (t, J = 8 Hz, 1H), 7.36 (t, J = 11 Hz, 1H), 8.04 (d, J = 13 Hz, 1H), 8.69 (s, 1H)
〔実施例136〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(7−アミノ−5−アザスピロ[2.4]ヘプタン−5−イル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸 塩酸塩:
7−tert−ブチルオキシカルボニルアミノ−5−アザスピロ[2.4]ヘプタンB体173mg、トリエチルアミン164mgをジメチルスルホキシド2mlに加え、80℃で加熱撹拌しながら1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸200mgを加え、そのまま一晩撹拌した。
放冷後、反応液にジエチルエーテルを加え、ジエチルエーテル層を減圧濃縮した。残渣にクロロホルムを加え、水で洗浄し、硫酸マグネシウムで乾燥後、溶媒を留去した。残渣にジエチルエーテルを加え、固体を濾取した。この固体にクロロホルム30ml、4規定塩酸−ジオキサン5mlを加え、室温で2時間撹拌した。反応液を減圧濃縮し、残渣にジエチルエーテルを加え、固体を濾取し、ジエチルエーテルで洗浄した。120mgの標記化合物を得た。
性状:黄色粉末
融点:>222℃(分解)
1HNMR(d6−DMSO)δ;
0.78(m,4H),3.26−4.44(m,6H),7.09(m,1H),7.41(m,1H),8.12(d,J=13Hz,1H),8.35(brs,3H),8.73(s,1H)
Example 136
1- (3-Amino-4,6-difluorophenyl) -7- (7-amino-5-azaspiro [2.4] heptan-5-yl) -6-fluoro-1,4-dihydro-4-oxo -1,8-naphthyridine-3-carboxylic acid hydrochloride:
7-tert-Butyloxycarbonylamino-5-azaspiro [2.4] heptane B-form 173 mg and triethylamine 164 mg were added to 2 ml of dimethyl sulfoxide, and 1- (3-amino-4,6-difluoro was heated and stirred at 80 ° C. Phenyl) -7-chloro-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid (200 mg) was added and the mixture was stirred overnight.
After allowing to cool, diethyl ether was added to the reaction solution, and the diethyl ether layer was concentrated under reduced pressure. Chloroform was added to the residue, washed with water, dried over magnesium sulfate, and the solvent was distilled off. Diethyl ether was added to the residue, and the solid was collected by filtration. To this solid was added 30 ml of chloroform and 5 ml of 4N hydrochloric acid-dioxane, and the mixture was stirred at room temperature for 2 hours. The reaction mixture was concentrated under reduced pressure, diethyl ether was added to the residue, and the solid was collected by filtration and washed with diethyl ether. 120 mg of the title compound were obtained.
Properties: Yellow powder Melting point:> 222 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
0.78 (m, 4H), 3.26-4.44 (m, 6H), 7.09 (m, 1H), 7.41 (m, 1H), 8.12 (d, J = 13 Hz, 1H), 8.35 (brs, 3H), 8.73 (s, 1H)
〔実施例137〕
7−(3−アミノアゼチジン−1−イル)−6−フルオロ−1−(2,4−ジフルオロ−5−メチルアミノフェニル)−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
7−クロロ−6−フルオロ−1−(2,4−ジフルオロ−5−メチルアミノフェニル)−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸と3−アミノアゼチジン二塩酸塩とトリエチルアミンを用いた他は、実施例117と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>231℃(分解)
1HNMR(d6−DMSO)δ;
2.69(d,J=4.3Hz,3H),3.80−4.80(m,5H),5.83(brs,1H),6.96(t,J=8Hz,1H),7.41(t,J=11Hz,1H),8.14(d,J=12Hz,1H),8.20−8.60(br,2H),8.76(s,1H)
Example 137
7- (3-Aminoazetidin-1-yl) -6-fluoro-1- (2,4-difluoro-5-methylaminophenyl) -1,4-dihydro-4-oxo-1,8-naphthyridine- 3-carboxylic acid:
7-Chloro-6-fluoro-1- (2,4-difluoro-5-methylaminophenyl) -1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid and 3-aminoazetidine The title compound was obtained in the same manner as in Example 117 except that dihydrochloride and triethylamine were used.
Properties: Pale yellow powder Melting point:> 231 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
2.69 (d, J = 4.3 Hz, 3H), 3.80-4.80 (m, 5H), 5.83 (brs, 1H), 6.96 (t, J = 8 Hz, 1H), 7.41 (t, J = 11 Hz, 1H), 8.14 (d, J = 12 Hz, 1H), 8.20-8.60 (br, 2H), 8.76 (s, 1H)
〔実施例138〕
7−[(3S)−3−アミノピロリジン−1−イル]−1−(3−エトキシカルボニルアミノ−4,6−ジフルオロフェニル)−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸:
1−(3−エトキシカルボニルアミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボン酸68mg、(3S)−3−アミノピロリジン70mgを350μlのN,N−ジメチルホルムアミドに加え、80℃で20分間撹拌した。ついで0.5mlのエタノールを加えて放冷し析出物を濾取、エタノール、ジイソプロピルエーテルの順に洗って、73mgの標記化合物を得た。
性状:無色粉末
融点:>280℃
1HNMR(d6−DMSO)δ;
1.23(t,J=7Hz,3H),1.34(m,1H),1.53−1.95(m,3H),2.42(m),2.74(m),4.12(q,J=7Hz,2H),7.63(t,J=10Hz,1H),7.95(t,J=8Hz,1H),7.99(d,J=7Hz,1H),8.63(s,1H)
Example 138
7-[(3S) -3-Aminopyrrolidin-1-yl] -1- (3-ethoxycarbonylamino-4,6-difluorophenyl) -6-fluoro-4-oxo-1,4-dihydro-1, 8-Naphthyridine-3-carboxylic acid:
68 mg of 1- (3-ethoxycarbonylamino-4,6-difluorophenyl) -7-chloro-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid, (3S) 70 mg of -3-aminopyrrolidine was added to 350 μl of N, N-dimethylformamide and stirred at 80 ° C. for 20 minutes. Subsequently, 0.5 ml of ethanol was added and the mixture was allowed to cool. The precipitate was collected by filtration and washed with ethanol and diisopropyl ether in this order to obtain 73 mg of the title compound.
Properties: Colorless powder Melting point:> 280 ° C
1 H NMR (d 6 -DMSO) δ;
1.23 (t, J = 7 Hz, 3H), 1.34 (m, 1H), 1.53-1.95 (m, 3H), 2.42 (m), 2.74 (m), 4 .12 (q, J = 7 Hz, 2H), 7.63 (t, J = 10 Hz, 1H), 7.95 (t, J = 8 Hz, 1H), 7.99 (d, J = 7 Hz, 1H) , 8.63 (s, 1H)
〔実施例139〕
7−(3−アミノアゼチジン−1−イル)−1−(3−アミノ−4,6−ジフルオロフェニル)−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
3−アミノアゼチジン二塩酸塩61mg、N−メチルピロリジン119mgのアセトニトリル3ml溶液を80℃で撹拌している中に1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸100mgを加え、80℃で2時間50分間撹拌した。反応液を放冷後、ジエチルエーテルでデカンテーションを行い、少量のエタノールを加えて固体を分散させ濾取した。固体をエタノール、ジエチルエーテルの順に洗い、63mgの標記化合物を得た。
性状:淡黄色粉末
融点:>240℃(分解)
1HNMR(d6−DMSO)δ;
3.50−4.48(br,5H),5.35(brs,2H),6.73(d,J=9Hz,1H),6.96(t,J=9Hz,1H),7.35(t,J=10Hz,1H),8.32(d,J=9Hz,1H),8.69(s,1H)
[Example 139]
7- (3-Aminoazetidin-1-yl) -1- (3-amino-4,6-difluorophenyl) -1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid:
While stirring a solution of 61 mg of 3-aminoazetidine dihydrochloride and 119 mg of N-methylpyrrolidine in 3 ml of acetonitrile at 80 ° C., 1- (3-amino-4,6-difluorophenyl) -7-chloro-1, 4-Dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid (100 mg) was added, and the mixture was stirred at 80 ° C. for 2 hours and 50 minutes. The reaction solution was allowed to cool and then decanted with diethyl ether. A small amount of ethanol was added to disperse the solid and collected by filtration. The solid was washed with ethanol and diethyl ether in this order to obtain 63 mg of the title compound.
Properties: Pale yellow powder Melting point:> 240 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
3.50-4.48 (br, 5H), 5.35 (brs, 2H), 6.73 (d, J = 9 Hz, 1H), 6.96 (t, J = 9 Hz, 1H), 7. 35 (t, J = 10 Hz, 1H), 8.32 (d, J = 9 Hz, 1H), 8.69 (s, 1H)
〔実施例140〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
(3S)−3−アミノピロリジンを用いたほかは実施例139と同様にして標記化合物を得た。
性状:淡赤褐色粉末
融点:>261℃(分解)
1HNMR(d6−DMSO)δ;
1.53−1.84(m,1H),1.84−2.15(m,1H),5.33(brs,2H),6.82(t,J=10Hz,1H),6.97(t,J=8Hz,1H),7.35(t,J=10Hz,1H),8.28(d,J=10Hz,1H),8.65(s,1H)
Example 140
1- (3-amino-4,6-difluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -1,4-dihydro-4-oxo-1,8-naphthyridine-3- carboxylic acid:
The title compound was obtained in the same manner as in Example 139 except that (3S) -3-aminopyrrolidine was used.
Properties: Light reddish brown powder Melting point:> 261 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.53-1.84 (m, 1H), 1.84-2.15 (m, 1H), 5.33 (brs, 2H), 6.82 (t, J = 10 Hz, 1H), 6. 97 (t, J = 8 Hz, 1H), 7.35 (t, J = 10 Hz, 1H), 8.28 (d, J = 10 Hz, 1H), 8.65 (s, 1H)
〔実施例141〕
1−(3−アミノ−6−クロロ−4−フルオロフェニル)−7−(3−アミノアゼチジン−1−イル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−6−クロロ−4−フルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸を用いたほかは実施例139と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:200−203℃
1HNMR(d6−DMSO)δ;
3.70−4.48(br,3H),5.69(brs,2H),6.96(d,J=8Hz,1H),7.46(d,J=12Hz,1H),8.04(d,J=12Hz,1H),8.62(s,1H)
[Example 141]
1- (3-Amino-6-chloro-4-fluorophenyl) -7- (3-aminoazetidin-1-yl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine -3-carboxylic acid:
Except that 1- (3-amino-6-chloro-4-fluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid was used The title compound was obtained in the same manner as in Example 139.
Property: Pale yellow powder Melting point: 200-203 ° C
1 H NMR (d 6 -DMSO) δ;
3.70-4.48 (br, 3H), 5.69 (brs, 2H), 6.96 (d, J = 8 Hz, 1H), 7.46 (d, J = 12 Hz, 1H), 8. 04 (d, J = 12 Hz, 1H), 8.62 (s, 1H)
〔実施例142〕
1−(3−アミノ−6−メチル−4−フルオロフェニル)−7−(3−アミノアゼチジン−1−イル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−6−メチル−4−フルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸を用いたほかは実施例117と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>238℃(分解)
1HNMR(d6−DMSO)δ;
1.82(s,3H),2.94−4.28(br,5H),5.27(brs,3H),6.74(d,J=9Hz,1H),7.09(d,J=12Hz,1H),8.09(d,J=10Hz,1H),8.52(s,1H)
Example 142
1- (3-Amino-6-methyl-4-fluorophenyl) -7- (3-aminoazetidin-1-yl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine -3-carboxylic acid:
Except that 1- (3-amino-6-methyl-4-fluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid was used The title compound was obtained in the same manner as in Example 117.
Properties: Pale yellow powder Melting point:> 238 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.82 (s, 3H), 2.94-4.28 (br, 5H), 5.27 (brs, 3H), 6.74 (d, J = 9 Hz, 1H), 7.09 (d, J = 12 Hz, 1H), 8.09 (d, J = 10 Hz, 1H), 8.52 (s, 1H)
〔実施例143〕
1−(3−アミノ−4−フルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−4−フルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸、(3S)−3−アミノピロリジンを用いたほかは実施例60と同様にして標記化合物を得た。
性状:褐色粉末
融点:262−265℃
1HNMR(d6−DMSO)δ;
1.56−1.83(m,1H),1.86−2.09(m,1H),5.50(brs,2H),6.67−6.78(m,1H),6.92(d,J=9Hz,1H),7.17(t,J=12Hz,1H),8.03(d,J=13Hz,1H),8.53(s,1H)
[Example 143]
1- (3-Amino-4-fluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine 3-carboxylic acid:
1- (3-amino-4-fluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, (3S) -3-aminopyrrolidine The title compound was obtained in the same manner as in Example 60 except that
Properties: Brown powder Melting point: 262-265 ° C
1 H NMR (d 6 -DMSO) δ;
1.56-1.83 (m, 1H), 1.86-2.09 (m, 1H), 5.50 (brs, 2H), 6.67-6.78 (m, 1H), 6. 92 (d, J = 9 Hz, 1H), 7.17 (t, J = 12 Hz, 1H), 8.03 (d, J = 13 Hz, 1H), 8.53 (s, 1H)
〔実施例144〕
1−(3−アミノ−4−フルオロフェニル)−7−[(3S,4S)−3−アミノ−4−メチルピロリジン−1−イル]−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−4−フルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸、(3S,4S)−3−アミノ−4−メチルピロリジンを用いたほかは実施例60と同様にして標記化合物を得た。
性状:褐色粉末
融点:>270℃
1HNMR(d6−DMSO)δ;
0.96(d,J=7Hz,3H),2.12(brs,1H),5.50(s,2H),6.68−6.76(m,1H),6.89−7.01(m,1H),7.19(t,J=11Hz,1H),8.03(d,J=13Hz,1H),8.53(s,1H)
[Example 144]
1- (3-Amino-4-fluorophenyl) -7-[(3S, 4S) -3-amino-4-methylpyrrolidin-1-yl] -6-fluoro-1,4-dihydro-4-oxo- 1,8-naphthyridine-3-carboxylic acid:
1- (3-amino-4-fluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, (3S, 4S) -3- The title compound was obtained in the same manner as in Example 60 except that amino-4-methylpyrrolidine was used.
Properties: Brown powder Melting point:> 270 ° C
1 H NMR (d 6 -DMSO) δ;
0.96 (d, J = 7 Hz, 3H), 2.12 (brs, 1H), 5.50 (s, 2H), 6.68-6.76 (m, 1H), 6.89-7. 01 (m, 1H), 7.19 (t, J = 11 Hz, 1H), 8.03 (d, J = 13 Hz, 1H), 8.53 (s, 1H)
〔実施例145〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(シス−3−ヒドロキシ−4−メチルピロリジン−1−イル)−6−フルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、シス−3−ヒドロキシ−4−メチルピロリジンを用いたほかは実施例60と同様にして標記化合物を得た。
性状:褐色粉末
融点:174−180℃
1HNMR(d6−DMSO)δ;
0.94(d,J=7Hz,3H),2.11(m,1H),2.86−3.81(m,4H),3.86(m,1H),5.18(brs,2H),5.93(d,J=6Hz,1H),7.04(t,J=8Hz,1H),7.50(t,J=10Hz,1H),7.86(d,J=13Hz,1H),8.62(s1H)
Example 145
1- (3-Amino-4,6-difluorophenyl) -7- (cis-3-hydroxy-4-methylpyrrolidin-1-yl) -6-fluoro-1,4-dihydro-4-oxoquinoline-3 -Carboxylic acid:
1- (3-Amino-4,6-difluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, cis-3-hydroxy-4-methylpyrrolidine was used. The title compound was obtained in the same manner as in Example 60 except for the above.
Properties: Brown powder Melting point: 174-180 ° C
1 H NMR (d 6 -DMSO) δ;
0.94 (d, J = 7 Hz, 3H), 2.11 (m, 1H), 2.86-3.81 (m, 4H), 3.86 (m, 1H), 5.18 (brs, 2H), 5.93 (d, J = 6 Hz, 1H), 7.04 (t, J = 8 Hz, 1H), 7.50 (t, J = 10 Hz, 1H), 7.86 (d, J = 13Hz, 1H), 8.62 (s1H)
〔実施例146〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(トランス−3−アミノ−4−メチルピロリジン−1−イル)−6−フルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、トランス−3−アミノ−4−メチルピロリジン二塩酸塩を用いたほかは実施例60と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>164℃(分解)
1HNMR(d6−DMSO)δ;
1.09(d,J=7Hz,3H),2.28(m,1H),2.97−3.91(m,5H),5.58(brs,2H),5.96(d,J=7Hz,1H),7.05(t,J=8Hz,1H),7.52(t,J=10Hz,1H),7.92(d,J=14Hz,1H),8.66(s1H)
Example 146
1- (3-Amino-4,6-difluorophenyl) -7- (trans-3-amino-4-methylpyrrolidin-1-yl) -6-fluoro-1,4-dihydro-4-oxoquinoline-3 -Carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, trans-3-amino-4-methylpyrrolidine dihydrochloride The title compound was obtained in the same manner as in Example 60 except that
Properties: Pale yellow powder Melting point:> 164 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.09 (d, J = 7 Hz, 3H), 2.28 (m, 1H), 2.97-3.91 (m, 5H), 5.58 (brs, 2H), 5.96 (d, J = 7 Hz, 1H), 7.05 (t, J = 8 Hz, 1H), 7.52 (t, J = 10 Hz, 1H), 7.92 (d, J = 14 Hz, 1H), 8.66 ( s1H)
〔実施例147〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−7−[(3S)−3−メチルアミノピロリジン−1−イル]−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、(3S)−3−メチルアミノピロリジンを用いたほかは実施例60と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:188−199℃
1HNMR(d6−DMSO)δ;
1.86(brs,1H),2.00(brs,1H),2.30(s,3H),3.11−3.66(m,5H),5,54(brs,2H),5.95(d,J=7Hz,1H),7.04(t,J=8Hz,1H),7.50(t,J=11Hz,1H),7.86(d,J=14Hz,1H),8.63(s,1H)
[Example 147]
1- (3-Amino-4,6-difluorophenyl) -6-fluoro-7-[(3S) -3-methylaminopyrrolidin-1-yl] -1,4-dihydro-4-oxoquinoline-3- carboxylic acid:
Besides using 1- (3-amino-4,6-difluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, (3S) -3-methylaminopyrrolidine Gave the title compound as in Example 60.
Properties: Pale yellow powder Melting point: 188-199 ° C
1 H NMR (d 6 -DMSO) δ;
1.86 (brs, 1H), 2.00 (brs, 1H), 2.30 (s, 3H), 3.11-3.66 (m, 5H), 5, 54 (brs, 2H), 5 .95 (d, J = 7 Hz, 1H), 7.04 (t, J = 8 Hz, 1H), 7.50 (t, J = 11 Hz, 1H), 7.86 (d, J = 14 Hz, 1H) , 8.63 (s, 1H)
〔実施例148〕
7−(3−アミノアゼチジン−1−イル)−1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、3−アミノアゼチジン二塩酸塩を用いたほかは実施例60と同様にして標記化合物を得た。
性状:無色粉末
融点:>183℃(分解)
1HNMR(d6−DMSO)δ;
3.76(brs,2H),3.91(m,1H),4.24(brs,2H),5.55(brs,2H),5.77(d,J=7Hz,1H),7.02(t,J=8Hz,1H),7.50(t,J=10,1H),7.88(d,J=12Hz,1H),8.64(s,1H)
Example 148
7- (3-Aminoazetidin-1-yl) -1- (3-amino-4,6-difluorophenyl) -6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
Other than using 1- (3-amino-4,6-difluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, 3-aminoazetidine dihydrochloride The title compound was obtained in the same manner as in Example 60.
Properties: Colorless powder Melting point:> 183 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
3.76 (brs, 2H), 3.91 (m, 1H), 4.24 (brs, 2H), 5.55 (brs, 2H), 5.77 (d, J = 7 Hz, 1H), 7 .02 (t, J = 8 Hz, 1H), 7.50 (t, J = 10, 1H), 7.88 (d, J = 12 Hz, 1H), 8.64 (s, 1H)
〔実施例149〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(トランス−3−アミノ−4−ヒドロキシピロリジン−1−イル)−6,8−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−6,7,8−トリフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、トランス−3−アミノ−4−ヒドロキシピロリジン二塩酸塩を用いたほかは実施例60と同様にして標記化合物を得た。
性状:褐色粉末
融点:>145℃(分解)
1HNMR(d6−DMSO)δ;
3.92−4.26(m,4H),5.46(brs,2H),7.10(t,J=9Hz,1H),7.40(t,J=11Hz,1H),7.86(d,J=14Hz,1H),8.52(s,1H)
[Example 149]
1- (3-amino-4,6-difluorophenyl) -7- (trans-3-amino-4-hydroxypyrrolidin-1-yl) -6,8-difluoro-1,4-dihydro-4-oxoquinoline -3-carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, trans-3-amino-4-hydroxypyrrolidine The title compound was obtained in the same manner as in Example 60 except that dihydrochloride was used.
Properties: Brown powder Melting point:> 145 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
3.92-4.26 (m, 4H), 5.46 (brs, 2H), 7.10 (t, J = 9 Hz, 1H), 7.40 (t, J = 11 Hz, 1H), 7. 86 (d, J = 14 Hz, 1H), 8.52 (s, 1H)
〔実施例150〕
7−(3−アミノアゼチジン−1−イル)−1−(3−アミノ−4,6−ジフルオロフェニル)−6,8−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−6,7,8−トリフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、3−アミノアゼチジン二塩酸塩を用いたほかは実施例60と同様にして標記化合物を得た。
性状:無色粉末
融点:>203℃(分解)
1HNMR(d6−DMSO)δ;
3.90(m,1H),4.10(m,1H),4.49(m,2H),5.46(brs,2H),7.08(t,J=9Hz,1H),7.39(t,J=10Hz,1H),7.81(d,J=13Hz,1H),8.48(s,1H)
Example 150
7- (3-Aminoazetidin-1-yl) -1- (3-amino-4,6-difluorophenyl) -6,8-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid :
1- (3-amino-4,6-difluorophenyl) -6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, 3-aminoazetidine dihydrochloride is used The title compound was obtained in the same manner as in Example 60 except that.
Properties: Colorless powder Melting point:> 203 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
3.90 (m, 1H), 4.10 (m, 1H), 4.49 (m, 2H), 5.46 (brs, 2H), 7.08 (t, J = 9 Hz, 1H), 7 .39 (t, J = 10 Hz, 1H), 7.81 (d, J = 13 Hz, 1H), 8.48 (s, 1H)
〔実施例151〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6,8−ジフルオロ−7−(3−ヒドロキシアゼチジン−1−イル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−6,7,8−トリフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、3−ヒドロキシアゼチジン塩酸塩を用いたほかは実施例60と同様にして標記化合物を得た。
性状:無色粉末
融点:218−225℃
1HNMR(d6−DMSO)δ;
4.13(brs,2H),4.50(brs,3H),5.44(brs,2H),5.72(brs,1H),7.08(t,J=8Hz,1H),7.39(t,J=10Hz,1H),7.79(d,J=13Hz,1H),8.46(s,1H)
[Example 151]
1- (3-Amino-4,6-difluorophenyl) -6,8-difluoro-7- (3-hydroxyazetidin-1-yl) -1,4-dihydro-4-oxoquinoline-3-carboxylic acid :
1- (3-Amino-4,6-difluorophenyl) -6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, 3-hydroxyazetidine hydrochloride was used. The title compound was obtained in the same manner as in Example 60 except for the above.
Properties: colorless powder Melting point: 218-225 ° C
1 H NMR (d 6 -DMSO) δ;
4.13 (brs, 2H), 4.50 (brs, 3H), 5.44 (brs, 2H), 5.72 (brs, 1H), 7.08 (t, J = 8 Hz, 1H), 7 .39 (t, J = 10 Hz, 1H), 7.79 (d, J = 13 Hz, 1H), 8.46 (s, 1H)
〔実施例152〕
7−(3−アミノアゼチジン−1−イル)−1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、3−アミノアゼチジン二塩酸塩を用いたほかは実施例60と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>270℃
1HNMR(d6−DMSO)δ;
3.75(m,1H),4.10(m,2H),4.66(m,2H),5.43(brs,2H),6.97(t,J=8Hz,1H),7.36(t,J=11Hz,1H),7.87(d,J=14Hz,1H),8.44(s,1H)
Example 152
7- (3-Aminoazetidin-1-yl) -1- (3-amino-4,6-difluorophenyl) -8-chloro-6-fluoro-1,4-dihydro-4-oxoquinoline-3- carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, 3-aminoazetidine dihydrochloride The title compound was obtained in the same manner as in Example 60 except that it was used.
Properties: Pale yellow powder Melting point:> 270 ° C
1 H NMR (d 6 -DMSO) δ;
3.75 (m, 1H), 4.10 (m, 2H), 4.66 (m, 2H), 5.43 (brs, 2H), 6.97 (t, J = 8 Hz, 1H), 7 .36 (t, J = 11 Hz, 1H), 7.87 (d, J = 14 Hz, 1H), 8.44 (s, 1H)
〔実施例153〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、(3S)−3−アミノピロリジンを用いたほかは実施例60と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>205℃(分解)
1HNMR(d6−DMSO)δ;
1.17(m,1H),2.09(m,1H),3.02−3.81(m,5H),5.41(brs,2H),6.97(m,1H),7.38(t,J=11Hz,1H),7.94(d,J=14Hz,1H),8.50(s,1H)
Example 153
1- (3-Amino-4,6-difluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -8-chloro-6-fluoro-1,4-dihydro-4-oxoquinoline -3-carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, (3S) -3-aminopyrrolidine The title compound was obtained in the same manner as in Example 60 except that it was used.
Properties: Pale yellow powder Melting point:> 205 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.17 (m, 1H), 2.09 (m, 1H), 3.02-3.81 (m, 5H), 5.41 (brs, 2H), 6.97 (m, 1H), 7 .38 (t, J = 11 Hz, 1H), 7.94 (d, J = 14 Hz, 1H), 8.50 (s, 1H)
〔実施例154〕
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6−フルオロ−7−(3−ヒドロキシアゼチジン−1−イル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、3−ヒドロキシアゼチジン塩酸塩を用いたほかは実施例60と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:145−150℃
1HNMR(d6−DMSO)δ;
4.18(brs,2H),4.47(brs,1H),4.71(brs,2H),5.41(brs,2H),5.71(d,J=5Hz,1H),6.96(t,J=8Hz,1H),7.37(t,J=10Hz,1H),7.88(d,J=14Hz,1H),8.44(s,1H)
Example 154
1- (3-Amino-4,6-difluorophenyl) -8-chloro-6-fluoro-7- (3-hydroxyazetidin-1-yl) -1,4-dihydro-4-oxoquinoline-3- carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, 3-hydroxyazetidine hydrochloride is used The title compound was obtained in the same manner as in Example 60 except that.
Properties: Pale yellow powder Melting point: 145-150 ° C
1 H NMR (d 6 -DMSO) δ;
4.18 (brs, 2H), 4.47 (brs, 1H), 4.71 (brs, 2H), 5.41 (brs, 2H), 5.71 (d, J = 5 Hz, 1H), 6 .96 (t, J = 8 Hz, 1H), 7.37 (t, J = 10 Hz, 1H), 7.88 (d, J = 14 Hz, 1H), 8.44 (s, 1H)
〔実施例155〕
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6−フルオロ−7−ピペラジノ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、ピペラジンを用いたほかは実施例60と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>232℃(分解)
1HNMR(d6−DMSO)δ;
2.87(brs,4H),3.19(brs,4H),5.43(brs,2H),6.97(t,J=8Hz,1H),7.37(t,J=11Hz,1H),8.
07(d,J=12Hz,1H),8.54(s,1H)
Example 155
1- (3-Amino-4,6-difluorophenyl) -8-chloro-6-fluoro-7-piperazino-1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
Example 60, except that 1- (3-amino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, piperazine was used To give the title compound.
Properties: Pale yellow powder Melting point:> 232 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
2.87 (brs, 4H), 3.19 (brs, 4H), 5.43 (brs, 2H), 6.97 (t, J = 8 Hz, 1H), 7.37 (t, J = 11 Hz, 1H), 8.
07 (d, J = 12 Hz, 1H), 8.54 (s, 1H)
〔実施例156〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3−アミノ−3−メチルアゼチジン−1−イル)−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、3−アミノ−3−メチルアゼチジンを用いたほかは実施例117と同様にして標記化合物を得た。
性状:黄色粉末
融点:252−257℃
1HNMR(d6−DMSO)δ;
1.35(s,3H),4.17(brs,2H),4.30(brs,2H),5.42(brs,2H),6.96(t,J=8Hz,1H),7.36(t,J=10Hz,1H),7.87(d,J=14Hz,1H),8.43(s,1H)
Example 156
1- (3-Amino-4,6-difluorophenyl) -7- (3-amino-3-methylazetidin-1-yl) -8-chloro-6-fluoro-1,4-dihydro-4-oxo Quinoline-3-carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, 3-amino-3-methylazetidine The title compound was obtained in the same manner as in Example 117 except that
Property: Yellow powder Melting point: 252-257 ° C
1 H NMR (d 6 -DMSO) δ;
1.35 (s, 3H), 4.17 (brs, 2H), 4.30 (brs, 2H), 5.42 (brs, 2H), 6.96 (t, J = 8 Hz, 1H), 7 .36 (t, J = 10 Hz, 1H), 7.87 (d, J = 14 Hz, 1H), 8.43 (s, 1H)
〔実施例157〕
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6−フルオロ−7−(3−メチルアミノアゼチジン−1−イル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、3−メチルアミノアゼチジンを用いたほかは実施例117と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:220−224℃
1HNMR(d6−DMSO)δ;
2.20(s,3H),3.45(brs,1H),4.12(brs,2H),4.63(brs,2H),5.42(brs,2H),6.96(t,J=8Hz,1H),7.36(t,J=10Hz,1H),7.86(d,J=14Hz,1H),8.43(s,1H)
Example 157
1- (3-Amino-4,6-difluorophenyl) -8-chloro-6-fluoro-7- (3-methylaminoazetidin-1-yl) -1,4-dihydro-4-oxoquinoline-3 -Carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, 3-methylaminoazetidine was used. The title compound was obtained in the same manner as in Example 117 except for above.
Property: Pale yellow powder Melting point: 220-224 ° C
1 H NMR (d 6 -DMSO) δ;
2.20 (s, 3H), 3.45 (brs, 1H), 4.12 (brs, 2H), 4.63 (brs, 2H), 5.42 (brs, 2H), 6.96 (t , J = 8 Hz, 1H), 7.36 (t, J = 10 Hz, 1H), 7.86 (d, J = 14 Hz, 1H), 8.43 (s, 1H)
〔実施例158〕
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6−フルオロ−7−(3,5−ジメチルピペラジノ)−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、2,6−ジメチルピペラジンを用いたほかは実施例117と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>270℃
1HNMR(d6−DMSO)δ;
0.96(d,J=6Hz,6H),2.80(m,2H),2.91(m,2H),3.08(m,2H),5.43(brs,2H),6.97(t,J=8Hz,1H),7.38(t,J=11Hz,1H),8.07(d,J=12Hz,1H),8.56(s,1H)
Example 158
1- (3-Amino-4,6-difluorophenyl) -8-chloro-6-fluoro-7- (3,5-dimethylpiperazino) -1,4-dihydro-4-oxoquinoline-3-carvone acid:
1- (3-Amino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, 2,6-dimethylpiperazine was used. The title compound was obtained in the same manner as in Example 117 except for above.
Properties: Pale yellow powder Melting point:> 270 ° C
1 H NMR (d 6 -DMSO) δ;
0.96 (d, J = 6 Hz, 6H), 2.80 (m, 2H), 2.91 (m, 2H), 3.08 (m, 2H), 5.43 (brs, 2H), 6 .97 (t, J = 8 Hz, 1H), 7.38 (t, J = 11 Hz, 1H), 8.07 (d, J = 12 Hz, 1H), 8.56 (s, 1H)
〔実施例159〕
7−(3−アミノアゼチジン−1−イル)−1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−5−ヒドロキシ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−5−ヒドロキシ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、3−アミノアゼチジン二塩酸塩を用いたほかは実施例60と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>262℃(分解)
1HNMR(d6−DMSO)δ;
3.75−4.02(m,3H),4.24(brs,2H),5.25(d,J=7Hz,1H),5.54(brs,2H),6.98(t,J=8Hz,1H),7.49(t,J=10Hz,1H),8.48(s,1H)
Example 159
7- (3-Aminoazetidin-1-yl) -1- (3-amino-4,6-difluorophenyl) -6-fluoro-5-hydroxy-1,4-dihydro-4-oxoquinoline-3- carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -6,7-difluoro-5-hydroxy-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, 3-aminoazetidine dihydrochloride The title compound was obtained in the same manner as in Example 60 except that it was used.
Properties: Pale yellow powder Melting point:> 262 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
3.75-4.02 (m, 3H), 4.24 (brs, 2H), 5.25 (d, J = 7 Hz, 1H), 5.54 (brs, 2H), 6.98 (t, J = 8 Hz, 1H), 7.49 (t, J = 10 Hz, 1H), 8.48 (s, 1H)
〔実施例160〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6−フルオロ−5−ヒドロキシ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−5−ヒドロキシ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、(3S)−3−アミノピロリジンを用いたほかは実施例60と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>237℃(分解)
1HNMR(d6−DMSO)δ;
2.01(m,1H),2.21(m,1H),3.34−4.97(m,5H),5.46(d,J=7Hz,1H),6.98(t,J=8Hz,1H),7.50(t,J=10Hz,1H),8.64(s,1H)
Example 160
1- (3-amino-4,6-difluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6-fluoro-5-hydroxy-1,4-dihydro-4-oxoquinoline -3-carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -6,7-difluoro-5-hydroxy-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, (3S) -3-aminopyrrolidine. The title compound was obtained in the same manner as in Example 60 except that it was used.
Properties: Pale yellow powder Melting point:> 237 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
2.01 (m, 1H), 2.21 (m, 1H), 3.34-4.97 (m, 5H), 5.46 (d, J = 7 Hz, 1H), 6.98 (t, J = 8 Hz, 1H), 7.50 (t, J = 10 Hz, 1H), 8.64 (s, 1H)
〔実施例161〕
7−(3−アミノアゼチジン−1−イル)−1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−5−メチル−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−5−メチル−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、3−アミノアゼチジン二塩酸塩を用いたほかは実施例60と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>270℃
1HNMR(d6−DMSO)δ;
2.75(brs.3H),3.90(brs,2H),4.01(brs,1H),4.26(brs,2H),5.55(brs,2H),5.65(d,J=7Hz,1H),6.99(t,J=8Hz,1H),7.49(t,J=11Hz,1H),8.59(s,1H)
Example 161
7- (3-Aminoazetidin-1-yl) -1- (3-amino-4,6-difluorophenyl) -6-fluoro-5-methyl-1,4-dihydro-4-oxoquinoline-3- carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -6,7-difluoro-5-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, 3-aminoazetidine dihydrochloride The title compound was obtained in the same manner as in Example 60 except that it was used.
Properties: Pale yellow powder Melting point:> 270 ° C
1 H NMR (d 6 -DMSO) δ;
2.75 (brs. 3H), 3.90 (brs, 2H), 4.01 (brs, 1H), 4.26 (brs, 2H), 5.55 (brs, 2H), 5.65 (d , J = 7 Hz, 1H), 6.99 (t, J = 8 Hz, 1H), 7.49 (t, J = 11 Hz, 1H), 8.59 (s, 1H)
〔実施例162〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6−フルオロ−5−メチル−1,4−ジヒトロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−5−メチル−1、4−ジヒドロ−4−オキソキノリン−3−カルボン酸、(3S)−3−アミノピロリジンを用いたほかは実施例60と同様にして標記化合物を得た。
性状:淡褐色粉末
融点:>197℃(分解)
1HNMR(d6−DMSO)δ;
1.68(m,1H),1.96(m,1H),3.01−3.65(m,5H),5.53(brs,2H),5.81(d,J=7Hz,1H),6.99(t,J=8Hz,1H),7.49(t,J=11Hz,1H),8.55(s,1H)
[Example 162]
1- (3-Amino-4,6-difluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6-fluoro-5-methyl-1,4-dihumanro-4-oxoquinoline -3-carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -6,7-difluoro-5-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, (3S) -3-aminopyrrolidine The title compound was obtained in the same manner as in Example 60 except that it was used.
Property: Light brown powder Melting point:> 197 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.68 (m, 1H), 1.96 (m, 1H), 3.01-3.65 (m, 5H), 5.53 (brs, 2H), 5.81 (d, J = 7 Hz, 1H), 6.99 (t, J = 8 Hz, 1H), 7.49 (t, J = 11 Hz, 1H), 8.55 (s, 1H)
〔実施例163〕
5−アミノ−1−(3−アミノ−4,6−ジフルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6,8−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
5−アミノ−1−(3−アミノ−4,6−ジフルオロフェニル)−6,7,8−トリフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、(3S)−3−アミノピロリジンを用いたほかは実施例60と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>247℃(分解)
1HNMR(d6−DMSO)δ;
1.62(m,1H),1.89(m,1H),3.22(m,1H),3.39−3.78(m,4H),5.38(brs,2H),7.02(t,J=8Hz,1H),7.23(brs,2H),7.34(t,J=10Hz,1H),8.23(s,1H)
[Example 163]
5-Amino-1- (3-amino-4,6-difluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6,8-difluoro-1,4-dihydro-4- Oxoquinoline-3-carboxylic acid:
5-amino-1- (3-amino-4,6-difluorophenyl) -6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, (3S) -3- The title compound was obtained in the same manner as in Example 60 except that aminopyrrolidine was used.
Properties: Pale yellow powder Melting point:> 247 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.62 (m, 1H), 1.89 (m, 1H), 3.22 (m, 1H), 3.39-3.78 (m, 4H), 5.38 (brs, 2H), 7 .02 (t, J = 8 Hz, 1H), 7.23 (brs, 2H), 7.34 (t, J = 10 Hz, 1H), 8.23 (s, 1H)
〔実施例164〕
5−アミノ−7−(3−アミノアゼチジン−1−イル)−1−(3−アミノ−4,6−ジフルオロフェニル)−6,8−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
5−アミノ−1−(3−アミノ−4,6−ジフルオロフェニル)−6,7,8−トリフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、3−アミノアゼチジン二塩酸塩を用いたほかは実施例60と同様にして標記化合物を得た。
性状:黄色粉末
融点:>237℃(分解)
1HNMR(d6−DMSO)δ;
4.04(brs,1H),4.28(brs,2H),4.48(brs,2H),5.41(brs,2H),7.05(t,J=8Hz,1H),7.30(m,1H),8.25(s,1H)
Example 164
5-Amino-7- (3-aminoazetidin-1-yl) -1- (3-amino-4,6-difluorophenyl) -6,8-difluoro-1,4-dihydro-4-oxoquinoline- 3-carboxylic acid:
5-amino-1- (3-amino-4,6-difluorophenyl) -6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, 3-aminoazetidine di The title compound was obtained in the same manner as in Example 60 except that hydrochloride was used.
Properties: Yellow powder Melting point:> 237 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
4.04 (brs, 1H), 4.28 (brs, 2H), 4.48 (brs, 2H), 5.41 (brs, 2H), 7.05 (t, J = 8 Hz, 1H), 7 .30 (m, 1H), 8.25 (s, 1H)
〔実施例165〕
7−(3−アミノアゼチジン−1−イル)−1−(3−アミノ−6−クロロ−4−フルオロフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−6−クロロ−4−フルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸を用いたほかは実施例139と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>208℃(分解)
1HNMR(d6−DMSO)δ;
3.88−4.58(br,5H),5.69(d,J=8Hz,1H),5.92(brs,2H),7.08(d,J=8Hz,1H),7.59(d,J=10Hz,1H),7.93(d,J=13Hz,1H),8.61(s,1H)
Example 165
7- (3-Aminoazetidin-1-yl) -1- (3-amino-6-chloro-4-fluorophenyl) -6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid :
Example 139 except that 1- (3-amino-6-chloro-4-fluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid was used The title compound was obtained.
Properties: Pale yellow powder Melting point:> 208 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
3.88-4.58 (br, 5H), 5.69 (d, J = 8 Hz, 1H), 5.92 (brs, 2H), 7.08 (d, J = 8 Hz, 1H), 7. 59 (d, J = 10 Hz, 1H), 7.93 (d, J = 13 Hz, 1H), 8.61 (s, 1H)
〔実施例166〕
エチル 7−クロロ−1−(2,4−ジフルオロ−5−ホルミルアミノフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボキシレートの別途合成:
エチル 7−クロロ−6−フルオロ−1−(2,4−ジフルオロ−5−ニトロフェニル)−4−オキソ−1,4−ジヒドロ−1,8−ナフチリジン−3−カルボキシレート305mgを400mgの鉄粉とともに1.5mlのぎ酸に加え80℃で3時間撹拌した。セライトを通して不溶物を濾別したのち、減圧下に濃縮し、析出物をエタノールに分散して濾取、エタノール、ジイソプロピルエーテルの順に洗って、295mgの標記化合物を淡黄色粉末として得た。
Example 166
Separate synthesis of ethyl 7-chloro-1- (2,4-difluoro-5-formylaminophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate:
400 mg of iron powder from 305 mg of ethyl 7-chloro-6-fluoro-1- (2,4-difluoro-5-nitrophenyl) -4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate The mixture was added to 1.5 ml of formic acid and stirred at 80 ° C. for 3 hours. Insoluble material was filtered off through celite, and concentrated under reduced pressure. The precipitate was dispersed in ethanol, collected by filtration, and washed successively with ethanol and diisopropyl ether to give 295 mg of the title compound as a pale yellow powder.
〔参考例10〕
N−(t−ブトキシカルボニル)−2,4−ジフルオロ−m−フェニレンジアミン:
エタノールの代わりにt−ブタノールを用いたほかは参考例8と同様にして、N−(t−ブトキシカルボニル)−2,4−ジフルオロ−5−ニトロアニリンを無色結晶として得た。
この3.8gを、360mgの10%パラジウム炭素とともに50mlのメタノールに加え、室温で4日間水素添加した。触媒を濾別したのち溶媒等を減圧下留去し、析出物をジイソプロピルエーテルに分散して濾取し標記化合物3.2gを淡褐色の結晶として得た。
[Reference Example 10]
N- (t-butoxycarbonyl) -2,4-difluoro-m-phenylenediamine:
N- (t-butoxycarbonyl) -2,4-difluoro-5-nitroaniline was obtained as colorless crystals in the same manner as in Reference Example 8 except that t-butanol was used instead of ethanol.
3.8 g of this was added to 50 ml of methanol along with 360 mg of 10% palladium on carbon and hydrogenated at room temperature for 4 days. After the catalyst was filtered off, the solvent and the like were distilled off under reduced pressure. The precipitate was dispersed in diisopropyl ether and collected by filtration to obtain 3.2 g of the title compound as pale brown crystals.
〔参考例11〕
エチル 8−クロロ−1−(2−クロロ−4−フルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
2−クロロ−4−フルオロアニリンを用いたほかは参考例6と同様にして標記化合物を得た。
性状:無色粉末
融点:208−212℃
1HNMR(CDCl3)δ;
1.40(t,J=7Hz,3H),4.40(q,J=7Hz,2H),7.16−7.23(m,1H),7.34(dd,J=3Hz,J=8Hz.1H),7.48(dd,J=5Hz,J=9Hz,1H),8.27(s,1H),8.35(t,J=9Hz,1H)
[Reference Example 11]
Ethyl 8-chloro-1- (2-chloro-4-fluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate:
The title compound was obtained in the same manner as in Reference Example 6 except that 2-chloro-4-fluoroaniline was used.
Properties: Colorless powder Melting point: 208-212 ° C
1 H NMR (CDCl 3 ) δ;
1.40 (t, J = 7 Hz, 3H), 4.40 (q, J = 7 Hz, 2H), 7.16-7.23 (m, 1H), 7.34 (dd, J = 3 Hz, J = 8Hz.1H), 7.48 (dd, J = 5Hz, J = 9Hz, 1H), 8.27 (s, 1H), 8.35 (t, J = 9Hz, 1H)
〔参考例12〕
エチル 8−クロロ−6,7−ジフルオロ−1−(4−フルオロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
4−フルオロアニリンを用いたほかは参考例6と同様にして標記化合物を得た。
性状:無色粉末
融点:226−231℃
1HNMR(CDCl3)δ;
1.39(t,J=7Hz,3H),4.39(q,J=7Hz,2H),7.20−7.24(m,2H),7.34−7.35(m,2H),8.34(t,J=9Hz,1H),8.42(s,1H)
[Reference Example 12]
Ethyl 8-chloro-6,7-difluoro-1- (4-fluorophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate:
The title compound was obtained in the same manner as in Reference Example 6 except that 4-fluoroaniline was used.
Properties: Colorless powder Melting point: 226-231 ° C
1 H NMR (CDCl 3 ) δ;
1.39 (t, J = 7 Hz, 3H), 4.39 (q, J = 7 Hz, 2H), 7.20-7.24 (m, 2H), 7.34-7.35 (m, 2H) ), 8.34 (t, J = 9 Hz, 1H), 8.42 (s, 1H)
〔参考例13〕
エチル 8−クロロ−6,7−ジフルオロ−1−(4−フルオロ−2−メチルフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
2−メチル−4−フルオロアニリンを用いたほかは参考例6と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:180−182℃
1HNMR(CDCl3)δ;
1.40(t,J=7Hz,3H),2.10(s,3H),4.40(q,J=7Hz,2H),7.02−7.10(m,2H),7.22−7.36(m,1H),8.31(s.1H),8.37(t,J=9Hz,1H)
[Reference Example 13]
Ethyl 8-chloro-6,7-difluoro-1- (4-fluoro-2-methylphenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate:
The title compound was obtained in the same manner as in Reference Example 6 except that 2-methyl-4-fluoroaniline was used.
Property: Pale yellow powder Melting point: 180-182 ° C
1 H NMR (CDCl 3 ) δ;
1.40 (t, J = 7 Hz, 3H), 2.10 (s, 3H), 4.40 (q, J = 7 Hz, 2H), 7.02-7.10 (m, 2H), 7. 22-7.36 (m, 1H), 8.31 (s.1H), 8.37 (t, J = 9 Hz, 1H)
〔参考例14〕
エチル 1−(2−ブロモ−4−フルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
2−ブロモ−4−フルオロアニリンを用いたほかは参考例6と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:183−188℃
1HNMR(CDCl3)δ;
1.40(t,J=7Hz,3H),4.40(q,J=7Hz,2H),7.18−7.32(m,1H),7.48−7.55(m,2H),8.27(s,1H),8.36(t,J=9Hz,1H)
[Reference Example 14]
Ethyl 1- (2-bromo-4-fluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate:
The title compound was obtained in the same manner as in Reference Example 6 except that 2-bromo-4-fluoroaniline was used.
Properties: Pale yellow powder Melting point: 183-188 ° C
1 H NMR (CDCl 3 ) δ;
1.40 (t, J = 7 Hz, 3H), 4.40 (q, J = 7 Hz, 2H), 7.18-7.32 (m, 1H), 7.48-7.55 (m, 2H) ), 8.27 (s, 1H), 8.36 (t, J = 9 Hz, 1H)
〔参考例15〕
エチル 1−(2−メトキシ−4−フルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
2−メトキシ−4−フルオロアニリンを用いたほかは参考例6と同様にして標記化合物を得た。
性状:無色粉末
融点:240−246℃(分解)
1HNMR(CDCl3)δ;
1.40(t,J=7Hz,3H),3.77(s,3H),4.39(q,、J=7Hz,2H),6.72−6.89(m,2H),7.31(dd,J=6Hz,J=9Hz,1H),8.30(s,1H),8.34(t,J=10Hz,1H)
[Reference Example 15]
Ethyl 1- (2-methoxy-4-fluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate:
The title compound was obtained in the same manner as in Reference Example 6 except that 2-methoxy-4-fluoroaniline was used.
Properties: colorless powder Melting point: 240-246 ° C. (decomposition)
1 H NMR (CDCl 3 ) δ;
1.40 (t, J = 7 Hz, 3H), 3.77 (s, 3H), 4.39 (q, J = 7 Hz, 2H), 6.72-6.89 (m, 2H), 7 .31 (dd, J = 6 Hz, J = 9 Hz, 1H), 8.30 (s, 1H), 8.34 (t, J = 10 Hz, 1H)
〔参考例16〕
エチル 8−クロロ−1−(4−クロロ−2−フルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
4−クロロ−2−フルオロアニリンを用いたほかは参考例6と同様にして標記化合物を得た。
性状:無色粉末
融点:159−160℃
1HNMR(CDCl3)δ;
1.40(t,J=7Hz,3H),4.39(q,J=7Hz,2H),7.31−7.47(m,2H),8.32−8.40(m,2H)
[Reference Example 16]
Ethyl 8-chloro-1- (4-chloro-2-fluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate:
The title compound was obtained in the same manner as in Reference Example 6 except that 4-chloro-2-fluoroaniline was used.
Properties: Colorless powder Melting point: 159-160 ° C
1 H NMR (CDCl 3 ) δ;
1.40 (t, J = 7 Hz, 3H), 4.39 (q, J = 7 Hz, 2H), 7.31-7.47 (m, 2H), 8.32-8.40 (m, 2H) )
〔参考例17〕
エチル 8−クロロ−6,7−ジフルオロ−1−(2,4,6−トリフルオロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
2,4,6−トリフルオロアニリンを用いたほかは参考例6と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:135−149℃(分解)
1HNMR(CDCl3)δ;
1.40(t,J=7Hz,3H),4.40(q,J=7Hz,2H),6.93(t,J=7Hz,1H),8.25(s,1H),8.34(t,J=10Hz,1H)
[Reference Example 17]
Ethyl 8-chloro-6,7-difluoro-1- (2,4,6-trifluorophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate:
The title compound was obtained in the same manner as in Reference Example 6 except that 2,4,6-trifluoroaniline was used.
Properties: Pale yellow powder Melting point: 135-149 ° C (decomposition)
1 H NMR (CDCl 3 ) δ;
1.40 (t, J = 7 Hz, 3H), 4.40 (q, J = 7 Hz, 2H), 6.93 (t, J = 7 Hz, 1H), 8.25 (s, 1H), 8. 34 (t, J = 10Hz, 1H)
〔参考例18〕
8−クロロ−6,7−ジフルオロ−1−(2,4,6−トリフルオロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
エチル 8−クロロ−6,7−ジフルオロ−1−(2,4,6−トリフルオロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート1.2gを濃塩酸5ml、酢酸1mlを加え、3時間加熱還流した。放冷後、析出した固体を濾取し、エタノール、ジエチルエーテルで洗浄した。標記化合物を750mg得た。
性状:淡赤色粉末
融点:>158℃(分解)
1HNMR(d6−DMSO)δ;
7.60−7.72(m,2H),8.41(t,J=9Hz,1H),9.01(s,1H)
[Reference Example 18]
8-Chloro-6,7-difluoro-1- (2,4,6-trifluorophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
1.2 g of ethyl 8-chloro-6,7-difluoro-1- (2,4,6-trifluorophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate is added to 5 ml of concentrated hydrochloric acid and 1 ml of acetic acid. And heated to reflux for 3 hours. After allowing to cool, the precipitated solid was collected by filtration and washed with ethanol and diethyl ether. 750 mg of the title compound was obtained.
Properties: Pale red powder Melting point:> 158 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
7.60-7.72 (m, 2H), 8.41 (t, J = 9 Hz, 1H), 9.01 (s, 1H)
〔実施例167〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(トランス−3−アミノ−2−メチルアゼチジン−1−イル)−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、トランス−3−アミノ−2−メチルアゼチジンを用いたほかは実施例117と同様にして標記化合物を得た。
性状:褐色粉末
融点:>211℃(分解)
1HNMR(d6−DMSO)δ;
1.38(brs,3H),3.73−3.90(m,1H),4.69−4.82(m,1H),4.82−4.97(m,1H),5.32−5.48(m,1H),5.49(s,1H),6.70−7.59(m,2H),7.94(d,J=14Hz,1H),8.48(s,1H)
Example 167
1- (3-Amino-4,6-difluorophenyl) -7- (trans-3-amino-2-methylazetidin-1-yl) -8-chloro-6-fluoro-1,4-dihydro-4 -Oxo-quinoline-3-carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, trans-3-amino-2-methyl The title compound was obtained in the same manner as in Example 117 except that azetidine was used.
Properties: Brown powder Melting point:> 211 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.38 (brs, 3H), 3.73-3.90 (m, 1H), 4.69-4.82 (m, 1H), 4.82-4.97 (m, 1H), 5. 32-5.48 (m, 1H), 5.49 (s, 1H), 6.70-7.59 (m, 2H), 7.94 (d, J = 14 Hz, 1H), 8.48 ( s, 1H)
〔実施例168〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(4−メチルピペラジン−1−イル)−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、4−メチルピペラジンを用いたほかは実施例117と同様にして標記化合物を得た。
性状:黄色粉末
融点:198−205℃(分解)
1HNMR(d6−DMSO)δ;
2.54(s,3H),2.81(brs,4H),3.42(brs,4H),7.01(t,J=7Hz,1H),7.40(t,J=11Hz,1H),8.15(d,J=12Hz,1H),8.62(s,1H)
Example 168
1- (3-Amino-4,6-difluorophenyl) -7- (4-methylpiperazin-1-yl) -8-chloro-6-fluoro-1,4-dihydro-4-oxo-quinoline-3- carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, except that 4-methylpiperazine was used The title compound was obtained in the same manner as in Example 117.
Properties: Yellow powder Melting point: 198-205 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
2.54 (s, 3H), 2.81 (brs, 4H), 3.42 (brs, 4H), 7.01 (t, J = 7 Hz, 1H), 7.40 (t, J = 11 Hz, 1H), 8.15 (d, J = 12 Hz, 1H), 8.62 (s, 1H)
〔実施例169〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−[(3S,4R)3−アミノ−4−メチルピロリジン−1−イル]−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、(3S,4R)3−アミノ−4−メチルピロリジンを用いたほかは実施例117と同様にして標記化合物を得た。
性状:黄色粉末
融点:170−179℃(分解)
1HNMR(d6−DMSO)δ;
0.95−1.11(m,3H),1.88−2.09(m,1H),2.60−3.72(m,5H),5.38(s,1H),5.46(s,1H),6.82−7.52(m,2H),7.96(d,J=14Hz,1H),8.40(brs,1H)
Example 169
1- (3-Amino-4,6-difluorophenyl) -7-[(3S, 4R) 3-amino-4-methylpyrrolidin-1-yl] -8-chloro-6-fluoro-1,4-dihydro -4-oxo-quinoline-3-carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, (3S, 4R) 3-amino- The title compound was obtained in the same manner as in Example 117 except that 4-methylpyrrolidine was used.
Property: Yellow powder Melting point: 170-179 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
0.95-1.11 (m, 3H), 1.88-2.09 (m, 1H), 2.60-3.72 (m, 5H), 5.38 (s, 1H), 5. 46 (s, 1H), 6.82-7.52 (m, 2H), 7.96 (d, J = 14 Hz, 1H), 8.40 (brs, 1H)
〔実施例170〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−[(3R)−3−アミノピロリジン−1−イル]−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、(3R)−3−アミノピロリジンを用いたほかは実施例117と同様にして標記化合物を得た。
性状:褐色粉末
融点:169−179℃(分解)
1HNMR(d6−DMSO)δ;
1.52−1.80(m,1H),1.84−2.07(m,1H),2.71−3.82(m,5H),5.40(brs,2H),6.93(m,1H),7.36(t,J=10Hz,1H),7.88(d,J=14Hz,1H),8.40(s,1H)
Example 170
1- (3-Amino-4,6-difluorophenyl) -7-[(3R) -3-aminopyrrolidin-1-yl] -8-chloro-6-fluoro-1,4-dihydro-4-oxo- Quinoline-3-carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, (3R) -3-aminopyrrolidine The title compound was obtained in the same manner as in Example 117 except that it was used.
Properties: Brown powder Melting point: 169-179 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.52-1.80 (m, 1H), 1.84-2.07 (m, 1H), 2.71-3.82 (m, 5H), 5.40 (brs, 2H), 6. 93 (m, 1H), 7.36 (t, J = 10 Hz, 1H), 7.88 (d, J = 14 Hz, 1H), 8.40 (s, 1H)
〔実施例171〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3−アミノアゼチジン−1−イル)−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸 p−トルエンスルホン酸塩:
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3−アミノアゼチジン−1−イル)−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸440mgをN,N−ジメチルホルムアミド0.5mlに加え、p−トルエンスルホン酸 一水和物191mgを加え室温で撹袢した。反応液にジエチルエーテルを加え、上澄みを除いた。残渣にエタノールを加え、固体を濾取し、ジエチルエーテルで洗浄し、340mgの標記化合物を得た。
性状:黄色粉末
融点:211−220℃(分解)
1HNMR(d6−DMSO)δ;
2.28(s,3H),4.04(brs,1H),4.42(brs,2H),4.76(brs,2H),6.99(t,J=8Hz,1H),7.11(d,J=7Hz,2H),7.37(t,J=11Hz,1H),7.48(d,J=8Hz,2H),7.94(d,J=15Hz,1H),8.33(brs,3H),8.44(s,1H)
[Example 171]
1- (3-Amino-4,6-difluorophenyl) -7- (3-aminoazetidin-1-yl) -8-chloro-6-fluoro-1,4-dihydro-4-oxo-quinoline-3 -Carboxylic acid p-toluenesulfonate:
1- (3-Amino-4,6-difluorophenyl) -7- (3-aminoazetidin-1-yl) -8-chloro-6-fluoro-1,4-dihydro-4-oxo-quinoline-3 -440 mg of carboxylic acid was added to 0.5 ml of N, N-dimethylformamide, 191 mg of p-toluenesulfonic acid monohydrate was added, and the mixture was stirred at room temperature. Diethyl ether was added to the reaction solution, and the supernatant was removed. Ethanol was added to the residue and the solid was collected by filtration and washed with diethyl ether to give 340 mg of the title compound.
Properties: Yellow powder Melting point: 211-220 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
2.28 (s, 3H), 4.04 (brs, 1H), 4.42 (brs, 2H), 4.76 (brs, 2H), 6.99 (t, J = 8 Hz, 1H), 7 .11 (d, J = 7 Hz, 2H), 7.37 (t, J = 11 Hz, 1H), 7.48 (d, J = 8 Hz, 2H), 7.94 (d, J = 15 Hz, 1H) , 8.33 (brs, 3H), 8.44 (s, 1H)
〔実施例172〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3−アミノアゼチジン−1−イル)−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸 メタンスルホン酸塩:
メタンスルホン酸を用いたほかは実施例171と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:180−190℃(分解)
1HNMR(d6−DMSO)δ;
2.35(s,3H),4.04(brs,1H),4.43(brs,2H),4.75(brs,2H),6.99(t,J=8Hz,1H),7.37(t,J=11Hz,1H),7.95(d,J=14Hz,1H),8.36(brs,3H),8.48(s,1H)
[Example 172]
1- (3-Amino-4,6-difluorophenyl) -7- (3-aminoazetidin-1-yl) -8-chloro-6-fluoro-1,4-dihydro-4-oxo-quinoline-3 -Carboxylic acid methanesulfonate:
The title compound was obtained in the same manner as in Example 171 except that methanesulfonic acid was used.
Properties: Pale yellow powder Melting point: 180-190 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
2.35 (s, 3H), 4.04 (brs, 1H), 4.43 (brs, 2H), 4.75 (brs, 2H), 6.99 (t, J = 8 Hz, 1H), 7 .37 (t, J = 11 Hz, 1H), 7.95 (d, J = 14 Hz, 1H), 8.36 (brs, 3H), 8.48 (s, 1H)
〔実施例173〕
エチル 8−クロロ−6,7−ジフルオロ−1−(2−クロロ−4−フルオロ−5−ニトロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 8−クロロ−6,7−ジフルオロ−1−(2−クロロ−4−フルオロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例97と同様にして標記化合物を得た。
性状:褐色粉末
融点:197−201℃
1HNMR(d6−DMSO)δ;
1.27(t,J=7Hz,3H),4.25(q,J=7Hz,2H),8.23−8.32(m,2H),8.55(s,1H),8.94(d,J=7Hz,1H)
[Example 173]
Ethyl 8-chloro-6,7-difluoro-1- (2-chloro-4-fluoro-5-nitrophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate:
The same procedure as in Example 97 except that ethyl 8-chloro-6,7-difluoro-1- (2-chloro-4-fluorophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate was used. To give the title compound.
Property: Brown powder Melting point: 197-201 ° C
1 H NMR (d 6 -DMSO) δ;
1.27 (t, J = 7 Hz, 3H), 4.25 (q, J = 7 Hz, 2H), 8.23-8.32 (m, 2H), 8.55 (s, 1H), 8. 94 (d, J = 7Hz, 1H)
〔実施例174〕
1−(3−アミノ−6−クロロ−4−フルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
エチル 8−クロロ−6,7−ジフルオロ−1−(2−クロロ−4−フルオロ−5−ニトロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート1.5g、鉄2gをぎ酸5mlに加え、60℃で2時間加熱撹拌した。不溶物をセライトで濾去し、ぎ酸、クロロホルムで洗浄した。濾液を減圧濃縮し、残渣にエタノールを加え、固体を濾取し、ジエチルエーテルで洗浄した。この固体に濃塩酸4ml、酢酸4mlを加え、1時間加熱還流した。放冷後、析出物を濾取し、エタノール、ジエチルエーテルで洗浄し標記化合物を970mg得た。
性状:淡黄色粉末
融点:237−242℃
1HNMR(d6−DMSO)δ;
7.12(d,J=8Hz,1H),7.50(d,J=12Hz,1H),8.41(t,J=9Hz,1H),8.60(s,1H)
Example 174
1- (3-Amino-6-chloro-4-fluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
1.5 g of ethyl 8-chloro-6,7-difluoro-1- (2-chloro-4-fluoro-5-nitrophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate, 2 g of iron The mixture was added to 5 ml of formic acid and stirred at 60 ° C. for 2 hours. The insoluble material was filtered off through celite and washed with formic acid and chloroform. The filtrate was concentrated under reduced pressure, ethanol was added to the residue, and the solid was collected by filtration and washed with diethyl ether. To this solid was added 4 ml of concentrated hydrochloric acid and 4 ml of acetic acid, and the mixture was heated to reflux for 1 hour. After allowing to cool, the precipitate was collected by filtration and washed with ethanol and diethyl ether to obtain 970 mg of the title compound.
Property: Pale yellow powder Melting point: 237-242 ° C
1 H NMR (d 6 -DMSO) δ;
7.12 (d, J = 8 Hz, 1H), 7.50 (d, J = 12 Hz, 1H), 8.41 (t, J = 9 Hz, 1H), 8.60 (s, 1H)
〔実施例175〕
7−(3−アミノアゼチジン−1−イル)−1−(3−アミノ−6−クロロ−4−フルオロフェニル)−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
8−クロロ−6,7−ジフルオロ−1−(3−アミノ−6−クロロ−4−フルオロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸を用いたほかは実施例117と同様にして標記化合物を得た。
性状:無色粉末
融点:>265℃(分解)
1HNMR(d6−DMSO)δ;
3.70(brs,1H),4.06(brs,2H),4.67(brs,2H),5.76(s,2H),6.99(d,J=8Hz,1H),7.46(d,J=11Hz,1H),7.88(d,J=14Hz,1H),8.48(s,1H)
Example 175
7- (3-Aminoazetidin-1-yl) -1- (3-amino-6-chloro-4-fluorophenyl) -8-chloro-6-fluoro-1,4-dihydro-4-oxo-quinoline -3-carboxylic acid:
Example 117 except that 8-chloro-6,7-difluoro-1- (3-amino-6-chloro-4-fluorophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylic acid was used To give the title compound.
Properties: colorless powder Melting point:> 265 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
3.70 (brs, 1H), 4.06 (brs, 2H), 4.67 (brs, 2H), 5.76 (s, 2H), 6.99 (d, J = 8 Hz, 1H), 7 .46 (d, J = 11 Hz, 1H), 7.88 (d, J = 14 Hz, 1H), 8.48 (s, 1H)
〔実施例176〕
1−(3−アミノ−6−クロロ−4−フルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
8−クロロ−6,7−ジフルオロ−1−(3−アミノ−6−クロロ−4−フルオロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、(3S)−3−アミノピロリジンを用いたほかは実施例117と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>195℃(分解)
1HNMR(d6−DMSO)δ;
1.52−1.74(m,1H),1.91−2.15(m,1H),2.71−3.80(m,5H),5.75(brs,2H),6.99(t,J=8Hz,1H),7.46(t,J=11Hz,1H),7.92(d,J=14Hz,1H),8.35(s,1H)
Example 176
1- (3-Amino-6-chloro-4-fluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -8-chloro-6-fluoro-1,4-dihydro-4- Oxo-quinoline-3-carboxylic acid:
8-chloro-6,7-difluoro-1- (3-amino-6-chloro-4-fluorophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylic acid, (3S) -3-amino The title compound was obtained in the same manner as in Example 117 except that pyrrolidine was used.
Properties: Pale yellow powder Melting point:> 195 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.52-1.74 (m, 1H), 1.91-2.15 (m, 1H), 2.71-3.80 (m, 5H), 5.75 (brs, 2H), 6. 99 (t, J = 8 Hz, 1H), 7.46 (t, J = 11 Hz, 1H), 7.92 (d, J = 14 Hz, 1H), 8.35 (s, 1H)
〔実施例177〕
エチル 8−クロロ−6,7−ジフルオロ−1−(4−フルオロ−5−ニトロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 8−クロロ−6,7−ジフルオロ−1−(4−フルオロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例97と同様にして標記化合物を得た。
性状:無色粉末
融点:249−256℃
1HNMR(d6−DMSO)δ;
1.26(t,J=7Hz,3H),4.23(q,J=7Hz,2H),7.84(t,J=10Hz,1H),8.14−8.19(m,1H),8.23(t,J=9Hz,1H),8.50(s,1H),8.65−8.68(m,1H)
Example 177
Ethyl 8-chloro-6,7-difluoro-1- (4-fluoro-5-nitrophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate:
The title compound was prepared in the same manner as in Example 97 except that ethyl 8-chloro-6,7-difluoro-1- (4-fluorophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate was used. Obtained.
Properties: Colorless powder Melting point: 249-256 ° C
1 H NMR (d 6 -DMSO) δ;
1.26 (t, J = 7 Hz, 3H), 4.23 (q, J = 7 Hz, 2H), 7.84 (t, J = 10 Hz, 1H), 8.14-8.19 (m, 1H) ), 8.23 (t, J = 9 Hz, 1H), 8.50 (s, 1H), 8.65-8.68 (m, 1H)
〔実施例178〕
8−クロロ−6,7−ジフルオロ−1−(3−アミノ−4−フルオロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
エチル 8−クロロ−5,6,7−トリフルオロ−1−(4−フルオロ−5−ニトロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例174と同様にして標記化合物を得た。
性状:無色粉末
融点:238−243℃
1HNMR(d6−DMSO)δ;
6.74−6.89(m,1H),6.95−7.07(m,1H),7.21(t,J=8Hz,1H),8.40(t,J=9Hz,1H),8.56(s,1H)
Example 178
8-Chloro-6,7-difluoro-1- (3-amino-4-fluorophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
Example 174 except that ethyl 8-chloro-5,6,7-trifluoro-1- (4-fluoro-5-nitrophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate was used To give the title compound.
Properties: Colorless powder Melting point: 238-243 ° C
1 H NMR (d 6 -DMSO) δ;
6.74-6.89 (m, 1H), 6.95-7.07 (m, 1H), 7.21 (t, J = 8 Hz, 1H), 8.40 (t, J = 9 Hz, 1H) ), 8.56 (s, 1H)
〔実施例179〕
7−(3−アミノアゼチジン−1−イル)−1−(3−アミノ−4−フルオロフェニル)−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
8−クロロ−6,7−ジフルオロ−1−(3−アミノ−4−フルオロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸を用いたほかは実施例117と同様にして標記化合物を得た。
性状:黄色粉末
融点:236−246℃(分解)
1HNMR(d6−DMSO)δ;
3.77(brs,1H),4.12(brs,2H),4.66(brs,2H),5.58(s,2H),6.60−6.72(m,1H),6.87(d,J=8Hz,1H),7.16(t,J=10Hz,1H),7.87(d,J=14Hz,1H),8.39(s,1H)
Example 179
7- (3-Aminoazetidin-1-yl) -1- (3-amino-4-fluorophenyl) -8-chloro-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carvone acid:
The same procedure as in Example 117 except that 8-chloro-6,7-difluoro-1- (3-amino-4-fluorophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylic acid was used. The title compound was obtained.
Properties: Yellow powder Melting point: 236-246 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
3.77 (brs, 1H), 4.12 (brs, 2H), 4.66 (brs, 2H), 5.58 (s, 2H), 6.60-6.72 (m, 1H), 6 .87 (d, J = 8 Hz, 1H), 7.16 (t, J = 10 Hz, 1H), 7.87 (d, J = 14 Hz, 1H), 8.39 (s, 1H)
〔実施例180〕
エチル 8−クロロ−6,7−ジフルオロ−1−(4−フルオロ−2−メチル−5−ニトロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 8−クロロ−6,7−ジフルオロ−1−(2−メチル−4−フルオロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例97と同様にして標記化合物を得た。
性状:赤色粉末
融点:187−191℃
1HNMR(CDCl3)δ;
1.40(t,J=7Hz,3H),2.25(s,3H),4.20(q,J=7Hz,2H),7.36(d,J=11Hz,1H),8.11(d,J=7Hz,1H)8.26(s,1H),8.38(t,J=9Hz,1H)
Example 180
Ethyl 8-chloro-6,7-difluoro-1- (4-fluoro-2-methyl-5-nitrophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate:
The same procedure as in Example 97 except that ethyl 8-chloro-6,7-difluoro-1- (2-methyl-4-fluorophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate was used. To give the title compound.
Property: Red powder Melting point: 187-191 ° C
1 H NMR (CDCl 3 ) δ;
1.40 (t, J = 7 Hz, 3H), 2.25 (s, 3H), 4.20 (q, J = 7 Hz, 2H), 7.36 (d, J = 11 Hz, 1H), 8. 11 (d, J = 7 Hz, 1H) 8.26 (s, 1H), 8.38 (t, J = 9 Hz, 1H)
〔実施例181〕
8−クロロ−6,7−ジフルオロ−1−(3−アミノ−4−フルオロ−6−メチルフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
エチル 8−クロロ−6,7−ジフルオロ−1−(4−フルオロ−2−メチル−5−ニトロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例174と同様にして標記化合物を得た。
性状:無色粉末
融点:225−230℃
1HNMR(d6−DMSO)δ;
1.89(s,3H),7.00(d,J=8Hz,1H),7.16(d,J=12Hz,1H),8.42(t,J=9Hz,1H),8.51(s,1H)
[Example 181]
8-chloro-6,7-difluoro-1- (3-amino-4-fluoro-6-methylphenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
Example except that ethyl 8-chloro-6,7-difluoro-1- (4-fluoro-2-methyl-5-nitrophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate was used The title compound was obtained in the same manner as 174.
Properties: Colorless powder Melting point: 225-230 ° C
1 H NMR (d 6 -DMSO) δ;
1.89 (s, 3H), 7.00 (d, J = 8 Hz, 1H), 7.16 (d, J = 12 Hz, 1H), 8.42 (t, J = 9 Hz, 1H), 8. 51 (s, 1H)
〔実施例182〕
1−(3−アミノ−4−フルオロ−6−メチルフェニル)−7−(3−アミノアゼチジン−1−イル)−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
8−クロロ−6,7−ジフルオロ−1−(3−アミノ−4−フルオロ−6−メチルフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸を用いたほかは実施例117と同様にして標記化合物を得た。
性状:褐色粉末
融点:>251℃(分解)
1HNMR(d6−DMSO)δ;
1.88(s,3H),3.71(brs,1H),4.06(brs,2H),4.65(brs,2H),5.38(s,2H),6.79(d,J=7Hz,1H),7.06(d,J=11Hz,1H),7.91(d,J=13Hz,1H),8.29(s,1H)
[Example 182]
1- (3-Amino-4-fluoro-6-methylphenyl) -7- (3-aminoazetidin-1-yl) -8-chloro-6-fluoro-1,4-dihydro-4-oxo-quinoline -3-carboxylic acid:
Example 117 except that 8-chloro-6,7-difluoro-1- (3-amino-4-fluoro-6-methylphenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylic acid was used To give the title compound.
Properties: Brown powder Melting point:> 251 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.88 (s, 3H), 3.71 (brs, 1H), 4.06 (brs, 2H), 4.65 (brs, 2H), 5.38 (s, 2H), 6.79 (d , J = 7 Hz, 1H), 7.06 (d, J = 11 Hz, 1H), 7.91 (d, J = 13 Hz, 1H), 8.29 (s, 1H)
〔実施例183〕
エチル 1−(2−ブロモ−4−フルオロ−5−ニトロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 1−(2−ブロモ−4−フルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例97と同様にして標記化合物を得た。
性状:褐色粉末
融点:205−214℃
1HNMR(d6−DMSO)δ;
1.27(t,J=7Hz,3H),4.25(q,J=7Hz,2H),8.27(t,J=9Hz,1H),8.41(d,J=11Hz,1H),8.53(s,1H),8.91(d,J=8Hz,1H)
[Example 183]
Ethyl 1- (2-bromo-4-fluoro-5-nitrophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate:
The same procedure as in Example 97 except that ethyl 1- (2-bromo-4-fluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate was used. To give the title compound.
Property: Brown powder Melting point: 205-214 ° C
1 H NMR (d 6 -DMSO) δ;
1.27 (t, J = 7 Hz, 3H), 4.25 (q, J = 7 Hz, 2H), 8.27 (t, J = 9 Hz, 1H), 8.41 (d, J = 11 Hz, 1H) ), 8.53 (s, 1H), 8.91 (d, J = 8 Hz, 1H)
〔実施例184〕
8−クロロ−6,7−ジフルオロ−1−(3−アミノ−6−ブロモ−4−フルオロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
エチル 1−(2−ブロモ−4−フルオロ−5−ニトロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例117と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:231−239℃
1HNMR(d6−DMSO)δ;
7.14(d,J=9Hz,1H),7.58(d,J=11Hz,1H),8.43(t,J=9Hz,1H),8.58(s,1H)
Example 184
8-Chloro-6,7-difluoro-1- (3-amino-6-bromo-4-fluorophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
Example 1 except that ethyl 1- (2-bromo-4-fluoro-5-nitrophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate was used The title compound was obtained in the same manner as 117.
Property: Pale yellow powder Melting point: 231-239 ° C
1 H NMR (d 6 -DMSO) δ;
7.14 (d, J = 9 Hz, 1H), 7.58 (d, J = 11 Hz, 1H), 8.43 (t, J = 9 Hz, 1H), 8.58 (s, 1H)
〔実施例185〕
7−(3−アミノアゼチジン−1−イル)−1−(3−アミノ−6−ブロモ−4−フルオロフェニル)−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
8−クロロ−6,7−ジフルオロ−1−(3−アミノ−6−ブロモ−4−フルオロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸を用いたほかは実施例117と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>200℃(分解)
1HNMR(d6−DMSO)δ;
3.89(brs,1H),4.27(brs,2H),4.71(brs,2H),5.81(s,2H),7.03(d,J=8Hz,1H),7.55(d,J=11Hz,1H),7.93(d,J=14Hz,1H),8.33(s,1H)
Example 185
7- (3-Aminoazetidin-1-yl) -1- (3-amino-6-bromo-4-fluorophenyl) -8-chloro-6-fluoro-1,4-dihydro-4-oxo-quinoline -3-carboxylic acid:
Example 117 except that 8-chloro-6,7-difluoro-1- (3-amino-6-bromo-4-fluorophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylic acid was used To give the title compound.
Properties: Pale yellow powder Melting point:> 200 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
3.89 (brs, 1H), 4.27 (brs, 2H), 4.71 (brs, 2H), 5.81 (s, 2H), 7.03 (d, J = 8 Hz, 1H), 7 .55 (d, J = 11 Hz, 1H), 7.93 (d, J = 14 Hz, 1H), 8.33 (s, 1H)
〔実施例186〕
エチル 1−(2−メトキシ−4−フルオロ−5−ニトロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 1−(2−メトキシ−4−フルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例97と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:220−225℃
1HNMR(CDCl3)δ;
1.40(t,J=7Hz,3H),3.92(s,3H),4.40(q,J=7Hz,2H),6.94(d,J=12Hz,1H),8.21−8.30(m,1H),8.26(s,1H),8.34(t,J=9Hz,1H)
Example 186
Ethyl 1- (2-methoxy-4-fluoro-5-nitrophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate:
The same procedure as in Example 97 except that ethyl 1- (2-methoxy-4-fluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate was used. To give the title compound.
Property: Pale yellow powder Melting point: 220-225 ° C
1 H NMR (CDCl 3 ) δ;
1.40 (t, J = 7 Hz, 3H), 3.92 (s, 3H), 4.40 (q, J = 7 Hz, 2H), 6.94 (d, J = 12 Hz, 1H), 8. 21-8.30 (m, 1H), 8.26 (s, 1H), 8.34 (t, J = 9 Hz, 1H)
〔実施例187〕
8−クロロ−6,7−ジフルオロ−1−(3−アミノ−6−メトキシ−4−フルオロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
エチル 1−(2−メトキシ−4−フルオロ−5−ニトロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例174と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:143−151℃
1HNMR(d6−DMSO)δ;
3.70(s,3H),7.19−7.37(m,2H),8.40(t,J=9H−z,1H),8.56(s,1H)
Example 187
8-chloro-6,7-difluoro-1- (3-amino-6-methoxy-4-fluorophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
Example 1 except that ethyl 1- (2-methoxy-4-fluoro-5-nitrophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate was used The title compound was obtained in the same manner as 174.
Properties: Pale yellow powder Melting point: 143-151 ° C
1 H NMR (d 6 -DMSO) δ;
3.70 (s, 3H), 7.19-7.37 (m, 2H), 8.40 (t, J = 9Hz, 1H), 8.56 (s, 1H)
〔実施例188〕
1−(3−アミノ−6−メトキシ−4−フルオロフェニル)−7−(3−アミノアゼチジン−1−イル)−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
8−クロロ−6,7−ジフルオロ−1−(3−アミノ−6−メトキシ−4−フルオロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸を用いたほかは実施例117と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>244℃(分解)
1HNMR(d6−DMSO)δ;
3.68(brs,4H),4.05(brs,2H),4.65(brs,2H),5.01(s,2H),6.87(brs,1H),7.09(d,J=12Hz,1H),7.86(d,J=14Hz,1H),8.29(s,1H)
Example 188
1- (3-Amino-6-methoxy-4-fluorophenyl) -7- (3-aminoazetidin-1-yl) -8-chloro-6-fluoro-1,4-dihydro-4-oxo-quinoline -3-carboxylic acid:
Example 117 except that 8-chloro-6,7-difluoro-1- (3-amino-6-methoxy-4-fluorophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylic acid was used To give the title compound.
Properties: Pale yellow powder Melting point:> 244 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
3.68 (brs, 4H), 4.05 (brs, 2H), 4.65 (brs, 2H), 5.01 (s, 2H), 6.87 (brs, 1H), 7.09 (d , J = 12 Hz, 1H), 7.86 (d, J = 14 Hz, 1H), 8.29 (s, 1H)
〔実施例189〕
エチル 1−(3−ベンジルオキシカルボニルアミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−5−ニトロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 3−クロロ−2,4,5−トリフルオロ−6−ニトロベンゾイルアセテートを用いたほかは実施例102と同様にして標記化合物を得た。
性状:褐色粉末
融点:233−241℃
1HNMR(d6−DMSO)δ;
1.38(t,J=7Hz,3H),4.38(q,J=7Hz,2H),5.21(s,2H),7.01−7.15(m,2H),7.40(s,5H),8.32−8.40(m,1H),8.36(s,1H)
Example 189
Ethyl 1- (3-benzyloxycarbonylamino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-5-nitro-1,4-dihydro-4-oxoquinoline-3-carboxylate:
The title compound was obtained in the same manner as in Example 102 except that ethyl 3-chloro-2,4,5-trifluoro-6-nitrobenzoyl acetate was used.
Properties: Brown powder Melting point: 233-241 ° C
1 H NMR (d 6 -DMSO) δ;
1.38 (t, J = 7 Hz, 3H), 4.38 (q, J = 7 Hz, 2H), 5.21 (s, 2H), 7.01-7.15 (m, 2H), 7. 40 (s, 5H), 8.32-8.40 (m, 1H), 8.36 (s, 1H)
〔実施例190〕
5−アミノ−1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
エチル 1−(3−ベンジルオキシカルボニルアミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−5−ニトロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例174と同様にして標記化合物を得た。
性状:黄色粉末
融点:>270℃
1HNMR(d6−DMSO)δ;
7.02(t,J=8Hz,1H),7.39(t.J=10Hz,1H),8.46(s,1H)
Example 190
5-Amino-1- (3-amino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
Use ethyl 1- (3-benzyloxycarbonylamino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-5-nitro-1,4-dihydro-4-oxoquinoline-3-carboxylate In the same manner as in Example 174, the title compound was obtained.
Property: Yellow powder Melting point:> 270 ° C
1 H NMR (d 6 -DMSO) δ;
7.02 (t, J = 8 Hz, 1H), 7.39 (t.J = 10 Hz, 1H), 8.46 (s, 1H)
〔実施例191〕
5−アミノ−1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3−アミノアゼチジン−1−イル)−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
5−アミノ−1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸を用いたほかは実施例117と同様にして標記化合物を得た。
性状:褐色粉末
融点:>229℃(分解)
1HNMR(d6−DMSO)δ;
3.98(brs,1H),4.38(brs,2H),4.67(brs,2H),5.39(s,2H),6.90(t,J=8Hz,1H),7.34(t,J=11Hz,1H),8.29(s,1H)
Example 191
5-Amino-1- (3-amino-4,6-difluorophenyl) -7- (3-aminoazetidin-1-yl) -8-chloro-6-fluoro-1,4-dihydro-4-oxo -Quinoline-3-carboxylic acid:
Implemented except using 5-amino-1- (3-amino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid The title compound was obtained in the same manner as in Example 117.
Properties: Brown powder Melting point:> 229 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
3.98 (brs, 1H), 4.38 (brs, 2H), 4.67 (brs, 2H), 5.39 (s, 2H), 6.90 (t, J = 8 Hz, 1H), 7 .34 (t, J = 11 Hz, 1H), 8.29 (s, 1H)
〔実施例192〕
エチル 1−(3−ベンジルオキシカルボニルアミノ−4,5,6−トリフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 3−クロロ−2,4,5−トリフルオロベンゾイルアセテート、N−ベンジルオキシカルボニル−4,5,6−トリフルオロ−m−フェニレンジアミンを用いたほかは実施例102と同様にして標記化合物を得た。
1HNMR(d6−DMSO)δ;
1.42(t,J=7Hz,3H),4.40(q,J=7Hz,2H),5.21(s,2H),7.05(brs,1H),7.39(s,5H),8.19(brs,1H),8.31(s,1H),8.34(t,J=8Hz,1H)
Example 192
Ethyl 1- (3-benzyloxycarbonylamino-4,5,6-trifluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate:
The title compound was prepared in the same manner as in Example 102 except that ethyl 3-chloro-2,4,5-trifluorobenzoyl acetate and N-benzyloxycarbonyl-4,5,6-trifluoro-m-phenylenediamine were used. Obtained.
1 H NMR (d 6 -DMSO) δ;
1.42 (t, J = 7 Hz, 3H), 4.40 (q, J = 7 Hz, 2H), 5.21 (s, 2H), 7.05 (brs, 1H), 7.39 (s, 5H), 8.19 (brs, 1H), 8.31 (s, 1H), 8.34 (t, J = 8 Hz, 1H)
〔実施例193〕
1−(3−アミノ−4,5,6−トリフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
エチル 1−(3−ベンジルオキシカルボニルアミノ−4,5,6−トリフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例103と同様にして標記化合物を得た。
性状:無色粉末
融点:232−238℃
1HNMR(d6−DMSO)δ;
6.88(dd,J=4Hz,J=9Hz,1H),8.40(t,J=9Hz,1H),8.79(s,1H)
Example 193
1- (3-Amino-4,5,6-trifluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
Ethyl 1- (3-benzyloxycarbonylamino-4,5,6-trifluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate was used. The title compound was obtained in the same manner as in Example 103 except for the above.
Property: Colorless powder Melting point: 232-238 ° C
1 H NMR (d 6 -DMSO) δ;
6.88 (dd, J = 4 Hz, J = 9 Hz, 1H), 8.40 (t, J = 9 Hz, 1H), 8.79 (s, 1H)
〔実施例194〕
7−(3−アミノアゼチジン−1−イル)−1−(3−アミノ−4,5,6−トリフルオロフェニル)−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,5,6−トリフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸を用いたほかは実施例117と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>224℃(分解)
1HNMR(d6−DMSO)δ;
3.73(brs,1H),4.08(brs,2H),4.68(brs,2H),5.78(s,2H),6.78(t,J=6Hz,1H),7.87(d,J=14Hz,1H),8.55(s,1H)
Example 194
7- (3-Aminoazetidin-1-yl) -1- (3-amino-4,5,6-trifluorophenyl) -8-chloro-6-fluoro-1,4-dihydro-4-oxoquinoline -3-carboxylic acid:
Examples except that 1- (3-amino-4,5,6-trifluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid was used The title compound was obtained in the same manner as 117.
Properties: Pale yellow powder Melting point:> 224 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
3.73 (brs, 1H), 4.08 (brs, 2H), 4.68 (brs, 2H), 5.78 (s, 2H), 6.78 (t, J = 6 Hz, 1H), 7 .87 (d, J = 14 Hz, 1H), 8.55 (s, 1H)
〔実施例195〕
エチル 1−(3−tert−ブチルオキシカルボニルアミノ−4,6−ジフルオロフェニル)−8−ブロモ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 3−ブロモ−2,4,5−トリフルオロベンゾイルアセテート、参考例10のN−(t−ブトキシカルボニル)−2,4−ジフルオロ−m−フェニレンジアミンを用いたほかは実施例102と同様にして標記化合物を得た。
1HNMR(CDCl3)δ;
1.40(t,J=7Hz,3H),1.54(s,9H),4.40(q,J=7Hz,2H),6.81(brs,1H),7.07(t,J=10Hz,1H),8.25−8.48(m,2H),8.38(s,1H)
Example 195
Ethyl 1- (3-tert-butyloxycarbonylamino-4,6-difluorophenyl) -8-bromo-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate:
Ethyl 3-bromo-2,4,5-trifluorobenzoyl acetate and Example 102 except that N- (t-butoxycarbonyl) -2,4-difluoro-m-phenylenediamine of Reference Example 10 was used. To give the title compound.
1 H NMR (CDCl 3 ) δ;
1.40 (t, J = 7 Hz, 3H), 1.54 (s, 9H), 4.40 (q, J = 7 Hz, 2H), 6.81 (brs, 1H), 7.07 (t, J = 10 Hz, 1H), 8.25-8.48 (m, 2H), 8.38 (s, 1H)
〔実施例196〕
1−(3−アミノ−4,6−ジフルオロフェニル)−8−ブロモ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
エチル 1−(3−tert−ブチルオキシカルボニルアミノ−4,6−ジフルオロフェニル)−8−ブロモ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例103と同様にして標記化合物を得た。
性状:黄色粉末
融点:228−232℃
1HNMR(d6−DMSO)δ;
7.05(t,J=8Hz,1H),7.43(t,J=11Hz,1H),8.43(t,J=9Hz,1H),8.69(s,1H)
Example 196
1- (3-Amino-4,6-difluorophenyl) -8-bromo-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
Besides using ethyl 1- (3-tert-butyloxycarbonylamino-4,6-difluorophenyl) -8-bromo-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate Gave the title compound as in Example 103.
Property: Yellow powder Melting point: 228-232 ° C
1 H NMR (d 6 -DMSO) δ;
7.05 (t, J = 8 Hz, 1H), 7.43 (t, J = 11 Hz, 1H), 8.43 (t, J = 9 Hz, 1H), 8.69 (s, 1H)
〔実施例197〕
7−(3−アミノアゼチジン−1−イル)−1−(3−アミノ−4,6−ジフルオロフェニル)−8−ブロモ−6−フルオロ−1,4−ジヒドロ−4−オキソ−キノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−8−ブロモ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸を用いたほかは実施例117と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>206℃(分解)
1HNMR(d6−DMSO)δ;
3.76(brs,1H),4.07(brs,2H),4.68(brs,2H),5.41(s,2H),6.92(t,J=8Hz,1H),7.38(t,J=11Hz,1H),7.90(d,J=14Hz,1H),8.46(s,1H)
Example 197
7- (3-Aminoazetidin-1-yl) -1- (3-amino-4,6-difluorophenyl) -8-bromo-6-fluoro-1,4-dihydro-4-oxo-quinoline-3 -Carboxylic acid:
Similar to Example 117 except that 1- (3-amino-4,6-difluorophenyl) -8-bromo-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid was used. To give the title compound.
Properties: Pale yellow powder Melting point:> 206 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
3.76 (brs, 1H), 4.07 (brs, 2H), 4.68 (brs, 2H), 5.41 (s, 2H), 6.92 (t, J = 8 Hz, 1H), 7 .38 (t, J = 11 Hz, 1H), 7.90 (d, J = 14 Hz, 1H), 8.46 (s, 1H)
〔実施例198〕
エチル 1−[3−(N−t−ブトキシカルボニル−N−メチルアミノ)−4,6−ジフルオロフェニル]−8−クロロ−6,7−ジフルオロ−4−オキソ−1,4−ジヒドロ−キノリン−3−カルボキシレート:
1.40gの3−クロロ−2,4,5−トリフルオロベンゾイル酢酸エチルエステルから常法によって作成した3−エトキシ−2−(3’−クロロ−2’,4’,5’−トリフルオロベンゾイル)アクリル酸エチルエステルを溶かしたクロロホルム溶液10mlに、N−(t−ブトキシカルボニル)−4,6−ジフルオロ−m−フェニレンジアミンをTLCで反応の終点を追いながら加えた。この溶液を減圧下に濃縮した。これに、1.4gの無水炭酸カリウムと6mlのN、N−ジメチルホルムアミドを加えて90℃で10分撹拌した。放冷したのち、さらに1.4gの無水炭酸カリウムと5.0gのヨウ化メチルを加えて60℃で2時間撹拌した。50mlのクロロホルムと500mlの蒸留水を加えて分液、ついでクロロホルム層を、500mlの蒸留水で2回洗浄した後、無水硫酸マグネシウムで乾燥後減圧下に濃縮し、3mlのエタノールを加えて放置した。析出物を濾取、エタノール、ジイソプロピルエーテルの順に洗って、1.38gの標記化合物を得た。
性状:淡黄色粉末
融点:192−194℃
1HNMR(CDCl3)δ;
1.43(t,J=7Hz,3H),1.44(s,9H),3.22(s,3H),4.41(q,J=7Hz,2H),7.10(t,J=9Hz,1H),7.38(t,J=8Hz,1H),8.34(dd,J=8Hz,10Hz,1H),8.58(s,1H)
Example 198
Ethyl 1- [3- (Nt-butoxycarbonyl-N-methylamino) -4,6-difluorophenyl] -8-chloro-6,7-difluoro-4-oxo-1,4-dihydro-quinoline- 3-carboxylate:
3-Ethoxy-2- (3′-chloro-2 ′, 4 ′, 5′-trifluorobenzoyl) prepared from 1.40 g of 3-chloro-2,4,5-trifluorobenzoylacetic acid ethyl ester by a conventional method ) N- (t-Butoxycarbonyl) -4,6-difluoro-m-phenylenediamine was added to 10 ml of a chloroform solution in which acrylic acid ethyl ester had been dissolved while following the end point of the reaction by TLC. The solution was concentrated under reduced pressure. To this, 1.4 g of anhydrous potassium carbonate and 6 ml of N, N-dimethylformamide were added and stirred at 90 ° C. for 10 minutes. After allowing to cool, 1.4 g of anhydrous potassium carbonate and 5.0 g of methyl iodide were further added and stirred at 60 ° C. for 2 hours. 50 ml of chloroform and 500 ml of distilled water were added for liquid separation, and the chloroform layer was washed twice with 500 ml of distilled water, then dried over anhydrous magnesium sulfate, concentrated under reduced pressure, and 3 ml of ethanol was added and left standing. . The precipitate was collected by filtration and washed with ethanol and diisopropyl ether in this order to obtain 1.38 g of the title compound.
Properties: Pale yellow powder Melting point: 192-194 ° C
1 H NMR (CDCl 3 ) δ;
1.43 (t, J = 7 Hz, 3H), 1.44 (s, 9H), 3.22 (s, 3H), 4.41 (q, J = 7 Hz, 2H), 7.10 (t, J = 9 Hz, 1H), 7.38 (t, J = 8 Hz, 1H), 8.34 (dd, J = 8 Hz, 10 Hz, 1H), 8.58 (s, 1H)
〔実施例199〕
1−(3−メチルアミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−4−オキソ−1,4−ジヒドロ−キノリン−3−カルボン酸:
エチル 1−[3−(N−t−ブトキシカルボニル−N−メチルアミノ)−4,6−ジフルオロフェニル]−8−クロロ−6,7−ジフルオロ−4−オキソ−1,4−ジヒドロ−キノリン−3−カルボキシレート1.26gを4mlの4規定塩酸と酢酸の混液(1;1,v/v)に加えて、1時間半撹拌加熱環流した。5mlの蒸留水を加えた後放冷し、析出物を濾取し、エタノール,ジイソプロピルエーテルの順に洗って890mgの標記化合物を得た。
性状:淡黄色粉末
融点:217−220℃
1HNMR(d6−DMSO)δ;
2.67(d,J=5Hz,3H),5.95(brs,1H),7.06(t,J=8Hz,1H),7.45(dd,J=10Hz,12Hz,1H),8.41(dd,J=9Hz,10Hz,1H),8.72(S,1H)
Example 199
1- (3-Methylamino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid:
Ethyl 1- [3- (Nt-butoxycarbonyl-N-methylamino) -4,6-difluorophenyl] -8-chloro-6,7-difluoro-4-oxo-1,4-dihydro-quinoline- 1.26 g of 3-carboxylate was added to 4 ml of a mixed solution of 4N hydrochloric acid and acetic acid (1; 1, v / v), and the mixture was refluxed with stirring for 1.5 hours. 5 ml of distilled water was added and the mixture was allowed to cool. The precipitate was collected by filtration and washed with ethanol and diisopropyl ether in this order to obtain 890 mg of the title compound.
Properties: Pale yellow powder Melting point: 217-220 ° C
1 H NMR (d 6 -DMSO) δ;
2.67 (d, J = 5 Hz, 3H), 5.95 (brs, 1H), 7.06 (t, J = 8 Hz, 1H), 7.45 (dd, J = 10 Hz, 12 Hz, 1H), 8.41 (dd, J = 9 Hz, 10 Hz, 1H), 8.72 (S, 1H)
〔実施例200〕
7−(3−アミノアゼチジニル)−1−(3−メチルアミノ−4,6−ジフルオロフェニル)−8−クロロ−6−フルオロ−4−オキソ−1,4−ジヒドロ−キノリン−3−カルボン酸:
1−(3−メチルアミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−4−オキソ−1,4−ジヒドロ−キノリン−3−カルボン酸150mg、3−アミノアゼチジン二塩酸塩110mg、N−メチルピロリジン250mgを650mgのN、N−ジメチルホルムアミドに加え、1時間90℃で撹拌した。0.5mlのエタノールを加えた後放冷し、析出物を濾取、エタノール、ジイソプロピルエーテルの順に洗って、130mgの標記化合物を得た。
性状:無色粉末
融点:209−212℃
1HNMR(d6−DMSO)δ;
2.68(d,J=5Hz,3H),3.69(m,1H),4.02(m,2H),4.65(m,2H),5.89(brs,1H),6.96(t,J=8Hz,1H),7.40(t,J=10Hz,1H),7.88(d,J=14Hz,1H),8.48(S,1H)
Example 200
7- (3-Aminoazetidinyl) -1- (3-methylamino-4,6-difluorophenyl) -8-chloro-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carvone acid:
1- (3-Methylamino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid 150 mg, 3-aminoazetidine di 110 mg of hydrochloride and 250 mg of N-methylpyrrolidine were added to 650 mg of N, N-dimethylformamide and stirred at 90 ° C. for 1 hour. 0.5 ml of ethanol was added and the mixture was allowed to cool. The precipitate was collected by filtration and washed with ethanol and diisopropyl ether in this order to obtain 130 mg of the title compound.
Properties: Colorless powder Melting point: 209-212 ° C
1 H NMR (d 6 -DMSO) δ;
2.68 (d, J = 5 Hz, 3H), 3.69 (m, 1H), 4.02 (m, 2H), 4.65 (m, 2H), 5.89 (brs, 1H), 6 .96 (t, J = 8 Hz, 1H), 7.40 (t, J = 10 Hz, 1H), 7.88 (d, J = 14 Hz, 1H), 8.48 (S, 1H)
〔実施例201〕
エチル 1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−8−メトキシ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 2,4,5−トリフルオロ−3−メトキシベンゾイルアセテート4.1gに無水酢酸8.6ml,オルト蟻酸トリエチル3.2mlを加え2時間加熱還流後、溶媒を留去し、残渣にトルエンを加え共沸させた。残渣にクロロホルム10mlを加え、0℃で、N−ベンジルオキシカルボニル−2,4−ジフルオロ−m−フェニレンジアミン1.81gのクロロホルム10ml溶液を滴下し、室温で3日間撹拌した。反応液の溶媒を留去し、シリカゲルカラムクロマトグラフィーに付し(溶出溶媒;酢酸エチル:ヘキサン=1:8)より精製し得た油状物2.4gのうち580mgのN,N−ジメチルホルムアミド4ml溶液へ、炭酸カリウム138mgを加え、100℃で25分間撹拌した。反応液を氷水中に注入し、反応液に氷水、酢酸エチルを加え有機層を分取し、水で洗い、硫酸マグネシウムで乾燥後、溶媒を留去し、残渣をシリカゲルカラムクロマトグラフィーに付し(溶出溶媒;クロロホルム:メタノール=10:1)、得た固体を濾取し、ジエチルエーテルで洗い標記化合物250mgを得た。
性状:淡黄色粉末
融点:159−162℃
1HNMR(CDCl3)δ;
1.39(t,J=7Hz,3H),3.57(s,3H),4.37(q,J=7Hz,2H),6.84(t,J=8Hz,1H),7.00(t,J=9Hz,1H),8.08(t,J=9Hz,1H),8.26(s,1H)
Example 201
Ethyl 1- (3-amino-4,6-difluorophenyl) -6,7-difluoro-8-methoxy-1,4-dihydro-4-oxoquinoline-3-carboxylate:
To 4.1 g of ethyl 2,4,5-trifluoro-3-methoxybenzoyl acetate, 8.6 ml of acetic anhydride and 3.2 ml of triethyl orthoformate were added and heated under reflux for 2 hours. The solvent was distilled off, and toluene was added to the residue. Azeotropically. To the residue was added 10 ml of chloroform, and at 0 ° C., a solution of 1.81 g of N-benzyloxycarbonyl-2,4-difluoro-m-phenylenediamine in 10 ml of chloroform was added dropwise and stirred at room temperature for 3 days. The solvent of the reaction solution was distilled off, and the residue was purified by silica gel column chromatography (elution solvent; ethyl acetate: hexane = 1: 8). Of the oily product 2.4 g, 580 mg of N, N-dimethylformamide 4 ml To the solution, 138 mg of potassium carbonate was added and stirred at 100 ° C. for 25 minutes. The reaction solution is poured into ice water, ice water and ethyl acetate are added to the reaction solution, the organic layer is separated, washed with water, dried over magnesium sulfate, the solvent is distilled off, and the residue is subjected to silica gel column chromatography. (Elution solvent; chloroform: methanol = 10: 1), the obtained solid was collected by filtration and washed with diethyl ether to obtain 250 mg of the title compound.
Properties: Pale yellow powder Melting point: 159-162 ° C
1 H NMR (CDCl 3 ) δ;
1.39 (t, J = 7 Hz, 3H), 3.57 (s, 3H), 4.37 (q, J = 7 Hz, 2H), 6.84 (t, J = 8 Hz, 1H), 7. 00 (t, J = 9 Hz, 1H), 8.08 (t, J = 9 Hz, 1H), 8.26 (s, 1H)
〔実施例202〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−8−メトキシ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
エチル 1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−8−メトキシ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例103と同様にして標記化合物を得た。
性状:無色粉末
融点:>277℃(分解)
1HNMR(d6−DMSO)δ;
3.12(s,3H),6.71(t,J=9Hz,1H),7.00(t,J=10Hz,1H),7.73(t,J=9Hz,1H),8.20(s,1H)
Example 202
1- (3-Amino-4,6-difluorophenyl) -6,7-difluoro-8-methoxy-1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
Example 103 except that ethyl 1- (3-amino-4,6-difluorophenyl) -6,7-difluoro-8-methoxy-1,4-dihydro-4-oxoquinoline-3-carboxylate was used In the same manner, the title compound was obtained.
Properties: Colorless powder Melting point:> 277 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
3.12 (s, 3H), 6.71 (t, J = 9 Hz, 1H), 7.00 (t, J = 10 Hz, 1H), 7.73 (t, J = 9 Hz, 1H), 8. 20 (s, 1H)
〔実施例203〕
7−(3−アミノアゼチジン−1−イル)−1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−8−メトキシ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−8−メトキシ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸170mgをジエチルエーテル4mlに懸濁させ、氷冷下三フッ化ホウ素ジエチルエーテル錯体9mlを加え、室温で1.5時間撹拌した。反応液にジエチルエーテルを加え析出した固体を濾取し、エタノール、ジエチルエーテルの順に洗い淡黄色粉末を得た。
3−アミノアゼチジン・2塩酸塩70mg、トリエチルアミン0.17mlのジメチルスルホキシド1ml溶液を70℃で撹拌し、上記の化合物100mgを加え、同温で2時間撹拌した。反応液にジエチルエーテルを加えデカントを行い、残渣に80%メタノール5ml、トリエチルアミン5mlを加え一晩還流し、反応液にエタノールを加え固体を濾取し、黄褐色粉末の標記化合物34mgを得た。
性状:黄色粉末
融点:>290℃
1HNMR(d6−DMSO)δ;
3.11(s,3H),3.74−3.89(m,2H),3.90−4.02(m,1H),4.38−4.48(m,2H),5.36(brs,2H),7.14(t,J=9Hz,1H),7.30(t,J=10Hz,1H),7.76(d,J=12Hz,1H),8.39(s,1H)
Example 203
7- (3-Aminoazetidin-1-yl) -1- (3-amino-4,6-difluorophenyl) -6-fluoro-8-methoxy-1,4-dihydro-4-oxoquinoline-3- carboxylic acid:
170 mg of 1- (3-amino-4,6-difluorophenyl) -6,7-difluoro-8-methoxy-1,4-dihydro-4-oxoquinoline-3-carboxylic acid was suspended in 4 ml of diethyl ether, Under ice-cooling, 9 ml of boron trifluoride diethyl ether complex was added and stirred at room temperature for 1.5 hours. Diethyl ether was added to the reaction solution, and the precipitated solid was collected by filtration and washed with ethanol and diethyl ether in this order to obtain a pale yellow powder.
A solution of 70 mg of 3-aminoazetidine dihydrochloride and 0.17 ml of triethylamine in 1 ml of dimethyl sulfoxide was stirred at 70 ° C., 100 mg of the above compound was added, and the mixture was stirred at the same temperature for 2 hours. Diethyl ether was added to the reaction solution, followed by decantation. The residue was refluxed overnight with 5 ml of 80% methanol and 5 ml of triethylamine. Ethanol was added to the reaction solution and the solid was collected by filtration to obtain 34 mg of the title compound as a tan powder.
Property: Yellow powder Melting point:> 290 ° C
1 H NMR (d 6 -DMSO) δ;
3.11 (s, 3H), 3.74-3.89 (m, 2H), 3.90-4.02 (m, 1H), 4.38-4.48 (m, 2H), 5. 36 (brs, 2H), 7.14 (t, J = 9 Hz, 1H), 7.30 (t, J = 10 Hz, 1H), 7.76 (d, J = 12 Hz, 1H), 8.39 ( s, 1H)
〔実施例204〕
8−クロロ−6,7−ジフルオロ−1−(2,4,6−トリフルオロ−3−ニトロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
8−クロロ−6,7−ジフルオロ−1−(2,4,6−トリフルオロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸を用いたほかは実施例9と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:157−159℃
1HNMR(d6−DMSO)δ;
8.16(t,J=11Hz,1H),8.40(t,J=9Hz,1H),9.06(s,1H)
Example 204
8-chloro-6,7-difluoro-1- (2,4,6-trifluoro-3-nitrophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
The same as Example 9 except that 8-chloro-6,7-difluoro-1- (2,4,6-trifluorophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylic acid was used. To give the title compound.
Properties: Pale yellow powder Melting point: 157-159 ° C
1 H NMR (d 6 -DMSO) δ;
8.16 (t, J = 11 Hz, 1H), 8.40 (t, J = 9 Hz, 1H), 9.06 (s, 1H)
〔実施例205〕
エチル 8−クロロ−6,7−ジフルオロ−1−(2,4,6−トリフルオロ−3−ニトロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
8−クロロ−6,7−ジフルオロ−1−(2,4,6−トリフルオロ−3−ニトロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸(830mg)に塩化チオニル2mlを加え80℃で一晩撹拌した。反応液に氷冷下エタノール4mlをゆつくりと滴下したのち、反応液の溶媒を留去し析出した固体を濾取し標記化合物310mgを得た。
性状:淡黄色粉末
融点:167−169℃
1HNMR(CDCl3)δ;
1.41(t,J=7Hz,3H),4.41(q,J=7Hz,2H),7.19(t,J=9Hz,1H),8.22(s,1H),8.35(t,J=9Hz,1H)
Example 205
Ethyl 8-chloro-6,7-difluoro-1- (2,4,6-trifluoro-3-nitrophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate:
2-chloro-6,7-difluoro-1- (2,4,6-trifluoro-3-nitrophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylic acid (830 mg) in 2 ml of thionyl chloride And stirred at 80 ° C. overnight. After slowly adding dropwise 4 ml of ethanol to the reaction solution under ice cooling, the solvent of the reaction solution was distilled off and the precipitated solid was collected by filtration to obtain 310 mg of the title compound.
Properties: Pale yellow powder Melting point: 167-169 ° C
1 H NMR (CDCl 3 ) δ;
1.41 (t, J = 7 Hz, 3H), 4.41 (q, J = 7 Hz, 2H), 7.19 (t, J = 9 Hz, 1H), 8.22 (s, 1H), 8. 35 (t, J = 9Hz, 1H)
〔実施例206〕
エチル 8−クロロ−6,7−ジフルオロ−1−(2,4,6−トリフルオロ−3−ホルミルアミノフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 8−クロロ−6,7−ジフルオロ−1−(2,4,6−トリフルオロ−3−ニトロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例166と同様にして標記化合物を得た。
性状:淡褐色粉末
融点:197−199℃
Example 206
Ethyl 8-chloro-6,7-difluoro-1- (2,4,6-trifluoro-3-formylaminophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate:
Except for using ethyl 8-chloro-6,7-difluoro-1- (2,4,6-trifluoro-3-nitrophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate The title compound was obtained in the same manner as in Example 166.
Properties: Light brown powder Melting point: 197-199 ° C
〔実施例207〕
1−(3−アミノ−2,4,6−トリフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
エチル 8−クロロ−6,7−ジフルオロ−1−(2,4,6−トリフルオロ−3−ホルミルアミノフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例19と同様にして標記化合物を得た。
性状:淡黄色粉末
1HNMR(d6−DMSO)δ;
5.57(brs,2H),7.42(t,J=11Hz,1H),8.40(t,J=9Hz,1H),8.91(s,1H)
Example 207
1- (3-Amino-2,4,6-trifluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
Other than using ethyl 8-chloro-6,7-difluoro-1- (2,4,6-trifluoro-3-formylaminophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate The title compound was obtained in the same manner as in Example 19.
Properties: Pale yellow powder
1 H NMR (d 6 -DMSO) δ;
5.57 (brs, 2H), 7.42 (t, J = 11 Hz, 1H), 8.40 (t, J = 9 Hz, 1H), 8.91 (s, 1H)
〔実施例208〕
7−(3−アミノアゼチジン−1−イル)−1−(3−アミノ−2,4,6−トリフルオロフェニル)−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−2,4,6−トリフルオロフェニル)−8−クロロ−6.7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸を用いたほかは実施例117と同様にして標記化合物を得た。
性状:淡褐色粉末
融点:>290℃
1HNMR(d6−DMSO)δ;
3.77−3.86(m,1H),4.15−4.27(m,2H),4.64−4.75(m,1H),5.52(brs,2H),7.38(t,J=10Hz,1H),7.91(d,J=13Hz,1H),8.66(s,1H)
Example 208
7- (3-Aminoazetidin-1-yl) -1- (3-amino-2,4,6-trifluorophenyl) -8-chloro-6-fluoro-1,4-dihydro-4-oxoquinoline -3-carboxylic acid:
Examples except that 1- (3-amino-2,4,6-trifluorophenyl) -8-chloro-6.7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid was used The title compound was obtained in the same manner as 117.
Properties: Light brown powder Melting point:> 290 ° C
1 H NMR (d 6 -DMSO) δ;
3.77-3.86 (m, 1H), 4.15-4.27 (m, 2H), 4.64-4.75 (m, 1H), 5.52 (brs, 2H), 7. 38 (t, J = 10 Hz, 1H), 7.91 (d, J = 13 Hz, 1H), 8.66 (s, 1H)
〔実施例209〕
エチル 1−(3−ベンジルオキシカルボニルアミノ−4,6−ジフルオロフェニル)−6−クロロ−7,8−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 5−クロロ−2,3,4−トリフルオロベンゾイルアセテート、3−ベンジルオキシカルボニル−2,4−ジフルオロ−m−フェニレンジアミンを用いたほかは実施例102と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:204−205℃
1HNMR(CDCl3)δ;
1.39(t,J=7Hz,3H),4.38(q,J−7Hz,2H),7.02(brs,1H),7.11(t,J=10Hz,1H),7.39(s,5H),8.28(s,1H),8.35−8.50(m,2H)
Example 209
Ethyl 1- (3-benzyloxycarbonylamino-4,6-difluorophenyl) -6-chloro-7,8-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate:
The title compound was obtained in the same manner as in Example 102 except that ethyl 5-chloro-2,3,4-trifluorobenzoyl acetate and 3-benzyloxycarbonyl-2,4-difluoro-m-phenylenediamine were used.
Properties: Pale yellow powder Melting point: 204-205 ° C
1 H NMR (CDCl 3 ) δ;
1.39 (t, J = 7 Hz, 3H), 4.38 (q, J-7 Hz, 2H), 7.02 (brs, 1H), 7.11 (t, J = 10 Hz, 1H), 7. 39 (s, 5H), 8.28 (s, 1H), 8.35-8.50 (m, 2H)
〔実施例210〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6−クロロ−7,8−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
エチル 1−(3−ベンジルオキシカルボニルアミノ−4,6−ジフルオロフェニル)−6−クロロ−7,8−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例103と同様にして標記化合物を得た。
性状:無色粉末
融点:276−278℃
1HNMR(d6−DMSO)δ;
7.15(t,J=9Hz,1H),7.45(t,J=11Hz,1H),8.38(d,J=8Hz,1H),8.73(s,1H)
Example 210
1- (3-Amino-4,6-difluorophenyl) -6-chloro-7,8-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
Implemented except using ethyl 1- (3-benzyloxycarbonylamino-4,6-difluorophenyl) -6-chloro-7,8-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate The title compound was obtained in the same manner as in Example 103.
Properties: colorless powder Melting point: 276-278 ° C
1 H NMR (d 6 -DMSO) δ;
7.15 (t, J = 9 Hz, 1H), 7.45 (t, J = 11 Hz, 1H), 8.38 (d, J = 8 Hz, 1H), 8.73 (s, 1H)
〔実施例211〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−[(3S)−3−アミノピロリジン−1−イル]−6−クロロ−8−フルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−6−クロロ−7,8−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸を用いたほかは実施例60と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>240℃(分解)
1HNMR(d6−DMSO)δ;
1.51−1.68(m,1H),1.88−2.04(m,1H),5.44(brs,2H),7.09(t,J=8Hz,1H),7.39(t,J=11Hz,1H),8.05(s,1H),8.48(s,1H)
Example 211
1- (3-amino-4,6-difluorophenyl) -7-[(3S) -3-aminopyrrolidin-1-yl] -6-chloro-8-fluoro-1,4-dihydro-4-oxoquinoline -3-carboxylic acid:
Similar to Example 60 except that 1- (3-amino-4,6-difluorophenyl) -6-chloro-7,8-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid was used. To give the title compound.
Properties: Pale yellow powder Melting point:> 240 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
1.51-1.68 (m, 1H), 1.88-2.04 (m, 1H), 5.44 (brs, 2H), 7.09 (t, J = 8 Hz, 1H), 7. 39 (t, J = 11 Hz, 1H), 8.05 (s, 1H), 8.48 (s, 1H)
〔実施例212〕
7−(3−アミノアゼチジン−1−イル)−1−(3−アミノ−4,6−ジフルオロフェニル)−6−クロロ−8−フルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−6−クロロ−7,8−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、3−アミノアゼチジン二塩酸塩を用いたほかは実施例60と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:190−193℃
1HNMR(d6−DMSO)δ;
3.65−3.77(m,1H),3.97−4.10(m,2H),4.52−4.68(m,2H),5.44(brs,2H),7.07(t,J=8Hz,1H),7.38(t,J=11Hz,1H),7.96(s,1H),8.45(s,1H)
Example 212
7- (3-Aminoazetidin-1-yl) -1- (3-amino-4,6-difluorophenyl) -6-chloro-8-fluoro-1,4-dihydro-4-oxoquinoline-3- carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -6-chloro-7,8-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, 3-aminoazetidine dihydrochloride The title compound was obtained in the same manner as in Example 60 except that it was used.
Properties: Pale yellow powder Melting point: 190-193 ° C
1 H NMR (d 6 -DMSO) δ;
3.65-3.77 (m, 1H), 3.97-4.10 (m, 2H), 4.52-4.68 (m, 2H), 5.44 (brs, 2H), 7. 07 (t, J = 8 Hz, 1H), 7.38 (t, J = 11 Hz, 1H), 7.96 (s, 1H), 8.45 (s, 1H)
〔実施例213〕
エチル 8−クロロ−1−(4−クロロ−2−フルオロ−5−ニトロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 8−クロロ−1−(4−クロロ−2−フルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例97と同様にして標記化合物を得た。
性状:無色粉末
融点:206−208℃
1HNMR(CDCl3)δ;
1.40(t,J=7Hz,3H),4.40(q,J=7Hz,2H),7.57(d,J=9Hz,1H),8.16(d,J=7Hz,1H),8.30(s,1H),8.34(t,J=10Hz,1H)
[Example 213]
Ethyl 8-chloro-1- (4-chloro-2-fluoro-5-nitrophenyl) -6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate:
The same as Example 97 except that ethyl 8-chloro-1- (4-chloro-2-fluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate was used. To give the title compound.
Properties: Colorless powder Melting point: 206-208 ° C
1 H NMR (CDCl 3 ) δ;
1.40 (t, J = 7 Hz, 3H), 4.40 (q, J = 7 Hz, 2H), 7.57 (d, J = 9 Hz, 1H), 8.16 (d, J = 7 Hz, 1H) ), 8.30 (s, 1H), 8.34 (t, J = 10 Hz, 1H)
〔実施例214〕
エチル 8−クロロ−1−(4−クロロ−6−フルオロ−3−ホルミルアミノフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 8−クロロ−1−(4−クロロ−2−フルオロ−5−ニトロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例166と同様にして標記化合物を得た。
性状:淡褐色粉末
融点:241−244℃
Example 214
Ethyl 8-chloro-1- (4-chloro-6-fluoro-3-formylaminophenyl) -6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate:
Example except that ethyl 8-chloro-1- (4-chloro-2-fluoro-5-nitrophenyl) -6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate was used Similar to 166, the title compound was obtained.
Property: Light brown powder Melting point: 241-244 ° C
〔実施例215〕
1−(3−アミノ−4−クロロ−6−フルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
エチル 8−クロロ−1−(4−クロロ−6−フルオロ−3−ホルミルアミノフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例19と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:255−258℃
1HNMR(d6−DMSO)δ;
7.08(d,J=7Hz,1H),7.55(d,J=10Hz,1H),8.40(t,J=9Hz,1H),8.70(s,1H)
[Example 215]
1- (3-Amino-4-chloro-6-fluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
Implemented except using ethyl 8-chloro-1- (4-chloro-6-fluoro-3-formylaminophenyl) -6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate The title compound was obtained in the same manner as in Example 19.
Property: Pale yellow powder Melting point: 255-258 ° C
1 H NMR (d 6 -DMSO) δ;
7.08 (d, J = 7 Hz, 1H), 7.55 (d, J = 10 Hz, 1H), 8.40 (t, J = 9 Hz, 1H), 8.70 (s, 1H)
〔実施例216〕
7−(3−アミノアゼチジン−1−イル)−1−(3−アミノ−4−クロロ−6−フルオロフェニル)−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4−クロロ−6−フルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、3−アミノアゼチジン二塩酸塩を用いたほかは実施例60と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:>290℃
1HNMR(d6−DMSO)δ;
3.66−3.79(m,1H),4.00−4.15(m,2H),4.60−4.74(m,2H),5.61(brs,2H),7.00(d,J=10Hz,1H),7.50(d,J=10Hz,1H),7.87(d,J=14Hz,1H)
[Example 216]
7- (3-Aminoazetidin-1-yl) -1- (3-amino-4-chloro-6-fluorophenyl) -8-chloro-6-fluoro-1,4-dihydro-4-oxoquinoline- 3-carboxylic acid:
1- (3-Amino-4-chloro-6-fluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, 3-aminoazetidine dihydrochloride The title compound was obtained in the same manner as in Example 60 except that the salt was used.
Properties: Pale yellow powder Melting point:> 290 ° C
1 H NMR (d 6 -DMSO) δ;
3.66-3.79 (m, 1H), 4.00-4.15 (m, 2H), 4.60-4.74 (m, 2H), 5.61 (brs, 2H), 7. 00 (d, J = 10 Hz, 1H), 7.50 (d, J = 10 Hz, 1H), 7.87 (d, J = 14 Hz, 1H)
〔実施例217〕
エチル 1−(3−t−ブトキシカルボニルアミノ−4−フルオロ−2−メトキシフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 3−クロロ−2,4,5−トリフルオロベンゾイルアセテート、3−t−ブトキシカルボニルアミノ−4−フルオロ−2−メトキシアニリンを用いたほかは実施例102と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:184−189℃
1HNMR(CDCl3)δ;
1.39(t,J=7Hz,3H),3.64(s,3H),4.39(q,J=7Hz,2H),6.05(brs,1H),7.06(t,J=8Hz,1H),7.21−7.29(m,1H),8.31−8.40(m,2H)
[Example 217]
Ethyl 1- (3-t-butoxycarbonylamino-4-fluoro-2-methoxyphenyl) -6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate:
The title compound was obtained in the same manner as in Example 102 except that ethyl 3-chloro-2,4,5-trifluorobenzoyl acetate and 3-t-butoxycarbonylamino-4-fluoro-2-methoxyaniline were used.
Properties: Pale yellow powder Melting point: 184-189 ° C
1 H NMR (CDCl 3 ) δ;
1.39 (t, J = 7 Hz, 3H), 3.64 (s, 3H), 4.39 (q, J = 7 Hz, 2H), 6.05 (brs, 1H), 7.06 (t, J = 8 Hz, 1H), 7.21-7.29 (m, 1H), 8.31-8.40 (m, 2H)
〔実施例218〕
1−(3−アミノ−4−フルオロ−2−メトキシフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
エチル 1−(3−t−ブトキシカルボニルアミノ−4−フルオロ−2−メトキシフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例103と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:203−215℃(分解)
1HNMR(d6−DMSO)δ;
3.43(s,3H).6.78−6.90(m,1H),7.08(t,J=8Hz,1H),8.42(t,J=7Hz,1H),8.61(s.1H)
Example 218
1- (3-Amino-4-fluoro-2-methoxyphenyl) -6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
Example 1 except that ethyl 1- (3-t-butoxycarbonylamino-4-fluoro-2-methoxyphenyl) -6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate was used The title compound was obtained in the same manner as 103.
Properties: Pale yellow powder Melting point: 203-215 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
3.43 (s, 3H). 6.78-6.90 (m, 1H), 7.08 (t, J = 8 Hz, 1H), 8.42 (t, J = 7 Hz, 1H), 8.61 (s.1H)
〔実施例219〕
7−(3−アミノアゼチジン−1−イル)−1−(3−アミノ−4−フルオロ−2−メトキシフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4−フルオロ−2−メトキシフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸、3−アミノアゼチジン二塩酸塩、N−メチルピロリジンを用いたほかは実施例117と同様にして標記化合物を得た。
性状:無色粉末
融点:>179℃(分解)
1HNMR(d6−DMSO)δ;
3.42(s,3H),3.96−4.13(m,2H),4.55−4.72(m,2H),5.40(brs,2H),6.71−6.83(m,1H),7.03(t,J=7Hz,1H),7.88(d,J=14Hz,1H),8.39(s,1H)
[Example 219]
7- (3-Aminoazetidin-1-yl) -1- (3-amino-4-fluoro-2-methoxyphenyl) -6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid :
1- (3-amino-4-fluoro-2-methoxyphenyl) -6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, 3-aminoazetidine dihydrochloride, N- The title compound was obtained in the same manner as in Example 117 except that methylpyrrolidine was used.
Properties: Colorless powder Melting point:> 179 ° C (decomposition)
1 H NMR (d 6 -DMSO) δ;
3.42 (s, 3H), 3.96-4.13 (m, 2H), 4.55-4.72 (m, 2H), 5.40 (brs, 2H), 6.71-6. 83 (m, 1H), 7.03 (t, J = 7 Hz, 1H), 7.88 (d, J = 14 Hz, 1H), 8.39 (s, 1H)
〔実施例220〕
エチル 6,7,8−トリクロロ−1−(3−ベンジルオキシカルボニルアミノ−4,6−ジフルオロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 2,3,4,5−テトラクロロベンゾイルアセテートと、3−ベンジルオキシカルボニル−2,4−ジフルオロ−m−フェニレンジアミンを用いたほかは実施例102と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:128−129℃
1HNMR(CDCl3)δ;
1.40(t,J=7Hz,3H),4.40(q,J=7Hz,2H),7.03−7.14(m,2H),7.40(s,5H),8.27(s,1H),8.60(s,1H)
Example 220
Ethyl 6,7,8-trichloro-1- (3-benzyloxycarbonylamino-4,6-difluorophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate:
The title compound was obtained in the same manner as in Example 102 except that ethyl 2,3,4,5-tetrachlorobenzoyl acetate and 3-benzyloxycarbonyl-2,4-difluoro-m-phenylenediamine were used.
Properties: Pale yellow powder Melting point: 128-129 ° C
1 H NMR (CDCl 3 ) δ;
1.40 (t, J = 7 Hz, 3H), 4.40 (q, J = 7 Hz, 2H), 7.03-7.14 (m, 2H), 7.40 (s, 5H), 8. 27 (s, 1H), 8.60 (s, 1H)
〔実施例221〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6,7,8−トリクロロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
エチル 6,7,8−トリクロロ−1−(3−ベンジルオキシカルボニルアミノ−4,6−ジフルオロフェニル)−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例103と同様にして標記化合物を得た。
性状:無色粉末
融点:251−252℃
1HNMR(d6−DMSO)δ;
7.01(t,J=8Hz,1H),7.41(t,J=10Hz,1H),8.52(s,1H),8.66(s,1H)
[Example 221]
1- (3-Amino-4,6-difluorophenyl) -6,7,8-trichloro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
Example 103, except that ethyl 6,7,8-trichloro-1- (3-benzyloxycarbonylamino-4,6-difluorophenyl) -1,4-dihydro-4-oxoquinoline-3-carboxylate was used To give the title compound.
Properties: Colorless powder Melting point: 251-252 ° C
1 H NMR (d 6 -DMSO) δ;
7.01 (t, J = 8 Hz, 1H), 7.41 (t, J = 10 Hz, 1H), 8.52 (s, 1H), 8.66 (s, 1H)
〔実施例222〕
エチル 1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−8−メチル−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレート:
エチル 2,4,5−トリフルオロ−3−メチルベンゾイルアセテートを用いたほかは実施例201と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:221−223℃
1HNMR(CDCl3)δ;
1.38(t,J=7Hz,3H),1.85(s,3H),3.98(brs,2H),4.37(q,J=7Hz,2H),6.81(t,J=8Hz,1H),7.02(t,J=10Hz,1H),8.19(t,J=10Hz,1H),8.32(s,1H)
Example 222
Ethyl 1- (3-amino-4,6-difluorophenyl) -6,7-difluoro-8-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylate:
The title compound was obtained in the same manner as in Example 201 except that ethyl 2,4,5-trifluoro-3-methylbenzoyl acetate was used.
Property: Pale yellow powder Melting point: 221-223 ° C
1 H NMR (CDCl 3 ) δ;
1.38 (t, J = 7 Hz, 3H), 1.85 (s, 3H), 3.98 (brs, 2H), 4.37 (q, J = 7 Hz, 2H), 6.81 (t, J = 8 Hz, 1H), 7.02 (t, J = 10 Hz, 1H), 8.19 (t, J = 10 Hz, 1H), 8.32 (s, 1H)
〔実施例223〕
1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−8−メチル−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
エチル 1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−8−メチル−1,4−ジヒドロ−4−オキソキノリン−3−カルボキシレートを用いたほかは実施例103と同様にして標記化合物を得た。
性状:淡黄色粉末
融点:264−267℃
1HNMR(d6−DMSO)δ;
1.86(d,J=3Hz,1H),7.12(t,J=8Hz,1H),7,47(t,J=11Hz,1H),8.25(t,J=9Hz,1H),8.69(s,1H)
[Example 223]
1- (3-Amino-4,6-difluorophenyl) -6,7-difluoro-8-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
Example 103 except that ethyl 1- (3-amino-4,6-difluorophenyl) -6,7-difluoro-8-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylate was used In the same manner, the title compound was obtained.
Properties: Pale yellow powder Melting point: 264-267 ° C
1 H NMR (d 6 -DMSO) δ;
1.86 (d, J = 3 Hz, 1H), 7.12 (t, J = 8 Hz, 1H), 7, 47 (t, J = 11 Hz, 1H), 8.25 (t, J = 9 Hz, 1H) ), 8.69 (s, 1H)
〔実施例224〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3−アミノメチル−3−ヒドロキシアゼチジン−1−イル)−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸と3−アミノメチル−3−ヒドロキシアゼチジン二塩酸塩とトリエチルアミンを用いた他は、実施例117と同様にして標記化合物を得た。
性状;淡黄色粉末
融点:>209℃(分解)
1HNMR(d6−DMSO)δ;
2.83(brs,2H),4.21(brs,2H),4.52(brs,2H),5.42(brs,2H),6.90−7.10(m,1H),7.36(t,1H),7.85(d,J=14.5Hz,1H),8.39(s,1H)
[Example 224]
1- (3-Amino-4,6-difluorophenyl) -7- (3-aminomethyl-3-hydroxyazetidin-1-yl) -8-chloro-6-fluoro-1,4-dihydro-4- Oxoquinoline-3-carboxylic acid:
1- (3-Amino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid and 3-aminomethyl-3-hydroxyazeti The title compound was obtained in the same manner as in Example 117 except that gin dihydrochloride and triethylamine were used.
Properties: Pale yellow powder melting point:> 209 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
2.83 (brs, 2H), 4.21 (brs, 2H), 4.52 (brs, 2H), 5.42 (brs, 2H), 6.90-7.10 (m, 1H), 7 .36 (t, 1H), 7.85 (d, J = 14.5 Hz, 1H), 8.39 (s, 1H)
〔実施例225〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3−アミノメチルアゼチジン−1−イル)−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸と3−アミノメチルアゼチジン二塩酸塩とトリエチルアミンを用いた他は、実施例117と同様にして標記化合物を得た。
性状;淡黄色粉末
融点:>217℃(分解)
1HNMR(d6−DMSO+d−TFA)δ;
2.89(brs,1H),3.11(brs,2H),4.29(brs,2H),4.58(brs,2H),6.90−7.05(m,1H),7.36(t,1H),7.90(d,J=13Hz,1H),8.46(s,1H)
Example 225
1- (3-Amino-4,6-difluorophenyl) -7- (3-aminomethylazetidin-1-yl) -8-chloro-6-fluoro-1,4-dihydro-4-oxoquinoline-3 -Carboxylic acid:
1- (3-Amino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid and 3-aminomethylazetidine dihydrochloride The title compound was obtained in the same manner as in Example 117 except that triethylamine was used.
Properties: Pale yellow powder melting point:> 217 ° C. (decomposition)
1 HNMR (d 6 -DMSO + d-TFA) δ;
2.89 (brs, 1H), 3.11 (brs, 2H), 4.29 (brs, 2H), 4.58 (brs, 2H), 6.90-7.05 (m, 1H), 7 .36 (t, 1H), 7.90 (d, J = 13 Hz, 1H), 8.46 (s, 1H)
〔実施例226〕
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−7−(3−ジメチルアミノアゼチジン−1−イル)−6−フルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6.7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸と3−ジメチルアミノアゼチジン二塩酸塩とトリエチルアミンを用いたほかは、実施例117と同様にして標記化合物を得た。
性状;黄色粉末
融点:>256℃(分解)
1HNMR(d6−DMSO)δ;
2.07(s,6H),3.03(brs,1H),4.23(brs,2H),4.54(brs,2H),5.41(brs,2H),6.98(t,J=8Hz,1H),7.37(t,J=11Hz,1H),7.87(d,J=13Hz,1H),8.45(s,1H)
[Example 226]
1- (3-Amino-4,6-difluorophenyl) -8-chloro-7- (3-dimethylaminoazetidin-1-yl) -6-fluoro-1,4-dihydro-4-oxoquinoline-3 -Carboxylic acid:
1- (3-Amino-4,6-difluorophenyl) -8-chloro-6.7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid and 3-dimethylaminoazetidine dihydrochloride The title compound was obtained in the same manner as in Example 117 except that triethylamine was used.
Properties; Yellow powder melting point:> 256 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
2.07 (s, 6H), 3.03 (brs, 1H), 4.23 (brs, 2H), 4.54 (brs, 2H), 5.41 (brs, 2H), 6.98 (t , J = 8 Hz, 1H), 7.37 (t, J = 11 Hz, 1H), 7.87 (d, J = 13 Hz, 1H), 8.45 (s, 1H)
〔実施例227〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3−アミノメチルピロリジン−1−イル)−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸と3−アミノメチルピロリジン二塩酸塩とトリエチルアミンを用いた他は、実施例117と同様にして標記化合物を得た。
性状;黄色粉末
融点:183.0−185.5℃
1HNMR(d6−DMSO)δ;
1.50−1.80(br,1H),1.85−2.10(br,1H),2.35−2.60(m,1H),2.80(brs,2H),3.00−3.65(m,4H),5.45(brs,2H),6.90−7.05(m,1H),7.35(t,1H),7.96(d,J=12Hz,1H),8.55(s,1H)
[Example 227]
1- (3-Amino-4,6-difluorophenyl) -7- (3-aminomethylpyrrolidin-1-yl) -8-chloro-6-fluoro-1,4-dihydro-4-oxoquinoline-3- carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid and 3-aminomethylpyrrolidine dihydrochloride The title compound was obtained in the same manner as in Example 117 except that triethylamine was used.
Properties; Yellow powder melting point: 183.0-185.5 ° C
1 H NMR (d 6 -DMSO) δ;
1.50-1.80 (br, 1H), 1.85-2.10 (br, 1H), 2.35-2.60 (m, 1H), 2.80 (brs, 2H), 3. 00-3.65 (m, 4H), 5.45 (brs, 2H), 6.90-7.05 (m, 1H), 7.35 (t, 1H), 7.96 (d, J = 12Hz, 1H), 8.55 (s, 1H)
〔実施例228〕
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−7−(3−ヒドロキシカルボニルアゼチジン−1−イル)−6−フルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸とアゼチジン−3−カルボン酸塩酸塩とトリエチルアミンを用いた他は、実施例117と同様にして標記化合物を得た。
性状;淡黄色粉末
融点:227.0−231.0℃
1HNMR(d6−DMSO)δ;
3.25−3.60(m,1H),4.50(brs,2H),4.66(brs,2H),5.42(brs,2H),6.96(t,J=8Hz,1H),7.37(t,J=10Hz,1H),7.89(d,J=13.7Hz,1H),8.46(s,1H)
Example 228
1- (3-Amino-4,6-difluorophenyl) -8-chloro-7- (3-hydroxycarbonylazetidin-1-yl) -6-fluoro-1,4-dihydro-4-oxoquinoline-3 -Carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid and azetidine-3-carboxylic acid hydrochloride The title compound was obtained in the same manner as in Example 117 except that triethylamine was used.
Properties: Light yellow powder Melting point: 227.0-231.0 ° C
1 H NMR (d 6 -DMSO) δ;
3.25-3.60 (m, 1H), 4.50 (brs, 2H), 4.66 (brs, 2H), 5.42 (brs, 2H), 6.96 (t, J = 8 Hz, 1H), 7.37 (t, J = 10 Hz, 1H), 7.89 (d, J = 13.7 Hz, 1H), 8.46 (s, 1H)
〔実施例229〕
7−(3−アセチルアミノアゼチジン−1−イル)−1−(3−アミノ−4,6−ジフルオロフェニル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸と3−アセチルアミノアゼチジン塩酸塩とトリエチルアミンを用いたほかは、実施例117と同様にして標記化合物を得た。
性状;淡褐色粉末
融点:289.0−295.0℃
1HNMR(d6−DMSO)δ;
1.81(s,3H),3.60−4.90(m,5H),5.35(brs,2H),6.94(t,1H),7.35(t,J=10Hz,1H),8.06(d,J=10Hz,1H),8.54(brs,1H),8.69(s,1H)
Example 229
7- (3-acetylaminoazetidin-1-yl) -1- (3-amino-4,6-difluorophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine 3-carboxylic acid:
1- (3-Amino-4,6-difluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid and 3-acetylaminoazetidine The title compound was obtained in the same manner as in Example 117 except that hydrochloride and triethylamine were used.
Properties: Light brown powder Melting point: 289.0-295.0 ° C
1 H NMR (d 6 -DMSO) δ;
1.81 (s, 3H), 3.60-4.90 (m, 5H), 5.35 (brs, 2H), 6.94 (t, 1H), 7.35 (t, J = 10 Hz, 1H), 8.06 (d, J = 10 Hz, 1H), 8.54 (brs, 1H), 8.69 (s, 1H)
〔実施例230〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−((1R,4R)−2,5−ジアザビシクロ[2.2.1]ヘプタン−2−イル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸と(1R,4R)−2,5−ジアザビシクロ[2.2.1]ヘプタン二塩酸塩とトリエチルアミンを用いたほかは、実施例117と同様にして標記化合物を得た。
性状;淡黄色粉末
融点:>284℃(分解)
1HNMR(d6−DMSO+d−TFA)δ;
1.90(d,J=11Hz,1H),2.11(d,J=11Hz,1H),3.15−3.90(m,5H),4.45(s,1H),5.20−6.10(br,2H),6.98(t,1H),7.36(t,J=10Hz,1H),8.18(d,J=12Hz,1H),8.76(s,1H),9.15−9.30(br,2H)
Example 230
1- (3-Amino-4,6-difluorophenyl) -7-((1R, 4R) -2,5-diazabicyclo [2.2.1] heptan-2-yl) -6-fluoro-1,4 -Dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid:
1- (3-amino-4,6-difluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid and (1R, 4R)- The title compound was obtained in the same manner as in Example 117 except that 2,5-diazabicyclo [2.2.1] heptane dihydrochloride and triethylamine were used.
Properties: Pale yellow powder melting point:> 284 ° C. (decomposition)
1 HNMR (d 6 -DMSO + d-TFA) δ;
1.90 (d, J = 11 Hz, 1H), 2.11 (d, J = 11 Hz, 1H), 3.15-3.90 (m, 5H), 4.45 (s, 1H), 5. 20-6.10 (br, 2H), 6.98 (t, 1H), 7.36 (t, J = 10 Hz, 1H), 8.18 (d, J = 12 Hz, 1H), 8.76 ( s, 1H), 9.15-9.30 (br, 2H)
〔実施例231〕
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−7−(3,7−ジアザビシクロ[3.3.0]オクタン−3−イル)−6−フルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸 塩酸塩:
1−(4−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸100mgと3−t−ブトキシカルボニル−3,7−ジアザビシクロ[3.3.0]オクタン104mg、トリエチルアミン150mgをアセトニトリル3mlに溶解し、80℃で3時間撹拌した。溶媒を減圧下に留去した。クロロホルム30mlで抽出した。有機層を3%クエン酸水溶液20mlで洗浄した。乾燥後に留去した。これをジクロロメタン20mlに溶解した。4N塩酸/ジオキサン5mlを加えて室温で2時間撹拌した。溶媒を減圧下に留去した。残渣をイソプロピルエーテルで固化させてろ取した。淡黄色粉末の標記化合物を120mg得た。
性状;淡黄色粉末
融点:199.5−204.0℃
1HNMR(d6−DMSO)δ;
2.85−3.10(m,4H),3.30−3.70(m,6H),7.02(t,J=8Hz,1H),7.41(t,J=10Hz,1H),8.08(d,J=12.5Hz,1H),8.59(s,1H),9.13(brs,1H),9.26(brs,1H)
[Example 231]
1- (3-Amino-4,6-difluorophenyl) -8-chloro-7- (3,7-diazabicyclo [3.3.0] octane-3-yl) -6-fluoro-1,4-dihydro -4-oxoquinoline-3-carboxylic acid hydrochloride:
1- (4-amino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid 100 mg and 3-t-butoxycarbonyl-3 , 7-diazabicyclo [3.3.0] octane 104 mg and triethylamine 150 mg were dissolved in 3 ml of acetonitrile and stirred at 80 ° C. for 3 hours. The solvent was distilled off under reduced pressure. Extracted with 30 ml of chloroform. The organic layer was washed with 20 ml of 3% aqueous citric acid solution. Distilled off after drying. This was dissolved in 20 ml of dichloromethane. 4N hydrochloric acid / dioxane (5 ml) was added, and the mixture was stirred at room temperature for 2 hours. The solvent was distilled off under reduced pressure. The residue was solidified with isopropyl ether and collected by filtration. 120 mg of the title compound was obtained as a pale yellow powder.
Properties: Pale yellow powder melting point: 199.5-204.0 ° C
1 H NMR (d 6 -DMSO) δ;
2.85-3.10 (m, 4H), 3.30-3.70 (m, 6H), 7.02 (t, J = 8 Hz, 1H), 7.41 (t, J = 10 Hz, 1H) ), 8.08 (d, J = 12.5 Hz, 1H), 8.59 (s, 1H), 9.13 (brs, 1H), 9.26 (brs, 1H)
〔実施例232〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3,7−ジアザビシクロ[3.3.0]オクタン−3−イル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸 塩酸塩:
1−(3−アミノ−4,6−ジフルオロフェニル)−7−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボン酸と3−t−ブトキシカルボニル−3,7−ジアザビシクロ[3.3.0]オクタンを用いる他は、実施例231と同様にして標記化合物を得た。
性状;淡黄色粉末
融点:203.0−208.0℃
1HNMR(d6−DMSO)δ;
3.06(brs,4H),3.36(brs,2H),3.40−3.90(m,4H),7.12(t,1H),7.42(t,J=11Hz,1H),8.09(d,J=13Hz,1H),8.72(s,1H),9.46(brs,2H)
[Example 232]
1- (3-Amino-4,6-difluorophenyl) -7- (3,7-diazabicyclo [3.3.0] octane-3-yl) -6-fluoro-1,4-dihydro-4-oxo -1,8-naphthyridine-3-carboxylic acid hydrochloride:
1- (3-Amino-4,6-difluorophenyl) -7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid and 3-t-butoxycarbonyl The title compound was obtained in the same manner as in Example 231 except that -3,7-diazabicyclo [3.3.0] octane was used.
Properties: Pale yellow powder melting point: 203.0-208.0 ° C
1 H NMR (d 6 -DMSO) δ;
3.06 (brs, 4H), 3.36 (brs, 2H), 3.40-3.90 (m, 4H), 7.12 (t, 1H), 7.42 (t, J = 11 Hz, 1H), 8.09 (d, J = 13 Hz, 1H), 8.72 (s, 1H), 9.46 (brs, 2H)
〔実施例233〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3,7−ジアザビシクロ[3.3.0]オクタン−3−イル)−6−フルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸 塩酸塩:
1−(3−アミノ−4,6−ジフルオロフェニル)−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸と3−t−ブトキシカルボニル−3,7−ジアザビシクロ[3.3.0]オクタンを用いるほかは、実施例231と同様にして標記化合物を得た。
性状;黄色粉末
融点:221−224.5℃
1HNMR(d6−DMSO)δ;
2.95−3.20(m,4H),3.25−3.65(m,6H),6.06(d,1H),7.12(t,1H),7.53(t,1H),7.91(d,J=14Hz,1H),8.67(s,1H),9.30−9.70(br,2H)
[Example 233]
1- (3-Amino-4,6-difluorophenyl) -7- (3,7-diazabicyclo [3.3.0] octane-3-yl) -6-fluoro-1,4-dihydro-4-oxo Quinoline-3-carboxylic acid hydrochloride:
1- (3-amino-4,6-difluorophenyl) -6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid and 3-t-butoxycarbonyl-3,7-diazabicyclo [ 3.3.0] The title compound was obtained in the same manner as in Example 231 except that octane was used.
Properties; Yellow powder melting point: 221-224.5 ° C
1 H NMR (d 6 -DMSO) δ;
2.95-3.20 (m, 4H), 3.25-3.65 (m, 6H), 6.06 (d, 1H), 7.12 (t, 1H), 7.53 (t, 1H), 7.91 (d, J = 14 Hz, 1H), 8.67 (s, 1H), 9.30-9.70 (br, 2H)
〔実施例234〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3−アミノエチルアゼチジン−1−イル)−8−クロロ−6−フルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸 トリフルオロ酢酸塩:
1−(3−アミノ−4,6−ジフルオロフェニル)−8−クロロ−6,7−ジフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸と3−t−ブトキシカルボニルアミノエチルアゼチジンとトリエチルアミンを用いた他は、実施例231と同様に反応させた。脱保護は4N塩酸/ジオキサンではなくトリフルオロ酢酸を使用して標記化合物を得た。
性状;黄色粉末
融点:140.0−141.5℃
1HNMR(d6−DMSO)δ;
1.80−1.95(m,2H),2.60−2.85(m,3H),4.14(brs,2H),4.57(brs,2H),6.95(dd,J=7Hz,J=9Hz,1H),7.36(t,J=11Hz,1H),7.70(brs,3H),7.87(d,J=13.5Hz,1H),8.45(s,1H)
[Example 234]
1- (3-Amino-4,6-difluorophenyl) -7- (3-aminoethylazetidin-1-yl) -8-chloro-6-fluoro-1,4-dihydro-4-oxoquinoline-3 -Carboxylic acid trifluoroacetate:
1- (3-amino-4,6-difluorophenyl) -8-chloro-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid and 3-t-butoxycarbonylaminoethylazeti The reaction was conducted in the same manner as in Example 231 except that gin and triethylamine were used. Deprotection gave the title compound using trifluoroacetic acid instead of 4N hydrochloric acid / dioxane.
Properties; Yellow powder melting point: 140.0-141.5 ° C
1 H NMR (d 6 -DMSO) δ;
1.80-1.95 (m, 2H), 2.60-2.85 (m, 3H), 4.14 (brs, 2H), 4.57 (brs, 2H), 6.95 (dd, J = 7 Hz, J = 9 Hz, 1H), 7.36 (t, J = 11 Hz, 1H), 7.70 (brs, 3H), 7.87 (d, J = 13.5 Hz, 1H), 8. 45 (s, 1H)
〔実施例235〕
5−ベンジルオキシ−1−(3−ベンジルオキシカルボニルアミノ−4,6−ジフルオロフェニル)−6,7,8−トリフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸エチルエステル:
エチル 6−ベンジルオキシ−2,3,4,5−テトラフルオロベンゾイルアセテート1.11g,オルトギ酸エチル0.75ml,無水酢酸0.85mlを130℃で1時間撹拌した。減圧下に留去した。残渣にジクロロメタン10mlを加えた。ここにN−ベンジルオキシカルボニル−2,4−ジフルオロ−m−フェニレンジアミン0.8gを加えて、室温で2時間撹拌した。溶媒を減圧下に留去した。これをN、N−ジメチルホルムアミド3mlに溶解した。炭酸カリウム0.41gを加えて100℃で10分撹拌した。反応液に5%クエン酸50mlを加えた。クロロホルム50mlで抽出した。有機層を飽和食塩水で洗浄し、硫酸マグネシウムで乾燥した。減圧下に留去した。残渣をカラムクロマト(シリカゲル,クロロホルム/酢酸エチル=20/1)に付した。赤色油状物の上記化合物を1.4g得た。
性状;赤色油状物
1HNMR(CDCl3)δ;
1.37(t,J=7Hz,3H),4.38(t,J=7Hz,2H),5.21(s,1H),5.26(s,1H),7.01(s,1H),7.08(t,J=10Hz,1H),7.25−7.55(brs,8H),7.55−7.65(m,2H),8.14(s,1H),8.40(brs,1H)
Example 235
5-Benzyloxy-1- (3-benzyloxycarbonylamino-4,6-difluorophenyl) -6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid ethyl ester:
Ethyl 6-benzyloxy-2,3,4,5-tetrafluorobenzoyl acetate (1.11 g), ethyl orthoformate (0.75 ml) and acetic anhydride (0.85 ml) were stirred at 130 ° C. for 1 hour. Distilled off under reduced pressure. To the residue was added 10 ml of dichloromethane. N-benzyloxycarbonyl-2,4-difluoro-m-phenylenediamine 0.8g was added here, and it stirred at room temperature for 2 hours. The solvent was distilled off under reduced pressure. This was dissolved in 3 ml of N, N-dimethylformamide. 0.41 g of potassium carbonate was added and stirred at 100 ° C. for 10 minutes. 50 ml of 5% citric acid was added to the reaction solution. Extracted with 50 ml of chloroform. The organic layer was washed with saturated brine and dried over magnesium sulfate. Distilled off under reduced pressure. The residue was subjected to column chromatography (silica gel, chloroform / ethyl acetate = 20/1). 1.4 g of the above compound as a red oil was obtained.
Properties: Red oil
1 H NMR (CDCl 3 ) δ;
1.37 (t, J = 7 Hz, 3H), 4.38 (t, J = 7 Hz, 2H), 5.21 (s, 1H), 5.26 (s, 1H), 7.01 (s, 1H), 7.08 (t, J = 10 Hz, 1H), 7.25-7.55 (brs, 8H), 7.55-7.65 (m, 2H), 8.14 (s, 1H) , 8.40 (brs, 1H)
〔実施例236〕
1−(3−アミノ−4,6−ジフルオロフェニル)−5−ヒドロキシ−6,7,8−トリフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
実施例235で合成した化合物1.3gを酢酸8ml,6N−塩酸10mlに加えて、100℃で4時間撹拌した。溶媒を減圧下に留去した。残渣に水を加えた。固体をろ取した。水、エタノール、イソプロピルエーテルで洗浄した。黄色固体の上記化合物を0.55g得た。
性状;黄色粉末
融点:>278.0℃(分解)
1HNMR(d6−DMSO)δ;
5.47(brs,2H),7.08(dd,J=8Hz,J=9Hz,1H),7.41(dd,J=10Hz,J=11Hz,1H),8.59(s,1H)
[Example 236]
1- (3-Amino-4,6-difluorophenyl) -5-hydroxy-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid:
1.3 g of the compound synthesized in Example 235 was added to 8 ml of acetic acid and 10 ml of 6N-hydrochloric acid, and stirred at 100 ° C. for 4 hours. The solvent was distilled off under reduced pressure. Water was added to the residue. The solid was collected by filtration. Washed with water, ethanol, isopropyl ether. 0.55 g of the above compound as a yellow solid was obtained.
Properties; Melting point of yellow powder:> 278.0 ° C. (decomposition)
1 H NMR (d 6 -DMSO) δ;
5.47 (brs, 2H), 7.08 (dd, J = 8 Hz, J = 9 Hz, 1H), 7.41 (dd, J = 10 Hz, J = 11 Hz, 1H), 8.59 (s, 1H) )
〔実施例237〕
1−(3−アミノ−4,6−ジフルオロフェニル)−7−(3−アミノアゼチジン−1−イル)−6,8−ジフルオロ−5−ヒドロキシ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸:
1−(3−アミノ−4,6−ジフルオロフェニル)−5−ヒドロキシ−6,7,8−トリフルオロ−1,4−ジヒドロ−4−オキソキノリン−3−カルボン酸と3−アミノアゼチジン二塩酸塩とトリエチルアミンを用いた他は、実施例117と同様にして標記化合物を得た。
性状;黄色粉末
融点:>261℃(分解)
1HNMR(d6−DMSO+d−TFA)δ;
3.93(brs,1H),4.14(brs,2H),4.48(brs,2H),5.43(brs,2H),7.04(t,1H),7.36(t,J=10Hz,1H),8.36(s,1H)
[Example 237]
1- (3-amino-4,6-difluorophenyl) -7- (3-aminoazetidin-1-yl) -6,8-difluoro-5-hydroxy-1,4-dihydro-4-oxoquinoline- 3-carboxylic acid:
1- (3-Amino-4,6-difluorophenyl) -5-hydroxy-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid and 3-aminoazetidine The title compound was obtained in the same manner as in Example 117 except that hydrochloride and triethylamine were used.
Properties; Yellow powder melting point:> 261 ° C. (decomposition)
1 HNMR (d 6 -DMSO + d-TFA) δ;
3.93 (brs, 1H), 4.14 (brs, 2H), 4.48 (brs, 2H), 5.43 (brs, 2H), 7.04 (t, 1H), 7.36 (t , J = 10 Hz, 1H), 8.36 (s, 1H)
〔試験例1〕
抗菌作用:
日本化学療法学会標準法(CHEMOTHERAPY,29(1),76.1981)に準じ、最小発育阻止濃度(MIC:μg/ml)を測定した。結果を表1に示す。
Antibacterial action:
The minimum inhibitory concentration (MIC: μg / ml) was measured according to the standard method of the Japanese Society of Chemotherapy (CHEMOTHERAPY, 29 (1), 76.1981). The results are shown in Table 1.
〔試験例2〕
細胞毒性試験:
96ウェル組織培養プレートの各ウェルに10%牛胎児血清、0.1mM非必須アミノ酸加イーグルMEM培地に懸濁したHelaS3細胞およびIMR32細胞(各々5×103個/ウェル、4×104個/ウェル)を接種した。種々の濃度の薬剤を加え、5%CO2存在下で37℃6時間培養し、培養終了後5%グルタルアルデヒドで固定、0.05%メチレンブルーで染色した。さらに0.3N HClで染色色素を抽出、650nmの波長で吸光度を測定し、IC50値を算出した。結果を表2に示す。
Cytotoxicity test:
HelaS3 cells and IMR32 cells (5 × 10 3 cells / well, 4 × 10 4 cells / well each) suspended in Eagle's MEM medium supplemented with 10% fetal bovine serum and 0.1 mM non-essential amino acids in each well of a 96-well tissue culture plate Was inoculated. Various concentrations of drugs were added, and the cells were cultured at 37 ° C. for 6 hours in the presence of 5% CO 2. After the cultivation, the cells were fixed with 5% glutaraldehyde and stained with 0.05% methylene blue. Further, the dye was extracted with 0.3N HCl, the absorbance was measured at a wavelength of 650 nm, and the IC50 value was calculated. The results are shown in Table 2.
〔試験例3〕
光毒性試験:
雌ICRマウス(5〜6週齢)に被験化合物を静脈内投与(40mg/kg/10ml)した後、紫外線(320〜400nm,1.8mW/cm2/sec)を4時間照射した。照射直後を0時間とし、24,48時間後の耳の異常を観察した。耳の異常については、異常なし(0点)、軽度の紅斑(1点)、中等度の紅斑(2点)、重度の紅斑または浮腫(3点)として評価した。結果を表3に示す。
Phototoxicity test:
Female ICR mice (5-6 weeks old) were intravenously administered (40 mg / kg / 10 ml) with the test compound, and then irradiated with ultraviolet rays (320-400 nm, 1.8 mW / cm 2 / sec) for 4 hours. Immediately after irradiation, 0 hour was set, and ear abnormalities were observed after 24 and 48 hours. Ear abnormalities were evaluated as no abnormalities (0 points), mild erythema (1 point), moderate erythema (2 points), severe erythema or edema (3 points). The results are shown in Table 3.
〔試験例4〕
染色体異常試験:
60mmシャーレに10%牛胎児血清加イーグルMEM培地に懸濁したCHL細胞(0.2〜2×105個/ウェル)を接種した。5%CO2存在下で37℃4〜72時間前培養し、種々の濃度の薬剤を含んだ培地に交換、引き続き同一条件下で培養を行った。代謝活性化法(S9添加培地)の場合は、6時間培養後、薬剤、S9無添加培地に交換してさらに18時間培養を行った。直接法の場合は、24時間および48時間の2通りの培養を行った。培養後、日本環境変異原学会の定法に基づき染色体標本を作成し、検鏡により100個の分裂中期像を観察後、構造異常の割合を算出した。
その結果、実施例48及び実施例117の化合物は、0から200μg/mlまで陰性であった。
[Test Example 4]
Chromosome abnormality test:
A 60 mm dish was inoculated with CHL cells (0.2-2 × 10 5 cells / well) suspended in Eagle's MEM medium supplemented with 10% fetal bovine serum. The cells were pre-cultured at 37 ° C. for 4 to 72 hours in the presence of 5% CO 2, exchanged with media containing various concentrations of drugs, and then cultured under the same conditions. In the case of the metabolic activation method (S9-added medium), after culturing for 6 hours, the medium was replaced with a drug and S9-free medium and further cultured for 18 hours. In the case of the direct method, two types of culture were performed for 24 hours and 48 hours. After culturing, a chromosome sample was prepared based on a standard method of the Japanese Society for Environmental Mutagenology, and after observation of 100 metaphase images with a microscope, the proportion of structural abnormalities was calculated.
As a result, the compounds of Example 48 and Example 117 were negative from 0 to 200 μg / ml.
Claims (2)
〔式中、R1は水素原子又はカルボキシ保護基を示し、R2はニトロ基、アミノ基若しくは、低級アルキル基,低級アルケニル基,炭素数7〜11のアラルキル基,炭素数6〜14のアリール基,ホルミル基,低級アルカノイル基,低級アルコキシカルボニル基,炭素数7〜15のアロイル基,アミノ酸残基あるいはオリゴペプチド残基及びこれらの官能基がアシル基や低級アラルキル等のペプチド化学で慣用の保護基で保護されたアミノ酸残基あるいはオリゴペプチド残基、又は環状アミノ基で置換された置換アミノ基を示し、R3はハロゲン原子を示し、R4及びR5は同一又は異なっていてもよい水素原子、ハロゲン原子、低級アルキル基又は低級アルコキシ基を示し、R6は水素原子、ハロゲン原子、ヒドロキシ基、低級アルキル基又はアミノ基を示し、R7は水素原子又はハロゲン原子を示し、Aは窒素原子又は−CX=(ここで、Xは水素原子、ハロゲン原子、低級アルキル基又は低級アルコキシ基を示す)を示し、Zは次式(a)
(ここで、eは3又は4の数を示し、J1,J2及びJ3は同一又は異なっていてもよく、水素原子、ヒドロキシル基、低級アルキル基、アミノ低級アルキル基、アミノ基、低級アルキルアミノ基、低級アルコキシ基、ハロゲン原子を示す)で示される飽和環状アミノ基を示す。〕
で表されるピリドンカルボン酸誘導体又はその塩。 The following general formula (1)
[Wherein, R 1 represents a hydrogen atom or a carboxy protecting group, and R 2 represents a nitro group, an amino group, a lower alkyl group, a lower alkenyl group, an aralkyl group having 7 to 11 carbon atoms, or an aryl having 6 to 14 carbon atoms. Group, formyl group, lower alkanoyl group, lower alkoxycarbonyl group, aroyl group having 7 to 15 carbon atoms, amino acid residue or oligopeptide residue, and these functional groups are commonly used in peptide chemistry such as acyl group and lower aralkyl. An amino acid residue or oligopeptide residue protected with a group, or a substituted amino group substituted with a cyclic amino group, R 3 represents a halogen atom, and R 4 and R 5 may be the same or different hydrogen atom, a halogen atom, a lower alkyl group or a lower alkoxy group, R 6 is a hydrogen atom, a halogen atom, hydroxy group, lower alkyl group or Shows the amino group, R 7 represents a hydrogen atom or a halogen atom, A is a nitrogen atom or -CX = (wherein, X represents a hydrogen atom, a halogen atom, a lower alkyl group or a lower alkoxy group) a, Z Is the following formula (a)
(Wherein e represents a number of 3 or 4, J 1 , J 2 and J 3 may be the same or different, and are a hydrogen atom, a hydroxyl group, a lower alkyl group, an amino lower alkyl group, an amino group, a lower group, An alkylamino group, a lower alkoxy group and a halogen atom). ]
Or a salt thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003379669A JP3951136B2 (en) | 1994-10-20 | 2003-11-10 | Novel pyridonecarboxylic acid derivative or salt thereof and antibacterial agent comprising the substance as an active ingredient |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25504694 | 1994-10-20 | ||
JP1267395 | 1995-01-30 | ||
JP2003379669A JP3951136B2 (en) | 1994-10-20 | 2003-11-10 | Novel pyridonecarboxylic acid derivative or salt thereof and antibacterial agent comprising the substance as an active ingredient |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1996513774 Division | 1995-10-20 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006295115A Division JP4009874B2 (en) | 1994-10-20 | 2006-10-31 | Novel pyridonecarboxylic acid derivative or salt thereof and antibacterial agent comprising the substance as an active ingredient |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2004115530A JP2004115530A (en) | 2004-04-15 |
JP3951136B2 true JP3951136B2 (en) | 2007-08-01 |
Family
ID=32303039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003379669A Expired - Fee Related JP3951136B2 (en) | 1994-10-20 | 2003-11-10 | Novel pyridonecarboxylic acid derivative or salt thereof and antibacterial agent comprising the substance as an active ingredient |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3951136B2 (en) |
-
2003
- 2003-11-10 JP JP2003379669A patent/JP3951136B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2004115530A (en) | 2004-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR900004995B1 (en) | Antibacterial carboxylic acids | |
JP3001848B2 (en) | Substituted monocyclic or bicyclic pyrrolidine derivatives | |
HU196986B (en) | Process for producing new naphtiridine- and quinoline-carboxylic acids of antibacterial activity and pharmaceutical compositions containing them | |
EP0787720B1 (en) | Pyridonecarboxylate derivative or salt thereof and antibacterial containing the same as active ingredient | |
JPH05213947A (en) | 7-azaisoindolinyl-quinolone-and naphthilidone- carboxylic acid derivative | |
US5153203A (en) | Quinolone derivatives and salts thereof, preparation processes thereof, and antibacterial agents containing the same | |
JPH05271229A (en) | Quinolone-and naphthyridone-carboxylic acid derivatives | |
EP0945435B1 (en) | Novel pyridonecarboxylic acid derivatives or salts thereof and drugs containing the same as the active ingredient | |
CZ190393A3 (en) | Derivatives of 7-isoindolinylquinoline and 7-isoindolinylnaphthhydridone | |
JP2948660B2 (en) | New pyridonecarboxylic acid derivatives | |
JP2817907B2 (en) | Intermediate for antibacterial agent production | |
KR100499366B1 (en) | Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents comprising the same as active ingredient | |
JPH02279683A (en) | Substituted azetidinylpyridonecarboxilic acid derivative, its production and pharmaceutical usage | |
IE62205B1 (en) | Individual stereoisomers of 7-(3-(1-aminoalkyl)-1-pyrrolidinyl)-quinolones and naphthyridones as antibacterial agents | |
JP3951136B2 (en) | Novel pyridonecarboxylic acid derivative or salt thereof and antibacterial agent comprising the substance as an active ingredient | |
JP4009874B2 (en) | Novel pyridonecarboxylic acid derivative or salt thereof and antibacterial agent comprising the substance as an active ingredient | |
BG62965B1 (en) | Derivatives of quinolon- and naphthyridon-carbonic acids | |
US5605910A (en) | Quinolone-and naphthyridonecarboxylic acid derivatives | |
JPH06192262A (en) | 7-(aminomethyloxa-7-azabicyclo(3.3.0)oct-7-yl)- quinolonecarboxylic acid and 7-(aminomethyloxa-7-aza- bicyclo(3.3.0)oct-7-yl)naphthylidonecarboxylic acid derivative | |
JPH07300472A (en) | New quinolone carboxylic acid derivative and its preparation | |
JPH0348682A (en) | Pyridonecarboxylic acid compound | |
JPH037260A (en) | Novel quinoline derivative or salt thereof and antimicrobial agent containing the same derivative | |
IE19970856A1 (en) | 7-(1-Pyrrolidinyl)-3-quinolone and naphthyridone carboxylic acid derivatives, method for their preparation and for substituted mono- and bicyclic pyrrolidine intermediates, and their antibacterial and feed additive compositions | |
NZ250005A (en) | 4-amino-hexahydroisoindoles as process intermediates | |
PH27114A (en) | Antibacterial agents II |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060510 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060706 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060906 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061031 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070328 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070410 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100511 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110511 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110511 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110511 Year of fee payment: 4 |
|
LAPS | Cancellation because of no payment of annual fees |